data_2cnr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cnr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.577 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.577 ' H ' HG21 ' A' ' 4' ' ' THR . 17.9 tt0 -57.62 -56.02 27.27 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -168.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.21 -34.46 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.541 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.91 -53.28 49.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.324 0.583 . . . . 0.0 110.297 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.688 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.4 -34.98 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.953 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.503 HG21 HG23 ' A' ' 74' ' ' THR . 2.1 t -59.85 -41.77 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.863 -0.153 . . . . 0.0 110.932 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.14 86.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.66 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.73 -31.44 73.19 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.882 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -72.09 -50.63 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -54.24 -49.66 68.97 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.487 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -53.07 -36.27 60.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.876 HG22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -34.31 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.785 -174.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.749 HG12 HD13 ' A' ' 37' ' ' LEU . 44.6 t -69.24 -25.13 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.56 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -62.98 -21.43 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.147 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.54 -27.64 51.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.713 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.732 HD12 ' HB ' ' A' ' 47' ' ' VAL . 49.8 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.381 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.22 -87.17 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.6 53.38 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.529 -1.32 . . . . 0.0 114.128 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.729 HG13 HD11 ' A' ' 37' ' ' LEU . 19.3 mm -88.63 125.86 61.74 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.13 144.57 46.58 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.406 2.071 . . . . 0.0 111.434 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.61 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 19.4 m -54.58 -32.94 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.47 -18.08 49.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 22' ' ' ILE . 25.9 t0 -86.75 -18.31 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 13' ' ' ALA . 93.0 t -63.8 112.71 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.666 0.746 . . . . 0.0 110.325 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' O ' HG11 ' A' ' 70' ' ' VAL . 50.0 mttp -135.51 162.81 31.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.758 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.871 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 8.7 mp -76.97 -3.09 37.14 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.87 0.366 . . . . 0.0 110.499 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -8.06 22.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -101.53 140.06 36.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.873 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.6 m -85.31 133.56 34.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.072 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.587 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -59.98 -46.9 87.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.428 0.633 . . . . 0.0 110.321 178.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.9 p -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.392 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 26.4 t70 -93.88 -68.85 0.78 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.095 0.474 . . . . 0.0 112.091 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.51 -49.06 58.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.644 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.749 HD13 HG12 ' A' ' 16' ' ' VAL . 3.4 mm? -67.47 -21.01 65.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.072 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 59.0 38.24 24.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.829 0.823 . . . . 0.0 109.621 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -101.13 156.08 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.595 -174.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.689 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-20 -99.84 155.08 17.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.12 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.9 m -51.41 -45.02 62.41 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.068 0.855 . . . . 0.0 111.426 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -48.17 59.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.2 m -54.31 -51.06 65.85 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.615 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.689 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.5 ptm -60.4 -47.5 85.81 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.677 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.844 HG21 ' HB ' ' A' ' 64' ' ' VAL . 54.6 t -61.61 -27.88 42.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.288 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.96 -65.37 0.85 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.834 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.732 ' HB ' HD12 ' A' ' 19' ' ' ILE . 13.3 t -86.09 -20.82 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.865 -173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.8 t -79.92 -26.45 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.309 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.7 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -70.62 -35.73 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.384 0.611 . . . . 0.0 109.524 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.5 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 110.054 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.876 ' HB1' HG22 ' A' ' 15' ' ' ILE . . . -84.09 -33.53 24.35 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.765 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.2 pt-20 -67.97 -49.72 60.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.196 0.522 . . . . 0.0 109.815 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.596 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 21.3 mt-10 -67.38 -21.89 65.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.1 ptm180 -72.32 -19.62 61.63 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.04 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 93.2 m-85 -99.89 -4.49 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 109.874 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t0 65.23 67.92 0.51 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.666 HG11 ' O ' ' A' ' 52' ' ' GLU . 7.5 p -117.45 164.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.706 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -122.59 109.73 14.67 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 111.049 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -140.61 143.15 31.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.962 173.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -60.92 138.37 78.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.249 1.966 . . . . 0.0 111.575 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -47.52 -57.19 5.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.844 0.83 . . . . 0.0 111.162 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.576 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 12.0 t70 -64.7 -20.72 66.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.5 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.82 -22.02 66.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.24 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.844 ' HB ' HG21 ' A' ' 45' ' ' VAL . 58.6 t -64.25 -29.35 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.688 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -74.66 -14.45 60.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 110.809 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 9.7 t30 -79.63 -32.6 41.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.534 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.983 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -82.78 122.85 28.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -88.86 -11.37 44.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 31.6 p -125.55 155.99 39.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -67.08 -32.58 58.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.871 ' HA2' ' HA ' ' A' ' 29' ' ' LEU . . . -70.76 -35.08 66.36 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.909 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.64 -37.75 82.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 67' ' ' LEU . . . -63.31 -46.56 86.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.809 175.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.818 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -62.78 -49.52 74.65 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.64 -170.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.515 ' HD2' HD13 ' A' ' 78' ' ' LEU . 30.8 mmmt -62.47 -37.03 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.443 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 27.9 t80 -67.43 -40.82 85.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.02 0.438 . . . . 0.0 110.015 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.408 HG22 HG13 ' A' ' 57' ' ' VAL . 65.4 mt -62.76 -36.84 77.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.236 0.541 . . . . 0.0 110.119 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.818 ' HG ' ' O ' ' A' ' 74' ' ' THR . 90.0 mt -71.83 -26.73 62.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.24 -35.72 27.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.741 0.305 . . . . 0.0 111.044 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' O ' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -106.24 20.63 18.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.883 -173.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.0 pt20 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.209 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.625 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 120.593 0.235 . . . . 0.0 110.77 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 13.1 tt0 -68.06 -47.53 68.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -168.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.625 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.4 pm0 -61.89 -42.03 98.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.177 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 10.5 tp10 -69.24 -51.72 34.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.628 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.739 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.4 -36.26 77.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.027 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.428 ' N ' HG21 ' A' ' 8' ' ' ILE . 1.5 t -61.1 -41.85 90.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.21 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.18 97.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.438 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 15' ' ' ILE . . . -64.63 -45.52 92.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.177 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.69 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.48 -50.97 70.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -53.13 -57.59 9.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.52 -33.34 74.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.191 0.52 . . . . 0.0 110.504 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.696 HG22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.0 -34.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.961 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 12' ' ' LEU . 22.0 t -74.16 -24.98 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.822 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.2 -28.72 69.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.844 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.78 -38.42 90.92 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.477 0.656 . . . . 0.0 109.726 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.641 HD13 ' HB ' ' A' ' 47' ' ' VAL . 17.2 mt -75.53 -53.28 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.172 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.86 -86.18 0.53 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.796 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.26 61.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.06 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 37' ' ' LEU . 16.7 mm -88.37 134.2 35.0 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.26 142.16 57.37 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.263 1.975 . . . . 0.0 111.197 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 28.8 m -62.4 -30.67 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 111.505 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 2.0 pm0 -80.56 -17.04 52.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.211 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.85 -14.34 42.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 110.256 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 13' ' ' ALA . 89.0 t -71.87 115.24 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.708 0.766 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -136.17 169.42 17.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.914 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.712 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.4 mp -78.37 -2.7 39.51 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.11 0.481 . . . . 0.0 110.701 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.96 -21.82 17.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.681 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.573 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.88 144.02 25.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.389 -170.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.846 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 15.7 m -83.98 135.13 34.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.479 -172.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.595 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -62.05 -46.9 87.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.293 0.568 . . . . 0.0 110.438 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.8 p -77.64 -29.5 51.72 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.846 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 25.9 t70 -92.22 -66.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.72 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.96 -56.37 5.8 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.084 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.717 HD11 HG13 ' A' ' 22' ' ' ILE . 2.8 mm? -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.749 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.87 65.9 1.38 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.981 0.8 . . . . 0.0 110.044 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.485 ' CG1' ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -123.22 143.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.082 -172.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.688 ' O ' ' HG2' ' A' ' 44' ' ' MET . 5.3 m-20 -88.71 162.6 16.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -53.76 -49.57 67.93 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.957 0.785 . . . . 0.0 110.594 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -49.77 72.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 109.676 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.539 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -55.32 -50.28 70.01 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.046 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.688 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.0 ptm -62.43 -43.5 98.66 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.977 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.578 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 94.7 t -69.02 -25.63 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.848 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -72.8 -65.79 0.75 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.618 -0.676 . . . . 0.0 111.349 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.641 ' HB ' HD13 ' A' ' 19' ' ' ILE . 7.4 t -87.71 -22.48 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.263 -173.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.573 ' HB ' ' O ' ' A' ' 44' ' ' MET . 36.1 t -78.98 -26.43 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.803 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -69.64 -38.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.06 -25.1 63.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 110.675 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.696 ' HB1' HG22 ' A' ' 15' ' ' ILE . . . -84.71 -37.24 21.18 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.803 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 8.1 pt-20 -68.15 -48.9 64.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.568 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.9 mt-10 -64.18 -27.98 69.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.081 -174.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -76.12 -9.43 58.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 80.5 m-85 -105.93 17.96 22.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 66.62 24.16 10.17 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.595 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 77' ' ' ILE . 11.3 p -113.86 151.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 58' ' ' LYS . 2.1 tmtt? -135.78 113.77 11.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.222 170.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 64' ' ' VAL . 13.0 pt -102.98 165.61 13.33 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.697 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 50.1 Cg_exo -54.94 119.4 6.44 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.527 1.485 . . . . 0.0 111.01 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.57 -40.55 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 110.553 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.47 -23.39 67.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.408 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 20.5 t70 -78.04 -25.63 47.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.782 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.717 HG21 HD12 ' A' ' 59' ' ' ILE . 44.7 t -62.32 -32.06 53.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.596 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.97 -31.86 66.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.974 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -72.04 -39.7 68.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.743 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.993 HD12 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.24 131.69 39.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.385 0.612 . . . . 0.0 110.872 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -104.94 -1.29 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.517 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 66.0 p -126.85 147.87 50.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -66.22 -32.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 109.798 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -67.71 -43.38 84.86 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.87 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.26 -41.69 84.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 67' ' ' LEU . . . -59.5 -59.76 4.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.153 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.778 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 12.7 m -58.27 -47.11 84.64 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.02 -173.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD3' HD23 ' A' ' 29' ' ' LEU . 35.3 tptt -66.04 -33.33 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.447 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 54.1 t80 -66.92 -42.19 85.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.603 HG21 HG12 ' A' ' 57' ' ' VAL . 66.3 mt -58.12 -46.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.286 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 74' ' ' THR . 81.7 mt -66.66 -38.17 86.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.311 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -74.27 -21.04 59.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -128.48 29.11 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 3.6 pt20 . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 120.783 0.325 . . . . 0.0 111.444 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.584 ' H ' HG23 ' A' ' 4' ' ' THR . 5.9 tt0 -63.04 -56.01 20.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.968 0.168 . . . . 0.0 111.178 -171.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.1 pm0 -60.67 -36.04 77.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.69 0.281 . . . . 0.0 111.279 -173.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -69.34 -56.27 7.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.445 0.64 . . . . 0.0 110.397 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.707 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.25 -34.62 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.946 -177.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -61.43 -39.12 81.75 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.794 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.9 88.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.637 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.4 -39.08 91.54 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.658 HD21 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -66.72 -51.63 53.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.35 -48.69 76.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.734 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -51.83 -36.44 48.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.819 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.826 HG22 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.19 -40.27 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.142 -174.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.663 HG12 HD13 ' A' ' 37' ' ' LEU . 13.2 t -68.34 -24.63 29.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.347 0.594 . . . . 0.0 109.592 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.95 -27.19 65.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.57 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.89 -47.88 42.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.205 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.538 HD13 ' HB ' ' A' ' 47' ' ' VAL . 20.1 mt -59.02 -52.79 56.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.057 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.99 -84.48 0.61 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.835 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.38 59.48 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.985 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.739 HG13 HD11 ' A' ' 37' ' ' LEU . 29.0 mm -94.91 128.54 38.88 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 148.48 42.67 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.567 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.6 m -64.65 -17.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.66 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.15 -21.31 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.196 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' HB3' HG21 ' A' ' 22' ' ' ILE . 22.2 t0 -99.17 -13.51 19.73 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 111.457 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.96 121.95 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.328 0.585 . . . . 0.0 110.3 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 70' ' ' VAL . 50.4 mtpt -145.23 165.61 27.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.683 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.571 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 8.4 mp -75.64 -0.97 22.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.464 0.65 . . . . 0.0 109.863 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -97.17 -22.39 16.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.007 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.662 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.04 141.57 29.28 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.608 -172.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 13.7 t -81.21 132.97 35.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.245 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.573 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.55 -47.76 84.31 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.552 0.692 . . . . 0.0 110.074 176.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.6 p -74.58 -37.46 62.91 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.549 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 33.5 t70 -92.35 -59.7 2.02 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.16 -49.43 23.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.739 HD11 HG13 ' A' ' 22' ' ' ILE . 3.2 mm? -72.58 -16.55 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.621 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 57.07 34.59 25.13 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.064 0.935 . . . . 0.0 109.455 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -87.79 160.47 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 -171.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.764 ' O ' ' HG2' ' A' ' 44' ' ' MET . 1.2 t70 -112.93 155.46 24.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.976 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 34.9 t -41.74 -59.47 1.65 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.362 1.039 . . . . 0.0 112.17 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.77 62.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.512 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 24.5 m -53.46 -51.2 63.47 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.802 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.764 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.1 ptm -62.98 -47.49 82.95 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.668 HG21 ' HB ' ' A' ' 64' ' ' VAL . 97.1 t -66.2 -22.6 30.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.881 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -75.39 -66.94 0.71 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.609 -0.682 . . . . 0.0 111.752 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 15' ' ' ILE . 4.9 t -84.17 -22.85 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.799 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.0 t -79.9 -22.6 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.214 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.1 t -68.44 -37.32 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 166.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.33 -25.01 68.1 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.378 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.826 ' HB2' HG22 ' A' ' 15' ' ' ILE . . . -82.54 -37.4 25.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.351 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.729 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 3.5 pt-20 -67.17 -48.66 67.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.473 0.654 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.604 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 85.1 mt-10 -70.44 -23.61 62.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.949 -172.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.3 ptm180 -73.36 -10.81 60.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.891 0.377 . . . . 0.0 110.367 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 55.1 m-85 -109.41 19.49 19.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.426 175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 66.95 26.8 9.05 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.476 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.637 HG12 HG21 ' A' ' 77' ' ' ILE . 10.2 p -118.02 155.63 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' A' ' 58' ' ' LYS . 35.7 tptt -134.83 114.71 12.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.179 0.514 . . . . 0.0 110.585 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.651 HD12 HG23 ' A' ' 64' ' ' VAL . 20.5 pt -104.11 163.33 17.54 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.439 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 27.8 Cg_exo -61.16 132.36 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.963 1.775 . . . . 0.0 111.165 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.76 -51.48 49.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.0 111.002 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.24 -20.57 64.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.92 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 9.0 t70 -71.67 -34.44 69.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.816 -0.174 . . . . 0.0 110.968 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.668 ' HB ' HG21 ' A' ' 45' ' ' VAL . 41.9 t -59.91 -39.48 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 15.7 tptp -72.03 -20.17 61.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.92 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -75.13 -35.16 61.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -81.04 153.78 27.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.0 mptp? -104.99 -29.05 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.086 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.784 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.1 p -111.11 156.64 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.26 -31.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.4 -35.72 92.1 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.196 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 63.3 m-20 -56.26 -57.35 12.62 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.662 0.268 . . . . 0.0 110.431 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -55.99 -44.7 78.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.372 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.755 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 19.7 m -56.51 -53.74 53.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.752 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -66.23 -37.19 84.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 40.5 t80 -59.68 -41.71 91.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.698 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.637 HG21 HG12 ' A' ' 57' ' ' VAL . 58.6 mt -64.94 -48.44 84.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.803 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 74' ' ' THR . 85.8 mt -64.63 -44.26 91.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.444 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -5.26 59.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 76' ' ' TYR . 26.3 m-70 -126.43 15.43 7.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -49.81 -53.12 27.28 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 7' ' ' GLU . 8.3 pt-20 -55.22 -49.09 72.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 111.54 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 6' ' ' GLU . 36.5 mt-10 -66.55 -50.7 62.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.214 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.721 HG22 HD23 ' A' ' 78' ' ' LEU . 3.0 tt -67.13 -35.33 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.862 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.96 -35.9 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.379 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.22 -43.42 78.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.924 0.392 . . . . 0.0 110.665 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.3 85.51 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.801 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -43.86 97.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.12 -54.89 37.49 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.149 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -52.8 -43.39 65.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.56 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.683 HG23 ' HB3' ' A' ' 51' ' ' ALA . 7.3 mm -62.27 -53.8 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.247 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.721 HG12 HD13 ' A' ' 37' ' ' LEU . 12.1 t -70.48 -23.34 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 0.0 110.635 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -60.79 -29.23 69.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.41 -43.23 67.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 110.274 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.519 HD13 ' HB ' ' A' ' 47' ' ' VAL . 17.4 mt -65.53 -52.56 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.185 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -76.4 0.57 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.1 51.31 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.379 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.763 HG13 HD11 ' A' ' 37' ' ' LEU . 10.6 mm -80.55 124.86 81.82 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.741 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 8.1 Cg_endo -53.38 147.27 37.73 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.698 2.266 . . . . 0.0 111.525 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.669 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.1 m -61.39 -30.82 48.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -172.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.21 -17.29 52.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.856 0.36 . . . . 0.0 111.401 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.741 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 2.7 t70 -86.03 -18.97 31.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.941 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 13' ' ' ALA . 84.5 t -67.41 120.39 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.658 0.742 . . . . 0.0 110.525 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HE3' ' OD1' ' A' ' 30' ' ' ASP . 26.2 mtpp -142.36 165.23 27.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.441 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 7.6 mp -77.95 -3.27 41.05 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' OD1' ' HE3' ' A' ' 28' ' ' LYS . 12.8 p-10 -107.29 -8.31 16.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.494 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -90.71 139.81 30.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.7 m -89.1 135.59 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.376 -171.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.529 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -58.04 -47.56 82.72 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 110.193 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 p -72.12 -32.13 66.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.481 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.76 -69.84 0.73 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.272 0.558 . . . . 0.0 111.602 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.67 -48.4 26.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.941 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.763 HD11 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -66.68 -17.91 65.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.441 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.04 36.06 18.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.935 0.874 . . . . 0.0 109.679 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -98.47 150.13 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.746 -171.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.758 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.6 t70 -97.53 154.62 17.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.996 173.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 45' ' ' VAL . 30.4 m -51.99 -44.85 64.25 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.699 0.624 . . . . 0.0 111.632 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 tp -77.58 -39.34 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.954 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.48 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 51.6 m -55.34 -48.67 73.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.758 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 6.4 ptm -62.47 -45.84 91.22 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.749 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.831 HG21 ' HB ' ' A' ' 64' ' ' VAL . 85.2 t -64.36 -23.04 32.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.713 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.21 -65.73 0.81 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.936 -0.478 . . . . 0.0 111.696 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG11 HG22 ' A' ' 15' ' ' ILE . 18.9 t -89.67 -20.53 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.272 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 44' ' ' MET . 19.8 t -80.08 -17.0 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.0 t -78.57 -34.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 121.536 0.684 . . . . 0.0 109.209 165.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 47' ' ' VAL . . . -59.5 -24.18 63.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.567 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.683 ' HB3' HG23 ' A' ' 15' ' ' ILE . . . -81.76 -38.76 25.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.677 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.745 ' O ' HG11 ' A' ' 57' ' ' VAL . 5.9 pt-20 -60.4 -47.4 86.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.692 0.758 . . . . 0.0 109.46 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 22.6 mt-10 -74.75 -21.74 59.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.809 -171.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 3.7 ptp180 -74.21 -12.15 60.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.019 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.0 10.13 39.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.72 30.42 16.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.001 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.745 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -115.17 162.74 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.574 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 24.3 mmmt -128.7 116.02 18.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.252 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.472 HD13 HG21 ' A' ' 64' ' ' VAL . 44.2 pt -117.61 158.7 44.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.629 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 18.7 Cg_exo -69.43 135.44 31.25 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.548 2.165 . . . . 0.0 112.302 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.8 -58.15 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.592 0.711 . . . . 0.0 110.79 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -17.75 64.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.349 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.629 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.3 t0 -76.07 -19.56 58.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.105 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.831 ' HB ' HG21 ' A' ' 45' ' ' VAL . 24.6 t -72.73 -52.61 22.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.524 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -68.82 -7.25 32.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -76.43 -36.21 58.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.087 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.758 HD12 ' HB3' ' A' ' 73' ' ' ALA . 1.1 pp -89.24 128.17 35.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.47 0.652 . . . . 0.0 111.016 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.92 1.0 55.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.89 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 74.7 p -130.15 147.91 51.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.553 0.216 . . . . 0.0 110.543 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 31' ' ' LYS . 1.6 p -69.43 -34.42 62.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.943 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.6 -41.37 97.28 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.91 -49.75 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.758 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -52.45 -54.27 34.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.627 0.727 . . . . 0.0 111.164 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.1 m -58.08 -48.55 79.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.636 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HD2' HD13 ' A' ' 78' ' ' LEU . 12.2 tptp -69.2 -29.09 66.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.216 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.24 -46.35 80.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.802 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.51 -36.78 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.307 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 74' ' ' THR . 92.3 mt -70.6 -31.86 69.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.768 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.26 -42.2 17.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.064 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -96.08 13.24 27.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.496 179.277 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.593 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.593 ' H ' HG21 ' A' ' 4' ' ' THR . 15.2 tp60 -48.7 -53.36 19.15 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -46.85 87.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.32 -43.41 50.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.845 0.355 . . . . 0.0 111.284 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.652 HG22 HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.48 -34.1 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.59 -42.41 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.129 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.92 92.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.607 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.578 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -66.8 -39.18 93.48 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.534 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.92 -49.45 70.37 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -56.02 -50.45 70.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.68 -36.51 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -39.36 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.254 -175.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.724 HG12 HD13 ' A' ' 37' ' ' LEU . 41.7 t -70.11 -24.99 26.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.097 0.475 . . . . 0.0 110.079 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -62.29 -24.53 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -72.33 -39.46 68.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 109.795 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.708 HD13 ' HB ' ' A' ' 47' ' ' VAL . 26.9 mt -72.63 -50.64 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.226 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.83 -77.75 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.259 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.62 44.19 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.788 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.742 HG13 HD11 ' A' ' 37' ' ' LEU . 9.1 mm -75.04 134.97 74.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.61 144.14 53.9 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.469 2.113 . . . . 0.0 111.449 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.623 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 82.3 t -59.69 -38.13 74.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.364 . . . . 0.0 111.021 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -74.29 -17.95 60.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.68 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 22' ' ' ILE . 14.0 t0 -87.51 -16.84 33.55 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.214 -0.304 . . . . 0.0 111.594 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.459 HG23 ' HA ' ' A' ' 13' ' ' ALA . 89.8 t -64.97 116.96 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.566 0.698 . . . . 0.0 110.445 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -141.02 162.02 36.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.194 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HG ' ' CA ' ' A' ' 71' ' ' GLY . 9.7 mp -79.25 -4.19 49.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.35 -8.38 21.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -97.56 134.57 40.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 18.1 m -89.39 140.91 29.04 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 111.46 -170.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.639 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 1.1 m-85 -58.81 -50.92 72.15 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 110.152 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.3 p -69.53 -33.06 72.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.406 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.18 -68.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' CG ' ' HZ3' ' A' ' 31' ' ' LYS . 10.3 t0 -78.42 -51.52 9.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.4 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.742 HD11 HG13 ' A' ' 22' ' ' ILE . 3.8 mm? -64.8 -13.31 55.09 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 58.13 38.83 26.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 109.539 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.41 149.79 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.913 -172.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.76 166.29 11.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.466 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 15.4 p -54.83 -56.72 16.36 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.099 0.249 . . . . 0.0 111.634 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.34 -38.87 92.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.533 0.206 . . . . 0.0 111.263 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.497 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 25.1 m -52.66 -54.37 34.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.031 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 1.014 ' HE1' ' HA ' ' A' ' 65' ' ' LYS . 15.2 ptt? -64.26 -48.02 77.34 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.646 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.9 HG21 ' HB ' ' A' ' 64' ' ' VAL . 99.1 t -55.28 -28.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.994 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.22 -66.13 0.87 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.761 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.708 ' HB ' HD13 ' A' ' 19' ' ' ILE . 14.4 t -83.33 -22.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.134 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 44' ' ' MET . 44.9 t -79.9 -19.92 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.917 -0.489 . . . . 0.0 110.295 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.696 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -75.22 -32.88 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.249 167.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.32 66.97 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.605 169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.718 ' HB2' HG22 ' A' ' 15' ' ' ILE . . . -82.53 -32.48 28.62 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.888 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.709 ' O ' HG11 ' A' ' 57' ' ' VAL . 5.8 pt-20 -66.11 -54.08 29.99 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.638 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 16.5 mt-10 -71.61 -20.36 61.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.227 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 13.3 ptm180 -69.68 -15.24 63.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.101 0.477 . . . . 0.0 110.048 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.578 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 65.3 m-85 -107.3 15.03 25.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.014 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.33 27.37 8.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.72 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.1 p -113.67 165.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.53 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 17.1 pttm -132.26 119.1 20.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 110.427 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.04 154.65 53.36 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -63.73 128.96 23.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.899 1.732 . . . . 0.0 111.524 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.49 -40.07 58.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.479 0.657 . . . . 0.0 109.709 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.78 -35.5 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.104 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -74.42 -29.64 61.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.9 ' HB ' HG21 ' A' ' 45' ' ' VAL . 21.7 t -61.58 -40.59 87.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.376 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 1.014 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.17 -5.65 59.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 177.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -80.82 -23.64 39.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.067 0.46 . . . . 0.0 110.282 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -95.28 143.72 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.412 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 11.9 mptt -101.54 -17.66 16.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.774 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 19.1 p -118.77 156.06 30.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.586 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -65.38 -33.99 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.035 0.445 . . . . 0.0 109.944 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' CA ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.8 -35.58 86.99 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 69.5 m-20 -58.8 -58.54 8.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.516 0.186 . . . . 0.0 110.638 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -55.26 -47.65 75.15 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.736 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.0 m -57.02 -54.08 50.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.088 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -69.78 -31.43 69.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.211 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -61.08 -45.28 95.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.933 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.603 HG21 HG13 ' A' ' 57' ' ' VAL . 61.2 mt -59.49 -44.5 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 74' ' ' THR . 81.2 mt -71.96 -29.11 63.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.964 -174.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.76 -24.89 61.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.651 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -124.1 28.92 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.148 0.499 . . . . 0.0 112.089 -173.719 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.499 ' H ' HG23 ' A' ' 4' ' ' THR . 12.2 tt0 -55.35 -56.61 18.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.19 -34.41 78.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 0.0 111.491 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -70.7 -51.21 29.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.692 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.46 -32.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.77 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.2 -44.02 90.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.89 87.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 110.69 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.86 -42.86 59.92 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.983 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.612 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.56 -40.95 98.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.743 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -57.85 -51.67 68.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.103 177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -54.21 -39.59 66.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.197 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.742 HG23 ' HB3' ' A' ' 51' ' ' ALA . 6.4 mm -67.93 -52.77 35.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.218 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.76 HG12 HD13 ' A' ' 37' ' ' LEU . 5.8 t -68.03 -22.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.148 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.51 -31.61 69.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -76.66 -24.82 53.27 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 110.411 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.556 HG23 HG21 ' A' ' 39' ' ' VAL . 22.2 mt -81.92 -54.36 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.671 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.41 -78.05 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.938 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.74 57.49 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.557 -1.306 . . . . 0.0 114.696 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.732 HG13 HD11 ' A' ' 37' ' ' LEU . 20.9 mm -90.72 129.81 43.24 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 164.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.54 147.16 39.73 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.349 2.033 . . . . 0.0 111.981 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 25.3 m -61.09 -26.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.441 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.34 -17.52 48.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.64 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 22' ' ' ILE . 2.3 t70 -96.23 -15.55 21.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.743 HG22 ' HA ' ' A' ' 13' ' ' ALA . 76.9 t -68.66 126.74 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.592 0.711 . . . . 0.0 110.571 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HE2' ' HB3' ' A' ' 30' ' ' ASP . 42.5 mtpt -140.2 173.45 11.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.692 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 30.2 mt -82.07 -3.29 54.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.895 0.855 . . . . 0.0 108.695 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.554 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 6.2 t70 -95.62 -27.1 15.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.592 -170.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' O ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -91.86 144.15 25.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.991 -174.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 22.3 m -84.54 135.35 34.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.647 ' CD2' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -60.82 -48.13 83.2 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.242 0.544 . . . . 0.0 110.135 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 p -66.59 -38.07 86.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.503 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -92.75 -65.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.989 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.3 m-20 -69.42 -48.53 60.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.848 -174.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.76 HD13 HG12 ' A' ' 16' ' ' VAL . 3.6 mm? -74.87 -4.59 38.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.131 -171.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.36 58.8 5.1 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.934 0.772 . . . . 0.0 109.34 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG21 HG23 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -122.44 152.21 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.689 -170.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.529 ' H ' ' HB3' ' A' ' 43' ' ' SER . 12.4 t70 -119.46 162.31 19.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.621 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.623 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 p -39.25 -58.09 1.25 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -74.35 -44.52 51.99 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.375 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.529 ' HB3' ' H ' ' A' ' 40' ' ' ASP . 30.6 t -45.27 -58.98 2.9 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.643 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.442 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 10.4 ptm -60.78 -50.15 74.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.754 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG21 ' HB ' ' A' ' 64' ' ' VAL . 70.0 t -63.76 -21.64 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.103 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.944 -0.472 . . . . 0.0 111.372 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 15' ' ' ILE . 6.6 t -89.92 -21.67 6.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.858 -173.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 44' ' ' MET . 38.6 t -79.78 -24.01 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.172 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.711 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.4 t -70.27 -39.06 76.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 167.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.0 -21.56 61.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.579 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB3' HG23 ' A' ' 15' ' ' ILE . . . -84.59 -46.57 11.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.842 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 10.6 pt-20 -63.25 -46.53 86.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 110.159 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.78 -24.98 64.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.485 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 14.7 ptm180 -75.19 -18.65 60.12 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.215 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -97.27 9.89 41.0 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.39 0.614 . . . . 0.0 109.361 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 66.36 52.6 1.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.198 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 52' ' ' GLU . 7.3 p -137.52 152.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -134.32 112.12 10.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.679 0.276 . . . . 0.0 110.54 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.668 HD12 HG23 ' A' ' 64' ' ' VAL . 8.1 pt -110.01 165.23 13.06 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.37 134.74 43.15 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.699 1.599 . . . . 0.0 111.393 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 45' ' ' VAL . 1.6 m-20 -51.38 -43.8 61.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.742 0.782 . . . . 0.0 110.068 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.13 -31.33 65.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.861 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.47 -35.23 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.166 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.695 ' HB ' HG21 ' A' ' 45' ' ' VAL . 55.5 t -58.45 -42.63 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.623 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 16.6 tptp -74.66 -20.63 59.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.838 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -73.63 -28.24 61.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.054 0.454 . . . . 0.0 110.011 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -88.22 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 111.004 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -99.72 -14.8 18.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.354 -171.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 26.2 p -115.45 157.68 23.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.647 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.2 p -70.19 -24.27 25.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.448 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -37.14 94.02 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.815 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.678 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.2 m-20 -56.92 -58.07 9.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.41 0.148 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.621 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -55.65 -50.17 70.94 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.27 0.557 . . . . 0.0 110.747 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.754 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 37.0 m -55.25 -50.68 68.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.926 -176.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -67.74 -31.27 71.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.357 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.45 -42.96 86.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.756 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.471 HG21 HG13 ' A' ' 57' ' ' VAL . 91.0 mt -59.81 -40.31 82.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.262 174.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 74' ' ' THR . 87.8 mt -73.07 -38.86 66.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.002 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.84 -27.44 55.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.283 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -116.55 26.57 9.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 111.419 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.407 -177.835 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.457 ' H ' HG23 ' A' ' 4' ' ' THR . 12.6 tt0 -51.58 -56.11 15.39 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -169.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -64.83 -35.37 80.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.73 -48.46 31.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.851 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.735 HG22 HD23 ' A' ' 78' ' ' LEU . 1.8 tt -68.57 -33.34 59.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.06 -35.96 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.301 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.25 85.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.762 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -71.02 -38.23 63.98 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.588 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.32 -44.44 96.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -58.78 -48.75 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.16 -32.88 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.139 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.979 HG22 ' HB1' ' A' ' 51' ' ' ALA . 4.1 mm -78.08 -50.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.561 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 37' ' ' LEU . 9.3 t -67.11 -23.53 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.23 0.538 . . . . 0.0 109.982 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.44 -25.11 65.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.33 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' HG13 ' A' ' 47' ' ' VAL . 7.6 tp10 -73.65 -30.13 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.091 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.572 HD13 ' HB ' ' A' ' 47' ' ' VAL . 36.2 mt -84.53 -52.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.679 -172.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 -88.26 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.752 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.38 56.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.512 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 HD11 ' A' ' 37' ' ' LEU . 26.9 mm -98.27 122.27 54.48 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 163.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.51 145.99 44.55 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.444 2.096 . . . . 0.0 111.5 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.72 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 35.3 m -58.7 -22.02 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.176 0.512 . . . . 0.0 111.887 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.81 -17.66 46.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.797 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 22' ' ' ILE . 3.4 t70 -102.24 -9.42 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -172.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 13' ' ' ALA . 36.1 t -68.13 123.14 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.396 0.617 . . . . 0.0 110.404 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' O ' HG11 ' A' ' 70' ' ' VAL . 57.0 mttt -141.21 166.16 25.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.575 -171.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HG ' ' CA ' ' A' ' 71' ' ' GLY . 10.2 mp -78.59 -2.98 41.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.296 0.57 . . . . 0.0 109.485 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.09 -20.2 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.648 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -99.79 144.74 28.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.948 -172.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.748 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 18.5 t -87.39 134.0 33.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.086 -172.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -58.57 -42.66 88.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.0 110.253 176.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.0 p -79.02 -32.55 45.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.636 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.748 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.8 t70 -92.95 -56.59 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.052 0.453 . . . . 0.0 111.824 -175.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -88.93 -40.35 13.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.119 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.741 HD13 HG12 ' A' ' 16' ' ' VAL . 3.8 mm? -78.32 -3.85 45.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.526 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 52.7 38.84 27.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.082 0.467 . . . . 0.0 110.865 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 44' ' ' MET . 0.4 OUTLIER -108.41 141.03 24.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.46 . . . . 0.0 111.874 -170.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.748 ' O ' ' HG2' ' A' ' 44' ' ' MET . 13.8 m-20 -95.23 162.39 13.71 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.931 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -50.37 -41.7 52.18 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.942 0.776 . . . . 0.0 111.137 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.55 -53.36 16.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.564 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.516 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 18.7 m -51.41 -48.81 62.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.526 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.748 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.4 ptm -60.56 -56.76 17.51 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.768 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.787 HG21 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.37 -24.47 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.468 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.08 -65.44 0.8 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.596 -0.69 . . . . 0.0 111.287 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.65 HG11 HG21 ' A' ' 15' ' ' ILE . 11.1 t -88.01 -20.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.698 -173.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.4 t -79.83 -19.75 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.976 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -73.83 -34.56 40.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 165.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -63.02 -21.78 66.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.843 169.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.979 ' HB1' HG22 ' A' ' 15' ' ' ILE . . . -84.47 -34.39 23.41 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.706 ' O ' HG11 ' A' ' 57' ' ' VAL . 9.6 pt-20 -68.57 -49.9 55.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.564 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 37.9 mt-10 -67.56 -25.1 65.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.469 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -72.11 -16.61 62.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.054 0.454 . . . . 0.0 110.63 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.762 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 82.0 m-85 -106.53 15.77 25.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.66 33.16 18.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.861 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.706 HG11 ' O ' ' A' ' 52' ' ' GLU . 7.2 p -111.64 161.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -134.88 110.8 9.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 pt -121.27 160.81 44.07 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.1 Cg_exo -66.28 137.91 49.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.645 2.23 . . . . 0.0 111.683 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.78 -44.53 96.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.118 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.38 -18.35 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.985 0.421 . . . . 0.0 110.661 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 7.3 t70 -67.14 -41.93 85.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.787 ' HB ' HG21 ' A' ' 45' ' ' VAL . 37.7 t -59.77 -47.66 90.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.129 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.38 -1.5 30.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.396 . . . . 0.0 111.683 -176.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -92.05 -36.6 13.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.33 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -74.58 138.35 42.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.777 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -94.98 -20.63 19.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.155 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.8 p -116.48 156.39 26.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.614 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -66.53 -29.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' CA ' ' HG ' ' A' ' 29' ' ' LEU . . . -63.71 -36.23 93.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.589 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.4 m-20 -55.03 -59.27 4.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.595 0.235 . . . . 0.0 111.041 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 67' ' ' LEU . . . -55.27 -47.9 74.8 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.776 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 11.5 m -57.54 -51.64 68.65 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.83 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -65.84 -34.92 79.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.136 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.81 -45.8 90.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.241 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.59 HG22 HG13 ' A' ' 57' ' ' VAL . 81.2 mt -57.18 -45.53 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.893 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' A' ' 74' ' ' THR . 94.6 mt -65.05 -21.85 66.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.554 -171.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.71 -22.7 27.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.175 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.02 27.8 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.4 pt20 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.499 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 120.659 0.266 . . . . 0.0 110.836 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.499 ' H ' HG21 ' A' ' 4' ' ' THR . 0.4 OUTLIER -58.58 -52.95 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -176.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 3.0 pm0 -59.5 -35.15 73.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.042 0.448 . . . . 0.0 111.264 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.53 -58.4 4.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.623 0.725 . . . . 0.0 110.599 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.685 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.67 -33.51 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.326 -175.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.92 -42.14 91.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.93 -0.123 . . . . 0.0 110.78 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.92 91.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.367 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.671 ' HA2' ' CE2' ' A' ' 55' ' ' PHE . . . -69.75 -41.49 73.89 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.526 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.585 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.14 -47.49 84.3 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.666 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -50.4 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.71 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.67 -37.0 58.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.898 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.761 HG23 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.27 -34.23 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.599 -174.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.734 HG12 HD13 ' A' ' 37' ' ' LEU . 47.0 t -70.7 -24.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 O-C-N 121.645 -0.659 . . . . 0.0 109.482 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.21 -20.73 66.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.943 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -75.49 -29.47 59.55 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.207 0.527 . . . . 0.0 110.209 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.694 HD13 ' HB ' ' A' ' 47' ' ' VAL . 28.1 mt -83.74 -52.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.13 -91.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.264 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.44 54.36 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.036 -1.554 . . . . 0.0 114.789 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.712 HG13 HD11 ' A' ' 37' ' ' LEU . 22.2 mm -87.92 125.11 65.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 164.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 146.14 51.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.6 2.2 . . . . 0.0 111.169 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 33.2 m -60.68 -26.75 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.865 0.364 . . . . 0.0 111.773 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.26 -18.88 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.088 0.471 . . . . 0.0 111.355 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.475 ' HB3' HG21 ' A' ' 22' ' ' ILE . 25.2 t0 -90.28 -18.9 24.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.971 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 13' ' ' ALA . 87.7 t -66.52 117.02 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.651 0.739 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HE2' ' OD1' ' A' ' 30' ' ' ASP . 31.1 mtpt -141.82 170.76 15.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.688 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.64 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 23.4 mt -81.57 -4.18 55.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.007 0.432 . . . . 0.0 110.221 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 3.7 p-10 -111.36 13.5 21.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -173.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.537 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -114.18 143.21 45.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.539 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 35' ' ' ASP . 13.4 m -82.11 136.16 35.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.754 0.311 . . . . 0.0 110.637 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -65.15 -47.63 76.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.258 0.551 . . . . 0.0 109.931 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.3 p -67.2 -38.23 84.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.327 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.62 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.5 m-20 -91.73 -68.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.706 -173.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.86 -48.4 54.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.244 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.734 HD13 HG12 ' A' ' 16' ' ' VAL . 3.8 mm? -68.86 -10.94 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 55.73 51.7 12.02 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.81 0.814 . . . . 0.0 109.551 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -122.18 146.35 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.539 -169.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.748 ' O ' ' HG2' ' A' ' 44' ' ' MET . 20.2 m-20 -102.71 162.68 12.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.978 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.592 ' HG ' ' HB2' ' A' ' 65' ' ' LYS . 31.5 t -49.16 -51.07 34.72 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.258 0.974 . . . . 0.0 111.195 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.01 -43.4 68.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.586 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 12.0 m -55.21 -55.8 27.16 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.748 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.6 ptm -55.43 -58.4 7.9 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.474 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.629 HG21 ' HB ' ' A' ' 64' ' ' VAL . 63.7 t -58.09 -26.46 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.695 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.1 -65.65 0.78 Allowed 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.601 -0.687 . . . . 0.0 111.415 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.694 ' HB ' HD13 ' A' ' 19' ' ' ILE . 11.0 t -84.88 -23.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.808 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 44' ' ' MET . 65.6 t -74.1 -31.11 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.998 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.815 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 6.2 t -69.36 -34.72 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.376 0.608 . . . . 0.0 109.678 171.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.87 67.49 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.95 -0.469 . . . . 0.0 110.616 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 15' ' ' ILE . . . -85.01 -41.12 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.875 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.815 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -61.62 -44.29 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.181 0.515 . . . . 0.0 110.315 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.83 -31.62 71.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.347 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.2 ptm180 -74.76 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.053 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.671 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 57.3 m-85 -104.51 13.21 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.606 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 57.45 70.54 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.083 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 52' ' ' GLU . 10.0 p -129.43 165.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 171.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.51 ' N ' HG21 ' A' ' 57' ' ' VAL . 64.3 mttm -128.08 111.55 13.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 0.0 110.232 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.502 HD13 ' CD2' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -149.12 132.84 8.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.429 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 20.5 Cg_exo -64.96 140.96 68.57 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.134 1.89 . . . . 0.0 111.299 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HB2' ' CG1' ' A' ' 45' ' ' VAL . 7.8 p-10 -56.51 -32.01 64.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.74 0.781 . . . . 0.0 110.083 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 28.7 t70 -60.11 -27.03 66.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.429 -1.259 . . . . 0.0 111.53 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.04 -36.12 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.817 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 21.4 t -60.69 -44.35 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.613 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HB2' ' HG ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -79.8 -2.41 43.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 0.0 111.36 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -92.78 -19.49 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.163 0.506 . . . . 0.0 109.78 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 1.5 pp -93.97 128.3 40.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -97.14 3.55 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.545 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.594 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 81.5 p -129.03 143.99 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.56 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -64.71 -37.24 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.991 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 29' ' ' LEU . . . -63.45 -32.6 84.7 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.818 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 11.7 t70 -59.96 -51.22 70.58 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -55.51 -49.58 72.21 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.693 175.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.779 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 1.8 m -58.91 -52.53 65.35 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.642 -173.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD2' HD13 ' A' ' 78' ' ' LEU . 14.5 tptp -65.97 -34.79 78.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.071 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CD2' HD13 ' A' ' 59' ' ' ILE . 53.0 t80 -62.33 -47.28 84.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.766 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.419 ' HA ' HG23 ' A' ' 57' ' ' VAL . 54.0 mt -58.81 -46.7 90.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.594 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 74' ' ' THR . 86.7 mt -61.44 -26.4 67.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.946 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.57 -29.74 21.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 111.598 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -115.73 30.45 7.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt20 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.496 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.586 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 120.464 0.173 . . . . 0.0 110.957 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.586 ' H ' HG21 ' A' ' 4' ' ' THR . 47.2 tt0 -54.39 -56.38 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.89 -32.78 74.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 111.452 -173.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.05 -47.94 19.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.755 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.23 -34.72 67.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.97 -38.41 79.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.635 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.58 80.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.757 0.313 . . . . 0.0 110.476 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.584 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.11 -36.93 91.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.851 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -68.58 -49.34 60.13 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -57.74 -46.23 84.75 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -51.27 -36.37 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.567 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.827 HG22 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.1 -37.6 11.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.556 -175.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.699 HG12 HD13 ' A' ' 37' ' ' LEU . 21.3 t -68.82 -25.32 30.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.85 -0.532 . . . . 0.0 110.16 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.61 -24.2 67.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.924 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.09 -41.74 63.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.945 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.599 HD13 ' HB ' ' A' ' 47' ' ' VAL . 25.3 mt -68.08 -53.26 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.152 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.89 -84.93 0.61 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.763 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.78 54.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.389 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.727 HG13 HD11 ' A' ' 37' ' ' LEU . 23.7 mm -82.27 130.45 59.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 166.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.33 137.52 38.89 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.195 1.93 . . . . 0.0 111.07 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 29.0 m -56.8 -27.73 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.46 -18.29 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.518 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -90.71 -16.59 28.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.104 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.37 116.9 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.671 0.748 . . . . 0.0 110.19 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' O ' HG11 ' A' ' 70' ' ' VAL . 25.5 mtpp -134.65 167.22 21.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.93 -173.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.702 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 8.7 mp -79.45 -2.96 44.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.494 0.664 . . . . 0.0 109.754 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.16 -13.23 19.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.955 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.573 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -100.72 143.29 31.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.492 -174.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.821 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 75.4 m -84.22 134.89 34.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.373 -173.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -58.7 -42.15 87.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 110.169 176.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 p -77.67 -36.49 51.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.269 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 10.8 t70 -91.02 -57.28 2.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.573 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 1.8 m-20 -77.48 -56.8 4.23 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.727 HD11 HG13 ' A' ' 22' ' ' ILE . 2.7 mm? -68.67 -13.64 62.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.429 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 54.13 36.44 24.82 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.187 0.994 . . . . 0.0 110.292 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -97.59 148.71 5.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.223 -171.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.1 m-20 -94.83 163.43 13.35 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 44' ' ' MET . 66.9 m -56.25 -42.69 77.79 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.441 0.463 . . . . 0.0 111.534 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -72.37 -47.08 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.813 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HB2' HG21 ' A' ' 39' ' ' VAL . 14.5 m -50.82 -51.93 46.16 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.717 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 3.5 ptp -59.18 -59.41 5.51 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.751 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 81.8 t -58.59 -21.68 18.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.025 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -70.04 -65.82 0.67 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.961 -0.462 . . . . 0.0 110.835 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' A' ' 19' ' ' ILE . 11.6 t -89.51 -22.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.274 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.29 -25.19 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 122.165 -0.335 . . . . 0.0 110.481 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.6 t -74.93 -36.4 38.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.44 64.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.12 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.827 ' HB2' HG22 ' A' ' 15' ' ' ILE . . . -85.67 -33.12 21.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.705 ' O ' HG11 ' A' ' 57' ' ' VAL . 6.8 pt-20 -68.61 -49.2 61.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 109.792 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 35.1 mt-10 -66.63 -27.44 67.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.303 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.3 ptm180 -73.63 -12.88 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.084 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.584 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 67.5 m-85 -104.22 3.69 33.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.326 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 57.43 58.79 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.245 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -120.59 162.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.991 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -124.14 110.89 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.981 0.419 . . . . 0.0 110.587 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.451 HD13 ' HD2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -134.57 136.93 26.52 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.942 176.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 126.57 21.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.259 1.973 . . . . 0.0 111.47 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.62 -35.55 68.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.93 -19.52 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.96 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 23.6 t70 -82.53 -21.26 35.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.56 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.606 ' HB ' HG21 ' A' ' 45' ' ' VAL . 45.6 t -66.58 -38.88 82.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -84.16 -3.51 58.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.105 0.479 . . . . 0.0 110.611 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 30.7 t30 -82.11 -36.19 27.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.221 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.637 ' CD1' ' HB3' ' A' ' 73' ' ' ALA . 1.4 pp -84.07 126.83 33.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.522 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -2.59 55.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.996 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.821 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 78.6 p -122.48 147.93 45.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.551 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -66.49 -33.28 62.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.896 178.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 29' ' ' LEU . . . -64.08 -36.84 93.77 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.131 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 1.9 t0 -60.63 -47.07 87.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.637 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . . . -56.14 -54.76 41.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.459 0.647 . . . . 0.0 110.412 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.828 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.8 m -53.69 -50.49 65.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.617 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.682 ' HD2' HD11 ' A' ' 78' ' ' LEU . 12.9 tptm -66.12 -35.78 81.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.755 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.451 ' HD2' HD13 ' A' ' 59' ' ' ILE . 72.2 t80 -64.71 -42.24 95.4 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.99 -42.37 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.116 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.828 ' HG ' ' O ' ' A' ' 74' ' ' THR . 82.2 mt -63.85 -23.0 67.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.209 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.76 -40.71 13.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.984 0.421 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -104.38 20.3 18.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.816 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.3 pt20 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.622 0.248 . . . . 0.0 110.61 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.601 ' H ' HG23 ' A' ' 4' ' ' THR . 20.8 tt0 -54.54 -55.35 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -169.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -67.33 -34.38 77.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.197 0.522 . . . . 0.0 110.977 -173.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -75.09 -47.12 30.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.409 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.705 HG23 HD22 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -69.39 -31.45 49.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.09 -41.13 90.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 110.325 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.68 93.8 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.353 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.78 -51.16 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.662 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.94 -52.68 62.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.05 -40.88 46.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.718 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -85.01 -29.75 6.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.158 -172.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.719 HG12 HD13 ' A' ' 37' ' ' LEU . 42.2 t -76.43 -24.73 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 121.711 -0.618 . . . . 0.0 109.818 176.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.97 -30.96 71.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.505 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 15.4 tp10 -62.79 -41.47 99.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.178 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 28.9 mt -76.84 -54.45 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.001 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.51 -77.75 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.792 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.76 61.23 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.504 -1.332 . . . . 0.0 114.817 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.758 HG13 HD11 ' A' ' 37' ' ' LEU . 17.1 mm -87.98 129.22 51.02 Favored Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.7 141.28 35.27 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 111.548 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 91.1 t -56.32 -33.68 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.212 -174.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -76.65 -21.53 55.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.015 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.49 -15.54 37.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.552 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 13' ' ' ALA . 72.6 t -69.17 121.0 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HE2' ' OD1' ' A' ' 30' ' ' ASP . 57.9 mtpt -144.39 177.16 8.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.256 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.608 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 19.8 mt -81.69 -7.32 59.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.048 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -92.83 -32.44 14.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.456 -171.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.629 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.71 139.23 32.88 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.702 -168.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.747 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.3 m -87.65 135.34 33.4 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.636 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.01 -45.6 82.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.407 0.622 . . . . 0.0 110.403 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.1 p -75.46 -33.41 60.84 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.214 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 15.2 t70 -91.64 -58.01 2.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.947 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.92 -47.15 8.06 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.633 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.758 HD11 HG13 ' A' ' 22' ' ' ILE . 3.9 mm? -67.38 -16.72 64.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.021 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.63 32.82 16.13 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.57 0.544 . . . . 0.0 110.535 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -99.25 147.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.592 -171.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.1 m-20 -96.67 164.53 12.55 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 45' ' ' VAL . 8.7 p -55.65 -48.78 74.42 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.673 0.608 . . . . 0.0 111.522 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -50.95 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.513 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 19.1 m -47.6 -52.46 17.74 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.839 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.516 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 8.8 ptm -61.98 -50.67 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.262 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.621 HG21 ' HB ' ' A' ' 64' ' ' VAL . 86.5 t -60.38 -25.23 33.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.944 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.51 -65.82 0.77 Allowed 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.879 -0.513 . . . . 0.0 111.226 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.595 HG11 HG12 ' A' ' 15' ' ' ILE . 6.7 t -88.36 -21.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.108 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -79.45 -27.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.102 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.681 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.44 -34.7 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.421 0.629 . . . . 0.0 109.389 169.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.39 68.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.355 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 15' ' ' ILE . . . -80.36 -35.75 34.99 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.707 ' O ' HG11 ' A' ' 57' ' ' VAL . 11.2 pt-20 -70.57 -52.72 19.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 29.8 mt-10 -66.08 -20.68 66.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.5 ptm180 -71.97 -5.31 33.93 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.803 -0.56 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -119.76 13.02 12.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.738 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 59.77 41.92 17.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.727 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.707 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.5 p -115.17 137.56 48.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -134.28 117.89 16.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.252 0.548 . . . . 0.0 111.263 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.622 HD12 ' CG2' ' A' ' 64' ' ' VAL . 6.4 pt -116.38 164.94 16.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.591 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 63' ' ' ASP . 34.4 Cg_exo -61.76 134.48 50.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.586 1.524 . . . . 0.0 110.932 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.31 -41.14 62.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.632 . . . . 0.0 111.061 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.01 -20.49 66.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.229 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.19 -41.95 66.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.604 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.622 ' CG2' HD12 ' A' ' 59' ' ' ILE . 48.2 t -59.22 -43.48 89.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -22.54 66.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.005 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.29 -17.71 23.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.442 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 1.3 pp -87.93 128.27 35.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.512 0.672 . . . . 0.0 110.688 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -90.83 -8.43 49.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.808 -170.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 13.2 p -128.73 157.16 42.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.36 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 28' ' ' LYS . 1.5 p -76.68 -18.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.88 -42.78 24.47 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.105 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.68 -39.29 84.02 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.44 -56.87 16.3 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.304 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.786 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -59.36 -50.6 73.33 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.52 -177.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD2' HD11 ' A' ' 78' ' ' LEU . 1.5 tptm -62.4 -37.57 86.31 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.713 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.62 -41.06 98.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.609 HG22 HG13 ' A' ' 57' ' ' VAL . 27.7 mt -62.61 -52.36 60.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' A' ' 74' ' ' THR . 84.2 mt -60.41 -35.0 74.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.36 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.34 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.533 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -98.95 7.85 45.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.435 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 77' ' ' ILE . 5.2 mm-40 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.959 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.78 -56.41 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.64 -30.54 65.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.747 0.308 . . . . 0.0 111.296 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -65.12 -53.53 43.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 110.24 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.695 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.82 -33.55 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.661 -178.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.91 -37.63 78.7 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.779 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.73 94.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.498 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.97 -39.87 89.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.937 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -63.05 -48.88 76.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.612 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -55.71 -50.0 71.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.032 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.93 -38.45 67.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.136 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.888 HG23 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.74 -33.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 37' ' ' LEU . 43.8 t -74.34 -23.91 18.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -63.36 -24.43 67.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.741 174.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.02 -27.9 63.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.533 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.829 HD13 ' HB ' ' A' ' 47' ' ' VAL . 47.3 mt -91.26 -53.79 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.559 -173.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.81 -82.03 0.64 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.07 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.32 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.723 HG13 HD11 ' A' ' 37' ' ' LEU . 20.5 mm -88.33 130.73 44.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 166.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 9.8 Cg_endo -53.3 141.49 59.96 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.368 2.046 . . . . 0.0 111.017 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.609 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 34.9 m -62.88 -20.66 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.411 . . . . 0.0 111.717 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.44 -20.63 39.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.538 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -97.9 -8.75 27.55 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.161 -173.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 13' ' ' ALA . 68.9 t -67.23 110.21 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.688 0.756 . . . . 0.0 109.379 175.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' O ' HG11 ' A' ' 70' ' ' VAL . 55.5 mtpt -135.84 164.49 27.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.267 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.702 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.1 mp -74.68 -2.89 28.27 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.182 0.515 . . . . 0.0 110.238 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -104.26 -7.65 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.555 -171.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.629 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -103.78 141.58 35.85 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.29 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.768 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 16.2 m -83.64 132.3 34.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.089 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.599 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.63 -48.63 80.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.244 0.545 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -70.26 -35.55 73.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.491 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.768 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 14.4 t70 -91.5 -69.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.617 -173.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.15 -44.35 63.24 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.749 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 16' ' ' VAL . 3.6 mm? -70.53 -15.87 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.51 29.99 19.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.569 0.7 . . . . 0.0 109.832 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.48 145.13 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.926 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.1 159.09 15.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 m -53.41 -42.64 67.22 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.335 0.397 . . . . 0.0 111.67 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -45.61 50.0 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.468 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 14.7 m -52.03 -53.04 46.61 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.535 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 9.6 ptm -59.09 -49.8 76.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.933 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.714 HG23 ' HB ' ' A' ' 64' ' ' VAL . 97.7 t -61.82 -26.22 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.2 -65.73 0.81 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.667 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.829 ' HB ' HD13 ' A' ' 19' ' ' ILE . 20.3 t -89.27 -19.83 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.138 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 44' ' ' MET . 28.0 t -79.97 -22.0 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.661 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.755 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -76.39 -30.93 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 167.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.81 -25.34 67.44 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.552 168.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.888 ' HB1' HG23 ' A' ' 15' ' ' ILE . . . -82.28 -36.28 27.23 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.599 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.755 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.6 pt-20 -64.04 -45.76 87.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.634 0.73 . . . . 0.0 109.586 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.64 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 42.2 mt-10 -75.13 -21.47 58.83 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.246 -171.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -77.35 -4.84 47.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.214 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.07 16.66 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 59.13 51.54 6.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.601 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.675 HG11 ' O ' ' A' ' 52' ' ' GLU . 8.0 p -133.07 155.43 41.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -134.91 111.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.555 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.652 HG12 ' OE1' ' A' ' 52' ' ' GLU . 14.6 pt -104.9 163.35 17.35 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.567 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.652 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.6 Cg_exo -61.59 136.02 60.37 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 121.937 1.758 . . . . 0.0 112.019 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.6 -52.91 34.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.389 0.614 . . . . 0.0 111.075 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 6.1 p-10 -71.59 -18.32 62.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.482 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.652 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.8 t0 -75.2 -22.57 57.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.387 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.714 ' HB ' HG23 ' A' ' 45' ' ' VAL . 61.7 t -67.18 -43.79 88.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.541 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.97 -14.25 60.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.086 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 39.4 t30 -73.81 -40.62 63.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.043 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.5 pp -79.26 134.35 36.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.344 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.17 -1.02 27.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.305 -171.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.508 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 44.3 p -131.8 149.13 52.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.176 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -69.88 -21.27 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 109.745 177.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.702 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.53 -39.51 34.98 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.573 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.08 -35.44 79.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.492 0.663 . . . . 0.0 109.215 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -58.4 -46.42 86.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.326 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.769 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.12 -51.84 58.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.946 -174.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HD3' HD13 ' A' ' 78' ' ' LEU . 34.1 mmtp -57.26 -37.81 72.91 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.532 0.52 . . . . 0.0 110.848 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.485 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 35.5 t80 -63.07 -43.57 98.19 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.269 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.429 HG21 HG13 ' A' ' 57' ' ' VAL . 56.4 mt -65.31 -48.15 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.159 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 74' ' ' THR . 96.8 mt -56.04 -46.17 78.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.587 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -71.7 -6.27 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -128.91 1.55 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.461 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 8.6 pt20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.885 -0.143 . . . . 0.0 111.082 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.542 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.542 ' H ' HG21 ' A' ' 4' ' ' THR . 49.0 tt0 -59.95 -55.67 31.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.35 -39.87 89.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.67 -53.57 49.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.409 0.623 . . . . 0.0 110.53 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.717 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.53 -30.23 46.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.086 -177.184 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -62.38 -39.48 84.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.766 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.45 97.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.59 -47.41 84.09 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.992 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.582 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.8 -39.07 90.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.041 0.448 . . . . 0.0 109.807 177.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.715 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -58.09 -55.73 31.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.218 177.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.46 -41.01 52.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.919 0.866 . . . . 0.0 109.832 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.933 HG13 ' HB3' ' A' ' 51' ' ' ALA . 9.4 mm -64.2 -57.84 9.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.56 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.763 HG12 HD13 ' A' ' 37' ' ' LEU . 4.2 t -72.05 -23.89 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.446 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -59.48 -30.33 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.612 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.77 -20.6 49.5 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.406 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.594 HD13 ' HB ' ' A' ' 47' ' ' VAL . 47.4 mt -90.47 -54.23 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.929 -175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.06 -93.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.29 0.07 OUTLIER Glycine 0 CA--C 1.522 0.504 0 C-N-CA 119.189 -1.482 . . . . 0.0 115.471 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.728 HG13 HD11 ' A' ' 37' ' ' LEU . 17.5 mm -86.68 124.14 69.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 118.124 0.962 . . . . 0.0 108.608 166.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.55 155.3 42.79 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.736 2.291 . . . . 0.0 112.034 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.715 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 90.9 t -57.54 -40.9 77.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.761 -173.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.28 -16.53 52.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.875 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' HB3' HG21 ' A' ' 22' ' ' ILE . 24.5 t70 -80.65 -15.51 56.38 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.739 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 13' ' ' ALA . 57.6 t -65.08 121.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.737 0.78 . . . . 0.0 110.555 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 16.9 mtpp -139.64 146.79 40.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.901 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.556 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 39.1 mt -70.95 -7.22 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 110.19 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 6.3 p-10 -107.99 8.97 28.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.955 -177.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HG2' ' CG1' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -105.85 145.91 30.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.842 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 14.8 m -95.45 138.04 33.68 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -170.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.691 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.5 m-85 -58.34 -46.24 86.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.388 0.614 . . . . 0.0 110.229 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.8 p -77.55 -30.76 52.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.717 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' A' ' 32' ' ' SER . 1.4 t70 -92.53 -50.25 5.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.857 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.83 -52.27 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.762 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.763 HD13 HG12 ' A' ' 16' ' ' VAL . 3.3 mm? -67.85 -11.5 58.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.723 -168.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.93 35.75 25.6 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.53 0.519 . . . . 0.0 110.536 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' CG1' ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.405 -172.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.33 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.195 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 44' ' ' MET . 40.7 m -51.52 -59.48 4.21 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.622 0.576 . . . . 0.0 112.083 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.14 -40.89 77.99 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.961 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.478 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -50.42 -56.6 10.75 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.605 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 11.8 ptm -62.7 -47.0 85.53 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.908 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.619 HG21 ' HB ' ' A' ' 64' ' ' VAL . 85.0 t -68.18 -24.48 30.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.005 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.49 -66.13 0.81 Allowed 'General case' 0 C--O 1.242 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 111.493 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.636 HG11 HG22 ' A' ' 15' ' ' ILE . 7.8 t -84.28 -24.67 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.509 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.619 ' HA ' HG23 ' A' ' 15' ' ' ILE . 40.5 t -77.47 -20.24 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.419 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.682 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 2.9 t -74.78 -33.16 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -18.35 64.48 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.396 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.933 ' HB3' HG13 ' A' ' 15' ' ' ILE . . . -82.29 -38.31 24.55 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.845 176.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.691 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.7 -45.99 77.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.15 -176.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.09 -27.1 66.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.31 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.8 ptp180 -79.2 -7.14 58.0 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.393 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -116.12 15.62 16.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t70 54.71 70.74 0.59 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.732 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.691 HG11 ' O ' ' A' ' 52' ' ' GLU . 7.1 p -139.13 165.89 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -133.78 110.49 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.991 0.424 . . . . 0.0 110.179 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.1 pt -121.85 154.63 60.8 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.474 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 26.3 Cg_exo -64.32 141.74 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 111.956 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.54 -51.4 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.437 0.637 . . . . 0.0 109.509 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.162 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -65.72 -34.85 79.15 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.229 0.331 . . . . 0.0 110.963 -177.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 45' ' ' VAL . 43.0 t -61.5 -39.16 81.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.077 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -18.22 51.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 110.608 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -74.37 -24.15 59.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.152 0.501 . . . . 0.0 109.904 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -97.57 130.21 44.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.43 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -96.08 -1.56 48.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.543 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.842 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 59.2 p -122.41 146.5 47.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.691 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 2.1 p -65.92 -34.91 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.852 177.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.55 -30.28 76.08 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.89 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 2.3 t70 -68.1 -49.1 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -58.48 -45.73 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.586 0.707 . . . . 0.0 110.099 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.726 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 17.0 m -59.62 -51.7 68.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.628 -177.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -66.09 -30.46 70.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.197 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.62 -46.58 85.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.918 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.599 HG22 HG13 ' A' ' 57' ' ' VAL . 87.4 mt -63.62 -40.98 91.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.219 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 74' ' ' THR . 92.2 mt -66.64 -26.68 67.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.847 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.03 -34.03 20.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.423 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -119.77 20.73 12.21 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.3 pt20 . . . . . 0 C--N 1.325 -0.497 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.734 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.616 HG23 ' H ' ' A' ' 5' ' ' GLN . 1.2 m . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.616 ' H ' HG23 ' A' ' 4' ' ' THR . 38.0 tt0 -58.66 -55.62 32.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -54.0 -44.83 71.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -67.72 -56.29 9.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.399 0.618 . . . . 0.0 111.027 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.665 HG22 HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -67.44 -30.65 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.139 -174.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.66 -43.53 97.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.446 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.34 92.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.685 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.546 ' HA2' ' CZ ' ' A' ' 55' ' ' PHE . . . -68.5 -44.15 74.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.427 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.554 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.37 -46.31 89.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.75 -52.51 63.69 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.766 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.79 -36.48 58.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.646 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.07 -31.89 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.672 -173.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.711 HG12 HD13 ' A' ' 37' ' ' LEU . 19.9 t -74.2 -28.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.246 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.25 -29.76 67.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.949 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.73 -22.12 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.718 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.542 HD13 ' HB ' ' A' ' 47' ' ' VAL . 17.1 mt -92.89 -54.02 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.296 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.47 -93.12 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.27 50.99 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.696 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.753 HG13 HD11 ' A' ' 37' ' ' LEU . 22.7 mm -94.08 120.21 65.87 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 162.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.31 153.79 72.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 111.722 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.624 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.4 m -60.66 -17.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.43 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.57 -20.98 53.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.763 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HB3' HG21 ' A' ' 22' ' ' ILE . 17.7 t0 -106.07 -11.84 15.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.871 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 13' ' ' ALA . 97.3 t -71.85 123.24 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.273 0.558 . . . . 0.0 110.954 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -148.09 166.36 28.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -171.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.422 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 24.2 mt -78.35 -3.34 42.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.036 0.446 . . . . 0.0 110.64 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.69 -30.06 15.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.527 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -84.88 139.67 31.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.396 0.617 . . . . 0.0 110.504 -168.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.755 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 16.2 m -85.26 138.61 32.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.834 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.558 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -58.46 -51.24 70.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.303 0.573 . . . . 0.0 110.55 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.6 p -69.8 -33.84 72.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.291 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 36.2 t70 -92.42 -69.25 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.774 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.569 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -69.46 -55.55 9.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.063 -177.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.753 HD11 HG13 ' A' ' 22' ' ' ILE . 3.6 mm? -63.64 -16.64 61.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 63.3 24.5 14.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.774 0.797 . . . . 0.0 109.712 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.682 HG23 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -92.72 150.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.613 -172.473 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.4 161.63 14.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.795 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 17.8 m -48.3 -50.9 28.3 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.447 0.467 . . . . 0.0 111.544 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.426 HD11 ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -70.96 -42.6 69.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -176.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 39' ' ' VAL . 15.2 m -50.95 -52.06 46.21 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.466 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 1.085 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 13.1 ptt? -63.67 -47.84 79.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.797 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.907 HG23 ' HB ' ' A' ' 64' ' ' VAL . 80.1 t -57.38 -26.64 26.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.051 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.37 -65.73 0.82 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.958 -0.464 . . . . 0.0 111.185 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.591 HG11 HG12 ' A' ' 15' ' ' ILE . 21.0 t -87.05 -21.3 7.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.36 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.6 t -79.51 -20.48 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.634 -0.666 . . . . 0.0 110.219 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.6 t -75.87 -34.64 28.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.36 -24.08 63.08 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.99 168.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.745 ' HB2' HG23 ' A' ' 15' ' ' ILE . . . -84.12 -33.85 24.23 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.117 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.648 ' HG3' ' N ' ' A' ' 53' ' ' GLU . 2.5 pt-20 -64.19 -48.12 77.15 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.559 0.695 . . . . 0.0 109.561 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.648 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 32.2 mt-10 -72.73 -22.38 60.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.254 -172.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -80.79 -10.64 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.215 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.546 ' CZ ' ' HA2' ' A' ' 11' ' ' GLY . 58.1 m-85 -105.7 4.08 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 57.04 70.93 0.61 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.64 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.0 p -132.39 166.67 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -123.79 110.56 15.06 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.622 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.481 HG13 ' HD2' ' A' ' 60' ' ' PRO . 5.9 tt -134.86 135.46 23.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 0.0 110.588 172.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 59' ' ' ILE . 18.6 Cg_endo -66.88 150.79 83.08 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.572 2.182 . . . . 0.0 112.849 175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.7 -48.06 50.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.948 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 1.045 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -53.74 -44.37 69.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.588 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -62.94 -33.89 76.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -171.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.907 ' HB ' HG23 ' A' ' 45' ' ' VAL . 12.0 t -68.37 -41.33 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.841 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 1.085 ' HA ' ' HE2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -85.29 -0.76 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 122.105 -0.372 . . . . 0.0 111.766 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -91.19 -31.24 16.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.834 0.35 . . . . 0.0 110.302 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 73' ' ' ALA . 2.9 pp -81.63 145.23 30.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.431 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -110.51 -5.19 15.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.897 -172.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.755 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 43.8 p -127.25 153.72 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 31' ' ' LYS . 2.1 p -74.12 -22.4 18.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.47 0.652 . . . . 0.0 110.025 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -73.43 -31.47 60.99 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.182 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.05 -46.2 85.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -57.09 -45.15 83.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.815 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.673 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -67.13 -45.52 76.88 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.633 -175.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 1.001 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 5.8 mmpt? -62.53 -31.02 71.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.58 -49.34 48.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 109.918 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.6 mt -58.29 -49.35 82.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 74' ' ' THR . 73.5 mt -69.45 -20.97 63.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.235 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.4 -21.88 32.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.205 0.526 . . . . 0.0 110.692 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -125.19 22.7 7.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.449 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.6 pt20 . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.016 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.588 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.588 ' H ' HG21 ' A' ' 4' ' ' THR . 13.6 tt0 -53.2 -56.43 16.47 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -171.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.87 -38.39 90.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -67.67 -54.18 21.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.143 0.497 . . . . 0.0 111.124 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -67.14 -32.74 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.33 -39.37 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.569 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.95 94.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.61 59.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.054 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.632 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -61.37 -53.83 51.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -58.04 -50.6 72.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.934 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -55.29 -35.83 65.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.347 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.629 HG22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -81.15 -31.71 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.807 -177.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 37' ' ' LEU . 22.4 t -74.61 -26.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 O-C-N 121.915 -0.491 . . . . 0.0 109.69 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.4 -28.62 70.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -66.58 -36.31 82.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.149 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.67 HD13 ' HB ' ' A' ' 47' ' ' VAL . 27.3 mt -80.27 -52.61 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.421 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.87 -84.7 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.82 53.63 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.933 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.725 HG13 HD11 ' A' ' 37' ' ' LEU . 22.8 mm -89.43 125.05 62.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 165.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.3 146.57 60.58 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.452 2.101 . . . . 0.0 111.395 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.629 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 31.4 m -54.51 -35.06 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -81.31 -17.79 48.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.836 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.507 ' HB3' HG22 ' A' ' 22' ' ' ILE . 12.6 t70 -83.35 -22.51 32.82 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.999 0.428 . . . . 0.0 110.603 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 13' ' ' ALA . 72.4 t -62.78 129.18 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.908 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -145.64 159.37 43.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.398 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.2 mp -77.37 -3.83 42.1 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.981 0.419 . . . . 0.0 110.547 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.12 1.58 24.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.17 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.72 140.44 37.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.683 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.877 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.7 m -87.41 136.83 32.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.463 -170.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.637 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.17 -49.79 76.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 110.196 177.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.5 p -69.54 -34.32 74.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 9.5 t70 -91.59 -68.68 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.307 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.8 m-20 -72.92 -52.38 14.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.895 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.741 HD13 HG12 ' A' ' 16' ' ' VAL . 3.7 mm? -66.35 -10.45 43.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.127 -172.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 61.38 31.44 19.2 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.803 0.69 . . . . 0.0 109.944 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 43' ' ' SER . 0.5 OUTLIER -102.66 153.13 5.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.418 -171.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.7 170.89 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.605 170.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.612 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 24.8 t -57.33 -59.77 4.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.421 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.587 HD11 ' O ' ' A' ' 42' ' ' LEU . 2.0 tm? -68.53 -39.15 81.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.372 -176.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.484 ' HB2' HG21 ' A' ' 39' ' ' VAL . 13.3 m -48.87 -53.53 19.1 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.008 0.432 . . . . 0.0 111.637 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 1.0 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 20.3 ptt? -65.27 -42.83 92.81 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 98.7 t -60.18 -26.19 35.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.07 0.462 . . . . 0.0 110.389 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.12 -65.39 0.85 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.856 -0.528 . . . . 0.0 111.413 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.67 ' HB ' HD13 ' A' ' 19' ' ' ILE . 15.8 t -85.72 -23.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.137 -173.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.2 t -79.32 -23.21 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.481 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.739 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.3 t -76.63 -31.8 20.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 109.329 169.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.64 -25.85 67.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.379 0.609 . . . . 0.0 109.789 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB1' HG22 ' A' ' 15' ' ' ILE . . . -82.07 -37.7 26.0 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.972 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.9 pt-20 -61.83 -51.63 67.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.484 0.659 . . . . 0.0 109.643 -175.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.631 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.7 mt-10 -71.35 -22.85 61.85 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.649 -171.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.2 ptm180 -75.01 -19.37 60.11 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -97.91 6.92 47.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t0 60.54 57.94 2.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.656 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.707 HG11 ' O ' ' A' ' 52' ' ' GLU . 13.3 p -134.3 161.65 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.201 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 58' ' ' LYS . 13.4 tptp -127.82 112.93 15.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.111 175.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 tt -118.12 117.32 35.23 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.819 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.58 138.88 39.47 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.448 2.099 . . . . 0.0 111.726 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.604 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 5.2 p-10 -58.33 -29.55 66.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.529 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.615 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 32.7 t70 -67.53 -25.31 65.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.023 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.81 -37.94 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.643 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 46.7 t -63.54 -53.86 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.045 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 1.0 ' HA ' ' HE2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -63.36 -9.95 14.42 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 176.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.5 -41.36 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.773 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.691 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 1.2 pp -67.6 137.1 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.453 0.644 . . . . 0.0 110.988 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -96.21 -20.68 18.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.195 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.877 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 14.8 p -119.95 154.55 34.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.528 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.4 p -63.53 -31.15 51.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 109.999 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -63.72 -33.79 88.2 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.523 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 51.1 m-20 -57.92 -52.73 64.29 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -57.49 -52.21 66.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.743 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.772 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.0 m -56.94 -52.92 63.27 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.019 -173.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -65.98 -31.34 72.19 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.592 0.234 . . . . 0.0 110.452 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.94 -43.07 84.16 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.257 0.551 . . . . 0.0 109.619 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.62 HG21 HG13 ' A' ' 57' ' ' VAL . 46.5 mt -59.99 -46.57 93.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.239 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 74' ' ' THR . 95.0 mt -62.35 -28.03 69.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.109 -175.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.69 -39.62 44.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.093 0.473 . . . . 0.0 111.084 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.461 ' O ' HG21 ' A' ' 57' ' ' VAL . 69.0 m-70 -105.62 21.69 16.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.272 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.915 -172.116 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.433 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.433 ' H ' HG21 ' A' ' 4' ' ' THR . 12.7 tt0 -50.49 -56.3 12.16 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.26 -41.24 88.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.69 -45.92 41.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.75 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.92 -33.97 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.36 -39.75 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.983 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.37 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.14 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.493 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.48 -45.4 78.49 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.992 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.34 -40.01 96.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.633 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -54.89 41.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 41.9 tt0 -52.9 -42.44 65.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.432 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.904 HG13 ' HB1' ' A' ' 51' ' ' ALA . 8.0 mm -62.61 -53.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.292 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 37' ' ' LEU . 13.2 t -71.2 -23.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.461 . . . . 0.0 110.303 -177.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -65.85 -19.68 65.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.009 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 5.1 mm-40 -83.16 -29.66 28.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.145 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 32.3 mt -84.86 -53.02 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.631 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.34 -86.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.05 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.35 56.84 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.573 -1.299 . . . . 0.0 114.492 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.68 HG13 HD11 ' A' ' 37' ' ' LEU . 12.8 mm -87.88 124.81 66.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 164.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 147.95 49.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 111.757 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 79.2 t -54.61 -40.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.645 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -75.41 -17.02 60.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.298 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG21 ' A' ' 22' ' ' ILE . 1.6 t70 -90.09 -5.71 56.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.142 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG23 ' CB ' ' A' ' 13' ' ' ALA . 46.0 t -68.83 116.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.549 0.69 . . . . 0.0 109.696 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 13.6 mtpp -132.78 144.89 50.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.454 -171.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.2 mp -74.08 -3.43 29.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.873 0.368 . . . . 0.0 110.997 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 5.8 p-10 -108.03 -7.91 16.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.762 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.93 140.0 30.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.442 -177.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.8 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.2 m -87.98 135.77 33.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.448 -170.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.531 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -56.67 -48.16 78.22 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.277 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.5 p -71.8 -33.65 68.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.201 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 5.0 t70 -92.13 -65.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.199 0.523 . . . . 0.0 111.651 -173.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.1 m-20 -75.82 -52.76 9.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.673 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.805 HD13 HG12 ' A' ' 16' ' ' VAL . 2.9 mm? -66.19 -14.54 62.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.791 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 61.76 32.91 18.13 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.856 0.836 . . . . 0.0 109.38 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 43' ' ' SER . 0.4 OUTLIER -98.81 146.96 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.809 -171.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.495 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 8.2 m-20 -95.92 173.84 7.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.683 ' HB3' ' HD3' ' A' ' 65' ' ' LYS . 13.6 m -57.25 -56.32 23.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.565 . . . . 0.0 110.471 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -65.59 -40.49 92.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.543 ' HB2' HG23 ' A' ' 39' ' ' VAL . 14.7 m -50.59 -54.72 20.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 1.017 ' HE1' ' HA ' ' A' ' 65' ' ' LYS . 15.3 ptt? -66.36 -40.96 90.11 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.646 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.656 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 82.5 t -63.09 -24.95 37.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.704 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -74.32 -66.41 0.73 Allowed 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.74 -0.6 . . . . 0.0 111.659 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.607 HG11 HG22 ' A' ' 15' ' ' ILE . 11.8 t -91.12 -22.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.578 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 44' ' ' MET . 21.5 t -80.46 -21.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.619 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.1 t -73.95 -33.57 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.609 0.718 . . . . 0.0 109.302 167.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.36 66.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.339 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.904 ' HB1' HG13 ' A' ' 15' ' ' ILE . . . -81.14 -45.75 15.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.67 ' O ' HG11 ' A' ' 57' ' ' VAL . 8.1 pt-20 -59.31 -49.11 79.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.034 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.8 pt-20 -62.68 -30.67 71.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.724 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -78.7 -5.0 51.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.275 0.56 . . . . 0.0 110.343 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.493 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 68.7 m-85 -114.2 22.38 13.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.345 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 71.75 17.47 5.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.507 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.67 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -114.49 158.29 14.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.075 -0.391 . . . . 0.0 110.435 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 50.1 mtpt -134.06 111.3 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 ' HB ' ' HE2' ' A' ' 76' ' ' TYR . 21.4 pt -108.53 163.36 17.14 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.808 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.0 Cg_exo -65.3 129.61 23.21 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.942 1.761 . . . . 0.0 111.623 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.79 -49.2 63.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 110.06 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.41 -19.52 64.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.275 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.808 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 2.7 t0 -74.0 -38.08 64.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 22.2 t -60.12 -42.75 91.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 1.017 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 17.6 tptp -59.91 -31.08 69.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.795 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.63 -26.99 40.98 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.154 -0.341 . . . . 0.0 111.255 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.712 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -83.7 136.58 34.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.292 -178.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.36 -22.77 22.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.131 -173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.8 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 32.8 p -120.2 156.98 30.05 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.887 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -67.72 -36.96 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.1 -41.51 96.59 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.025 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.96 -50.73 72.19 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.712 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -54.79 -50.28 68.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.58 0.705 . . . . 0.0 110.936 176.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.742 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 12.4 m -58.98 -49.49 77.69 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.686 -174.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.535 ' HD2' HD11 ' A' ' 78' ' ' LEU . 7.6 tptm -65.95 -38.65 89.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.46 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 59.3 t80 -56.91 -43.34 81.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.604 HG21 HG13 ' A' ' 57' ' ' VAL . 82.0 mt -65.18 -49.9 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.536 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.75 HD23 HG22 ' A' ' 8' ' ' ILE . 91.5 mt -54.15 -44.99 71.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.21 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -86.68 -3.63 59.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.459 ' O ' HG21 ' A' ' 57' ' ' VAL . 29.9 m-70 -124.69 15.22 8.73 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.244 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.546 0.213 . . . . 0.0 111.498 -173.155 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.57 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.57 ' H ' HG21 ' A' ' 4' ' ' THR . 24.8 tt0 -58.99 -55.71 31.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -167.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -32.22 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.868 0.366 . . . . 0.0 111.144 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.05 -47.65 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.725 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.35 -33.11 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.11 -43.02 95.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.1 95.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.937 0.398 . . . . 0.0 110.875 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.8 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.51 -33.03 75.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.341 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -68.62 -48.64 63.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -58.13 -46.77 85.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.58 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -52.39 -36.74 54.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.496 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.683 HG23 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.59 -35.6 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.81 -174.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.709 HG12 HD13 ' A' ' 37' ' ' LEU . 36.2 t -71.17 -23.97 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 109.776 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -62.6 -24.57 67.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.28 -38.48 63.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 109.958 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.694 HD13 ' HB ' ' A' ' 47' ' ' VAL . 24.9 mt -71.04 -53.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.694 -174.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.24 -86.14 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.452 -175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 64.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.685 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.716 HG13 HD11 ' A' ' 37' ' ' LEU . 23.2 mm -99.61 131.35 24.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 164.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.99 148.34 48.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.465 2.11 . . . . 0.0 111.633 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.649 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 93.9 t -59.88 -38.57 76.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.15 0.5 . . . . 0.0 111.304 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -76.71 -18.31 58.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB3' HG21 ' A' ' 22' ' ' ILE . 11.2 t70 -83.23 -22.74 33.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.68 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.2 t -66.4 122.28 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.572 0.701 . . . . 0.0 110.729 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -144.04 169.76 17.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.207 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.73 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 9.6 mp -81.57 -2.5 50.25 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.494 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -110.38 2.01 18.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.83 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.05 141.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.694 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 24.9 m -88.4 136.46 32.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.881 0.372 . . . . 0.0 111.658 -170.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.58 -47.83 84.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.535 0.684 . . . . 0.0 110.426 178.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 38.9 p -72.95 -33.66 66.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.354 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.694 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.5 t70 -91.67 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 111.539 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -49.11 18.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.287 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.716 HD11 HG13 ' A' ' 22' ' ' ILE . 3.5 mm? -70.23 -14.73 62.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.659 -176.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.49 31.88 20.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.847 0.832 . . . . 0.0 110.129 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -97.66 151.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.881 -169.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.4 m-20 -104.0 166.25 10.53 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 p -51.23 -55.65 16.98 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.709 0.631 . . . . 0.0 111.32 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -62.96 -48.97 76.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.598 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.567 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 13.0 m -50.94 -54.29 25.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.646 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.68 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 4.8 ptm -59.74 -49.43 77.78 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.701 HG21 ' HB ' ' A' ' 64' ' ' VAL . 85.5 t -68.81 -22.31 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.16 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.82 -66.2 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.661 -0.649 . . . . 0.0 111.743 -174.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.694 ' HB ' HD13 ' A' ' 19' ' ' ILE . 16.6 t -87.88 -21.74 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.052 -173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.9 t -78.82 -26.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.286 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.693 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -72.72 -35.04 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.01 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.23 0.538 . . . . 0.0 109.918 171.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 15' ' ' ILE . . . -83.49 -39.6 20.3 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.131 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 4.5 pt-20 -59.81 -48.31 82.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.494 0.664 . . . . 0.0 109.559 -175.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.2 mt-10 -64.56 -33.64 76.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.169 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -81.31 -6.03 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.374 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.8 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 62.1 m-85 -105.25 6.71 33.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 170.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.38 68.36 0.77 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.553 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -140.59 161.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.353 174.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -122.88 110.56 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 169.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.5 pt -119.08 151.35 50.49 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.75 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.1 Cg_exo -61.79 121.21 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.991 1.794 . . . . 0.0 110.847 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.06 -39.29 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 0.0 110.215 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.33 -36.36 81.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.75 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -66.91 -34.79 78.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.315 -174.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HB ' HG21 ' A' ' 45' ' ' VAL . 21.3 t -58.42 -36.45 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.165 0.507 . . . . 0.0 110.657 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.669 ' HZ1' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -75.19 -28.46 60.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.895 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.49 -21.87 44.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.691 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -84.71 123.48 30.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 0.0 110.585 177.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -82.3 -14.68 54.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.009 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 73.4 p -119.71 148.74 43.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.33 -36.16 76.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.041 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' HA2' ' HA ' ' A' ' 29' ' ' LEU . . . -66.97 -30.21 75.7 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.953 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 4.0 t70 -61.6 -40.68 95.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . . . -67.97 -39.46 83.33 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.114 176.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.775 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -65.15 -51.81 58.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.007 -172.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.42 -37.03 79.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.246 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -63.34 -38.61 91.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.396 0.617 . . . . 0.0 110.706 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 57' ' ' VAL . 52.5 mt -68.99 -33.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.533 0.682 . . . . 0.0 110.261 175.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 74' ' ' THR . 96.8 mt -77.97 -35.51 50.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.416 -172.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.9 -4.88 58.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.6 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -123.44 15.01 9.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.0 pt20 . . . . . 0 C--O 1.234 0.27 0 CA-C-O 120.698 0.285 . . . . 0.0 111.557 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.698 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.3 tt0 -55.61 -55.59 30.31 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.2 pt-20 -64.5 -39.17 93.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.899 0.381 . . . . 0.0 111.566 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.34 -54.35 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.0 110.885 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.67 -31.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.689 -177.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.698 ' HB ' ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -69.71 -31.73 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.253 -177.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.82 74.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.63 78.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.774 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -72.32 -49.39 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -52.52 -53.63 43.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -50.23 -42.45 51.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.117 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.983 HG23 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.38 -27.94 6.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.536 -169.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.754 HG12 HD11 ' A' ' 37' ' ' LEU . 45.8 t -76.05 -24.76 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -68.05 -21.49 65.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.043 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 5.2 mm-40 -70.54 -29.07 65.45 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.349 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.737 HD13 ' HB ' ' A' ' 47' ' ' VAL . 39.3 mt -92.88 -55.29 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.553 -171.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.13 -89.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.205 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.52 44.11 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.206 -1.473 . . . . 0.0 115.117 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.761 HG13 HD12 ' A' ' 37' ' ' LEU . 14.2 mm -78.24 124.82 85.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.8 142.72 83.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.274 1.982 . . . . 0.0 111.152 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.461 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 34.6 m -59.2 -20.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.976 0.417 . . . . 0.0 111.657 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.82 -18.67 46.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.249 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 22' ' ' ILE . 1.5 t70 -100.77 -7.91 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.647 0.26 . . . . 0.0 111.329 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 13' ' ' ALA . 84.6 t -68.21 118.2 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.325 0.583 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.426 ' O ' HG11 ' A' ' 70' ' ' VAL . 49.6 mtpt -143.17 160.33 40.63 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.207 -170.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.604 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.0 mp -74.14 -3.75 31.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.091 0.472 . . . . 0.0 110.864 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.61 -15.58 18.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.904 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.83 142.94 28.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.427 -173.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.754 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 16.0 t -84.4 134.24 34.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.889 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.03 -49.8 76.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.529 0.68 . . . . 0.0 109.843 177.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.1 p -71.95 -31.82 66.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.179 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.9 t70 -92.68 -68.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.896 -175.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -77.08 -45.24 27.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.976 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD12 HG13 ' A' ' 22' ' ' ILE . 4.0 mm? -66.73 -16.26 64.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.616 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 57.29 42.52 25.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.872 0.844 . . . . 0.0 108.83 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -110.64 144.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.638 -173.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 166.61 15.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.768 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 8.2 m -54.77 -52.29 63.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.586 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -72.62 -42.02 64.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.216 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.408 ' O ' HD12 ' A' ' 19' ' ' ILE . 54.8 m -48.11 -55.23 10.77 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 123.29 0.369 . . . . 0.0 111.238 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.972 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 19.9 ptt? -64.35 -48.6 74.91 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.569 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.769 HG21 ' HB ' ' A' ' 64' ' ' VAL . 55.7 t -54.78 -28.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.854 0.359 . . . . 0.0 111.209 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.6 -65.52 0.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.85 -0.531 . . . . 0.0 111.565 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.737 ' HB ' HD13 ' A' ' 19' ' ' ILE . 15.2 t -85.36 -22.61 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.645 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 44' ' ' MET . 55.6 t -78.83 -25.51 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.521 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.694 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.92 -36.25 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.18 -23.47 66.63 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.232 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.983 ' HB1' HG23 ' A' ' 15' ' ' ILE . . . -83.34 -35.94 24.79 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.911 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -69.94 -48.62 57.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.42 -23.57 66.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.848 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 4.4 ptm180 -71.96 -10.71 60.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.478 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -111.09 18.42 19.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.913 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 68.89 25.63 6.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.93 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.652 HG12 HG21 ' A' ' 77' ' ' ILE . 11.5 p -115.16 151.25 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -135.08 124.41 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.196 0.522 . . . . 0.0 110.905 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.523 HD13 ' CG2' ' A' ' 64' ' ' VAL . 7.0 pt -116.02 166.23 12.87 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.93 125.67 17.08 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 121.401 1.401 . . . . 0.0 110.446 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.57 -42.93 24.76 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.479 0.657 . . . . 0.0 110.861 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.1 t70 -63.08 -19.71 64.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.656 -176.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.92 -25.4 40.53 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.377 -0.202 . . . . 0.0 111.517 -173.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.769 ' HB ' HG21 ' A' ' 45' ' ' VAL . 43.8 t -64.77 -33.38 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.972 ' HA ' ' HE2' ' A' ' 44' ' ' MET . 3.5 tmmm? -66.1 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.403 171.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -71.1 -26.82 63.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.954 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.1 pp -94.63 134.65 36.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.388 0.613 . . . . 0.0 110.751 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -97.36 -6.58 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.795 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 69.6 p -129.69 152.24 49.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -70.55 -22.27 23.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 109.831 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.604 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.79 -36.79 41.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.586 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.47 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 6.0 t0 -58.62 -42.55 88.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.622 0.725 . . . . 0.0 109.082 176.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -60.19 -48.26 82.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.921 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.742 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -63.08 -50.65 69.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.547 -172.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HD3' HD13 ' A' ' 78' ' ' LEU . 23.7 mmtp -58.96 -39.67 82.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.124 0.265 . . . . 0.0 111.251 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.446 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 42.2 t80 -62.93 -44.59 95.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.026 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.652 HG21 HG12 ' A' ' 57' ' ' VAL . 61.2 mt -61.76 -44.56 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.734 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 74' ' ' THR . 92.3 mt -65.55 -40.95 93.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.322 -174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -75.07 -32.51 61.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.927 0.394 . . . . 0.0 111.669 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.52 22.54 15.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--N 1.325 -0.462 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.762 -177.716 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.512 ' H ' HG21 ' A' ' 4' ' ' THR . 19.2 tt0 -55.73 -55.97 25.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -67.64 -36.37 80.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.682 0.277 . . . . 0.0 111.546 -175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.47 -52.71 56.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.326 0.584 . . . . 0.0 110.613 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.694 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -69.91 -33.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.012 -178.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -59.99 -41.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.78 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.15 94.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.507 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.93 96.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.129 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.616 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -47.56 82.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' HA ' HG23 ' A' ' 27' ' ' VAL . . . -55.42 -50.13 70.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.543 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.64 -36.42 62.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.828 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.52 -32.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.807 -174.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.713 HG12 HD13 ' A' ' 37' ' ' LEU . 21.2 t -72.31 -24.27 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 121.63 -0.669 . . . . 0.0 109.981 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -62.56 -28.69 70.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.703 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.68 -23.65 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.356 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.595 HD13 ' HB ' ' A' ' 47' ' ' VAL . 44.5 mt -86.78 -52.98 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.995 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.46 -75.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.71 53.73 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.874 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.764 HG13 HD11 ' A' ' 37' ' ' LEU . 11.1 mm -80.94 129.94 65.56 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 165.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.651 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 7.3 Cg_endo -52.04 140.34 49.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.322 2.014 . . . . 0.0 111.187 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 23.3 m -57.34 -26.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 mm-40 -80.47 -18.74 47.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 1.8 t70 -95.23 -8.48 35.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.587 -172.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.677 HG23 ' HA ' ' A' ' 13' ' ' ALA . 53.1 t -68.5 111.22 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.611 0.72 . . . . 0.0 110.052 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -132.06 162.13 31.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.605 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 23.8 mt -74.64 -5.61 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.136 0.493 . . . . 0.0 110.378 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.88 -19.2 19.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.022 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -93.53 143.92 25.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.935 -175.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.887 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.0 m -90.39 135.04 33.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.294 -173.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.6 m-85 -54.73 -52.52 62.21 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 110.206 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -60.54 -43.95 96.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.757 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.14 -68.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.142 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.97 -45.91 83.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.833 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.764 HD11 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -72.98 -11.57 60.62 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t0 56.55 43.58 25.49 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.968 0.792 . . . . 0.0 108.896 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.504 ' CG2' HG23 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -105.61 146.33 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.417 -172.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 44' ' ' MET . 3.7 m-20 -91.79 153.44 19.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.445 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 50.6 m -55.87 -41.6 74.61 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.601 0.563 . . . . 0.0 111.677 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -72.48 -43.4 63.74 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.57 ' OG ' HG22 ' A' ' 19' ' ' ILE . 1.9 t -58.99 -49.48 77.73 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.974 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.479 ' HE1' HG13 ' A' ' 64' ' ' VAL . 13.6 ptm -57.1 -49.04 77.11 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.881 HG21 ' HB ' ' A' ' 64' ' ' VAL . 79.1 t -60.14 -25.92 34.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.295 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.87 -64.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.911 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.595 ' HB ' HD13 ' A' ' 19' ' ' ILE . 11.6 t -85.0 -22.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.349 -173.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 44' ' ' MET . 49.4 t -78.38 -28.15 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.134 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.702 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 12.7 t -71.36 -33.1 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.561 0.696 . . . . 0.0 109.3 169.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 47' ' ' VAL . . . -60.82 -26.7 67.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.095 0.474 . . . . 0.0 110.05 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB2' HG22 ' A' ' 15' ' ' ILE . . . -82.3 -38.1 24.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.892 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.702 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 9.2 pt-20 -63.86 -46.49 84.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.8 mt-10 -70.19 -26.4 63.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.252 -173.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -77.8 -6.15 53.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 67.1 m-85 -111.47 19.19 18.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 174.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.59 40.21 6.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.632 174.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.638 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.9 p -127.86 159.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 173.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.36 112.85 10.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.01 0.433 . . . . 0.0 110.095 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.491 HG12 ' OE2' ' A' ' 52' ' ' GLU . 14.2 pt -107.83 163.97 15.8 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.49 133.62 40.81 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.574 1.516 . . . . 0.0 109.771 170.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.63 -34.59 67.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 8.4 t70 -69.43 -18.24 63.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.818 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 66' ' ' ASN . 4.6 t70 -70.15 -31.01 68.31 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.231 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.881 ' HB ' HG21 ' A' ' 45' ' ' VAL . 41.1 t -62.42 -51.51 71.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.448 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -4.98 52.07 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.163 0.506 . . . . 0.0 111.142 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 2.5 t-20 -73.13 -39.08 66.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.8 HD13 ' HB3' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -89.69 147.04 24.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.216 175.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -108.27 -13.43 14.9 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.536 -174.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.887 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 61.4 p -108.2 151.66 25.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.689 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -70.03 -29.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.589 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.605 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -66.75 -30.75 76.73 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.744 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 4.8 t70 -65.59 -53.52 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.8 ' HB3' HD13 ' A' ' 67' ' ' LEU . . . -53.64 -50.52 65.54 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.425 0.631 . . . . 0.0 110.717 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 21.7 m -55.07 -52.82 62.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.98 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.481 ' HD2' HD11 ' A' ' 78' ' ' LEU . 13.3 tptp -64.68 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.15 -46.26 90.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.136 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.578 HG21 HG13 ' A' ' 57' ' ' VAL . 90.8 mt -60.68 -46.43 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.322 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 74' ' ' THR . 83.6 mt -55.14 -42.75 73.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.683 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.1 -4.97 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -128.47 7.52 5.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.86 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.433 0.159 . . . . 0.0 110.728 -176.243 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.515 ' H ' HG23 ' A' ' 4' ' ' THR . 16.0 tt0 -61.29 -55.67 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -63.28 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.541 -173.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.16 -51.43 46.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.712 HG22 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -66.35 -32.53 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.902 -178.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.96 -42.69 95.74 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.35 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.523 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.9 -49.05 61.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.7 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.596 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -42.32 88.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -58.64 -56.71 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.248 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -49.93 -44.52 50.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.836 0.826 . . . . 0.0 110.051 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.774 HG13 ' HB1' ' A' ' 51' ' ' ALA . 15.3 mm -60.88 -54.49 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.231 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.728 HG13 HD13 ' A' ' 37' ' ' LEU . 16.1 t -69.23 -24.2 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.583 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -63.33 -27.04 69.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.7 -30.66 62.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.888 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.691 HD13 ' HB ' ' A' ' 47' ' ' VAL . 42.6 mt -84.51 -54.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.323 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -122.78 -84.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.682 -171.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.74 43.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.44 -1.362 . . . . 0.0 114.54 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.749 HG13 HD11 ' A' ' 37' ' ' LEU . 18.3 mm -82.76 126.69 72.52 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 118.158 0.979 . . . . 0.0 108.655 167.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.729 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.7 Cg_endo -56.43 145.55 78.71 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.244 1.963 . . . . 0.0 111.48 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.669 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 27.0 m -56.61 -32.97 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.07 -17.12 51.19 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.558 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.729 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 16.1 t70 -87.28 -14.03 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.635 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.467 HG23 ' CB ' ' A' ' 13' ' ' ALA . 91.3 t -69.73 122.81 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.321 0.581 . . . . 0.0 110.443 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' O ' HG11 ' A' ' 70' ' ' VAL . 58.7 mtpt -145.78 164.16 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -171.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.447 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.3 mp -78.28 -2.72 39.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.69 -25.62 16.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.983 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -91.14 142.53 27.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.327 0.584 . . . . 0.0 110.842 -169.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 3.6 m -82.82 136.45 34.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.03 -172.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.51 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.67 -43.29 94.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.328 0.585 . . . . 0.0 110.117 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.9 p -72.69 -38.96 67.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.636 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.614 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.1 t70 -92.01 -60.65 1.8 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.896 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.05 -50.05 10.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.251 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.749 HD11 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -66.25 -28.12 68.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 t0 60.12 67.92 0.82 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.739 0.78 . . . . 0.0 109.873 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 43' ' ' SER . 0.6 OUTLIER -128.04 155.46 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.682 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -103.95 168.15 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.597 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 34.0 t -49.4 -57.58 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.721 0.638 . . . . 0.0 111.38 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.81 -40.39 83.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.017 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.706 ' HB2' HG21 ' A' ' 39' ' ' VAL . 4.6 m -51.68 -53.81 34.95 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.855 0.36 . . . . 0.0 111.149 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.92 ' HE1' ' HA ' ' A' ' 65' ' ' LYS . 14.4 ptt? -65.7 -49.89 66.87 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.759 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.884 HG21 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.31 -23.3 29.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.088 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.92 -65.41 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.934 -0.479 . . . . 0.0 111.208 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.691 ' HB ' HD13 ' A' ' 19' ' ' ILE . 11.6 t -86.12 -25.17 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.893 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 15' ' ' ILE . 21.6 t -80.27 -20.17 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.674 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.7 t -77.71 -33.36 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.552 0.691 . . . . 0.0 109.233 166.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.32 -19.9 62.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.399 0.618 . . . . 0.0 109.65 168.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.774 ' HB1' HG13 ' A' ' 15' ' ' ILE . . . -85.93 -33.39 21.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.966 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.726 ' O ' HG11 ' A' ' 57' ' ' VAL . 3.6 pt-20 -65.68 -50.85 63.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.585 -175.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.666 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 39.5 mt-10 -56.67 -37.53 70.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.44 -175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.3 ptp180 -72.2 -7.79 51.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.295 -174.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.56 10.47 21.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.589 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 63.22 39.28 9.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.643 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -114.84 165.49 9.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.578 ' N ' HG21 ' A' ' 57' ' ' VAL . 61.2 tttp -126.97 111.27 13.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.309 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 tt -131.71 120.32 17.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.136 0.493 . . . . 0.0 110.539 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 51.4 Cg_exo -56.8 148.78 64.25 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.038 2.492 . . . . 0.0 113.299 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.21 -47.24 65.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.05 -33.76 73.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.919 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -31.11 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.772 -174.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.884 ' HB ' HG21 ' A' ' 45' ' ' VAL . 11.1 t -73.34 -42.26 57.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.92 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 12.6 tmtt? -55.95 -40.62 73.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.921 171.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -76.5 -2.79 33.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -172.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 4.6 pp -107.03 139.47 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.093 0.473 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -114.24 1.06 14.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.668 -172.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 28.5 p -128.52 153.42 47.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 172.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 28' ' ' LYS . 1.1 p -68.88 -21.79 25.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -70.9 -32.24 66.55 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.95 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' A' ' 67' ' ' LEU . 13.1 m-20 -57.15 -51.21 70.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.796 0.332 . . . . 0.0 110.19 174.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.47 72.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.193 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.733 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -61.63 -53.1 60.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.686 -174.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HD2' HD13 ' A' ' 78' ' ' LEU . 3.7 tptp -62.98 -31.77 72.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.616 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.56 -45.96 77.63 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.408 ' HA ' HG23 ' A' ' 57' ' ' VAL . 52.4 mt -63.66 -46.25 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.224 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 74' ' ' THR . 97.6 mt -61.07 -25.36 66.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.78 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.75 -40.3 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -101.49 21.31 14.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -171.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.049 -179.105 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.562 ' H ' HG23 ' A' ' 4' ' ' THR . 12.3 tt0 -47.24 -55.32 8.85 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -169.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.1 pm0 -71.52 -36.4 71.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.741 0.305 . . . . 0.0 111.524 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -70.73 -47.53 59.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 110.145 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.727 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.76 -31.13 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.47 -39.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.01 97.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 110.402 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.529 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.41 -43.12 79.74 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.705 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.619 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.74 -48.56 80.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.676 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -51.92 -50.09 61.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.366 0.603 . . . . 0.0 111.359 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.88 -30.64 71.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.784 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.617 HG22 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.58 -34.73 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.026 -177.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.716 HG12 HD13 ' A' ' 37' ' ' LEU . 15.7 t -69.62 -24.86 27.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.479 0.657 . . . . 0.0 109.449 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.07 -24.06 66.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB2' HG13 ' A' ' 47' ' ' VAL . 3.8 mm-40 -72.94 -21.38 60.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.597 HD13 ' HB ' ' A' ' 47' ' ' VAL . 46.0 mt -93.56 -52.84 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.589 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.34 -88.58 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.1 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.363 -1.399 . . . . 0.0 114.907 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.732 HG13 HD11 ' A' ' 37' ' ' LEU . 14.6 mm -79.68 125.97 81.42 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.5 Cg_endo -56.02 148.32 58.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.3 2.0 . . . . 0.0 111.307 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.419 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 32.7 m -62.67 -19.25 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 -175.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.83 -19.75 47.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG22 ' A' ' 22' ' ' ILE . 40.8 t0 -98.88 -21.25 16.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.576 -171.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 13' ' ' ALA . 83.5 t -64.52 118.72 7.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.298 0.57 . . . . 0.0 110.826 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' HG11 ' A' ' 70' ' ' VAL . 58.5 mtpt -147.55 172.65 13.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.985 -172.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.3 mp -80.81 -3.86 52.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.311 0.576 . . . . 0.0 110.044 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.5 m-20 -92.79 -23.01 19.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.501 -173.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HZ3' ' HB2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -97.07 141.58 30.04 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.521 -169.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 27.4 m -82.37 136.28 35.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.586 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.54 -50.62 72.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.598 . . . . 0.0 110.104 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.4 p -65.43 -39.63 92.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.67 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 6.7 m-20 -91.99 -69.51 0.74 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.798 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HD12 ' A' ' 22' ' ' ILE . 4.0 m-20 -63.41 -49.71 72.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.682 -175.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.732 HD11 HG13 ' A' ' 22' ' ' ILE . 3.8 mm? -71.39 -9.85 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.28 -174.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.16 38.54 29.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.112 0.482 . . . . 0.0 110.238 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.18 147.47 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.148 0.499 . . . . 0.0 111.319 -171.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.2 169.34 9.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.101 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.0 m -59.93 -45.73 91.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.559 0.537 . . . . 0.0 111.806 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -46.99 64.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.501 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 5.3 m -49.16 -57.11 7.24 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.733 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.659 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 7.9 ptm -57.38 -51.81 67.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.739 HG21 ' HB ' ' A' ' 64' ' ' VAL . 77.2 t -63.57 -24.46 35.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -176.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -75.28 -64.24 1.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.606 -0.684 . . . . 0.0 111.665 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' HB ' HD13 ' A' ' 19' ' ' ILE . 16.7 t -85.08 -23.67 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.166 -174.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 44' ' ' MET . 39.4 t -79.28 -27.09 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.433 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.714 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.2 t -70.83 -35.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.764 0.792 . . . . 0.0 109.025 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -22.45 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG22 ' A' ' 15' ' ' ILE . . . -85.14 -39.36 17.97 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.945 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 7.1 pt-20 -60.67 -48.23 82.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.405 0.621 . . . . 0.0 109.588 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.57 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 36.2 mt-10 -62.48 -36.81 83.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.789 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 12.9 ptp180 -76.71 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 111.179 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.529 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 63.2 m-85 -103.66 15.05 29.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 109.781 172.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 58.79 59.08 2.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.489 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.688 HG11 ' O ' ' A' ' 52' ' ' GLU . 10.4 p -143.96 160.62 15.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -134.15 112.36 11.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.195 0.522 . . . . 0.0 110.041 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.61 HD13 HG23 ' A' ' 64' ' ' VAL . 18.2 pt -118.35 159.39 43.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 137.57 47.97 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.355 2.036 . . . . 0.0 111.838 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.53 -47.3 66.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.5 -32.25 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.277 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.29 -44.59 87.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.739 ' HB ' HG21 ' A' ' 45' ' ' VAL . 39.5 t -54.65 -42.17 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 110.453 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 2.1 tmtm? -77.3 -22.75 51.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.31 -37.9 51.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.422 -175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.644 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -72.58 137.76 46.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.825 0.821 . . . . 0.0 111.471 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -86.88 -28.78 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.671 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 p -117.63 154.23 31.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.549 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -63.75 -28.66 45.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -32.96 85.95 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.591 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.644 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 59.0 m-20 -60.8 -55.97 26.79 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.426 0.155 . . . . 0.0 110.586 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HB3' HD13 ' A' ' 67' ' ' LEU . . . -53.81 -52.65 59.64 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.318 0.58 . . . . 0.0 110.374 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.796 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.6 m -53.14 -51.3 62.4 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.769 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HD2' HD11 ' A' ' 78' ' ' LEU . 8.8 tptm -65.43 -36.23 83.31 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.728 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -66.61 -39.93 88.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.183 0.516 . . . . 0.0 109.755 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.605 HG22 HG13 ' A' ' 57' ' ' VAL . 71.3 mt -61.51 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 172.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 74' ' ' THR . 91.5 mt -65.21 -24.76 67.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.689 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -82.0 -51.06 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -92.29 11.52 25.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.155 -172.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 0.0 110.881 -178.194 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.61 113.92 13.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.172 0.51 . . . . 0.0 112.098 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.07 146.49 41.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.32 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.577 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -88.86 -170.08 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.304 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.577 ' H ' HG21 ' A' ' 4' ' ' THR . 17.9 tt0 -57.62 -56.02 27.27 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -168.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.21 -34.46 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.541 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.91 -53.28 49.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.324 0.583 . . . . 0.0 110.297 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.688 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.4 -34.98 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.953 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.503 HG21 HG23 ' A' ' 74' ' ' THR . 2.1 t -59.85 -41.77 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.863 -0.153 . . . . 0.0 110.932 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.14 86.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.66 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.73 -31.44 73.19 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.882 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -72.09 -50.63 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -54.24 -49.66 68.97 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.487 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -53.07 -36.27 60.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.876 HG22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -34.31 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.785 -174.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.749 HG12 HD13 ' A' ' 37' ' ' LEU . 44.6 t -69.24 -25.13 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.56 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -62.98 -21.43 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.147 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.54 -27.64 51.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.713 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.732 HD12 ' HB ' ' A' ' 47' ' ' VAL . 49.8 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.381 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.22 -87.17 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.6 53.38 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.529 -1.32 . . . . 0.0 114.128 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.729 HG13 HD11 ' A' ' 37' ' ' LEU . 19.3 mm -88.63 125.86 61.74 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.13 144.57 46.58 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.406 2.071 . . . . 0.0 111.434 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.61 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 19.4 m -54.58 -32.94 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.47 -18.08 49.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 22' ' ' ILE . 25.9 t0 -86.75 -18.31 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 13' ' ' ALA . 93.0 t -63.8 112.71 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.666 0.746 . . . . 0.0 110.325 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' O ' HG11 ' A' ' 70' ' ' VAL . 50.0 mttp -135.51 162.81 31.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.758 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.871 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 8.7 mp -76.97 -3.09 37.14 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.87 0.366 . . . . 0.0 110.499 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -8.06 22.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -101.53 140.06 36.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.873 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.6 m -85.31 133.56 34.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.072 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.587 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -59.98 -46.9 87.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.428 0.633 . . . . 0.0 110.321 178.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.9 p -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.392 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 26.4 t70 -93.88 -68.85 0.78 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.095 0.474 . . . . 0.0 112.091 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.51 -49.06 58.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.644 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.749 HD13 HG12 ' A' ' 16' ' ' VAL . 3.4 mm? -67.47 -21.01 65.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.072 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 59.0 38.24 24.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.829 0.823 . . . . 0.0 109.621 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -101.13 156.08 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.595 -174.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.689 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-20 -99.84 155.08 17.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.12 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.9 m -51.41 -45.02 62.41 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.068 0.855 . . . . 0.0 111.426 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -48.17 59.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.2 m -54.31 -51.06 65.85 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.615 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.689 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.5 ptm -60.4 -47.5 85.81 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.677 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.844 HG21 ' HB ' ' A' ' 64' ' ' VAL . 54.6 t -61.61 -27.88 42.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.288 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.96 -65.37 0.85 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.834 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.732 ' HB ' HD12 ' A' ' 19' ' ' ILE . 13.3 t -86.09 -20.82 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.865 -173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.8 t -79.92 -26.45 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.309 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.7 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -70.62 -35.73 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.384 0.611 . . . . 0.0 109.524 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.5 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 110.054 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.876 ' HB1' HG22 ' A' ' 15' ' ' ILE . . . -84.09 -33.53 24.35 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.765 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.2 pt-20 -67.97 -49.72 60.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.196 0.522 . . . . 0.0 109.815 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.596 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 21.3 mt-10 -67.38 -21.89 65.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.1 ptm180 -72.32 -19.62 61.63 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.04 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 93.2 m-85 -99.89 -4.49 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 109.874 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t0 65.23 67.92 0.51 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.666 HG11 ' O ' ' A' ' 52' ' ' GLU . 7.5 p -117.45 164.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.706 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -122.59 109.73 14.67 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 111.049 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -140.61 143.15 31.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.962 173.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -60.92 138.37 78.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.249 1.966 . . . . 0.0 111.575 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -47.52 -57.19 5.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.844 0.83 . . . . 0.0 111.162 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.576 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 12.0 t70 -64.7 -20.72 66.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.5 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.82 -22.02 66.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.24 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.844 ' HB ' HG21 ' A' ' 45' ' ' VAL . 58.6 t -64.25 -29.35 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.688 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -74.66 -14.45 60.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 110.809 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 9.7 t30 -79.63 -32.6 41.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.534 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.983 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -82.78 122.85 28.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -88.86 -11.37 44.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 31.6 p -125.55 155.99 39.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -67.08 -32.58 58.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.871 ' HA2' ' HA ' ' A' ' 29' ' ' LEU . . . -70.76 -35.08 66.36 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.909 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.64 -37.75 82.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 67' ' ' LEU . . . -63.31 -46.56 86.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.809 175.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.818 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -62.78 -49.52 74.65 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.64 -170.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.515 ' HD2' HD13 ' A' ' 78' ' ' LEU . 30.8 mmmt -62.47 -37.03 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.443 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 27.9 t80 -67.43 -40.82 85.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.02 0.438 . . . . 0.0 110.015 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.408 HG22 HG13 ' A' ' 57' ' ' VAL . 65.4 mt -62.76 -36.84 77.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.236 0.541 . . . . 0.0 110.119 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.818 ' HG ' ' O ' ' A' ' 74' ' ' THR . 90.0 mt -71.83 -26.73 62.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.24 -35.72 27.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.741 0.305 . . . . 0.0 111.044 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' O ' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -106.24 20.63 18.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.883 -173.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.0 pt20 -76.16 152.5 36.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.209 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.264 177.788 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.45 ' HB2' ' OE1' ' A' ' 81' ' ' GLN . . . -81.74 131.68 35.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.689 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.96 140.66 47.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.446 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.625 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -84.71 -169.98 2.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.593 0.235 . . . . 0.0 110.77 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 13.1 tt0 -68.06 -47.53 68.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -168.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.625 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.4 pm0 -61.89 -42.03 98.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.177 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 10.5 tp10 -69.24 -51.72 34.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.628 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.739 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.4 -36.26 77.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.027 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' N ' HG21 ' A' ' 8' ' ' ILE . 1.5 t -61.1 -41.85 90.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.21 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.18 97.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.438 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 15' ' ' ILE . . . -64.63 -45.52 92.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.177 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.69 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.48 -50.97 70.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -53.13 -57.59 9.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.52 -33.34 74.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.191 0.52 . . . . 0.0 110.504 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.696 HG22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.0 -34.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.961 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 12' ' ' LEU . 22.0 t -74.16 -24.98 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.822 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.2 -28.72 69.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.844 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.78 -38.42 90.92 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.477 0.656 . . . . 0.0 109.726 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.641 HD13 ' HB ' ' A' ' 47' ' ' VAL . 17.2 mt -75.53 -53.28 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.172 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.86 -86.18 0.53 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.796 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.26 61.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.06 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 37' ' ' LEU . 16.7 mm -88.37 134.2 35.0 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.26 142.16 57.37 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.263 1.975 . . . . 0.0 111.197 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 28.8 m -62.4 -30.67 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 111.505 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 2.0 pm0 -80.56 -17.04 52.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.211 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.85 -14.34 42.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 110.256 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 13' ' ' ALA . 89.0 t -71.87 115.24 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.708 0.766 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -136.17 169.42 17.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.914 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.712 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.4 mp -78.37 -2.7 39.51 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.11 0.481 . . . . 0.0 110.701 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.96 -21.82 17.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.681 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.573 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.88 144.02 25.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.389 -170.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.846 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 15.7 m -83.98 135.13 34.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.479 -172.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.595 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -62.05 -46.9 87.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.293 0.568 . . . . 0.0 110.438 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.8 p -77.64 -29.5 51.72 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.846 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 25.9 t70 -92.22 -66.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.72 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.96 -56.37 5.8 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.084 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.717 HD11 HG13 ' A' ' 22' ' ' ILE . 2.8 mm? -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.749 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.87 65.9 1.38 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.981 0.8 . . . . 0.0 110.044 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.485 ' CG1' ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -123.22 143.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.082 -172.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.688 ' O ' ' HG2' ' A' ' 44' ' ' MET . 5.3 m-20 -88.71 162.6 16.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -53.76 -49.57 67.93 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.957 0.785 . . . . 0.0 110.594 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -49.77 72.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 109.676 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.539 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -55.32 -50.28 70.01 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.046 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.688 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.0 ptm -62.43 -43.5 98.66 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.977 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.578 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 94.7 t -69.02 -25.63 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.848 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -72.8 -65.79 0.75 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.618 -0.676 . . . . 0.0 111.349 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.641 ' HB ' HD13 ' A' ' 19' ' ' ILE . 7.4 t -87.71 -22.48 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.263 -173.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.573 ' HB ' ' O ' ' A' ' 44' ' ' MET . 36.1 t -78.98 -26.43 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.803 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -69.64 -38.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.06 -25.1 63.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 110.675 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.696 ' HB1' HG22 ' A' ' 15' ' ' ILE . . . -84.71 -37.24 21.18 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.803 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 8.1 pt-20 -68.15 -48.9 64.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.568 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.9 mt-10 -64.18 -27.98 69.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.081 -174.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -76.12 -9.43 58.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 80.5 m-85 -105.93 17.96 22.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 66.62 24.16 10.17 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.595 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 77' ' ' ILE . 11.3 p -113.86 151.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 58' ' ' LYS . 2.1 tmtt? -135.78 113.77 11.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.222 170.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 64' ' ' VAL . 13.0 pt -102.98 165.61 13.33 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.697 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 50.1 Cg_exo -54.94 119.4 6.44 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.527 1.485 . . . . 0.0 111.01 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.57 -40.55 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 110.553 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.47 -23.39 67.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.408 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 20.5 t70 -78.04 -25.63 47.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.782 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.717 HG21 HD12 ' A' ' 59' ' ' ILE . 44.7 t -62.32 -32.06 53.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.596 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.97 -31.86 66.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.974 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -72.04 -39.7 68.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.743 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.993 HD12 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.24 131.69 39.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.385 0.612 . . . . 0.0 110.872 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -104.94 -1.29 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.517 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 66.0 p -126.85 147.87 50.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -66.22 -32.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 109.798 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -67.71 -43.38 84.86 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.87 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.26 -41.69 84.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 67' ' ' LEU . . . -59.5 -59.76 4.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.153 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.778 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 12.7 m -58.27 -47.11 84.64 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.02 -173.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD3' HD23 ' A' ' 29' ' ' LEU . 35.3 tptt -66.04 -33.33 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.447 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 54.1 t80 -66.92 -42.19 85.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.603 HG21 HG12 ' A' ' 57' ' ' VAL . 66.3 mt -58.12 -46.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.286 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 74' ' ' THR . 81.7 mt -66.66 -38.17 86.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.311 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -74.27 -21.04 59.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -128.48 29.11 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.45 ' OE1' ' HB2' ' A' ' 2' ' ' ALA . 3.6 pt20 -79.38 -179.53 6.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.783 0.325 . . . . 0.0 111.444 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.987 -178.306 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.773 0.32 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.32 44.01 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' O ' HD21 ' A' ' 78' ' ' LEU . . . -114.19 131.02 56.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.23 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -87.88 -166.25 1.53 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.584 ' H ' HG23 ' A' ' 4' ' ' THR . 5.9 tt0 -63.04 -56.01 20.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.968 0.168 . . . . 0.0 111.178 -171.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.1 pm0 -60.67 -36.04 77.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.69 0.281 . . . . 0.0 111.279 -173.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -69.34 -56.27 7.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.445 0.64 . . . . 0.0 110.397 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.707 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.25 -34.62 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.946 -177.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -61.43 -39.12 81.75 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.794 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.9 88.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.637 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.4 -39.08 91.54 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.658 HD21 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -66.72 -51.63 53.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.35 -48.69 76.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.734 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -51.83 -36.44 48.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.819 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.826 HG22 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.19 -40.27 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.142 -174.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.663 HG12 HD13 ' A' ' 37' ' ' LEU . 13.2 t -68.34 -24.63 29.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.347 0.594 . . . . 0.0 109.592 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.95 -27.19 65.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.57 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.89 -47.88 42.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.205 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.538 HD13 ' HB ' ' A' ' 47' ' ' VAL . 20.1 mt -59.02 -52.79 56.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.057 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.99 -84.48 0.61 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.835 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.38 59.48 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.985 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.739 HG13 HD11 ' A' ' 37' ' ' LEU . 29.0 mm -94.91 128.54 38.88 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 148.48 42.67 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.567 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.6 m -64.65 -17.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.66 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.15 -21.31 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.196 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' HB3' HG21 ' A' ' 22' ' ' ILE . 22.2 t0 -99.17 -13.51 19.73 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 111.457 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.96 121.95 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.328 0.585 . . . . 0.0 110.3 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 70' ' ' VAL . 50.4 mtpt -145.23 165.61 27.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.683 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.571 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 8.4 mp -75.64 -0.97 22.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.464 0.65 . . . . 0.0 109.863 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -97.17 -22.39 16.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.007 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.662 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.04 141.57 29.28 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.608 -172.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 13.7 t -81.21 132.97 35.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.245 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.573 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.55 -47.76 84.31 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.552 0.692 . . . . 0.0 110.074 176.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.6 p -74.58 -37.46 62.91 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.549 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 33.5 t70 -92.35 -59.7 2.02 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.16 -49.43 23.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.739 HD11 HG13 ' A' ' 22' ' ' ILE . 3.2 mm? -72.58 -16.55 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.621 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 57.07 34.59 25.13 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.064 0.935 . . . . 0.0 109.455 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -87.79 160.47 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 -171.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.764 ' O ' ' HG2' ' A' ' 44' ' ' MET . 1.2 t70 -112.93 155.46 24.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.976 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 34.9 t -41.74 -59.47 1.65 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.362 1.039 . . . . 0.0 112.17 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.77 62.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.512 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 24.5 m -53.46 -51.2 63.47 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.802 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.764 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.1 ptm -62.98 -47.49 82.95 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.668 HG21 ' HB ' ' A' ' 64' ' ' VAL . 97.1 t -66.2 -22.6 30.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.881 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -75.39 -66.94 0.71 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.609 -0.682 . . . . 0.0 111.752 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 15' ' ' ILE . 4.9 t -84.17 -22.85 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.799 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.0 t -79.9 -22.6 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.214 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.1 t -68.44 -37.32 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 166.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.33 -25.01 68.1 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.378 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.826 ' HB2' HG22 ' A' ' 15' ' ' ILE . . . -82.54 -37.4 25.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.351 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.729 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 3.5 pt-20 -67.17 -48.66 67.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.473 0.654 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.604 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 85.1 mt-10 -70.44 -23.61 62.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.949 -172.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.3 ptm180 -73.36 -10.81 60.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.891 0.377 . . . . 0.0 110.367 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 55.1 m-85 -109.41 19.49 19.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.426 175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 66.95 26.8 9.05 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.476 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.637 HG12 HG21 ' A' ' 77' ' ' ILE . 10.2 p -118.02 155.63 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' A' ' 58' ' ' LYS . 35.7 tptt -134.83 114.71 12.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.179 0.514 . . . . 0.0 110.585 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.651 HD12 HG23 ' A' ' 64' ' ' VAL . 20.5 pt -104.11 163.33 17.54 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.439 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 27.8 Cg_exo -61.16 132.36 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.963 1.775 . . . . 0.0 111.165 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.76 -51.48 49.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.0 111.002 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.24 -20.57 64.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.92 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 9.0 t70 -71.67 -34.44 69.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.816 -0.174 . . . . 0.0 110.968 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.668 ' HB ' HG21 ' A' ' 45' ' ' VAL . 41.9 t -59.91 -39.48 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 15.7 tptp -72.03 -20.17 61.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.92 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -75.13 -35.16 61.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -81.04 153.78 27.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.0 mptp? -104.99 -29.05 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.086 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.784 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.1 p -111.11 156.64 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.26 -31.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.4 -35.72 92.1 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.196 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 63.3 m-20 -56.26 -57.35 12.62 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.662 0.268 . . . . 0.0 110.431 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -55.99 -44.7 78.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.372 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.755 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 19.7 m -56.51 -53.74 53.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.752 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -66.23 -37.19 84.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 40.5 t80 -59.68 -41.71 91.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.698 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.637 HG21 HG12 ' A' ' 57' ' ' VAL . 58.6 mt -64.94 -48.44 84.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.803 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 74' ' ' THR . 85.8 mt -64.63 -44.26 91.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.444 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -5.26 59.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 76' ' ' TYR . 26.3 m-70 -126.43 15.43 7.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -76.56 153.21 35.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.502 -174.241 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.785 0.326 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.0 31.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.59 117.03 17.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 -175.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -81.1 177.86 8.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.535 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -49.81 -53.12 27.28 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 7' ' ' GLU . 8.3 pt-20 -55.22 -49.09 72.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 111.54 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 6' ' ' GLU . 36.5 mt-10 -66.55 -50.7 62.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.214 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.721 HG22 HD23 ' A' ' 78' ' ' LEU . 3.0 tt -67.13 -35.33 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.862 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.96 -35.9 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.379 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.22 -43.42 78.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.924 0.392 . . . . 0.0 110.665 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.3 85.51 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.801 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -43.86 97.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.12 -54.89 37.49 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.149 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -52.8 -43.39 65.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.56 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.683 HG23 ' HB3' ' A' ' 51' ' ' ALA . 7.3 mm -62.27 -53.8 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.247 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG12 HD13 ' A' ' 37' ' ' LEU . 12.1 t -70.48 -23.34 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 0.0 110.635 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -60.79 -29.23 69.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.41 -43.23 67.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 110.274 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.519 HD13 ' HB ' ' A' ' 47' ' ' VAL . 17.4 mt -65.53 -52.56 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.185 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -76.4 0.57 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.1 51.31 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.379 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.763 HG13 HD11 ' A' ' 37' ' ' LEU . 10.6 mm -80.55 124.86 81.82 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.741 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 8.1 Cg_endo -53.38 147.27 37.73 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.698 2.266 . . . . 0.0 111.525 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.669 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.1 m -61.39 -30.82 48.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -172.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.21 -17.29 52.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.856 0.36 . . . . 0.0 111.401 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.741 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 2.7 t70 -86.03 -18.97 31.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.941 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 13' ' ' ALA . 84.5 t -67.41 120.39 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.658 0.742 . . . . 0.0 110.525 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HE3' ' OD1' ' A' ' 30' ' ' ASP . 26.2 mtpp -142.36 165.23 27.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.441 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 7.6 mp -77.95 -3.27 41.05 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' OD1' ' HE3' ' A' ' 28' ' ' LYS . 12.8 p-10 -107.29 -8.31 16.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.494 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -90.71 139.81 30.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.7 m -89.1 135.59 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.376 -171.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.529 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -58.04 -47.56 82.72 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 110.193 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 p -72.12 -32.13 66.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.481 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.76 -69.84 0.73 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.272 0.558 . . . . 0.0 111.602 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.67 -48.4 26.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.941 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.763 HD11 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -66.68 -17.91 65.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.441 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.04 36.06 18.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.935 0.874 . . . . 0.0 109.679 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -98.47 150.13 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.746 -171.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.758 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.6 t70 -97.53 154.62 17.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.996 173.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 45' ' ' VAL . 30.4 m -51.99 -44.85 64.25 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.699 0.624 . . . . 0.0 111.632 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 tp -77.58 -39.34 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.954 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.48 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 51.6 m -55.34 -48.67 73.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.758 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 6.4 ptm -62.47 -45.84 91.22 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.749 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.831 HG21 ' HB ' ' A' ' 64' ' ' VAL . 85.2 t -64.36 -23.04 32.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.713 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.21 -65.73 0.81 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.936 -0.478 . . . . 0.0 111.696 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG11 HG22 ' A' ' 15' ' ' ILE . 18.9 t -89.67 -20.53 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.272 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 44' ' ' MET . 19.8 t -80.08 -17.0 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.0 t -78.57 -34.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 121.536 0.684 . . . . 0.0 109.209 165.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 47' ' ' VAL . . . -59.5 -24.18 63.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.567 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.683 ' HB3' HG23 ' A' ' 15' ' ' ILE . . . -81.76 -38.76 25.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.677 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.745 ' O ' HG11 ' A' ' 57' ' ' VAL . 5.9 pt-20 -60.4 -47.4 86.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.692 0.758 . . . . 0.0 109.46 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 22.6 mt-10 -74.75 -21.74 59.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.809 -171.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 3.7 ptp180 -74.21 -12.15 60.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.019 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.0 10.13 39.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.72 30.42 16.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.001 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.745 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -115.17 162.74 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.574 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 24.3 mmmt -128.7 116.02 18.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.252 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.472 HD13 HG21 ' A' ' 64' ' ' VAL . 44.2 pt -117.61 158.7 44.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.629 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 18.7 Cg_exo -69.43 135.44 31.25 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.548 2.165 . . . . 0.0 112.302 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.8 -58.15 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.592 0.711 . . . . 0.0 110.79 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -17.75 64.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.349 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.629 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.3 t0 -76.07 -19.56 58.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.105 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.831 ' HB ' HG21 ' A' ' 45' ' ' VAL . 24.6 t -72.73 -52.61 22.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.524 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -68.82 -7.25 32.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -76.43 -36.21 58.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.087 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.758 HD12 ' HB3' ' A' ' 73' ' ' ALA . 1.1 pp -89.24 128.17 35.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.47 0.652 . . . . 0.0 111.016 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.92 1.0 55.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.89 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 74.7 p -130.15 147.91 51.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.553 0.216 . . . . 0.0 110.543 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 31' ' ' LYS . 1.6 p -69.43 -34.42 62.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.943 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.6 -41.37 97.28 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.91 -49.75 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.758 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -52.45 -54.27 34.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.627 0.727 . . . . 0.0 111.164 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.1 m -58.08 -48.55 79.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.636 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HD2' HD13 ' A' ' 78' ' ' LEU . 12.2 tptp -69.2 -29.09 66.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.216 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.24 -46.35 80.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.802 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.51 -36.78 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.307 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 74' ' ' THR . 92.3 mt -70.6 -31.86 69.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.768 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.26 -42.2 17.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.064 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -96.08 13.24 27.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.91 135.3 55.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.496 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.075 -175.438 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.805 0.336 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.48 147.22 23.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.038 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.47 136.67 32.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.817 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.593 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -99.62 -170.96 1.97 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.593 ' H ' HG21 ' A' ' 4' ' ' THR . 15.2 tp60 -48.7 -53.36 19.15 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -46.85 87.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.32 -43.41 50.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.845 0.355 . . . . 0.0 111.284 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.652 HG22 HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.48 -34.1 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.59 -42.41 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.129 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.92 92.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.607 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.578 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -66.8 -39.18 93.48 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.534 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.92 -49.45 70.37 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -56.02 -50.45 70.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.68 -36.51 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.718 HG22 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -39.36 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.254 -175.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.724 HG12 HD13 ' A' ' 37' ' ' LEU . 41.7 t -70.11 -24.99 26.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.097 0.475 . . . . 0.0 110.079 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -62.29 -24.53 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -72.33 -39.46 68.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 109.795 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.708 HD13 ' HB ' ' A' ' 47' ' ' VAL . 26.9 mt -72.63 -50.64 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.226 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.83 -77.75 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.259 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.62 44.19 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.788 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.742 HG13 HD11 ' A' ' 37' ' ' LEU . 9.1 mm -75.04 134.97 74.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.61 144.14 53.9 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.469 2.113 . . . . 0.0 111.449 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.623 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 82.3 t -59.69 -38.13 74.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.364 . . . . 0.0 111.021 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -74.29 -17.95 60.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.68 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 22' ' ' ILE . 14.0 t0 -87.51 -16.84 33.55 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.214 -0.304 . . . . 0.0 111.594 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.459 HG23 ' HA ' ' A' ' 13' ' ' ALA . 89.8 t -64.97 116.96 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.566 0.698 . . . . 0.0 110.445 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -141.02 162.02 36.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.194 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HG ' ' CA ' ' A' ' 71' ' ' GLY . 9.7 mp -79.25 -4.19 49.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.35 -8.38 21.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -97.56 134.57 40.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 18.1 m -89.39 140.91 29.04 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 111.46 -170.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.639 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 1.1 m-85 -58.81 -50.92 72.15 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 110.152 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.3 p -69.53 -33.06 72.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.406 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.18 -68.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' CG ' ' HZ3' ' A' ' 31' ' ' LYS . 10.3 t0 -78.42 -51.52 9.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.4 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.742 HD11 HG13 ' A' ' 22' ' ' ILE . 3.8 mm? -64.8 -13.31 55.09 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 58.13 38.83 26.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 109.539 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.41 149.79 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.913 -172.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.76 166.29 11.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.466 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 15.4 p -54.83 -56.72 16.36 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.099 0.249 . . . . 0.0 111.634 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.34 -38.87 92.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.533 0.206 . . . . 0.0 111.263 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.497 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 25.1 m -52.66 -54.37 34.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.031 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 1.014 ' HE1' ' HA ' ' A' ' 65' ' ' LYS . 15.2 ptt? -64.26 -48.02 77.34 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.646 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.9 HG21 ' HB ' ' A' ' 64' ' ' VAL . 99.1 t -55.28 -28.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.994 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.22 -66.13 0.87 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.761 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.708 ' HB ' HD13 ' A' ' 19' ' ' ILE . 14.4 t -83.33 -22.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.134 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 44' ' ' MET . 44.9 t -79.9 -19.92 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.917 -0.489 . . . . 0.0 110.295 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.696 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -75.22 -32.88 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.249 167.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.32 66.97 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.605 169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.718 ' HB2' HG22 ' A' ' 15' ' ' ILE . . . -82.53 -32.48 28.62 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.888 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.709 ' O ' HG11 ' A' ' 57' ' ' VAL . 5.8 pt-20 -66.11 -54.08 29.99 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.638 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 16.5 mt-10 -71.61 -20.36 61.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.227 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 13.3 ptm180 -69.68 -15.24 63.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.101 0.477 . . . . 0.0 110.048 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.578 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 65.3 m-85 -107.3 15.03 25.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.014 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.33 27.37 8.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.72 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.1 p -113.67 165.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.53 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 17.1 pttm -132.26 119.1 20.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 110.427 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.04 154.65 53.36 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -63.73 128.96 23.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.899 1.732 . . . . 0.0 111.524 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.49 -40.07 58.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.479 0.657 . . . . 0.0 109.709 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.78 -35.5 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.104 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -74.42 -29.64 61.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.9 ' HB ' HG21 ' A' ' 45' ' ' VAL . 21.7 t -61.58 -40.59 87.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.376 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 1.014 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.17 -5.65 59.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 177.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -80.82 -23.64 39.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.067 0.46 . . . . 0.0 110.282 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -95.28 143.72 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.412 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 11.9 mptt -101.54 -17.66 16.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.774 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 19.1 p -118.77 156.06 30.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.586 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -65.38 -33.99 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.035 0.445 . . . . 0.0 109.944 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' CA ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.8 -35.58 86.99 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 69.5 m-20 -58.8 -58.54 8.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.516 0.186 . . . . 0.0 110.638 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -55.26 -47.65 75.15 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.736 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.0 m -57.02 -54.08 50.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.088 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -69.78 -31.43 69.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.211 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -61.08 -45.28 95.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.933 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.603 HG21 HG13 ' A' ' 57' ' ' VAL . 61.2 mt -59.49 -44.5 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 74' ' ' THR . 81.2 mt -71.96 -29.11 63.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.964 -174.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.76 -24.89 61.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.651 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -124.1 28.92 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -68.37 170.74 8.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.148 0.499 . . . . 0.0 112.089 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.755 179.322 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.848 0.356 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.12 166.64 10.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.472 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . . . -105.96 140.08 39.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.291 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -86.66 -168.98 2.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.95 178.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.499 ' H ' HG23 ' A' ' 4' ' ' THR . 12.2 tt0 -55.35 -56.61 18.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.19 -34.41 78.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 0.0 111.491 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 3' ' ' ALA . 39.5 mt-10 -70.7 -51.21 29.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.692 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.46 -32.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.77 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.2 -44.02 90.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.89 87.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 110.69 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.86 -42.86 59.92 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.983 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.612 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.56 -40.95 98.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.743 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -57.85 -51.67 68.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.103 177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -54.21 -39.59 66.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.197 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.742 HG23 ' HB3' ' A' ' 51' ' ' ALA . 6.4 mm -67.93 -52.77 35.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.218 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.76 HG12 HD13 ' A' ' 37' ' ' LEU . 5.8 t -68.03 -22.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.148 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.51 -31.61 69.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -76.66 -24.82 53.27 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 110.411 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.556 HG23 HG21 ' A' ' 39' ' ' VAL . 22.2 mt -81.92 -54.36 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.671 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.41 -78.05 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.938 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.74 57.49 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.557 -1.306 . . . . 0.0 114.696 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.732 HG13 HD11 ' A' ' 37' ' ' LEU . 20.9 mm -90.72 129.81 43.24 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 164.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.54 147.16 39.73 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.349 2.033 . . . . 0.0 111.981 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 25.3 m -61.09 -26.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.441 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.34 -17.52 48.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.64 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 22' ' ' ILE . 2.3 t70 -96.23 -15.55 21.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.743 HG22 ' HA ' ' A' ' 13' ' ' ALA . 76.9 t -68.66 126.74 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.592 0.711 . . . . 0.0 110.571 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HE2' ' HB3' ' A' ' 30' ' ' ASP . 42.5 mtpt -140.2 173.45 11.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.692 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 30.2 mt -82.07 -3.29 54.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.895 0.855 . . . . 0.0 108.695 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.554 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 6.2 t70 -95.62 -27.1 15.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.592 -170.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' O ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -91.86 144.15 25.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.991 -174.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 22.3 m -84.54 135.35 34.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.647 ' CD2' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -60.82 -48.13 83.2 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.242 0.544 . . . . 0.0 110.135 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 p -66.59 -38.07 86.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.503 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -92.75 -65.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.989 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.3 m-20 -69.42 -48.53 60.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.848 -174.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.76 HD13 HG12 ' A' ' 16' ' ' VAL . 3.6 mm? -74.87 -4.59 38.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.131 -171.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.36 58.8 5.1 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.934 0.772 . . . . 0.0 109.34 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.556 HG21 HG23 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -122.44 152.21 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.689 -170.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.529 ' H ' ' HB3' ' A' ' 43' ' ' SER . 12.4 t70 -119.46 162.31 19.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.621 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.623 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 p -39.25 -58.09 1.25 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -74.35 -44.52 51.99 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.375 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.529 ' HB3' ' H ' ' A' ' 40' ' ' ASP . 30.6 t -45.27 -58.98 2.9 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.643 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.442 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 10.4 ptm -60.78 -50.15 74.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.754 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG21 ' HB ' ' A' ' 64' ' ' VAL . 70.0 t -63.76 -21.64 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.103 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.944 -0.472 . . . . 0.0 111.372 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 15' ' ' ILE . 6.6 t -89.92 -21.67 6.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.858 -173.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 44' ' ' MET . 38.6 t -79.78 -24.01 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.172 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.711 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.4 t -70.27 -39.06 76.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 167.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.0 -21.56 61.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.579 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB3' HG23 ' A' ' 15' ' ' ILE . . . -84.59 -46.57 11.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.842 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 10.6 pt-20 -63.25 -46.53 86.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 110.159 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.78 -24.98 64.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.485 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 14.7 ptm180 -75.19 -18.65 60.12 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.215 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -97.27 9.89 41.0 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.39 0.614 . . . . 0.0 109.361 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 66.36 52.6 1.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.198 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 52' ' ' GLU . 7.3 p -137.52 152.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -134.32 112.12 10.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.679 0.276 . . . . 0.0 110.54 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.668 HD12 HG23 ' A' ' 64' ' ' VAL . 8.1 pt -110.01 165.23 13.06 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.37 134.74 43.15 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.699 1.599 . . . . 0.0 111.393 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 45' ' ' VAL . 1.6 m-20 -51.38 -43.8 61.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.742 0.782 . . . . 0.0 110.068 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.13 -31.33 65.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.861 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.47 -35.23 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.166 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.695 ' HB ' HG21 ' A' ' 45' ' ' VAL . 55.5 t -58.45 -42.63 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.623 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 16.6 tptp -74.66 -20.63 59.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.838 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -73.63 -28.24 61.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.054 0.454 . . . . 0.0 110.011 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -88.22 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 111.004 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -99.72 -14.8 18.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.354 -171.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 26.2 p -115.45 157.68 23.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.647 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.2 p -70.19 -24.27 25.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.448 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -37.14 94.02 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.815 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.678 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.2 m-20 -56.92 -58.07 9.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.41 0.148 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.621 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -55.65 -50.17 70.94 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.27 0.557 . . . . 0.0 110.747 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.754 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 37.0 m -55.25 -50.68 68.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.926 -176.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -67.74 -31.27 71.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.357 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.45 -42.96 86.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.756 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.471 HG21 HG13 ' A' ' 57' ' ' VAL . 91.0 mt -59.81 -40.31 82.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.262 174.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 74' ' ' THR . 87.8 mt -73.07 -38.86 66.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.002 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.84 -27.44 55.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.283 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -116.55 26.57 9.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 111.419 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.01 134.05 46.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.407 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.819 176.196 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.75 158.47 28.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.27 120.22 22.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.249 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -85.07 -171.47 3.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.457 ' H ' HG23 ' A' ' 4' ' ' THR . 12.6 tt0 -51.58 -56.11 15.39 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -169.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -64.83 -35.37 80.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.73 -48.46 31.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.851 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.735 HG22 HD23 ' A' ' 78' ' ' LEU . 1.8 tt -68.57 -33.34 59.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.06 -35.96 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.301 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.25 85.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.762 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -71.02 -38.23 63.98 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.588 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.32 -44.44 96.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -58.78 -48.75 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.16 -32.88 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.139 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.979 HG22 ' HB1' ' A' ' 51' ' ' ALA . 4.1 mm -78.08 -50.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.561 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 37' ' ' LEU . 9.3 t -67.11 -23.53 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.23 0.538 . . . . 0.0 109.982 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.44 -25.11 65.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.33 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' HG13 ' A' ' 47' ' ' VAL . 7.6 tp10 -73.65 -30.13 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.091 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.572 HD13 ' HB ' ' A' ' 47' ' ' VAL . 36.2 mt -84.53 -52.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.679 -172.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 -88.26 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.752 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.38 56.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.512 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 HD11 ' A' ' 37' ' ' LEU . 26.9 mm -98.27 122.27 54.48 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 163.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.51 145.99 44.55 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.444 2.096 . . . . 0.0 111.5 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.72 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 35.3 m -58.7 -22.02 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.176 0.512 . . . . 0.0 111.887 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.81 -17.66 46.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.797 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 22' ' ' ILE . 3.4 t70 -102.24 -9.42 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -172.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 13' ' ' ALA . 36.1 t -68.13 123.14 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.396 0.617 . . . . 0.0 110.404 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' O ' HG11 ' A' ' 70' ' ' VAL . 57.0 mttt -141.21 166.16 25.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.575 -171.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HG ' ' CA ' ' A' ' 71' ' ' GLY . 10.2 mp -78.59 -2.98 41.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.296 0.57 . . . . 0.0 109.485 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.09 -20.2 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.648 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -99.79 144.74 28.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.948 -172.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.748 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 18.5 t -87.39 134.0 33.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.086 -172.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -58.57 -42.66 88.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.0 110.253 176.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.0 p -79.02 -32.55 45.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.636 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.748 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.8 t70 -92.95 -56.59 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.052 0.453 . . . . 0.0 111.824 -175.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -88.93 -40.35 13.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.119 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.741 HD13 HG12 ' A' ' 16' ' ' VAL . 3.8 mm? -78.32 -3.85 45.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.526 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 52.7 38.84 27.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.082 0.467 . . . . 0.0 110.865 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 44' ' ' MET . 0.4 OUTLIER -108.41 141.03 24.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.46 . . . . 0.0 111.874 -170.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.748 ' O ' ' HG2' ' A' ' 44' ' ' MET . 13.8 m-20 -95.23 162.39 13.71 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.931 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -50.37 -41.7 52.18 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.942 0.776 . . . . 0.0 111.137 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.55 -53.36 16.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.564 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.516 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 18.7 m -51.41 -48.81 62.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.526 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.748 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.4 ptm -60.56 -56.76 17.51 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.768 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.787 HG21 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.37 -24.47 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.468 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.08 -65.44 0.8 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.596 -0.69 . . . . 0.0 111.287 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.65 HG11 HG21 ' A' ' 15' ' ' ILE . 11.1 t -88.01 -20.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.698 -173.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.4 t -79.83 -19.75 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.976 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -73.83 -34.56 40.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 165.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -63.02 -21.78 66.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.843 169.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.979 ' HB1' HG22 ' A' ' 15' ' ' ILE . . . -84.47 -34.39 23.41 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.706 ' O ' HG11 ' A' ' 57' ' ' VAL . 9.6 pt-20 -68.57 -49.9 55.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.564 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 37.9 mt-10 -67.56 -25.1 65.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.469 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -72.11 -16.61 62.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.054 0.454 . . . . 0.0 110.63 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.762 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 82.0 m-85 -106.53 15.77 25.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.66 33.16 18.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.861 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.706 HG11 ' O ' ' A' ' 52' ' ' GLU . 7.2 p -111.64 161.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -134.88 110.8 9.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 pt -121.27 160.81 44.07 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.1 Cg_exo -66.28 137.91 49.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.645 2.23 . . . . 0.0 111.683 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.78 -44.53 96.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.118 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.38 -18.35 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.985 0.421 . . . . 0.0 110.661 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 7.3 t70 -67.14 -41.93 85.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.787 ' HB ' HG21 ' A' ' 45' ' ' VAL . 37.7 t -59.77 -47.66 90.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.129 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.38 -1.5 30.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.396 . . . . 0.0 111.683 -176.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -92.05 -36.6 13.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.33 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -74.58 138.35 42.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.777 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -94.98 -20.63 19.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.155 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.8 p -116.48 156.39 26.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.614 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -66.53 -29.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' CA ' ' HG ' ' A' ' 29' ' ' LEU . . . -63.71 -36.23 93.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.589 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.4 m-20 -55.03 -59.27 4.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.595 0.235 . . . . 0.0 111.041 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 67' ' ' LEU . . . -55.27 -47.9 74.8 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.776 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 11.5 m -57.54 -51.64 68.65 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.83 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -65.84 -34.92 79.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.136 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.81 -45.8 90.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.241 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.59 HG22 HG13 ' A' ' 57' ' ' VAL . 81.2 mt -57.18 -45.53 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.893 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' A' ' 74' ' ' THR . 94.6 mt -65.05 -21.85 66.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.554 -171.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.71 -22.7 27.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.175 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.02 27.8 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.4 pt20 -74.74 148.09 40.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.773 179.068 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.05 156.19 19.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.984 0.421 . . . . 0.0 110.866 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.57 118.94 37.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.499 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -78.15 -176.82 4.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.836 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.499 ' H ' HG21 ' A' ' 4' ' ' THR . 0.4 OUTLIER -58.58 -52.95 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -176.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 3.0 pm0 -59.5 -35.15 73.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.042 0.448 . . . . 0.0 111.264 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.53 -58.4 4.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.623 0.725 . . . . 0.0 110.599 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.685 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.67 -33.51 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.326 -175.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.92 -42.14 91.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.93 -0.123 . . . . 0.0 110.78 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.92 91.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.367 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.671 ' HA2' ' CE2' ' A' ' 55' ' ' PHE . . . -69.75 -41.49 73.89 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.526 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.585 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.14 -47.49 84.3 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -50.4 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.71 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.67 -37.0 58.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.898 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.761 HG23 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.27 -34.23 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.599 -174.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.734 HG12 HD13 ' A' ' 37' ' ' LEU . 47.0 t -70.7 -24.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 O-C-N 121.645 -0.659 . . . . 0.0 109.482 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.21 -20.73 66.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.943 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -75.49 -29.47 59.55 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.207 0.527 . . . . 0.0 110.209 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.694 HD13 ' HB ' ' A' ' 47' ' ' VAL . 28.1 mt -83.74 -52.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.13 -91.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.264 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.44 54.36 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.036 -1.554 . . . . 0.0 114.789 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.712 HG13 HD11 ' A' ' 37' ' ' LEU . 22.2 mm -87.92 125.11 65.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 164.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 146.14 51.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.6 2.2 . . . . 0.0 111.169 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 33.2 m -60.68 -26.75 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.865 0.364 . . . . 0.0 111.773 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.26 -18.88 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.088 0.471 . . . . 0.0 111.355 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.475 ' HB3' HG21 ' A' ' 22' ' ' ILE . 25.2 t0 -90.28 -18.9 24.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.971 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 13' ' ' ALA . 87.7 t -66.52 117.02 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.651 0.739 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HE2' ' OD1' ' A' ' 30' ' ' ASP . 31.1 mtpt -141.82 170.76 15.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.688 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.64 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 23.4 mt -81.57 -4.18 55.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.007 0.432 . . . . 0.0 110.221 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 3.7 p-10 -111.36 13.5 21.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -173.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.537 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -114.18 143.21 45.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.539 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 35' ' ' ASP . 13.4 m -82.11 136.16 35.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.754 0.311 . . . . 0.0 110.637 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -65.15 -47.63 76.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.258 0.551 . . . . 0.0 109.931 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.3 p -67.2 -38.23 84.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.327 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.62 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.5 m-20 -91.73 -68.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.706 -173.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.86 -48.4 54.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.244 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.734 HD13 HG12 ' A' ' 16' ' ' VAL . 3.8 mm? -68.86 -10.94 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 55.73 51.7 12.02 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.81 0.814 . . . . 0.0 109.551 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -122.18 146.35 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.539 -169.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.748 ' O ' ' HG2' ' A' ' 44' ' ' MET . 20.2 m-20 -102.71 162.68 12.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.978 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.592 ' HG ' ' HB2' ' A' ' 65' ' ' LYS . 31.5 t -49.16 -51.07 34.72 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.258 0.974 . . . . 0.0 111.195 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.01 -43.4 68.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.586 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 12.0 m -55.21 -55.8 27.16 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.748 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.6 ptm -55.43 -58.4 7.9 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.474 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.629 HG21 ' HB ' ' A' ' 64' ' ' VAL . 63.7 t -58.09 -26.46 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.695 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.1 -65.65 0.78 Allowed 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.601 -0.687 . . . . 0.0 111.415 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.694 ' HB ' HD13 ' A' ' 19' ' ' ILE . 11.0 t -84.88 -23.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.808 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 44' ' ' MET . 65.6 t -74.1 -31.11 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.998 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.815 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 6.2 t -69.36 -34.72 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.376 0.608 . . . . 0.0 109.678 171.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.87 67.49 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.95 -0.469 . . . . 0.0 110.616 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 15' ' ' ILE . . . -85.01 -41.12 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.875 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.815 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -61.62 -44.29 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.181 0.515 . . . . 0.0 110.315 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.83 -31.62 71.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.347 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.2 ptm180 -74.76 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.053 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.671 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 57.3 m-85 -104.51 13.21 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.606 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 57.45 70.54 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.083 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 52' ' ' GLU . 10.0 p -129.43 165.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 171.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.51 ' N ' HG21 ' A' ' 57' ' ' VAL . 64.3 mttm -128.08 111.55 13.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 0.0 110.232 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.502 HD13 ' CD2' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -149.12 132.84 8.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.429 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 20.5 Cg_exo -64.96 140.96 68.57 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.134 1.89 . . . . 0.0 111.299 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HB2' ' CG1' ' A' ' 45' ' ' VAL . 7.8 p-10 -56.51 -32.01 64.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.74 0.781 . . . . 0.0 110.083 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 28.7 t70 -60.11 -27.03 66.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.429 -1.259 . . . . 0.0 111.53 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.04 -36.12 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.817 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 21.4 t -60.69 -44.35 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.613 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HB2' ' HG ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -79.8 -2.41 43.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 0.0 111.36 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -92.78 -19.49 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.163 0.506 . . . . 0.0 109.78 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 1.5 pp -93.97 128.3 40.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -97.14 3.55 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.545 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.594 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 81.5 p -129.03 143.99 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.56 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -64.71 -37.24 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.991 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 29' ' ' LEU . . . -63.45 -32.6 84.7 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.818 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 11.7 t70 -59.96 -51.22 70.58 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -55.51 -49.58 72.21 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.693 175.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.779 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 1.8 m -58.91 -52.53 65.35 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.642 -173.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD2' HD13 ' A' ' 78' ' ' LEU . 14.5 tptp -65.97 -34.79 78.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.071 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CD2' HD13 ' A' ' 59' ' ' ILE . 53.0 t80 -62.33 -47.28 84.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.766 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.419 ' HA ' HG23 ' A' ' 57' ' ' VAL . 54.0 mt -58.81 -46.7 90.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.594 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 74' ' ' THR . 86.7 mt -61.44 -26.4 67.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.946 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.57 -29.74 21.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 111.598 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -115.73 30.45 7.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt20 -89.04 154.86 19.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.496 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.204 178.329 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.58 106.85 18.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.57 142.6 46.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.586 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -75.53 -179.64 4.75 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.957 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.586 ' H ' HG21 ' A' ' 4' ' ' THR . 47.2 tt0 -54.39 -56.38 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.89 -32.78 74.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 111.452 -173.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.05 -47.94 19.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.755 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.23 -34.72 67.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.97 -38.41 79.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.635 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.58 80.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.757 0.313 . . . . 0.0 110.476 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.584 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.11 -36.93 91.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.851 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -68.58 -49.34 60.13 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -57.74 -46.23 84.75 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -51.27 -36.37 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.567 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.827 HG22 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.1 -37.6 11.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.556 -175.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG12 HD13 ' A' ' 37' ' ' LEU . 21.3 t -68.82 -25.32 30.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.85 -0.532 . . . . 0.0 110.16 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.61 -24.2 67.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.924 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.09 -41.74 63.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.945 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.599 HD13 ' HB ' ' A' ' 47' ' ' VAL . 25.3 mt -68.08 -53.26 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.152 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.89 -84.93 0.61 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.763 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.78 54.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.389 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.727 HG13 HD11 ' A' ' 37' ' ' LEU . 23.7 mm -82.27 130.45 59.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 166.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.33 137.52 38.89 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.195 1.93 . . . . 0.0 111.07 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 29.0 m -56.8 -27.73 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.46 -18.29 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.518 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -90.71 -16.59 28.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.104 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.37 116.9 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.671 0.748 . . . . 0.0 110.19 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' O ' HG11 ' A' ' 70' ' ' VAL . 25.5 mtpp -134.65 167.22 21.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.93 -173.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.702 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 8.7 mp -79.45 -2.96 44.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.494 0.664 . . . . 0.0 109.754 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.16 -13.23 19.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.955 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.573 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -100.72 143.29 31.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.492 -174.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.821 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 75.4 m -84.22 134.89 34.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.373 -173.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -58.7 -42.15 87.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 110.169 176.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 p -77.67 -36.49 51.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.269 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 10.8 t70 -91.02 -57.28 2.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.573 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 1.8 m-20 -77.48 -56.8 4.23 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.727 HD11 HG13 ' A' ' 22' ' ' ILE . 2.7 mm? -68.67 -13.64 62.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.429 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 54.13 36.44 24.82 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.187 0.994 . . . . 0.0 110.292 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -97.59 148.71 5.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.223 -171.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.1 m-20 -94.83 163.43 13.35 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 44' ' ' MET . 66.9 m -56.25 -42.69 77.79 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.441 0.463 . . . . 0.0 111.534 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -72.37 -47.08 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.813 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HB2' HG21 ' A' ' 39' ' ' VAL . 14.5 m -50.82 -51.93 46.16 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.717 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 3.5 ptp -59.18 -59.41 5.51 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.751 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 81.8 t -58.59 -21.68 18.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.025 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -70.04 -65.82 0.67 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.961 -0.462 . . . . 0.0 110.835 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' A' ' 19' ' ' ILE . 11.6 t -89.51 -22.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.274 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.29 -25.19 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 122.165 -0.335 . . . . 0.0 110.481 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.6 t -74.93 -36.4 38.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.44 64.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.12 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.827 ' HB2' HG22 ' A' ' 15' ' ' ILE . . . -85.67 -33.12 21.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.705 ' O ' HG11 ' A' ' 57' ' ' VAL . 6.8 pt-20 -68.61 -49.2 61.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 109.792 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 35.1 mt-10 -66.63 -27.44 67.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.303 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.3 ptm180 -73.63 -12.88 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.084 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.584 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 67.5 m-85 -104.22 3.69 33.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.326 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 57.43 58.79 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.245 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -120.59 162.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.991 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -124.14 110.89 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.981 0.419 . . . . 0.0 110.587 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.451 HD13 ' HD2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -134.57 136.93 26.52 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.942 176.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 126.57 21.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.259 1.973 . . . . 0.0 111.47 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.62 -35.55 68.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.93 -19.52 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.96 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 23.6 t70 -82.53 -21.26 35.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.56 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.606 ' HB ' HG21 ' A' ' 45' ' ' VAL . 45.6 t -66.58 -38.88 82.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -84.16 -3.51 58.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.105 0.479 . . . . 0.0 110.611 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 30.7 t30 -82.11 -36.19 27.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.221 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.637 ' CD1' ' HB3' ' A' ' 73' ' ' ALA . 1.4 pp -84.07 126.83 33.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.522 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -2.59 55.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.996 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.821 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 78.6 p -122.48 147.93 45.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.551 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -66.49 -33.28 62.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.896 178.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 29' ' ' LEU . . . -64.08 -36.84 93.77 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.131 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 1.9 t0 -60.63 -47.07 87.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.637 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . . . -56.14 -54.76 41.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.459 0.647 . . . . 0.0 110.412 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.828 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.8 m -53.69 -50.49 65.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.617 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.682 ' HD2' HD11 ' A' ' 78' ' ' LEU . 12.9 tptm -66.12 -35.78 81.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.755 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.451 ' HD2' HD13 ' A' ' 59' ' ' ILE . 72.2 t80 -64.71 -42.24 95.4 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.99 -42.37 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.116 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.828 ' HG ' ' O ' ' A' ' 74' ' ' THR . 82.2 mt -63.85 -23.0 67.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.209 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.76 -40.71 13.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.984 0.421 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -104.38 20.3 18.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.816 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.3 pt20 -86.33 139.93 30.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.622 0.248 . . . . 0.0 110.61 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.206 -178.031 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 121.236 0.541 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.69 166.5 22.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.328 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 7' ' ' GLU . . . -114.96 140.43 49.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.896 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -79.26 -174.85 4.35 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.292 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.601 ' H ' HG23 ' A' ' 4' ' ' THR . 20.8 tt0 -54.54 -55.35 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -169.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -67.33 -34.38 77.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.197 0.522 . . . . 0.0 110.977 -173.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 3' ' ' ALA . 40.0 tp10 -75.09 -47.12 30.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.409 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.705 HG23 HD22 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -69.39 -31.45 49.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.09 -41.13 90.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 110.325 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.68 93.8 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.353 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.78 -51.16 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.662 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.94 -52.68 62.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.05 -40.88 46.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.718 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -85.01 -29.75 6.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.158 -172.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.719 HG12 HD13 ' A' ' 37' ' ' LEU . 42.2 t -76.43 -24.73 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 121.711 -0.618 . . . . 0.0 109.818 176.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.97 -30.96 71.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.505 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 15.4 tp10 -62.79 -41.47 99.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.178 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 28.9 mt -76.84 -54.45 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.001 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.51 -77.75 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.792 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.76 61.23 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.504 -1.332 . . . . 0.0 114.817 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.758 HG13 HD11 ' A' ' 37' ' ' LEU . 17.1 mm -87.98 129.22 51.02 Favored Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.7 141.28 35.27 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 111.548 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 91.1 t -56.32 -33.68 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.212 -174.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -76.65 -21.53 55.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.015 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.49 -15.54 37.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.552 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 13' ' ' ALA . 72.6 t -69.17 121.0 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HE2' ' OD1' ' A' ' 30' ' ' ASP . 57.9 mtpt -144.39 177.16 8.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.256 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.608 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 19.8 mt -81.69 -7.32 59.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.048 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -92.83 -32.44 14.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.456 -171.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.629 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.71 139.23 32.88 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.702 -168.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.747 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.3 m -87.65 135.34 33.4 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.636 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.01 -45.6 82.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.407 0.622 . . . . 0.0 110.403 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.1 p -75.46 -33.41 60.84 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.214 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 15.2 t70 -91.64 -58.01 2.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.947 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.92 -47.15 8.06 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.633 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.758 HD11 HG13 ' A' ' 22' ' ' ILE . 3.9 mm? -67.38 -16.72 64.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.021 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.63 32.82 16.13 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.57 0.544 . . . . 0.0 110.535 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -99.25 147.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.592 -171.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.1 m-20 -96.67 164.53 12.55 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 45' ' ' VAL . 8.7 p -55.65 -48.78 74.42 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.673 0.608 . . . . 0.0 111.522 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -50.95 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.513 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 19.1 m -47.6 -52.46 17.74 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.839 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.516 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 8.8 ptm -61.98 -50.67 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.262 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.621 HG21 ' HB ' ' A' ' 64' ' ' VAL . 86.5 t -60.38 -25.23 33.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.944 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.51 -65.82 0.77 Allowed 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.879 -0.513 . . . . 0.0 111.226 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.595 HG11 HG12 ' A' ' 15' ' ' ILE . 6.7 t -88.36 -21.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.108 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -79.45 -27.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.102 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.681 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.44 -34.7 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.421 0.629 . . . . 0.0 109.389 169.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.39 68.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.355 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 15' ' ' ILE . . . -80.36 -35.75 34.99 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.707 ' O ' HG11 ' A' ' 57' ' ' VAL . 11.2 pt-20 -70.57 -52.72 19.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 29.8 mt-10 -66.08 -20.68 66.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.5 ptm180 -71.97 -5.31 33.93 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.803 -0.56 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -119.76 13.02 12.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.738 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 59.77 41.92 17.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.727 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.707 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.5 p -115.17 137.56 48.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -134.28 117.89 16.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.252 0.548 . . . . 0.0 111.263 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.622 HD12 ' CG2' ' A' ' 64' ' ' VAL . 6.4 pt -116.38 164.94 16.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.591 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 63' ' ' ASP . 34.4 Cg_exo -61.76 134.48 50.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.586 1.524 . . . . 0.0 110.932 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.31 -41.14 62.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.632 . . . . 0.0 111.061 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.01 -20.49 66.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.229 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.19 -41.95 66.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.604 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.622 ' CG2' HD12 ' A' ' 59' ' ' ILE . 48.2 t -59.22 -43.48 89.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -22.54 66.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.005 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.29 -17.71 23.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.442 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 1.3 pp -87.93 128.27 35.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.512 0.672 . . . . 0.0 110.688 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -90.83 -8.43 49.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.808 -170.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 13.2 p -128.73 157.16 42.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.36 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 28' ' ' LYS . 1.5 p -76.68 -18.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.88 -42.78 24.47 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.105 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.68 -39.29 84.02 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.44 -56.87 16.3 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.304 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.786 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -59.36 -50.6 73.33 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.52 -177.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD2' HD11 ' A' ' 78' ' ' LEU . 1.5 tptm -62.4 -37.57 86.31 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.713 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.62 -41.06 98.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.609 HG22 HG13 ' A' ' 57' ' ' VAL . 27.7 mt -62.61 -52.36 60.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' A' ' 74' ' ' THR . 84.2 mt -60.41 -35.0 74.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.36 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.34 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.533 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -98.95 7.85 45.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.435 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 77' ' ' ILE . 5.2 mm-40 -68.39 150.5 48.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.959 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.352 -177.232 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.682 0.277 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 126.95 32.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 110.96 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 7' ' ' GLU . . . -102.24 125.68 49.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.515 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -165.29 0.55 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.535 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.78 -56.41 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.64 -30.54 65.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.747 0.308 . . . . 0.0 111.296 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' CB ' ' HB2' ' A' ' 3' ' ' ALA . 71.1 mm-40 -65.12 -53.53 43.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 110.24 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.695 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.82 -33.55 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.661 -178.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.91 -37.63 78.7 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.779 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.73 94.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.498 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.97 -39.87 89.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.937 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -63.05 -48.88 76.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.612 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -55.71 -50.0 71.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.032 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.93 -38.45 67.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.136 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.888 HG23 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.74 -33.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 37' ' ' LEU . 43.8 t -74.34 -23.91 18.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -63.36 -24.43 67.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.741 174.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.02 -27.9 63.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.533 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.829 HD13 ' HB ' ' A' ' 47' ' ' VAL . 47.3 mt -91.26 -53.79 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.559 -173.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.81 -82.03 0.64 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.07 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.32 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.723 HG13 HD11 ' A' ' 37' ' ' LEU . 20.5 mm -88.33 130.73 44.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 166.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 9.8 Cg_endo -53.3 141.49 59.96 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.368 2.046 . . . . 0.0 111.017 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.609 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 34.9 m -62.88 -20.66 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.411 . . . . 0.0 111.717 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.44 -20.63 39.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.538 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -97.9 -8.75 27.55 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.161 -173.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 13' ' ' ALA . 68.9 t -67.23 110.21 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.688 0.756 . . . . 0.0 109.379 175.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' O ' HG11 ' A' ' 70' ' ' VAL . 55.5 mtpt -135.84 164.49 27.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.267 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.702 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.1 mp -74.68 -2.89 28.27 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.182 0.515 . . . . 0.0 110.238 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -104.26 -7.65 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.555 -171.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.629 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -103.78 141.58 35.85 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.29 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.768 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 16.2 m -83.64 132.3 34.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.089 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.599 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.63 -48.63 80.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.244 0.545 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -70.26 -35.55 73.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.491 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.768 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 14.4 t70 -91.5 -69.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.617 -173.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.15 -44.35 63.24 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.749 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 16' ' ' VAL . 3.6 mm? -70.53 -15.87 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.51 29.99 19.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.569 0.7 . . . . 0.0 109.832 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.48 145.13 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.926 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.1 159.09 15.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 m -53.41 -42.64 67.22 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.335 0.397 . . . . 0.0 111.67 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -45.61 50.0 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.468 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 14.7 m -52.03 -53.04 46.61 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.535 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 9.6 ptm -59.09 -49.8 76.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.933 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.714 HG23 ' HB ' ' A' ' 64' ' ' VAL . 97.7 t -61.82 -26.22 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.2 -65.73 0.81 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.667 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.829 ' HB ' HD13 ' A' ' 19' ' ' ILE . 20.3 t -89.27 -19.83 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.138 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 44' ' ' MET . 28.0 t -79.97 -22.0 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.661 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.755 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -76.39 -30.93 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 167.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.81 -25.34 67.44 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.552 168.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.888 ' HB1' HG23 ' A' ' 15' ' ' ILE . . . -82.28 -36.28 27.23 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.599 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.755 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.6 pt-20 -64.04 -45.76 87.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.634 0.73 . . . . 0.0 109.586 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.64 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 42.2 mt-10 -75.13 -21.47 58.83 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.246 -171.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -77.35 -4.84 47.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.214 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.07 16.66 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 59.13 51.54 6.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.601 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.675 HG11 ' O ' ' A' ' 52' ' ' GLU . 8.0 p -133.07 155.43 41.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -134.91 111.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.555 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.652 HG12 ' OE1' ' A' ' 52' ' ' GLU . 14.6 pt -104.9 163.35 17.35 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.567 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.652 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.6 Cg_exo -61.59 136.02 60.37 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 121.937 1.758 . . . . 0.0 112.019 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.6 -52.91 34.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.389 0.614 . . . . 0.0 111.075 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 6.1 p-10 -71.59 -18.32 62.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.482 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.652 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.8 t0 -75.2 -22.57 57.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.387 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.714 ' HB ' HG23 ' A' ' 45' ' ' VAL . 61.7 t -67.18 -43.79 88.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.541 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.97 -14.25 60.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.086 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 39.4 t30 -73.81 -40.62 63.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.043 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.5 pp -79.26 134.35 36.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.344 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.17 -1.02 27.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.305 -171.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.508 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 44.3 p -131.8 149.13 52.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.176 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -69.88 -21.27 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 109.745 177.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.702 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.53 -39.51 34.98 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.573 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.08 -35.44 79.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.492 0.663 . . . . 0.0 109.215 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -58.4 -46.42 86.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.326 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.769 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.12 -51.84 58.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.946 -174.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HD3' HD13 ' A' ' 78' ' ' LEU . 34.1 mmtp -57.26 -37.81 72.91 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.532 0.52 . . . . 0.0 110.848 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.485 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 35.5 t80 -63.07 -43.57 98.19 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.269 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.429 HG21 HG13 ' A' ' 57' ' ' VAL . 56.4 mt -65.31 -48.15 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.159 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 74' ' ' THR . 96.8 mt -56.04 -46.17 78.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.587 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -71.7 -6.27 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -128.91 1.55 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.461 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 8.6 pt20 -68.65 155.87 39.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.885 -0.143 . . . . 0.0 111.082 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.988 177.163 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HE1' ' HB2' ' A' ' 1' ' ' MET . 48.2 mtm . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.09 43.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.42 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.47 122.74 43.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.542 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -85.15 -161.67 0.62 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.911 -178.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.542 ' H ' HG21 ' A' ' 4' ' ' THR . 49.0 tt0 -59.95 -55.67 31.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.35 -39.87 89.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.67 -53.57 49.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.409 0.623 . . . . 0.0 110.53 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.717 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.53 -30.23 46.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.086 -177.184 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -62.38 -39.48 84.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.766 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.45 97.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.59 -47.41 84.09 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.992 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.582 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.8 -39.07 90.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.041 0.448 . . . . 0.0 109.807 177.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.715 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -58.09 -55.73 31.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.218 177.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.46 -41.01 52.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.919 0.866 . . . . 0.0 109.832 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.933 HG13 ' HB3' ' A' ' 51' ' ' ALA . 9.4 mm -64.2 -57.84 9.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.56 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.763 HG12 HD13 ' A' ' 37' ' ' LEU . 4.2 t -72.05 -23.89 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.446 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -59.48 -30.33 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.612 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.77 -20.6 49.5 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.406 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.594 HD13 ' HB ' ' A' ' 47' ' ' VAL . 47.4 mt -90.47 -54.23 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.929 -175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.06 -93.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.29 0.07 OUTLIER Glycine 0 CA--C 1.522 0.504 0 C-N-CA 119.189 -1.482 . . . . 0.0 115.471 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.728 HG13 HD11 ' A' ' 37' ' ' LEU . 17.5 mm -86.68 124.14 69.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 118.124 0.962 . . . . 0.0 108.608 166.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.55 155.3 42.79 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.736 2.291 . . . . 0.0 112.034 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.715 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 90.9 t -57.54 -40.9 77.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.761 -173.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.28 -16.53 52.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.875 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' HB3' HG21 ' A' ' 22' ' ' ILE . 24.5 t70 -80.65 -15.51 56.38 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.739 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 13' ' ' ALA . 57.6 t -65.08 121.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.737 0.78 . . . . 0.0 110.555 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 16.9 mtpp -139.64 146.79 40.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.901 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.556 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 39.1 mt -70.95 -7.22 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 110.19 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 6.3 p-10 -107.99 8.97 28.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.955 -177.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HG2' ' CG1' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -105.85 145.91 30.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.842 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 14.8 m -95.45 138.04 33.68 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -170.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.691 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.5 m-85 -58.34 -46.24 86.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.388 0.614 . . . . 0.0 110.229 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.8 p -77.55 -30.76 52.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.717 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' A' ' 32' ' ' SER . 1.4 t70 -92.53 -50.25 5.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.857 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.83 -52.27 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.762 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.763 HD13 HG12 ' A' ' 16' ' ' VAL . 3.3 mm? -67.85 -11.5 58.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.723 -168.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.93 35.75 25.6 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.53 0.519 . . . . 0.0 110.536 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' CG1' ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.405 -172.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.33 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.195 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 44' ' ' MET . 40.7 m -51.52 -59.48 4.21 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.622 0.576 . . . . 0.0 112.083 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.14 -40.89 77.99 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.961 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.478 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -50.42 -56.6 10.75 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.605 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 11.8 ptm -62.7 -47.0 85.53 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.908 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.619 HG21 ' HB ' ' A' ' 64' ' ' VAL . 85.0 t -68.18 -24.48 30.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.005 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.49 -66.13 0.81 Allowed 'General case' 0 C--O 1.242 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 111.493 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.636 HG11 HG22 ' A' ' 15' ' ' ILE . 7.8 t -84.28 -24.67 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.509 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.619 ' HA ' HG23 ' A' ' 15' ' ' ILE . 40.5 t -77.47 -20.24 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.419 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.682 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 2.9 t -74.78 -33.16 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -18.35 64.48 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.396 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.933 ' HB3' HG13 ' A' ' 15' ' ' ILE . . . -82.29 -38.31 24.55 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.845 176.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.691 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.7 -45.99 77.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.15 -176.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.09 -27.1 66.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.31 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.8 ptp180 -79.2 -7.14 58.0 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.393 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -116.12 15.62 16.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t70 54.71 70.74 0.59 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.732 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.691 HG11 ' O ' ' A' ' 52' ' ' GLU . 7.1 p -139.13 165.89 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -133.78 110.49 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.991 0.424 . . . . 0.0 110.179 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.1 pt -121.85 154.63 60.8 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.474 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 26.3 Cg_exo -64.32 141.74 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 111.956 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.54 -51.4 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.437 0.637 . . . . 0.0 109.509 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.162 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -65.72 -34.85 79.15 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.229 0.331 . . . . 0.0 110.963 -177.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 45' ' ' VAL . 43.0 t -61.5 -39.16 81.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.077 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -18.22 51.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 110.608 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -74.37 -24.15 59.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.152 0.501 . . . . 0.0 109.904 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -97.57 130.21 44.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.43 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -96.08 -1.56 48.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.543 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.842 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 59.2 p -122.41 146.5 47.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.691 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 2.1 p -65.92 -34.91 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.852 177.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.55 -30.28 76.08 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.89 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 2.3 t70 -68.1 -49.1 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -58.48 -45.73 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.586 0.707 . . . . 0.0 110.099 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.726 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 17.0 m -59.62 -51.7 68.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.628 -177.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -66.09 -30.46 70.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.197 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.62 -46.58 85.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.918 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.599 HG22 HG13 ' A' ' 57' ' ' VAL . 87.4 mt -63.62 -40.98 91.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.219 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 74' ' ' THR . 92.2 mt -66.64 -26.68 67.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.847 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.03 -34.03 20.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.423 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -119.77 20.73 12.21 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.3 pt20 -68.17 148.13 51.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.734 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.044 -177.007 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.45 156.02 16.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . . . -110.91 122.35 47.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.616 HG23 ' H ' ' A' ' 5' ' ' GLN . 1.2 m -89.33 -158.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.616 ' H ' HG23 ' A' ' 4' ' ' THR . 38.0 tt0 -58.66 -55.62 32.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -54.0 -44.83 71.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 3' ' ' ALA . 49.7 mm-40 -67.72 -56.29 9.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.399 0.618 . . . . 0.0 111.027 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.665 HG22 HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -67.44 -30.65 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.139 -174.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.66 -43.53 97.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.446 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.34 92.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.685 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.546 ' HA2' ' CZ ' ' A' ' 55' ' ' PHE . . . -68.5 -44.15 74.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.427 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.554 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.37 -46.31 89.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.75 -52.51 63.69 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.766 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.79 -36.48 58.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.646 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.07 -31.89 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.672 -173.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.711 HG12 HD13 ' A' ' 37' ' ' LEU . 19.9 t -74.2 -28.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.246 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.25 -29.76 67.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.949 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.73 -22.12 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.718 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.542 HD13 ' HB ' ' A' ' 47' ' ' VAL . 17.1 mt -92.89 -54.02 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.296 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.47 -93.12 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.27 50.99 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.696 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.753 HG13 HD11 ' A' ' 37' ' ' LEU . 22.7 mm -94.08 120.21 65.87 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 162.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.31 153.79 72.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 111.722 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.624 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.4 m -60.66 -17.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.43 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.57 -20.98 53.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.763 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HB3' HG21 ' A' ' 22' ' ' ILE . 17.7 t0 -106.07 -11.84 15.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.871 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 13' ' ' ALA . 97.3 t -71.85 123.24 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.273 0.558 . . . . 0.0 110.954 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -148.09 166.36 28.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -171.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.422 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 24.2 mt -78.35 -3.34 42.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.036 0.446 . . . . 0.0 110.64 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.69 -30.06 15.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.527 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -84.88 139.67 31.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.396 0.617 . . . . 0.0 110.504 -168.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.755 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 16.2 m -85.26 138.61 32.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.834 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.558 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -58.46 -51.24 70.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.303 0.573 . . . . 0.0 110.55 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.6 p -69.8 -33.84 72.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.291 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 36.2 t70 -92.42 -69.25 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.774 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.569 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -69.46 -55.55 9.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.063 -177.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.753 HD11 HG13 ' A' ' 22' ' ' ILE . 3.6 mm? -63.64 -16.64 61.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 63.3 24.5 14.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.774 0.797 . . . . 0.0 109.712 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.682 HG23 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -92.72 150.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.613 -172.473 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.4 161.63 14.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.795 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 17.8 m -48.3 -50.9 28.3 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.447 0.467 . . . . 0.0 111.544 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.426 HD11 ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -70.96 -42.6 69.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -176.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 39' ' ' VAL . 15.2 m -50.95 -52.06 46.21 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.466 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 1.085 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 13.1 ptt? -63.67 -47.84 79.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.797 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.907 HG23 ' HB ' ' A' ' 64' ' ' VAL . 80.1 t -57.38 -26.64 26.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.051 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.37 -65.73 0.82 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.958 -0.464 . . . . 0.0 111.185 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.591 HG11 HG12 ' A' ' 15' ' ' ILE . 21.0 t -87.05 -21.3 7.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.36 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.6 t -79.51 -20.48 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.634 -0.666 . . . . 0.0 110.219 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.6 t -75.87 -34.64 28.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.36 -24.08 63.08 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.99 168.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.745 ' HB2' HG23 ' A' ' 15' ' ' ILE . . . -84.12 -33.85 24.23 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.117 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.648 ' HG3' ' N ' ' A' ' 53' ' ' GLU . 2.5 pt-20 -64.19 -48.12 77.15 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.559 0.695 . . . . 0.0 109.561 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.648 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 32.2 mt-10 -72.73 -22.38 60.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.254 -172.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -80.79 -10.64 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.215 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.546 ' CZ ' ' HA2' ' A' ' 11' ' ' GLY . 58.1 m-85 -105.7 4.08 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 57.04 70.93 0.61 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.64 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.0 p -132.39 166.67 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -123.79 110.56 15.06 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.622 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.481 HG13 ' HD2' ' A' ' 60' ' ' PRO . 5.9 tt -134.86 135.46 23.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 0.0 110.588 172.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 59' ' ' ILE . 18.6 Cg_endo -66.88 150.79 83.08 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.572 2.182 . . . . 0.0 112.849 175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.7 -48.06 50.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.948 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 1.045 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -53.74 -44.37 69.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.588 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -62.94 -33.89 76.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -171.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.907 ' HB ' HG23 ' A' ' 45' ' ' VAL . 12.0 t -68.37 -41.33 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.841 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 1.085 ' HA ' ' HE2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -85.29 -0.76 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 122.105 -0.372 . . . . 0.0 111.766 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -91.19 -31.24 16.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.834 0.35 . . . . 0.0 110.302 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 73' ' ' ALA . 2.9 pp -81.63 145.23 30.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.431 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -110.51 -5.19 15.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.897 -172.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.755 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 43.8 p -127.25 153.72 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 31' ' ' LYS . 2.1 p -74.12 -22.4 18.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.47 0.652 . . . . 0.0 110.025 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -73.43 -31.47 60.99 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.182 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.05 -46.2 85.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -57.09 -45.15 83.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.815 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.673 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -67.13 -45.52 76.88 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.633 -175.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 1.001 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 5.8 mmpt? -62.53 -31.02 71.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.58 -49.34 48.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 109.918 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.6 mt -58.29 -49.35 82.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 74' ' ' THR . 73.5 mt -69.45 -20.97 63.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.235 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.4 -21.88 32.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.205 0.526 . . . . 0.0 110.692 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -125.19 22.7 7.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.449 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.6 pt20 -75.84 140.33 42.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.016 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 O-C-N 123.852 0.72 . . . . 0.0 111.665 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.73 138.38 44.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 111.15 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.21 106.12 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.588 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -73.05 -168.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.588 ' H ' HG21 ' A' ' 4' ' ' THR . 13.6 tt0 -53.2 -56.43 16.47 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -171.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.87 -38.39 90.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -67.67 -54.18 21.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.143 0.497 . . . . 0.0 111.124 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -67.14 -32.74 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.33 -39.37 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.569 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.95 94.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.61 59.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.054 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.632 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -61.37 -53.83 51.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -58.04 -50.6 72.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.934 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -55.29 -35.83 65.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.347 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.629 HG22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -81.15 -31.71 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.807 -177.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 37' ' ' LEU . 22.4 t -74.61 -26.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 O-C-N 121.915 -0.491 . . . . 0.0 109.69 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.4 -28.62 70.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -66.58 -36.31 82.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.149 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.67 HD13 ' HB ' ' A' ' 47' ' ' VAL . 27.3 mt -80.27 -52.61 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.421 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.87 -84.7 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.82 53.63 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.933 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.725 HG13 HD11 ' A' ' 37' ' ' LEU . 22.8 mm -89.43 125.05 62.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 165.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.3 146.57 60.58 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.452 2.101 . . . . 0.0 111.395 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.629 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 31.4 m -54.51 -35.06 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -81.31 -17.79 48.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.836 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.507 ' HB3' HG22 ' A' ' 22' ' ' ILE . 12.6 t70 -83.35 -22.51 32.82 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.999 0.428 . . . . 0.0 110.603 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 13' ' ' ALA . 72.4 t -62.78 129.18 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.908 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -145.64 159.37 43.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.398 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.2 mp -77.37 -3.83 42.1 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.981 0.419 . . . . 0.0 110.547 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.12 1.58 24.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.17 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.72 140.44 37.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.683 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.877 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.7 m -87.41 136.83 32.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.463 -170.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.637 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.17 -49.79 76.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 110.196 177.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.5 p -69.54 -34.32 74.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 9.5 t70 -91.59 -68.68 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.307 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.8 m-20 -72.92 -52.38 14.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.895 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.741 HD13 HG12 ' A' ' 16' ' ' VAL . 3.7 mm? -66.35 -10.45 43.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.127 -172.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 61.38 31.44 19.2 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.803 0.69 . . . . 0.0 109.944 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 43' ' ' SER . 0.5 OUTLIER -102.66 153.13 5.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.418 -171.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.7 170.89 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.605 170.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.612 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 24.8 t -57.33 -59.77 4.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.421 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.587 HD11 ' O ' ' A' ' 42' ' ' LEU . 2.0 tm? -68.53 -39.15 81.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.372 -176.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.484 ' HB2' HG21 ' A' ' 39' ' ' VAL . 13.3 m -48.87 -53.53 19.1 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.008 0.432 . . . . 0.0 111.637 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 1.0 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 20.3 ptt? -65.27 -42.83 92.81 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 98.7 t -60.18 -26.19 35.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.07 0.462 . . . . 0.0 110.389 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.12 -65.39 0.85 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.856 -0.528 . . . . 0.0 111.413 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.67 ' HB ' HD13 ' A' ' 19' ' ' ILE . 15.8 t -85.72 -23.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.137 -173.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.2 t -79.32 -23.21 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.481 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.739 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.3 t -76.63 -31.8 20.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 109.329 169.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.64 -25.85 67.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.379 0.609 . . . . 0.0 109.789 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB1' HG22 ' A' ' 15' ' ' ILE . . . -82.07 -37.7 26.0 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.972 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.9 pt-20 -61.83 -51.63 67.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.484 0.659 . . . . 0.0 109.643 -175.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.631 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.7 mt-10 -71.35 -22.85 61.85 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.649 -171.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.2 ptm180 -75.01 -19.37 60.11 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -97.91 6.92 47.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t0 60.54 57.94 2.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.656 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.707 HG11 ' O ' ' A' ' 52' ' ' GLU . 13.3 p -134.3 161.65 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.201 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 58' ' ' LYS . 13.4 tptp -127.82 112.93 15.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.111 175.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 tt -118.12 117.32 35.23 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.819 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.58 138.88 39.47 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.448 2.099 . . . . 0.0 111.726 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.604 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 5.2 p-10 -58.33 -29.55 66.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.529 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.615 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 32.7 t70 -67.53 -25.31 65.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.023 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.81 -37.94 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.643 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 46.7 t -63.54 -53.86 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.045 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 1.0 ' HA ' ' HE2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -63.36 -9.95 14.42 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 176.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.5 -41.36 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.773 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.691 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 1.2 pp -67.6 137.1 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.453 0.644 . . . . 0.0 110.988 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -96.21 -20.68 18.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.195 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.877 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 14.8 p -119.95 154.55 34.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.528 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.4 p -63.53 -31.15 51.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 109.999 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -63.72 -33.79 88.2 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.523 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 51.1 m-20 -57.92 -52.73 64.29 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -57.49 -52.21 66.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.743 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.772 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.0 m -56.94 -52.92 63.27 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.019 -173.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -65.98 -31.34 72.19 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.592 0.234 . . . . 0.0 110.452 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.94 -43.07 84.16 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.257 0.551 . . . . 0.0 109.619 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.62 HG21 HG13 ' A' ' 57' ' ' VAL . 46.5 mt -59.99 -46.57 93.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.239 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 74' ' ' THR . 95.0 mt -62.35 -28.03 69.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.109 -175.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.69 -39.62 44.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.093 0.473 . . . . 0.0 111.084 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.461 ' O ' HG21 ' A' ' 57' ' ' VAL . 69.0 m-70 -105.62 21.69 16.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.272 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -79.98 175.65 10.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.915 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.787 176.283 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HA ' ' OE1' ' A' ' 81' ' ' GLN . . . -69.97 111.9 5.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.164 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . . . -116.41 147.16 41.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.297 -172.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.433 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -90.4 -175.34 4.45 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.116 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' H ' HG21 ' A' ' 4' ' ' THR . 12.7 tt0 -50.49 -56.3 12.16 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.26 -41.24 88.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 3' ' ' ALA . 85.1 tt0 -74.69 -45.92 41.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.75 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.92 -33.97 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.36 -39.75 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.983 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.37 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.14 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.493 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.48 -45.4 78.49 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.992 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.34 -40.01 96.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.633 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -54.89 41.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 41.9 tt0 -52.9 -42.44 65.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.432 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.904 HG13 ' HB1' ' A' ' 51' ' ' ALA . 8.0 mm -62.61 -53.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.292 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 37' ' ' LEU . 13.2 t -71.2 -23.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.461 . . . . 0.0 110.303 -177.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -65.85 -19.68 65.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.009 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 5.1 mm-40 -83.16 -29.66 28.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.145 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 32.3 mt -84.86 -53.02 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.631 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.34 -86.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.05 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.35 56.84 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.573 -1.299 . . . . 0.0 114.492 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.68 HG13 HD11 ' A' ' 37' ' ' LEU . 12.8 mm -87.88 124.81 66.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 164.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 147.95 49.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 111.757 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 79.2 t -54.61 -40.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.645 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -75.41 -17.02 60.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.298 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG21 ' A' ' 22' ' ' ILE . 1.6 t70 -90.09 -5.71 56.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.142 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG23 ' CB ' ' A' ' 13' ' ' ALA . 46.0 t -68.83 116.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.549 0.69 . . . . 0.0 109.696 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 13.6 mtpp -132.78 144.89 50.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.454 -171.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.2 mp -74.08 -3.43 29.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.873 0.368 . . . . 0.0 110.997 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 5.8 p-10 -108.03 -7.91 16.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.762 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.93 140.0 30.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.442 -177.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.8 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.2 m -87.98 135.77 33.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.448 -170.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.531 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -56.67 -48.16 78.22 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.277 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.5 p -71.8 -33.65 68.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.201 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 5.0 t70 -92.13 -65.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.199 0.523 . . . . 0.0 111.651 -173.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.1 m-20 -75.82 -52.76 9.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.673 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.805 HD13 HG12 ' A' ' 16' ' ' VAL . 2.9 mm? -66.19 -14.54 62.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.791 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 61.76 32.91 18.13 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.856 0.836 . . . . 0.0 109.38 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 43' ' ' SER . 0.4 OUTLIER -98.81 146.96 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.809 -171.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.495 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 8.2 m-20 -95.92 173.84 7.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.683 ' HB3' ' HD3' ' A' ' 65' ' ' LYS . 13.6 m -57.25 -56.32 23.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.565 . . . . 0.0 110.471 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -65.59 -40.49 92.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.543 ' HB2' HG23 ' A' ' 39' ' ' VAL . 14.7 m -50.59 -54.72 20.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 1.017 ' HE1' ' HA ' ' A' ' 65' ' ' LYS . 15.3 ptt? -66.36 -40.96 90.11 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.646 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.656 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 82.5 t -63.09 -24.95 37.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.704 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -74.32 -66.41 0.73 Allowed 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.74 -0.6 . . . . 0.0 111.659 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.607 HG11 HG22 ' A' ' 15' ' ' ILE . 11.8 t -91.12 -22.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.578 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 44' ' ' MET . 21.5 t -80.46 -21.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.619 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.1 t -73.95 -33.57 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.609 0.718 . . . . 0.0 109.302 167.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.36 66.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.339 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.904 ' HB1' HG13 ' A' ' 15' ' ' ILE . . . -81.14 -45.75 15.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.67 ' O ' HG11 ' A' ' 57' ' ' VAL . 8.1 pt-20 -59.31 -49.11 79.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.034 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.8 pt-20 -62.68 -30.67 71.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.724 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -78.7 -5.0 51.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.275 0.56 . . . . 0.0 110.343 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.493 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 68.7 m-85 -114.2 22.38 13.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.345 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 71.75 17.47 5.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.507 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.67 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -114.49 158.29 14.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.075 -0.391 . . . . 0.0 110.435 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 50.1 mtpt -134.06 111.3 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 ' HB ' ' HE2' ' A' ' 76' ' ' TYR . 21.4 pt -108.53 163.36 17.14 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.808 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.0 Cg_exo -65.3 129.61 23.21 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.942 1.761 . . . . 0.0 111.623 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.79 -49.2 63.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 110.06 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.41 -19.52 64.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.275 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.808 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 2.7 t0 -74.0 -38.08 64.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 22.2 t -60.12 -42.75 91.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 1.017 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 17.6 tptp -59.91 -31.08 69.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.795 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.63 -26.99 40.98 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.154 -0.341 . . . . 0.0 111.255 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.712 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -83.7 136.58 34.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.292 -178.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.36 -22.77 22.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.131 -173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.8 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 32.8 p -120.2 156.98 30.05 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.887 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -67.72 -36.96 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.1 -41.51 96.59 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.025 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.96 -50.73 72.19 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.712 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -54.79 -50.28 68.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.58 0.705 . . . . 0.0 110.936 176.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.742 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 12.4 m -58.98 -49.49 77.69 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.686 -174.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.535 ' HD2' HD11 ' A' ' 78' ' ' LEU . 7.6 tptm -65.95 -38.65 89.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.46 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 59.3 t80 -56.91 -43.34 81.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.604 HG21 HG13 ' A' ' 57' ' ' VAL . 82.0 mt -65.18 -49.9 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.536 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD23 HG22 ' A' ' 8' ' ' ILE . 91.5 mt -54.15 -44.99 71.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.21 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -86.68 -3.63 59.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.459 ' O ' HG21 ' A' ' 57' ' ' VAL . 29.9 m-70 -124.69 15.22 8.73 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.244 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 2' ' ' ALA . 10.5 pt20 -86.15 153.99 21.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.546 0.213 . . . . 0.0 111.498 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.077 176.293 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.0 167.17 10.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.98 135.46 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.57 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -86.83 -167.17 1.79 Allowed 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.57 ' H ' HG21 ' A' ' 4' ' ' THR . 24.8 tt0 -58.99 -55.71 31.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -167.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -32.22 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.868 0.366 . . . . 0.0 111.144 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.05 -47.65 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.725 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.35 -33.11 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.11 -43.02 95.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.1 95.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.937 0.398 . . . . 0.0 110.875 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.8 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.51 -33.03 75.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.341 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -68.62 -48.64 63.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -58.13 -46.77 85.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.58 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -52.39 -36.74 54.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.496 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.683 HG23 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.59 -35.6 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.81 -174.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.709 HG12 HD13 ' A' ' 37' ' ' LEU . 36.2 t -71.17 -23.97 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 109.776 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -62.6 -24.57 67.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.28 -38.48 63.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 109.958 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.694 HD13 ' HB ' ' A' ' 47' ' ' VAL . 24.9 mt -71.04 -53.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.694 -174.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.24 -86.14 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.452 -175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 64.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.685 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.716 HG13 HD11 ' A' ' 37' ' ' LEU . 23.2 mm -99.61 131.35 24.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 164.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.99 148.34 48.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.465 2.11 . . . . 0.0 111.633 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.649 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 93.9 t -59.88 -38.57 76.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.15 0.5 . . . . 0.0 111.304 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -76.71 -18.31 58.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB3' HG21 ' A' ' 22' ' ' ILE . 11.2 t70 -83.23 -22.74 33.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.68 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.2 t -66.4 122.28 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.572 0.701 . . . . 0.0 110.729 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -144.04 169.76 17.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.207 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.73 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 9.6 mp -81.57 -2.5 50.25 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.494 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -110.38 2.01 18.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.83 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HE2' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.05 141.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.694 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 24.9 m -88.4 136.46 32.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.881 0.372 . . . . 0.0 111.658 -170.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.58 -47.83 84.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.535 0.684 . . . . 0.0 110.426 178.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 38.9 p -72.95 -33.66 66.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.354 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.694 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.5 t70 -91.67 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 111.539 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -49.11 18.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.287 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.716 HD11 HG13 ' A' ' 22' ' ' ILE . 3.5 mm? -70.23 -14.73 62.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.659 -176.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.49 31.88 20.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.847 0.832 . . . . 0.0 110.129 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -97.66 151.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.881 -169.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.4 m-20 -104.0 166.25 10.53 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 p -51.23 -55.65 16.98 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.709 0.631 . . . . 0.0 111.32 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -62.96 -48.97 76.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.598 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.567 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 13.0 m -50.94 -54.29 25.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.646 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.68 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 4.8 ptm -59.74 -49.43 77.78 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.701 HG21 ' HB ' ' A' ' 64' ' ' VAL . 85.5 t -68.81 -22.31 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.16 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.82 -66.2 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.661 -0.649 . . . . 0.0 111.743 -174.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.694 ' HB ' HD13 ' A' ' 19' ' ' ILE . 16.6 t -87.88 -21.74 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.052 -173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.9 t -78.82 -26.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.286 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.693 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -72.72 -35.04 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.01 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.23 0.538 . . . . 0.0 109.918 171.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 15' ' ' ILE . . . -83.49 -39.6 20.3 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.131 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 4.5 pt-20 -59.81 -48.31 82.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.494 0.664 . . . . 0.0 109.559 -175.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.2 mt-10 -64.56 -33.64 76.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.169 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -81.31 -6.03 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.374 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.8 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 62.1 m-85 -105.25 6.71 33.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 170.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.38 68.36 0.77 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.553 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -140.59 161.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.353 174.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -122.88 110.56 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 169.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.5 pt -119.08 151.35 50.49 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.75 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.1 Cg_exo -61.79 121.21 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.991 1.794 . . . . 0.0 110.847 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.06 -39.29 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 0.0 110.215 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.33 -36.36 81.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.75 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -66.91 -34.79 78.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.315 -174.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HB ' HG21 ' A' ' 45' ' ' VAL . 21.3 t -58.42 -36.45 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.165 0.507 . . . . 0.0 110.657 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.669 ' HZ1' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -75.19 -28.46 60.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.895 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.49 -21.87 44.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.691 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -84.71 123.48 30.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 0.0 110.585 177.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -82.3 -14.68 54.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.009 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 73.4 p -119.71 148.74 43.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.33 -36.16 76.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.041 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' HA2' ' HA ' ' A' ' 29' ' ' LEU . . . -66.97 -30.21 75.7 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.953 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 4.0 t70 -61.6 -40.68 95.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . . . -67.97 -39.46 83.33 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.114 176.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.775 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -65.15 -51.81 58.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.007 -172.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.42 -37.03 79.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.246 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -63.34 -38.61 91.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.396 0.617 . . . . 0.0 110.706 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 57' ' ' VAL . 52.5 mt -68.99 -33.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.533 0.682 . . . . 0.0 110.261 175.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 74' ' ' THR . 96.8 mt -77.97 -35.51 50.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.416 -172.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.9 -4.88 58.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.6 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -123.44 15.01 9.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.0 pt20 -73.93 157.82 35.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.698 0.285 . . . . 0.0 111.557 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.554 177.654 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.3 108.38 13.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . . . -91.33 138.38 31.63 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.183 -165.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -88.42 -168.87 2.34 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 174.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.698 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.3 tt0 -55.61 -55.59 30.31 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.2 pt-20 -64.5 -39.17 93.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.899 0.381 . . . . 0.0 111.566 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 3' ' ' ALA . 42.3 mt-10 -64.34 -54.35 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.0 110.885 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.67 -31.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.689 -177.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.698 ' HB ' ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -69.71 -31.73 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.253 -177.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.82 74.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.63 78.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.774 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -72.32 -49.39 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -52.52 -53.63 43.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -50.23 -42.45 51.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.117 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.983 HG23 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.38 -27.94 6.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.536 -169.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.754 HG12 HD11 ' A' ' 37' ' ' LEU . 45.8 t -76.05 -24.76 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -68.05 -21.49 65.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.043 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 5.2 mm-40 -70.54 -29.07 65.45 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.349 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.737 HD13 ' HB ' ' A' ' 47' ' ' VAL . 39.3 mt -92.88 -55.29 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.553 -171.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.13 -89.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.205 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.52 44.11 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.206 -1.473 . . . . 0.0 115.117 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.761 HG13 HD12 ' A' ' 37' ' ' LEU . 14.2 mm -78.24 124.82 85.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.8 142.72 83.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.274 1.982 . . . . 0.0 111.152 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.461 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 34.6 m -59.2 -20.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.976 0.417 . . . . 0.0 111.657 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.82 -18.67 46.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.249 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 22' ' ' ILE . 1.5 t70 -100.77 -7.91 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.647 0.26 . . . . 0.0 111.329 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 13' ' ' ALA . 84.6 t -68.21 118.2 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.325 0.583 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' O ' HG11 ' A' ' 70' ' ' VAL . 49.6 mtpt -143.17 160.33 40.63 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.207 -170.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.604 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.0 mp -74.14 -3.75 31.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.091 0.472 . . . . 0.0 110.864 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.61 -15.58 18.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.904 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.83 142.94 28.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.427 -173.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.754 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 16.0 t -84.4 134.24 34.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.889 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.03 -49.8 76.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.529 0.68 . . . . 0.0 109.843 177.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.1 p -71.95 -31.82 66.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.179 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.9 t70 -92.68 -68.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.896 -175.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -77.08 -45.24 27.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.976 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD12 HG13 ' A' ' 22' ' ' ILE . 4.0 mm? -66.73 -16.26 64.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.616 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 57.29 42.52 25.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.872 0.844 . . . . 0.0 108.83 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -110.64 144.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.638 -173.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 166.61 15.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.768 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 8.2 m -54.77 -52.29 63.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.586 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -72.62 -42.02 64.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.216 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.408 ' O ' HD12 ' A' ' 19' ' ' ILE . 54.8 m -48.11 -55.23 10.77 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 123.29 0.369 . . . . 0.0 111.238 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.972 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 19.9 ptt? -64.35 -48.6 74.91 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.569 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.769 HG21 ' HB ' ' A' ' 64' ' ' VAL . 55.7 t -54.78 -28.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.854 0.359 . . . . 0.0 111.209 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.6 -65.52 0.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.85 -0.531 . . . . 0.0 111.565 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.737 ' HB ' HD13 ' A' ' 19' ' ' ILE . 15.2 t -85.36 -22.61 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.645 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 44' ' ' MET . 55.6 t -78.83 -25.51 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.521 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.694 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.92 -36.25 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.18 -23.47 66.63 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.232 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.983 ' HB1' HG23 ' A' ' 15' ' ' ILE . . . -83.34 -35.94 24.79 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.911 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -69.94 -48.62 57.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.42 -23.57 66.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.848 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 4.4 ptm180 -71.96 -10.71 60.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.478 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -111.09 18.42 19.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.913 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 68.89 25.63 6.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.93 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.652 HG12 HG21 ' A' ' 77' ' ' ILE . 11.5 p -115.16 151.25 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -135.08 124.41 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.196 0.522 . . . . 0.0 110.905 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.523 HD13 ' CG2' ' A' ' 64' ' ' VAL . 7.0 pt -116.02 166.23 12.87 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.93 125.67 17.08 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 121.401 1.401 . . . . 0.0 110.446 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.57 -42.93 24.76 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.479 0.657 . . . . 0.0 110.861 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.1 t70 -63.08 -19.71 64.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.656 -176.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.92 -25.4 40.53 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.377 -0.202 . . . . 0.0 111.517 -173.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.769 ' HB ' HG21 ' A' ' 45' ' ' VAL . 43.8 t -64.77 -33.38 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.972 ' HA ' ' HE2' ' A' ' 44' ' ' MET . 3.5 tmmm? -66.1 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.403 171.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -71.1 -26.82 63.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.954 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.1 pp -94.63 134.65 36.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.388 0.613 . . . . 0.0 110.751 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -97.36 -6.58 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.795 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 69.6 p -129.69 152.24 49.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -70.55 -22.27 23.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 109.831 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.604 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.79 -36.79 41.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.586 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 6.0 t0 -58.62 -42.55 88.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.622 0.725 . . . . 0.0 109.082 176.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -60.19 -48.26 82.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.921 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.742 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -63.08 -50.65 69.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.547 -172.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HD3' HD13 ' A' ' 78' ' ' LEU . 23.7 mmtp -58.96 -39.67 82.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.124 0.265 . . . . 0.0 111.251 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.446 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 42.2 t80 -62.93 -44.59 95.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.026 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.652 HG21 HG12 ' A' ' 57' ' ' VAL . 61.2 mt -61.76 -44.56 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.734 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 74' ' ' THR . 92.3 mt -65.55 -40.95 93.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.322 -174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -75.07 -32.51 61.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.927 0.394 . . . . 0.0 111.669 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.52 22.54 15.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -77.02 -172.65 2.43 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.762 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.076 -179.085 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.8 128.56 42.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 173.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.84 138.66 48.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.237 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -84.78 -171.84 3.85 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.211 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.512 ' H ' HG21 ' A' ' 4' ' ' THR . 19.2 tt0 -55.73 -55.97 25.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -67.64 -36.37 80.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.682 0.277 . . . . 0.0 111.546 -175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.47 -52.71 56.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.326 0.584 . . . . 0.0 110.613 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.694 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -69.91 -33.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.012 -178.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -59.99 -41.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.78 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.15 94.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.507 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.93 96.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.129 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.616 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -47.56 82.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' HA ' HG23 ' A' ' 27' ' ' VAL . . . -55.42 -50.13 70.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.543 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.64 -36.42 62.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.828 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.778 HG22 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.52 -32.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.807 -174.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.713 HG12 HD13 ' A' ' 37' ' ' LEU . 21.2 t -72.31 -24.27 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 121.63 -0.669 . . . . 0.0 109.981 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -62.56 -28.69 70.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.703 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.68 -23.65 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.356 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.595 HD13 ' HB ' ' A' ' 47' ' ' VAL . 44.5 mt -86.78 -52.98 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.995 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.46 -75.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.71 53.73 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.874 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.764 HG13 HD11 ' A' ' 37' ' ' LEU . 11.1 mm -80.94 129.94 65.56 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 165.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.651 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 7.3 Cg_endo -52.04 140.34 49.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.322 2.014 . . . . 0.0 111.187 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 23.3 m -57.34 -26.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 mm-40 -80.47 -18.74 47.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 1.8 t70 -95.23 -8.48 35.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.587 -172.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.677 HG23 ' HA ' ' A' ' 13' ' ' ALA . 53.1 t -68.5 111.22 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.611 0.72 . . . . 0.0 110.052 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -132.06 162.13 31.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.605 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 23.8 mt -74.64 -5.61 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.136 0.493 . . . . 0.0 110.378 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.88 -19.2 19.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.022 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -93.53 143.92 25.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.935 -175.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.887 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.0 m -90.39 135.04 33.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.294 -173.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.6 m-85 -54.73 -52.52 62.21 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 110.206 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -60.54 -43.95 96.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.757 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.14 -68.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.142 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.97 -45.91 83.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.833 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.764 HD11 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -72.98 -11.57 60.62 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t0 56.55 43.58 25.49 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.968 0.792 . . . . 0.0 108.896 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.504 ' CG2' HG23 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -105.61 146.33 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.417 -172.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 44' ' ' MET . 3.7 m-20 -91.79 153.44 19.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.445 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 50.6 m -55.87 -41.6 74.61 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.601 0.563 . . . . 0.0 111.677 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -72.48 -43.4 63.74 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.57 ' OG ' HG22 ' A' ' 19' ' ' ILE . 1.9 t -58.99 -49.48 77.73 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.974 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.479 ' HE1' HG13 ' A' ' 64' ' ' VAL . 13.6 ptm -57.1 -49.04 77.11 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.881 HG21 ' HB ' ' A' ' 64' ' ' VAL . 79.1 t -60.14 -25.92 34.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.295 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.87 -64.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.911 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.595 ' HB ' HD13 ' A' ' 19' ' ' ILE . 11.6 t -85.0 -22.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.349 -173.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 44' ' ' MET . 49.4 t -78.38 -28.15 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.134 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.702 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 12.7 t -71.36 -33.1 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.561 0.696 . . . . 0.0 109.3 169.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 47' ' ' VAL . . . -60.82 -26.7 67.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.095 0.474 . . . . 0.0 110.05 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB2' HG22 ' A' ' 15' ' ' ILE . . . -82.3 -38.1 24.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.892 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.702 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 9.2 pt-20 -63.86 -46.49 84.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.8 mt-10 -70.19 -26.4 63.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.252 -173.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -77.8 -6.15 53.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 67.1 m-85 -111.47 19.19 18.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 174.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.59 40.21 6.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.632 174.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.638 HG11 ' O ' ' A' ' 52' ' ' GLU . 9.9 p -127.86 159.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 173.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.36 112.85 10.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.01 0.433 . . . . 0.0 110.095 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.491 HG12 ' OE2' ' A' ' 52' ' ' GLU . 14.2 pt -107.83 163.97 15.8 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.49 133.62 40.81 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.574 1.516 . . . . 0.0 109.771 170.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.63 -34.59 67.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 8.4 t70 -69.43 -18.24 63.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.818 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 66' ' ' ASN . 4.6 t70 -70.15 -31.01 68.31 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.231 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.881 ' HB ' HG21 ' A' ' 45' ' ' VAL . 41.1 t -62.42 -51.51 71.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.448 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -4.98 52.07 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.163 0.506 . . . . 0.0 111.142 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 2.5 t-20 -73.13 -39.08 66.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.8 HD13 ' HB3' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -89.69 147.04 24.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.216 175.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -108.27 -13.43 14.9 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.536 -174.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.887 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 61.4 p -108.2 151.66 25.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.689 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -70.03 -29.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.589 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.605 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -66.75 -30.75 76.73 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.744 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 4.8 t70 -65.59 -53.52 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.8 ' HB3' HD13 ' A' ' 67' ' ' LEU . . . -53.64 -50.52 65.54 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.425 0.631 . . . . 0.0 110.717 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 21.7 m -55.07 -52.82 62.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.98 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.481 ' HD2' HD11 ' A' ' 78' ' ' LEU . 13.3 tptp -64.68 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.15 -46.26 90.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.136 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.578 HG21 HG13 ' A' ' 57' ' ' VAL . 90.8 mt -60.68 -46.43 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.322 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 74' ' ' THR . 83.6 mt -55.14 -42.75 73.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.683 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.1 -4.97 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -128.47 7.52 5.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.86 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -77.47 157.46 30.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.433 0.159 . . . . 0.0 110.728 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.492 176.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.9 mmm . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.48 111.77 8.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . . . -115.65 145.53 42.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.612 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -87.7 -165.17 1.23 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 173.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' H ' HG23 ' A' ' 4' ' ' THR . 16.0 tt0 -61.29 -55.67 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -63.28 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.541 -173.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 3' ' ' ALA . 3.4 mp0 -68.16 -51.43 46.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.712 HG22 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -66.35 -32.53 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.902 -178.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.96 -42.69 95.74 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.35 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.523 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.9 -49.05 61.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.7 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.596 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -42.32 88.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -58.64 -56.71 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.248 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -49.93 -44.52 50.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.836 0.826 . . . . 0.0 110.051 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.774 HG13 ' HB1' ' A' ' 51' ' ' ALA . 15.3 mm -60.88 -54.49 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.231 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.728 HG13 HD13 ' A' ' 37' ' ' LEU . 16.1 t -69.23 -24.2 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.583 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -63.33 -27.04 69.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.7 -30.66 62.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.888 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.691 HD13 ' HB ' ' A' ' 47' ' ' VAL . 42.6 mt -84.51 -54.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.323 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -122.78 -84.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.682 -171.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.74 43.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.44 -1.362 . . . . 0.0 114.54 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.749 HG13 HD11 ' A' ' 37' ' ' LEU . 18.3 mm -82.76 126.69 72.52 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 118.158 0.979 . . . . 0.0 108.655 167.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.729 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.7 Cg_endo -56.43 145.55 78.71 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.244 1.963 . . . . 0.0 111.48 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.669 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 27.0 m -56.61 -32.97 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.07 -17.12 51.19 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.558 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.729 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 16.1 t70 -87.28 -14.03 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.635 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.467 HG23 ' CB ' ' A' ' 13' ' ' ALA . 91.3 t -69.73 122.81 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.321 0.581 . . . . 0.0 110.443 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' O ' HG11 ' A' ' 70' ' ' VAL . 58.7 mtpt -145.78 164.16 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -171.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.447 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.3 mp -78.28 -2.72 39.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.69 -25.62 16.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.983 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -91.14 142.53 27.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.327 0.584 . . . . 0.0 110.842 -169.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 3.6 m -82.82 136.45 34.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.03 -172.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.51 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.67 -43.29 94.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.328 0.585 . . . . 0.0 110.117 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.9 p -72.69 -38.96 67.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.636 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.614 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.1 t70 -92.01 -60.65 1.8 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.896 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.05 -50.05 10.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.251 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.749 HD11 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -66.25 -28.12 68.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 t0 60.12 67.92 0.82 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.739 0.78 . . . . 0.0 109.873 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 43' ' ' SER . 0.6 OUTLIER -128.04 155.46 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.682 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -103.95 168.15 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.597 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 34.0 t -49.4 -57.58 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.721 0.638 . . . . 0.0 111.38 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.81 -40.39 83.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.017 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.706 ' HB2' HG21 ' A' ' 39' ' ' VAL . 4.6 m -51.68 -53.81 34.95 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.855 0.36 . . . . 0.0 111.149 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.92 ' HE1' ' HA ' ' A' ' 65' ' ' LYS . 14.4 ptt? -65.7 -49.89 66.87 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.759 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.884 HG21 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.31 -23.3 29.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.088 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.92 -65.41 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.934 -0.479 . . . . 0.0 111.208 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.691 ' HB ' HD13 ' A' ' 19' ' ' ILE . 11.6 t -86.12 -25.17 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.893 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 15' ' ' ILE . 21.6 t -80.27 -20.17 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.674 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.7 t -77.71 -33.36 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.552 0.691 . . . . 0.0 109.233 166.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.32 -19.9 62.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.399 0.618 . . . . 0.0 109.65 168.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.774 ' HB1' HG13 ' A' ' 15' ' ' ILE . . . -85.93 -33.39 21.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.966 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.726 ' O ' HG11 ' A' ' 57' ' ' VAL . 3.6 pt-20 -65.68 -50.85 63.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.585 -175.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.666 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 39.5 mt-10 -56.67 -37.53 70.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.44 -175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.3 ptp180 -72.2 -7.79 51.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.295 -174.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.56 10.47 21.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.589 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 63.22 39.28 9.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.643 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -114.84 165.49 9.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.578 ' N ' HG21 ' A' ' 57' ' ' VAL . 61.2 tttp -126.97 111.27 13.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.309 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 tt -131.71 120.32 17.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.136 0.493 . . . . 0.0 110.539 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 51.4 Cg_exo -56.8 148.78 64.25 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.038 2.492 . . . . 0.0 113.299 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.21 -47.24 65.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.05 -33.76 73.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.919 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -31.11 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.772 -174.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.884 ' HB ' HG21 ' A' ' 45' ' ' VAL . 11.1 t -73.34 -42.26 57.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.92 ' HA ' ' HE1' ' A' ' 44' ' ' MET . 12.6 tmtt? -55.95 -40.62 73.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.921 171.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -76.5 -2.79 33.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -172.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 4.6 pp -107.03 139.47 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.093 0.473 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -114.24 1.06 14.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.668 -172.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 28.5 p -128.52 153.42 47.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 172.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 28' ' ' LYS . 1.1 p -68.88 -21.79 25.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -70.9 -32.24 66.55 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.95 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' A' ' 67' ' ' LEU . 13.1 m-20 -57.15 -51.21 70.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.796 0.332 . . . . 0.0 110.19 174.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.47 72.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.193 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.733 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -61.63 -53.1 60.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.686 -174.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HD2' HD13 ' A' ' 78' ' ' LEU . 3.7 tptp -62.98 -31.77 72.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.616 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.56 -45.96 77.63 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.408 ' HA ' HG23 ' A' ' 57' ' ' VAL . 52.4 mt -63.66 -46.25 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.224 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 74' ' ' THR . 97.6 mt -61.07 -25.36 66.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.78 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.75 -40.3 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -101.49 21.31 14.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -171.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -89.75 161.25 16.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.049 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.185 171.754 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.757 0.313 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.8 128.05 48.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.131 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.94 117.89 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -81.31 -175.44 5.47 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -176.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.562 ' H ' HG23 ' A' ' 4' ' ' THR . 12.3 tt0 -47.24 -55.32 8.85 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -169.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.1 pm0 -71.52 -36.4 71.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.741 0.305 . . . . 0.0 111.524 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -70.73 -47.53 59.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 110.145 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.727 HG22 HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.76 -31.13 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.47 -39.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.01 97.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 110.402 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.529 ' HA2' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.41 -43.12 79.74 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.705 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.619 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.74 -48.56 80.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.676 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -51.92 -50.09 61.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.366 0.603 . . . . 0.0 111.359 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.88 -30.64 71.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.784 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.617 HG22 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.58 -34.73 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.026 -177.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.716 HG12 HD13 ' A' ' 37' ' ' LEU . 15.7 t -69.62 -24.86 27.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.479 0.657 . . . . 0.0 109.449 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.07 -24.06 66.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB2' HG13 ' A' ' 47' ' ' VAL . 3.8 mm-40 -72.94 -21.38 60.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.597 HD13 ' HB ' ' A' ' 47' ' ' VAL . 46.0 mt -93.56 -52.84 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.589 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.34 -88.58 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.1 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.363 -1.399 . . . . 0.0 114.907 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.732 HG13 HD11 ' A' ' 37' ' ' LEU . 14.6 mm -79.68 125.97 81.42 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.5 Cg_endo -56.02 148.32 58.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.3 2.0 . . . . 0.0 111.307 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.419 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 32.7 m -62.67 -19.25 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 -175.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.83 -19.75 47.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG22 ' A' ' 22' ' ' ILE . 40.8 t0 -98.88 -21.25 16.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.576 -171.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 13' ' ' ALA . 83.5 t -64.52 118.72 7.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.298 0.57 . . . . 0.0 110.826 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' HG11 ' A' ' 70' ' ' VAL . 58.5 mtpt -147.55 172.65 13.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.985 -172.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.3 mp -80.81 -3.86 52.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.311 0.576 . . . . 0.0 110.044 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.5 m-20 -92.79 -23.01 19.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.501 -173.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HZ3' ' HB2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -97.07 141.58 30.04 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.521 -169.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 27.4 m -82.37 136.28 35.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.586 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.54 -50.62 72.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.598 . . . . 0.0 110.104 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.4 p -65.43 -39.63 92.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.67 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 6.7 m-20 -91.99 -69.51 0.74 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.798 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HD12 ' A' ' 22' ' ' ILE . 4.0 m-20 -63.41 -49.71 72.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.682 -175.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.732 HD11 HG13 ' A' ' 22' ' ' ILE . 3.8 mm? -71.39 -9.85 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.28 -174.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.16 38.54 29.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.112 0.482 . . . . 0.0 110.238 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.18 147.47 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.148 0.499 . . . . 0.0 111.319 -171.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.2 169.34 9.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.101 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.0 m -59.93 -45.73 91.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.559 0.537 . . . . 0.0 111.806 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -46.99 64.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.501 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 5.3 m -49.16 -57.11 7.24 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.733 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.659 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 7.9 ptm -57.38 -51.81 67.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.739 HG21 ' HB ' ' A' ' 64' ' ' VAL . 77.2 t -63.57 -24.46 35.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -176.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -75.28 -64.24 1.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.606 -0.684 . . . . 0.0 111.665 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' HB ' HD13 ' A' ' 19' ' ' ILE . 16.7 t -85.08 -23.67 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.166 -174.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 44' ' ' MET . 39.4 t -79.28 -27.09 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.433 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.714 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.2 t -70.83 -35.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.764 0.792 . . . . 0.0 109.025 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -22.45 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG22 ' A' ' 15' ' ' ILE . . . -85.14 -39.36 17.97 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.945 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 7.1 pt-20 -60.67 -48.23 82.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.405 0.621 . . . . 0.0 109.588 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.57 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 36.2 mt-10 -62.48 -36.81 83.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.789 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 12.9 ptp180 -76.71 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 111.179 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.529 ' HZ ' ' HA2' ' A' ' 11' ' ' GLY . 63.2 m-85 -103.66 15.05 29.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 109.781 172.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 58.79 59.08 2.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.489 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.688 HG11 ' O ' ' A' ' 52' ' ' GLU . 10.4 p -143.96 160.62 15.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -134.15 112.36 11.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.195 0.522 . . . . 0.0 110.041 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.61 HD13 HG23 ' A' ' 64' ' ' VAL . 18.2 pt -118.35 159.39 43.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 137.57 47.97 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.355 2.036 . . . . 0.0 111.838 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.53 -47.3 66.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.5 -32.25 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.277 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.29 -44.59 87.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.739 ' HB ' HG21 ' A' ' 45' ' ' VAL . 39.5 t -54.65 -42.17 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 110.453 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 2.1 tmtm? -77.3 -22.75 51.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.31 -37.9 51.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.422 -175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.644 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -72.58 137.76 46.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.825 0.821 . . . . 0.0 111.471 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -86.88 -28.78 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.671 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 p -117.63 154.23 31.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.549 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -63.75 -28.66 45.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -32.96 85.95 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.591 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.644 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 59.0 m-20 -60.8 -55.97 26.79 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.426 0.155 . . . . 0.0 110.586 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HB3' HD13 ' A' ' 67' ' ' LEU . . . -53.81 -52.65 59.64 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.318 0.58 . . . . 0.0 110.374 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.796 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.6 m -53.14 -51.3 62.4 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.769 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HD2' HD11 ' A' ' 78' ' ' LEU . 8.8 tptm -65.43 -36.23 83.31 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.728 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -66.61 -39.93 88.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.183 0.516 . . . . 0.0 109.755 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.605 HG22 HG13 ' A' ' 57' ' ' VAL . 71.3 mt -61.51 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 172.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 74' ' ' THR . 91.5 mt -65.21 -24.76 67.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.689 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -82.0 -51.06 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -92.29 11.52 25.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.155 -172.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.03 149.67 50.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 0.0 110.881 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.194 179.198 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.584 ' H ' HG22 ' A' ' 4' ' ' THR . 17.9 tt0 -57.62 -56.02 27.27 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -168.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.21 -34.46 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.541 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.91 -53.28 49.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.324 0.583 . . . . 0.0 110.297 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.761 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.4 -34.98 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.953 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG23 HG21 ' A' ' 74' ' ' THR . 2.1 t -59.85 -41.77 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.863 -0.153 . . . . 0.0 110.932 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.14 86.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.66 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.73 -31.44 73.19 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.882 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -72.09 -50.63 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.632 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.24 -49.66 68.97 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.487 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -53.07 -36.27 60.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.861 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -34.31 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.785 -174.377 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 37' ' ' LEU . 44.6 t -69.24 -25.13 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.56 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -62.98 -21.43 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.147 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.54 -27.64 51.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.713 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.75 HD11 ' HB ' ' A' ' 47' ' ' VAL . 49.8 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.381 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.22 -87.17 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.6 53.38 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.529 -1.32 . . . . 0.0 114.128 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.825 HG13 HD13 ' A' ' 37' ' ' LEU . 19.3 mm -88.63 125.86 61.74 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.13 144.57 46.58 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.406 2.071 . . . . 0.0 111.434 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.632 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 19.4 m -54.58 -32.94 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.47 -18.08 49.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.518 ' HB3' HG23 ' A' ' 22' ' ' ILE . 25.9 t0 -86.75 -18.31 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.461 HG21 ' CB ' ' A' ' 13' ' ' ALA . 93.0 t -63.8 112.71 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.666 0.746 . . . . 0.0 110.325 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.0 mttp -135.51 162.81 31.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.758 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.901 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.7 mp -76.97 -3.09 37.14 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.87 0.366 . . . . 0.0 110.499 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -8.06 22.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.593 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -101.53 140.06 36.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.873 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.6 m -85.31 133.56 34.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.072 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.581 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -59.98 -46.9 87.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.428 0.633 . . . . 0.0 110.321 178.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.9 p -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.392 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.66 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 26.4 t70 -93.88 -68.85 0.78 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.095 0.474 . . . . 0.0 112.091 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.51 -49.06 58.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.644 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.825 HD13 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -67.47 -21.01 65.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.072 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 59.0 38.24 24.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.829 0.823 . . . . 0.0 109.621 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -101.13 156.08 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.595 -174.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-20 -99.84 155.08 17.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.12 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.9 m -51.41 -45.02 62.41 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.068 0.855 . . . . 0.0 111.426 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -48.17 59.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.2 m -54.31 -51.06 65.85 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.615 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.684 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.5 ptm -60.4 -47.5 85.81 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.677 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.828 HG22 ' HB ' ' A' ' 64' ' ' VAL . 54.6 t -61.61 -27.88 42.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.288 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.96 -65.37 0.85 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.834 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HB ' HD11 ' A' ' 19' ' ' ILE . 13.3 t -86.09 -20.82 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.865 -173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.8 t -79.92 -26.45 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.309 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.699 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -70.62 -35.73 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.384 0.611 . . . . 0.0 109.524 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.5 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 110.054 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.861 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.09 -33.53 24.35 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.765 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.2 pt-20 -67.97 -49.72 60.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.196 0.522 . . . . 0.0 109.815 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.603 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 21.3 mt-10 -67.38 -21.89 65.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.1 ptm180 -72.32 -19.62 61.63 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.04 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.541 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 93.2 m-85 -99.89 -4.49 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 109.874 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t0 65.23 67.92 0.51 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.5 p -117.45 164.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.706 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 57' ' ' VAL . 33.1 mmtm -122.59 109.73 14.67 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 111.049 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -140.61 143.15 31.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.962 173.172 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -60.92 138.37 78.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.249 1.966 . . . . 0.0 111.575 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -47.52 -57.19 5.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.844 0.83 . . . . 0.0 111.162 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.597 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 12.0 t70 -64.7 -20.72 66.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.5 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.82 -22.02 66.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.24 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 45' ' ' VAL . 58.6 t -64.25 -29.35 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.688 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.597 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -74.66 -14.45 60.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 110.809 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 9.7 t30 -79.63 -32.6 41.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.534 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.979 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -82.78 122.85 28.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -88.86 -11.37 44.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 31.6 p -125.55 155.99 39.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -67.08 -32.58 58.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.505 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.901 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -70.76 -35.08 66.36 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.909 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.64 -37.75 82.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -63.31 -46.56 86.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.809 175.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.816 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -62.78 -49.52 74.65 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.64 -170.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HD2' HD12 ' A' ' 78' ' ' LEU . 30.8 mmmt -62.47 -37.03 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.457 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 27.9 t80 -67.43 -40.82 85.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.02 0.438 . . . . 0.0 110.015 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.76 -36.84 77.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.236 0.541 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.816 ' HG ' ' O ' ' A' ' 74' ' ' THR . 90.0 mt -71.83 -26.73 62.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.24 -35.72 27.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.741 0.305 . . . . 0.0 111.044 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 20.63 18.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.883 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HA ' HG23 ' A' ' 57' ' ' VAL . 13.3 pt20 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.209 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.635 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 120.593 0.235 . . . . 0.0 110.77 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -68.06 -47.53 68.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.635 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.4 pm0 -61.89 -42.03 98.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.177 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.24 -51.72 34.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.628 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.962 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.4 -36.26 77.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.027 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.1 -41.85 90.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.18 97.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.438 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 15' ' ' ILE . . . -64.63 -45.52 92.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.177 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.7 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.48 -50.97 70.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -53.13 -57.59 9.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.52 -33.34 74.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.191 0.52 . . . . 0.0 110.504 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.713 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.0 -34.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.961 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.704 HG11 HD12 ' A' ' 37' ' ' LEU . 22.0 t -74.16 -24.98 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.822 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.2 -28.72 69.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.844 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.78 -38.42 90.92 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.477 0.656 . . . . 0.0 109.726 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.2 mt -75.53 -53.28 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.172 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.86 -86.18 0.53 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.796 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.26 61.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.06 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.779 HG13 HD13 ' A' ' 37' ' ' LEU . 16.7 mm -88.37 134.2 35.0 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.26 142.16 57.37 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.263 1.975 . . . . 0.0 111.197 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.671 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 28.8 m -62.4 -30.67 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 111.505 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 2.0 pm0 -80.56 -17.04 52.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.211 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.85 -14.34 42.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 110.256 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' A' ' 13' ' ' ALA . 89.0 t -71.87 115.24 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.708 0.766 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 70' ' ' VAL . 26.0 mtpp -136.17 169.42 17.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.914 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.73 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.4 mp -78.37 -2.7 39.51 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.11 0.481 . . . . 0.0 110.701 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.96 -21.82 17.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.681 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.88 144.02 25.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.389 -170.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.879 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 15.7 m -83.98 135.13 34.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.479 -172.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -62.05 -46.9 87.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.293 0.568 . . . . 0.0 110.438 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.8 p -77.64 -29.5 51.72 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.879 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 25.9 t70 -92.22 -66.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.72 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.96 -56.37 5.8 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.084 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.779 HD13 HG13 ' A' ' 22' ' ' ILE . 2.8 mm? -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.749 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.87 65.9 1.38 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.981 0.8 . . . . 0.0 110.044 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.522 HG11 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -123.22 143.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.082 -172.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.677 ' O ' ' HG2' ' A' ' 44' ' ' MET . 5.3 m-20 -88.71 162.6 16.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -53.76 -49.57 67.93 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.957 0.785 . . . . 0.0 110.594 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -49.77 72.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 109.676 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.564 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -55.32 -50.28 70.01 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.046 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.677 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.0 ptm -62.43 -43.5 98.66 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.977 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 94.7 t -69.02 -25.63 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.848 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -72.8 -65.79 0.75 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.618 -0.676 . . . . 0.0 111.349 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.686 HG12 HG23 ' A' ' 15' ' ' ILE . 7.4 t -87.71 -22.48 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.263 -173.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 44' ' ' MET . 36.1 t -78.98 -26.43 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.798 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -69.64 -38.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.06 -25.1 63.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 110.675 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.713 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.71 -37.24 21.18 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.798 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 8.1 pt-20 -68.15 -48.9 64.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.576 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.9 mt-10 -64.18 -27.98 69.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.081 -174.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 54' ' ' ARG . 6.2 ptp180 -76.12 -9.43 58.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 111.096 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 80.5 m-85 -105.93 17.96 22.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 66.62 24.16 10.17 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.595 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 77' ' ' ILE . 11.3 p -113.86 151.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 58' ' ' LYS . 2.1 tmtt? -135.78 113.77 11.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.222 170.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.734 HD11 HG22 ' A' ' 64' ' ' VAL . 13.0 pt -102.98 165.61 13.33 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.697 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 50.1 Cg_exo -54.94 119.4 6.44 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.527 1.485 . . . . 0.0 111.01 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.57 -40.55 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 110.553 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.47 -23.39 67.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.408 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 20.5 t70 -78.04 -25.63 47.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.782 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.734 HG22 HD11 ' A' ' 59' ' ' ILE . 44.7 t -62.32 -32.06 53.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.97 -31.86 66.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.974 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -72.04 -39.7 68.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.743 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.087 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.24 131.69 39.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.385 0.612 . . . . 0.0 110.872 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -104.94 -1.29 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.517 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.71 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 66.0 p -126.85 147.87 50.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -66.22 -32.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 109.798 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -67.71 -43.38 84.86 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.87 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.26 -41.69 84.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.087 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -59.5 -59.76 4.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.153 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 12.7 m -58.27 -47.11 84.64 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.02 -173.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD3' HD21 ' A' ' 29' ' ' LEU . 35.3 tptt -66.04 -33.33 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.44 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 54.1 t80 -66.92 -42.19 85.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.692 HG23 HG11 ' A' ' 57' ' ' VAL . 66.3 mt -58.12 -46.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.286 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.962 HD21 HG21 ' A' ' 8' ' ' ILE . 81.7 mt -66.66 -38.17 86.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.311 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -74.27 -21.04 59.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -128.48 29.11 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 120.783 0.325 . . . . 0.0 111.444 -177.205 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.602 ' H ' HG22 ' A' ' 4' ' ' THR . 5.9 tt0 -63.04 -56.01 20.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.968 0.168 . . . . 0.0 111.178 -171.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.515 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.1 pm0 -60.67 -36.04 77.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.69 0.281 . . . . 0.0 111.279 -173.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -69.34 -56.27 7.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.445 0.64 . . . . 0.0 110.397 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.799 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.25 -34.62 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.946 -177.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -61.43 -39.12 81.75 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.794 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.9 88.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.637 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.4 -39.08 91.54 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.703 HD22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -66.72 -51.63 53.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.35 -48.69 76.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.734 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -51.83 -36.44 48.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.819 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.849 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.19 -40.27 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.142 -174.074 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 37' ' ' LEU . 13.2 t -68.34 -24.63 29.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.347 0.594 . . . . 0.0 109.592 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.95 -27.19 65.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.57 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.89 -47.88 42.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.205 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 47' ' ' VAL . 20.1 mt -59.02 -52.79 56.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.057 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.99 -84.48 0.61 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.835 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.38 59.48 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.985 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.83 HG13 HD13 ' A' ' 37' ' ' LEU . 29.0 mm -94.91 128.54 38.88 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 148.48 42.67 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.567 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.656 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.6 m -64.65 -17.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.66 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.15 -21.31 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.196 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' HB3' HG23 ' A' ' 22' ' ' ILE . 22.2 t0 -99.17 -13.51 19.73 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 111.457 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.96 121.95 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.328 0.585 . . . . 0.0 110.3 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.4 mtpt -145.23 165.61 27.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.683 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.592 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 8.4 mp -75.64 -0.97 22.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.464 0.65 . . . . 0.0 109.863 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -97.17 -22.39 16.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.007 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.04 141.57 29.28 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.608 -172.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.822 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 13.7 t -81.21 132.97 35.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.245 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.55 -47.76 84.31 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.552 0.692 . . . . 0.0 110.074 176.213 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.6 p -74.58 -37.46 62.91 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.549 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 33.5 t70 -92.35 -59.7 2.02 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.16 -49.43 23.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD13 HG13 ' A' ' 22' ' ' ILE . 3.2 mm? -72.58 -16.55 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.621 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 57.07 34.59 25.13 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.064 0.935 . . . . 0.0 109.455 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -87.79 160.47 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 -171.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.758 ' O ' ' HG2' ' A' ' 44' ' ' MET . 1.2 t70 -112.93 155.46 24.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.976 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 34.9 t -41.74 -59.47 1.65 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.362 1.039 . . . . 0.0 112.17 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.77 62.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.531 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 24.5 m -53.46 -51.2 63.47 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.802 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.758 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.1 ptm -62.98 -47.49 82.95 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' A' ' 64' ' ' VAL . 97.1 t -66.2 -22.6 30.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.881 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -75.39 -66.94 0.71 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.609 -0.682 . . . . 0.0 111.752 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.707 HG12 HG23 ' A' ' 15' ' ' ILE . 4.9 t -84.17 -22.85 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.799 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.0 t -79.9 -22.6 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.214 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.706 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.1 t -68.44 -37.32 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 166.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.33 -25.01 68.1 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.378 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.849 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.54 -37.4 25.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.351 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.706 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 3.5 pt-20 -67.17 -48.66 67.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.473 0.654 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.63 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 85.1 mt-10 -70.44 -23.61 62.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.949 -172.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.3 ptm180 -73.36 -10.81 60.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.891 0.377 . . . . 0.0 110.367 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 55.1 m-85 -109.41 19.49 19.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.426 175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 66.95 26.8 9.05 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.476 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.767 HG11 HG23 ' A' ' 77' ' ' ILE . 10.2 p -118.02 155.63 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 35.7 tptt -134.83 114.71 12.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.179 0.514 . . . . 0.0 110.585 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.674 HD11 HG22 ' A' ' 64' ' ' VAL . 20.5 pt -104.11 163.33 17.54 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.439 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 27.8 Cg_exo -61.16 132.36 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.963 1.775 . . . . 0.0 111.165 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.76 -51.48 49.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.0 111.002 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.24 -20.57 64.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.92 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 9.0 t70 -71.67 -34.44 69.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.816 -0.174 . . . . 0.0 110.968 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.674 ' HB ' HG22 ' A' ' 45' ' ' VAL . 41.9 t -59.91 -39.48 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 15.7 tptp -72.03 -20.17 61.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.92 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -75.13 -35.16 61.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -81.04 153.78 27.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.0 mptp? -104.99 -29.05 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.086 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.822 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.1 p -111.11 156.64 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.26 -31.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.592 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.4 -35.72 92.1 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.196 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 63.3 m-20 -56.26 -57.35 12.62 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.662 0.268 . . . . 0.0 110.431 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.617 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.99 -44.7 78.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.372 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.757 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 19.7 m -56.51 -53.74 53.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.752 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -66.23 -37.19 84.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 40.5 t80 -59.68 -41.71 91.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.698 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.767 HG23 HG11 ' A' ' 57' ' ' VAL . 58.6 mt -64.94 -48.44 84.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.803 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.799 HD21 HG21 ' A' ' 8' ' ' ILE . 85.8 mt -64.63 -44.26 91.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.444 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -5.26 59.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 76' ' ' TYR . 26.3 m-70 -126.43 15.43 7.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.596 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -49.81 -53.12 27.28 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 7' ' ' GLU . 8.3 pt-20 -55.22 -49.09 72.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 111.54 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 6' ' ' GLU . 36.5 mt-10 -66.55 -50.7 62.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.214 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.874 HG21 HD21 ' A' ' 78' ' ' LEU . 3.0 tt -67.13 -35.33 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.862 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.96 -35.9 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.379 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.22 -43.42 78.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.924 0.392 . . . . 0.0 110.665 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.3 85.51 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.801 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -43.86 97.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.12 -54.89 37.49 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.149 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -52.8 -43.39 65.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.56 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 47' ' ' VAL . 7.3 mm -62.27 -53.8 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.247 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.735 HG11 HD12 ' A' ' 37' ' ' LEU . 12.1 t -70.48 -23.34 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 0.0 110.635 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -60.79 -29.23 69.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.41 -43.23 67.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 110.274 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.543 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.4 mt -65.53 -52.56 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.185 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -76.4 0.57 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.1 51.31 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.379 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 37' ' ' LEU . 10.6 mm -80.55 124.86 81.82 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.749 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 8.1 Cg_endo -53.38 147.27 37.73 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.698 2.266 . . . . 0.0 111.525 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.1 m -61.39 -30.82 48.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -172.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.21 -17.29 52.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.856 0.36 . . . . 0.0 111.401 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.749 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 2.7 t70 -86.03 -18.97 31.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.941 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 13' ' ' ALA . 84.5 t -67.41 120.39 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.658 0.742 . . . . 0.0 110.525 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HE3' ' OD1' ' A' ' 30' ' ' ASP . 26.2 mtpp -142.36 165.23 27.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.441 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.565 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 7.6 mp -77.95 -3.27 41.05 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.421 ' OD1' ' HE3' ' A' ' 28' ' ' LYS . 12.8 p-10 -107.29 -8.31 16.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -90.71 139.81 30.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.7 m -89.1 135.59 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.376 -171.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -58.04 -47.56 82.72 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 110.193 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 p -72.12 -32.13 66.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.481 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.76 -69.84 0.73 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.272 0.558 . . . . 0.0 111.602 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.67 -48.4 26.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.941 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.813 HD13 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -66.68 -17.91 65.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.441 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.04 36.06 18.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.935 0.874 . . . . 0.0 109.679 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -98.47 150.13 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.746 -171.137 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.762 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.6 t70 -97.53 154.62 17.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.996 173.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 45' ' ' VAL . 30.4 m -51.99 -44.85 64.25 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.699 0.624 . . . . 0.0 111.632 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 tp -77.58 -39.34 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.954 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 51.6 m -55.34 -48.67 73.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.762 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 6.4 ptm -62.47 -45.84 91.22 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.749 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.2 t -64.36 -23.04 32.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.713 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.21 -65.73 0.81 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.936 -0.478 . . . . 0.0 111.696 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 15' ' ' ILE . 18.9 t -89.67 -20.53 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.272 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 44' ' ' MET . 19.8 t -80.08 -17.0 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.665 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.0 t -78.57 -34.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 121.536 0.684 . . . . 0.0 109.209 165.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -59.5 -24.18 63.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.567 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.7 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -81.76 -38.76 25.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.677 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.727 ' O ' HG12 ' A' ' 57' ' ' VAL . 5.9 pt-20 -60.4 -47.4 86.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.692 0.758 . . . . 0.0 109.46 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 22.6 mt-10 -74.75 -21.74 59.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.809 -171.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 3.7 ptp180 -74.21 -12.15 60.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.019 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.0 10.13 39.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.72 30.42 16.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.001 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -115.17 162.74 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.575 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 24.3 mmmt -128.7 116.02 18.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.252 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 64' ' ' VAL . 44.2 pt -117.61 158.7 44.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.666 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 18.7 Cg_exo -69.43 135.44 31.25 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.548 2.165 . . . . 0.0 112.302 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.8 -58.15 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.592 0.711 . . . . 0.0 110.79 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -17.75 64.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.349 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.666 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.3 t0 -76.07 -19.56 58.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.105 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.834 ' HB ' HG22 ' A' ' 45' ' ' VAL . 24.6 t -72.73 -52.61 22.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.514 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -68.82 -7.25 32.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -76.43 -36.21 58.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.087 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.741 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.1 pp -89.24 128.17 35.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.47 0.652 . . . . 0.0 111.016 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.92 1.0 55.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.89 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 74.7 p -130.15 147.91 51.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.553 0.216 . . . . 0.0 110.543 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 31' ' ' LYS . 1.6 p -69.43 -34.42 62.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.943 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.6 -41.37 97.28 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.91 -49.75 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -52.45 -54.27 34.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.627 0.727 . . . . 0.0 111.164 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.773 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.1 m -58.08 -48.55 79.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.636 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.622 ' HD2' HD12 ' A' ' 78' ' ' LEU . 12.2 tptp -69.2 -29.09 66.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.216 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.24 -46.35 80.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.802 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.51 -36.78 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.307 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 8' ' ' ILE . 92.3 mt -70.6 -31.86 69.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.768 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.26 -42.2 17.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.064 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -96.08 13.24 27.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.496 179.277 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.582 ' H ' HG22 ' A' ' 4' ' ' THR . 15.2 tp60 -48.7 -53.36 19.15 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -62.23 -46.85 87.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.16 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.32 -43.41 50.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.845 0.355 . . . . 0.0 111.284 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.691 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.48 -34.1 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.59 -42.41 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.129 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.92 92.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.607 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.571 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -66.8 -39.18 93.48 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.92 -49.45 70.37 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.02 -50.45 70.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.68 -36.51 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -39.36 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.254 -175.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 37' ' ' LEU . 41.7 t -70.11 -24.99 26.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.097 0.475 . . . . 0.0 110.079 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -62.29 -24.53 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -72.33 -39.46 68.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 109.795 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.724 HD11 ' HB ' ' A' ' 47' ' ' VAL . 26.9 mt -72.63 -50.64 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.226 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.83 -77.75 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.259 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.62 44.19 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.788 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.824 HG13 HD13 ' A' ' 37' ' ' LEU . 9.1 mm -75.04 134.97 74.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 26' ' ' ASP . 51.3 Cg_exo -53.61 144.14 53.9 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.469 2.113 . . . . 0.0 111.449 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 82.3 t -59.69 -38.13 74.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.364 . . . . 0.0 111.021 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -74.29 -17.95 60.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.68 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' HB3' HG23 ' A' ' 22' ' ' ILE . 14.0 t0 -87.51 -16.84 33.55 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.214 -0.304 . . . . 0.0 111.594 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 13' ' ' ALA . 89.8 t -64.97 116.96 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.566 0.698 . . . . 0.0 110.445 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -141.02 162.02 36.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.194 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' CA ' ' A' ' 71' ' ' GLY . 9.7 mp -79.25 -4.19 49.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.35 -8.38 21.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -97.56 134.57 40.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 18.1 m -89.39 140.91 29.04 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 111.46 -170.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.637 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 1.1 m-85 -58.81 -50.92 72.15 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 110.152 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.3 p -69.53 -33.06 72.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.406 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.18 -68.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 10.3 t0 -78.42 -51.52 9.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.4 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.824 HD13 HG13 ' A' ' 22' ' ' ILE . 3.8 mm? -64.8 -13.31 55.09 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 58.13 38.83 26.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 109.539 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.41 149.79 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.913 -172.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.76 166.29 11.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 p -54.83 -56.72 16.36 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.099 0.249 . . . . 0.0 111.634 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.34 -38.87 92.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.533 0.206 . . . . 0.0 111.263 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 25.1 m -52.66 -54.37 34.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.031 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.671 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 15.2 ptt? -64.26 -48.02 77.34 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.646 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.1 t -55.28 -28.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.994 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.22 -66.13 0.87 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.761 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.724 ' HB ' HD11 ' A' ' 19' ' ' ILE . 14.4 t -83.33 -22.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.134 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 44' ' ' MET . 44.9 t -79.9 -19.92 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.917 -0.489 . . . . 0.0 110.295 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -75.22 -32.88 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.249 167.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -62.0 -24.32 66.97 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.605 169.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.53 -32.48 28.62 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.888 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.8 pt-20 -66.11 -54.08 29.99 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.643 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 16.5 mt-10 -71.61 -20.36 61.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.227 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 13.3 ptm180 -69.68 -15.24 63.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.101 0.477 . . . . 0.0 110.048 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.571 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 65.3 m-85 -107.3 15.03 25.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.014 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.33 27.37 8.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.72 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.1 p -113.67 165.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.535 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 17.1 pttm -132.26 119.1 20.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 110.427 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.04 154.65 53.36 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -63.73 128.96 23.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.899 1.732 . . . . 0.0 111.524 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.49 -40.07 58.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.479 0.657 . . . . 0.0 109.709 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.78 -35.5 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.104 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -74.42 -29.64 61.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.898 ' HB ' HG22 ' A' ' 45' ' ' VAL . 21.7 t -61.58 -40.59 87.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.376 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.17 -5.65 59.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 177.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -80.82 -23.64 39.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.067 0.46 . . . . 0.0 110.282 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -95.28 143.72 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.412 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 11.9 mptt -101.54 -17.66 16.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.806 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 19.1 p -118.77 156.06 30.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.599 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -65.38 -33.99 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.035 0.445 . . . . 0.0 109.944 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' CA ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.8 -35.58 86.99 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 69.5 m-20 -58.8 -58.54 8.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.516 0.186 . . . . 0.0 110.638 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -55.26 -47.65 75.15 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.0 m -57.02 -54.08 50.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.088 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 1.6 tppp? -69.78 -31.43 69.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.211 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -61.08 -45.28 95.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.933 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.572 HG23 HG11 ' A' ' 57' ' ' VAL . 61.2 mt -59.49 -44.5 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 74' ' ' THR . 81.2 mt -71.96 -29.11 63.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.964 -174.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.76 -24.89 61.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.651 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -124.1 28.92 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.148 0.499 . . . . 0.0 112.089 -173.719 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.484 ' H ' HG22 ' A' ' 4' ' ' THR . 12.2 tt0 -55.35 -56.61 18.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.19 -34.41 78.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 0.0 111.491 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -70.7 -51.21 29.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.778 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.46 -32.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.77 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.2 -44.02 90.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.89 87.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 110.69 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -70.86 -42.86 59.92 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.983 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.56 -40.95 98.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.744 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.85 -51.67 68.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.103 177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -54.21 -39.59 66.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.197 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 51' ' ' ALA . 6.4 mm -67.93 -52.77 35.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.218 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.831 HG11 HD12 ' A' ' 37' ' ' LEU . 5.8 t -68.03 -22.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.148 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.51 -31.61 69.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -76.66 -24.82 53.27 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 110.411 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.51 HG21 HG23 ' A' ' 39' ' ' VAL . 22.2 mt -81.92 -54.36 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.671 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.41 -78.05 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.938 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.74 57.49 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.557 -1.306 . . . . 0.0 114.696 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.792 HG13 HD13 ' A' ' 37' ' ' LEU . 20.9 mm -90.72 129.81 43.24 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 164.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.54 147.16 39.73 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.349 2.033 . . . . 0.0 111.981 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.744 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 25.3 m -61.09 -26.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.441 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.34 -17.52 48.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.64 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 22' ' ' ILE . 2.3 t70 -96.23 -15.55 21.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.742 HG21 ' HA ' ' A' ' 13' ' ' ALA . 76.9 t -68.66 126.74 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.592 0.711 . . . . 0.0 110.571 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HE2' ' HB3' ' A' ' 30' ' ' ASP . 42.5 mtpt -140.2 173.45 11.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.692 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 30.2 mt -82.07 -3.29 54.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.895 0.855 . . . . 0.0 108.695 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.555 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 6.2 t70 -95.62 -27.1 15.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.592 -170.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.86 144.15 25.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.991 -174.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.793 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 22.3 m -84.54 135.35 34.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.653 ' CD2' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -60.82 -48.13 83.2 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.242 0.544 . . . . 0.0 110.135 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 p -66.59 -38.07 86.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.503 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -92.75 -65.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.989 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.3 m-20 -69.42 -48.53 60.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.848 -174.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.831 HD12 HG11 ' A' ' 16' ' ' VAL . 3.6 mm? -74.87 -4.59 38.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.131 -171.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.36 58.8 5.1 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.934 0.772 . . . . 0.0 109.34 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -122.44 152.21 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.689 -170.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.611 ' H ' ' HB3' ' A' ' 43' ' ' SER . 12.4 t70 -119.46 162.31 19.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.621 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.6 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 p -39.25 -58.09 1.25 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -74.35 -44.52 51.99 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.375 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 40' ' ' ASP . 30.6 t -45.27 -58.98 2.9 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.643 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.482 ' HE2' HG12 ' A' ' 64' ' ' VAL . 10.4 ptm -60.78 -50.15 74.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.754 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' A' ' 64' ' ' VAL . 70.0 t -63.76 -21.64 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.103 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.944 -0.472 . . . . 0.0 111.372 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.746 HG12 HG23 ' A' ' 15' ' ' ILE . 6.6 t -89.92 -21.67 6.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.858 -173.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 44' ' ' MET . 38.6 t -79.78 -24.01 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.172 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.693 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.4 t -70.27 -39.06 76.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 167.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.0 -21.56 61.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.579 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.59 -46.57 11.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.842 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 10.6 pt-20 -63.25 -46.53 86.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 110.159 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.78 -24.98 64.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.485 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 14.7 ptm180 -75.19 -18.65 60.12 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.215 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 88.0 m-85 -97.27 9.89 41.0 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.39 0.614 . . . . 0.0 109.361 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 66.36 52.6 1.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.198 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.3 p -137.52 152.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -134.32 112.12 10.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.679 0.276 . . . . 0.0 110.54 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.714 HD11 HG22 ' A' ' 64' ' ' VAL . 8.1 pt -110.01 165.23 13.06 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.37 134.74 43.15 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.699 1.599 . . . . 0.0 111.393 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB3' HG11 ' A' ' 45' ' ' VAL . 1.6 m-20 -51.38 -43.8 61.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.742 0.782 . . . . 0.0 110.068 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.13 -31.33 65.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.861 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.47 -35.23 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.166 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.714 HG22 HD11 ' A' ' 59' ' ' ILE . 55.5 t -58.45 -42.63 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.6 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 16.6 tptp -74.66 -20.63 59.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.838 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -73.63 -28.24 61.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.054 0.454 . . . . 0.0 110.011 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -88.22 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 111.004 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -99.72 -14.8 18.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.354 -171.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.793 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 26.2 p -115.45 157.68 23.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.653 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.2 p -70.19 -24.27 25.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.448 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -37.14 94.02 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.815 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.711 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.2 m-20 -56.92 -58.07 9.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.41 0.148 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.638 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.65 -50.17 70.94 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.27 0.557 . . . . 0.0 110.747 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.746 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 37.0 m -55.25 -50.68 68.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.926 -176.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -67.74 -31.27 71.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.357 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.45 -42.96 86.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.756 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.475 HG23 HG11 ' A' ' 57' ' ' VAL . 91.0 mt -59.81 -40.31 82.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.262 174.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 8' ' ' ILE . 87.8 mt -73.07 -38.86 66.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.002 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.84 -27.44 55.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.283 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -116.55 26.57 9.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 111.419 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.407 -177.835 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 4' ' ' THR . 12.6 tt0 -51.58 -56.11 15.39 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -169.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -64.83 -35.37 80.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.73 -48.46 31.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.851 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.895 HG21 HD21 ' A' ' 78' ' ' LEU . 1.8 tt -68.57 -33.34 59.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.06 -35.96 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.301 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.25 85.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.755 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -71.02 -38.23 63.98 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.32 -44.44 96.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.846 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.78 -48.75 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.16 -32.88 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.139 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.966 HG21 ' HB2' ' A' ' 51' ' ' ALA . 4.1 mm -78.08 -50.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.561 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.794 HG11 HD12 ' A' ' 37' ' ' LEU . 9.3 t -67.11 -23.53 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.23 0.538 . . . . 0.0 109.982 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.44 -25.11 65.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.33 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HB3' HG11 ' A' ' 47' ' ' VAL . 7.6 tp10 -73.65 -30.13 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.091 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.598 HD11 ' HB ' ' A' ' 47' ' ' VAL . 36.2 mt -84.53 -52.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.679 -172.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 -88.26 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.752 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.38 56.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.512 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.793 HG13 HD13 ' A' ' 37' ' ' LEU . 26.9 mm -98.27 122.27 54.48 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 163.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.51 145.99 44.55 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.444 2.096 . . . . 0.0 111.5 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.846 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 35.3 m -58.7 -22.02 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.176 0.512 . . . . 0.0 111.887 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.81 -17.66 46.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.797 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 22' ' ' ILE . 3.4 t70 -102.24 -9.42 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -172.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 13' ' ' ALA . 36.1 t -68.13 123.14 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.396 0.617 . . . . 0.0 110.404 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' O ' HG13 ' A' ' 70' ' ' VAL . 57.0 mttt -141.21 166.16 25.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.575 -171.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 10.2 mp -78.59 -2.98 41.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.296 0.57 . . . . 0.0 109.485 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.09 -20.2 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.648 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -99.79 144.74 28.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.948 -172.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.77 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 18.5 t -87.39 134.0 33.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.086 -172.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.632 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -58.57 -42.66 88.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.0 110.253 176.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.0 p -79.02 -32.55 45.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.636 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.8 t70 -92.95 -56.59 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.052 0.453 . . . . 0.0 111.824 -175.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -88.93 -40.35 13.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.119 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.794 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -78.32 -3.85 45.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.526 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 52.7 38.84 27.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.082 0.467 . . . . 0.0 110.865 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.611 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.4 OUTLIER -108.41 141.03 24.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.46 . . . . 0.0 111.874 -170.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.749 ' O ' ' HG2' ' A' ' 44' ' ' MET . 13.8 m-20 -95.23 162.39 13.71 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.931 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -50.37 -41.7 52.18 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.942 0.776 . . . . 0.0 111.137 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.55 -53.36 16.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.564 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.533 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 18.7 m -51.41 -48.81 62.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.526 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.749 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.4 ptm -60.56 -56.76 17.51 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.768 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.791 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.37 -24.47 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.468 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.08 -65.44 0.8 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.596 -0.69 . . . . 0.0 111.287 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.793 HG12 HG23 ' A' ' 15' ' ' ILE . 11.1 t -88.01 -20.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.698 -173.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.4 t -79.83 -19.75 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.976 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -73.83 -34.56 40.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 165.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -63.02 -21.78 66.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.843 169.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.966 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.47 -34.39 23.41 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.727 ' O ' HG12 ' A' ' 57' ' ' VAL . 9.6 pt-20 -68.57 -49.9 55.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.564 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 37.9 mt-10 -67.56 -25.1 65.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.469 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -72.11 -16.61 62.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.054 0.454 . . . . 0.0 110.63 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.755 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 82.0 m-85 -106.53 15.77 25.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.66 33.16 18.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.861 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.2 p -111.64 161.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' N ' HG22 ' A' ' 57' ' ' VAL . 18.0 mttp -134.88 110.8 9.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 pt -121.27 160.81 44.07 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.1 Cg_exo -66.28 137.91 49.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.645 2.23 . . . . 0.0 111.683 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.78 -44.53 96.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.118 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.38 -18.35 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.985 0.421 . . . . 0.0 110.661 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 7.3 t70 -67.14 -41.93 85.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.791 ' HB ' HG22 ' A' ' 45' ' ' VAL . 37.7 t -59.77 -47.66 90.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.129 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.512 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.38 -1.5 30.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.396 . . . . 0.0 111.683 -176.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -92.05 -36.6 13.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.33 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -74.58 138.35 42.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.777 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -94.98 -20.63 19.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.155 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.769 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.8 p -116.48 156.39 26.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.632 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -66.53 -29.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -63.71 -36.23 93.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.589 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.4 m-20 -55.03 -59.27 4.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.595 0.235 . . . . 0.0 111.041 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.27 -47.9 74.8 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.773 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 11.5 m -57.54 -51.64 68.65 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.83 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD2' HD12 ' A' ' 78' ' ' LEU . 10.8 tptp -65.84 -34.92 79.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.136 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.81 -45.8 90.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.241 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.723 HG23 HG11 ' A' ' 57' ' ' VAL . 81.2 mt -57.18 -45.53 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.893 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 8' ' ' ILE . 94.6 mt -65.05 -21.85 66.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.554 -171.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.71 -22.7 27.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.175 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.02 27.8 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.538 ' HA ' HG23 ' A' ' 57' ' ' VAL . 29.6 pt20 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 120.659 0.266 . . . . 0.0 110.836 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' H ' HG22 ' A' ' 4' ' ' THR . 0.4 OUTLIER -58.58 -52.95 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -176.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 3.0 pm0 -59.5 -35.15 73.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.042 0.448 . . . . 0.0 111.264 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.53 -58.4 4.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.623 0.725 . . . . 0.0 110.599 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.805 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.67 -33.51 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.326 -175.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.92 -42.14 91.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.93 -0.123 . . . . 0.0 110.78 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.92 91.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.367 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA3' ' CE2' ' A' ' 55' ' ' PHE . . . -69.75 -41.49 73.89 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.526 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.14 -47.49 84.3 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -50.4 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.71 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.67 -37.0 58.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.898 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.27 -34.23 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.599 -174.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.801 HG11 HD12 ' A' ' 37' ' ' LEU . 47.0 t -70.7 -24.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 O-C-N 121.645 -0.659 . . . . 0.0 109.482 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.21 -20.73 66.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.943 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -75.49 -29.47 59.55 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.207 0.527 . . . . 0.0 110.209 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 47' ' ' VAL . 28.1 mt -83.74 -52.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.13 -91.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.264 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.44 54.36 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.036 -1.554 . . . . 0.0 114.789 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.759 HG13 HD13 ' A' ' 37' ' ' LEU . 22.2 mm -87.92 125.11 65.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 164.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 146.14 51.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.6 2.2 . . . . 0.0 111.169 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.2 m -60.68 -26.75 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.865 0.364 . . . . 0.0 111.773 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.26 -18.88 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.088 0.471 . . . . 0.0 111.355 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 22' ' ' ILE . 25.2 t0 -90.28 -18.9 24.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.971 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 13' ' ' ALA . 87.7 t -66.52 117.02 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.651 0.739 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HE2' ' OD1' ' A' ' 30' ' ' ASP . 31.1 mtpt -141.82 170.76 15.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.688 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.669 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 23.4 mt -81.57 -4.18 55.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.007 0.432 . . . . 0.0 110.221 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 3.7 p-10 -111.36 13.5 21.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -173.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -114.18 143.21 45.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.539 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.643 ' HB2' ' HB2' ' A' ' 35' ' ' ASP . 13.4 m -82.11 136.16 35.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.754 0.311 . . . . 0.0 110.637 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -65.15 -47.63 76.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.258 0.551 . . . . 0.0 109.931 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.3 p -67.2 -38.23 84.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.327 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.5 m-20 -91.73 -68.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.706 -173.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.86 -48.4 54.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.244 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.801 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -68.86 -10.94 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 55.73 51.7 12.02 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.81 0.814 . . . . 0.0 109.551 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -122.18 146.35 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.539 -169.509 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' A' ' 44' ' ' MET . 20.2 m-20 -102.71 162.68 12.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.978 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 t -49.16 -51.07 34.72 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.258 0.974 . . . . 0.0 111.195 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.01 -43.4 68.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.586 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB2' ' H ' ' A' ' 40' ' ' ASP . 12.0 m -55.21 -55.8 27.16 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.743 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.6 ptm -55.43 -58.4 7.9 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.474 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' A' ' 64' ' ' VAL . 63.7 t -58.09 -26.46 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.695 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.1 -65.65 0.78 Allowed 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.601 -0.687 . . . . 0.0 111.415 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' HB ' HD11 ' A' ' 19' ' ' ILE . 11.0 t -84.88 -23.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.808 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 44' ' ' MET . 65.6 t -74.1 -31.11 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.998 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.8 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 6.2 t -69.36 -34.72 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.376 0.608 . . . . 0.0 109.678 171.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.87 67.49 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.95 -0.469 . . . . 0.0 110.616 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.01 -41.12 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.875 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.8 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -61.62 -44.29 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.181 0.515 . . . . 0.0 110.315 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.83 -31.62 71.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.347 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.2 ptm180 -74.76 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.053 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.679 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 57.3 m-85 -104.51 13.21 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.606 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 57.45 70.54 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.083 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 52' ' ' GLU . 10.0 p -129.43 165.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 171.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' N ' HG22 ' A' ' 57' ' ' VAL . 64.3 mttm -128.08 111.55 13.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 0.0 110.232 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -149.12 132.84 8.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.429 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 20.5 Cg_exo -64.96 140.96 68.57 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.134 1.89 . . . . 0.0 111.299 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.604 ' HB2' ' CG1' ' A' ' 45' ' ' VAL . 7.8 p-10 -56.51 -32.01 64.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.74 0.781 . . . . 0.0 110.083 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 28.7 t70 -60.11 -27.03 66.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.429 -1.259 . . . . 0.0 111.53 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.04 -36.12 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.817 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.655 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 21.4 t -60.69 -44.35 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.613 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -79.8 -2.41 43.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 0.0 111.36 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -92.78 -19.49 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.163 0.506 . . . . 0.0 109.78 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 1.5 pp -93.97 128.3 40.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -97.14 3.55 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.545 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.585 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 81.5 p -129.03 143.99 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -64.71 -37.24 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.991 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -63.45 -32.6 84.7 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.818 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 11.7 t70 -59.96 -51.22 70.58 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.632 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -55.51 -49.58 72.21 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.693 175.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.774 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 1.8 m -58.91 -52.53 65.35 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.642 -173.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HD2' HD12 ' A' ' 78' ' ' LEU . 14.5 tptp -65.97 -34.79 78.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.071 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CD2' HD12 ' A' ' 59' ' ' ILE . 53.0 t80 -62.33 -47.28 84.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.766 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.467 ' HA ' HG21 ' A' ' 57' ' ' VAL . 54.0 mt -58.81 -46.7 90.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.594 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 8' ' ' ILE . 86.7 mt -61.44 -26.4 67.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.946 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.57 -29.74 21.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 111.598 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -115.73 30.45 7.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 29.9 pt20 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.496 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 120.464 0.173 . . . . 0.0 110.957 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.595 ' H ' HG22 ' A' ' 4' ' ' THR . 47.2 tt0 -54.39 -56.38 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -66.89 -32.78 74.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 111.452 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.05 -47.94 19.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.95 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.23 -34.72 67.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.97 -38.41 79.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.635 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.58 80.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.757 0.313 . . . . 0.0 110.476 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.591 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.11 -36.93 91.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.851 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -68.58 -49.34 60.13 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.74 -46.23 84.75 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -51.27 -36.37 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.567 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.879 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.1 -37.6 11.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.556 -175.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 37' ' ' LEU . 21.3 t -68.82 -25.32 30.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.85 -0.532 . . . . 0.0 110.16 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.61 -24.2 67.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.924 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.09 -41.74 63.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.945 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 47' ' ' VAL . 25.3 mt -68.08 -53.26 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.152 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.89 -84.93 0.61 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.763 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.78 54.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.389 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.802 HG13 HD13 ' A' ' 37' ' ' LEU . 23.7 mm -82.27 130.45 59.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 166.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.33 137.52 38.89 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.195 1.93 . . . . 0.0 111.07 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 29.0 m -56.8 -27.73 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.46 -18.29 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.518 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -90.71 -16.59 28.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.104 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.37 116.9 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.671 0.748 . . . . 0.0 110.19 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 70' ' ' VAL . 25.5 mtpp -134.65 167.22 21.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.93 -173.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.741 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.7 mp -79.45 -2.96 44.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.494 0.664 . . . . 0.0 109.754 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.16 -13.23 19.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.955 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -100.72 143.29 31.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.492 -174.076 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.854 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 75.4 m -84.22 134.89 34.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.373 -173.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -58.7 -42.15 87.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 110.169 176.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 p -77.67 -36.49 51.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.269 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 10.8 t70 -91.02 -57.28 2.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 1.8 m-20 -77.48 -56.8 4.23 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.802 HD13 HG13 ' A' ' 22' ' ' ILE . 2.7 mm? -68.67 -13.64 62.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.429 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 54.13 36.44 24.82 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.187 0.994 . . . . 0.0 110.292 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -97.59 148.71 5.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.223 -171.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.1 m-20 -94.83 163.43 13.35 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' MET . 66.9 m -56.25 -42.69 77.79 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.441 0.463 . . . . 0.0 111.534 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -72.37 -47.08 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.813 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.464 ' HB2' HG22 ' A' ' 39' ' ' VAL . 14.5 m -50.82 -51.93 46.16 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 3.5 ptp -59.18 -59.41 5.51 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.733 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 81.8 t -58.59 -21.68 18.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.025 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -70.04 -65.82 0.67 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.961 -0.462 . . . . 0.0 110.835 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG12 HG23 ' A' ' 15' ' ' ILE . 11.6 t -89.51 -22.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.274 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.29 -25.19 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 122.165 -0.335 . . . . 0.0 110.481 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.733 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.6 t -74.93 -36.4 38.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.44 64.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.12 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.879 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.67 -33.12 21.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.714 ' O ' HG12 ' A' ' 57' ' ' VAL . 6.8 pt-20 -68.61 -49.2 61.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 109.792 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 35.1 mt-10 -66.63 -27.44 67.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.303 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.3 ptm180 -73.63 -12.88 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.084 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.591 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 67.5 m-85 -104.22 3.69 33.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.326 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 57.43 58.79 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.245 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -120.59 162.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.991 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 57' ' ' VAL . 80.5 tttt -124.14 110.89 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.981 0.419 . . . . 0.0 110.587 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 ' HD2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -134.57 136.93 26.52 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.942 176.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 126.57 21.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.259 1.973 . . . . 0.0 111.47 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.62 -35.55 68.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.93 -19.52 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.96 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 23.6 t70 -82.53 -21.26 35.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.56 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 45' ' ' VAL . 45.6 t -66.58 -38.88 82.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.681 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -84.16 -3.51 58.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.105 0.479 . . . . 0.0 110.611 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 30.7 t30 -82.11 -36.19 27.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.221 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.4 pp -84.07 126.83 33.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.522 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -2.59 55.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.996 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.854 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 78.6 p -122.48 147.93 45.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -66.49 -33.28 62.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.896 178.148 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -64.08 -36.84 93.77 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.131 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 1.9 t0 -60.63 -47.07 87.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -56.14 -54.76 41.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.459 0.647 . . . . 0.0 110.412 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.825 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.8 m -53.69 -50.49 65.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.617 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.696 ' HD2' HD12 ' A' ' 78' ' ' LEU . 12.9 tptm -66.12 -35.78 81.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.755 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' HD2' HD12 ' A' ' 59' ' ' ILE . 72.2 t80 -64.71 -42.24 95.4 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.99 -42.37 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.116 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 8' ' ' ILE . 82.2 mt -63.85 -23.0 67.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.209 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.76 -40.71 13.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.984 0.421 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -104.38 20.3 18.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.816 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HA ' HG23 ' A' ' 57' ' ' VAL . 12.4 pt20 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.622 0.248 . . . . 0.0 110.61 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.597 ' H ' HG22 ' A' ' 4' ' ' THR . 20.8 tt0 -54.54 -55.35 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -169.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -67.33 -34.38 77.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.197 0.522 . . . . 0.0 110.977 -173.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -75.09 -47.12 30.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.409 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.704 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -69.39 -31.45 49.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.09 -41.13 90.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 110.325 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.68 93.8 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.353 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.78 -51.16 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.94 -52.68 62.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.05 -40.88 46.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.718 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.807 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -85.01 -29.75 6.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.158 -172.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.801 HG11 HD12 ' A' ' 37' ' ' LEU . 42.2 t -76.43 -24.73 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 121.711 -0.618 . . . . 0.0 109.818 176.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.97 -30.96 71.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.505 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 15.4 tp10 -62.79 -41.47 99.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.178 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.534 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 28.9 mt -76.84 -54.45 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.001 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.51 -77.75 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.792 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.76 61.23 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.504 -1.332 . . . . 0.0 114.817 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.8 HG13 HD13 ' A' ' 37' ' ' LEU . 17.1 mm -87.98 129.22 51.02 Favored Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.7 141.28 35.27 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 111.548 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.66 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 91.1 t -56.32 -33.68 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.212 -174.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -76.65 -21.53 55.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.015 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.49 -15.54 37.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.552 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.454 HG21 ' CB ' ' A' ' 13' ' ' ALA . 72.6 t -69.17 121.0 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 70' ' ' VAL . 57.9 mtpt -144.39 177.16 8.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.256 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.617 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 19.8 mt -81.69 -7.32 59.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.048 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -92.83 -32.44 14.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.456 -171.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.651 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.71 139.23 32.88 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.702 -168.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.774 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.3 m -87.65 135.34 33.4 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.645 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.01 -45.6 82.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.407 0.622 . . . . 0.0 110.403 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.1 p -75.46 -33.41 60.84 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.214 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.774 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 15.2 t70 -91.64 -58.01 2.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.947 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.92 -47.15 8.06 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.633 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.801 HD12 HG11 ' A' ' 16' ' ' VAL . 3.9 mm? -67.38 -16.72 64.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.021 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.63 32.82 16.13 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.57 0.544 . . . . 0.0 110.535 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -99.25 147.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.592 -171.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.1 m-20 -96.67 164.53 12.55 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 p -55.65 -48.78 74.42 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.673 0.608 . . . . 0.0 111.522 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -50.95 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 19.1 m -47.6 -52.46 17.74 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.839 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 8.8 ptm -61.98 -50.67 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.262 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 64' ' ' VAL . 86.5 t -60.38 -25.23 33.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.944 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.51 -65.82 0.77 Allowed 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.879 -0.513 . . . . 0.0 111.226 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.591 HG12 HG12 ' A' ' 15' ' ' ILE . 6.7 t -88.36 -21.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.108 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -79.45 -27.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.102 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.653 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.44 -34.7 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.421 0.629 . . . . 0.0 109.389 169.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.39 68.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.355 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.807 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -80.36 -35.75 34.99 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.653 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 11.2 pt-20 -70.57 -52.72 19.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 29.8 mt-10 -66.08 -20.68 66.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.5 ptm180 -71.97 -5.31 33.93 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.803 -0.56 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.415 ' CB ' HE22 ' A' ' 81' ' ' GLN . 80.1 m-85 -119.76 13.02 12.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.738 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 59.77 41.92 17.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.727 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.701 HG11 HG23 ' A' ' 77' ' ' ILE . 9.5 p -115.17 137.56 48.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -134.28 117.89 16.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.252 0.548 . . . . 0.0 111.263 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.632 HD11 ' CG2' ' A' ' 64' ' ' VAL . 6.4 pt -116.38 164.94 16.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.591 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 63' ' ' ASP . 34.4 Cg_exo -61.76 134.48 50.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.586 1.524 . . . . 0.0 110.932 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.31 -41.14 62.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.632 . . . . 0.0 111.061 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.01 -20.49 66.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.229 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.19 -41.95 66.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.604 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 59' ' ' ILE . 48.2 t -59.22 -43.48 89.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -22.54 66.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.005 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.29 -17.71 23.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.442 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.3 pp -87.93 128.27 35.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.512 0.672 . . . . 0.0 110.688 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -90.83 -8.43 49.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.808 -170.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 13.2 p -128.73 157.16 42.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.36 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 28' ' ' LYS . 1.5 p -76.68 -18.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.88 -42.78 24.47 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.105 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.68 -39.29 84.02 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -57.44 -56.87 16.3 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.304 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.785 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -59.36 -50.6 73.33 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.52 -177.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HD2' HD12 ' A' ' 78' ' ' LEU . 1.5 tptm -62.4 -37.57 86.31 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.713 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.62 -41.06 98.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.701 HG23 HG11 ' A' ' 57' ' ' VAL . 27.7 mt -62.61 -52.36 60.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 74' ' ' THR . 84.2 mt -60.41 -35.0 74.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.36 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.34 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.533 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -98.95 7.85 45.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.435 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 77' ' ' ILE . 5.2 mm-40 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.959 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.78 -56.41 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.64 -30.54 65.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.747 0.308 . . . . 0.0 111.296 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -65.12 -53.53 43.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 110.24 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.8 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.82 -33.55 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.661 -178.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.91 -37.63 78.7 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.779 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.73 94.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.498 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.97 -39.87 89.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.937 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -63.05 -48.88 76.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.611 ' HA ' HG21 ' A' ' 27' ' ' VAL . . . -55.71 -50.0 71.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.032 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.93 -38.45 67.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.136 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.896 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.74 -33.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.752 HG11 HD12 ' A' ' 37' ' ' LEU . 43.8 t -74.34 -23.91 18.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -63.36 -24.43 67.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.741 174.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.02 -27.9 63.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.533 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.843 HD11 ' HB ' ' A' ' 47' ' ' VAL . 47.3 mt -91.26 -53.79 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.559 -173.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.81 -82.03 0.64 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.07 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.32 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.778 HG13 HD13 ' A' ' 37' ' ' LEU . 20.5 mm -88.33 130.73 44.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 166.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 9.8 Cg_endo -53.3 141.49 59.96 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.368 2.046 . . . . 0.0 111.017 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 34.9 m -62.88 -20.66 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.411 . . . . 0.0 111.717 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.44 -20.63 39.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -97.9 -8.75 27.55 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.161 -173.184 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 13' ' ' ALA . 68.9 t -67.23 110.21 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.688 0.756 . . . . 0.0 109.379 175.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' O ' HG13 ' A' ' 70' ' ' VAL . 55.5 mtpt -135.84 164.49 27.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.267 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.729 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.1 mp -74.68 -2.89 28.27 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.182 0.515 . . . . 0.0 110.238 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -104.26 -7.65 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.555 -171.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.612 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.78 141.58 35.85 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.29 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.796 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 16.2 m -83.64 132.3 34.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.089 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.63 -48.63 80.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.244 0.545 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -70.26 -35.55 73.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.491 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.796 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 14.4 t70 -91.5 -69.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.617 -173.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.15 -44.35 63.24 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.749 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.778 HD13 HG13 ' A' ' 22' ' ' ILE . 3.6 mm? -70.53 -15.87 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.51 29.99 19.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.569 0.7 . . . . 0.0 109.832 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.48 145.13 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.926 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.1 159.09 15.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 m -53.41 -42.64 67.22 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.335 0.397 . . . . 0.0 111.67 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -45.61 50.0 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.485 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 14.7 m -52.03 -53.04 46.61 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.527 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 9.6 ptm -59.09 -49.8 76.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.933 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.727 HG22 ' HB ' ' A' ' 64' ' ' VAL . 97.7 t -61.82 -26.22 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.2 -65.73 0.81 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.667 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 19' ' ' ILE . 20.3 t -89.27 -19.83 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.138 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 44' ' ' MET . 28.0 t -79.97 -22.0 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.661 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -76.39 -30.93 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 167.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.81 -25.34 67.44 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.552 168.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.28 -36.28 27.23 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.599 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.6 pt-20 -64.04 -45.76 87.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.634 0.73 . . . . 0.0 109.586 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.645 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 42.2 mt-10 -75.13 -21.47 58.83 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.246 -171.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -77.35 -4.84 47.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.214 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.07 16.66 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 59.13 51.54 6.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.601 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 52' ' ' GLU . 8.0 p -133.07 155.43 41.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -134.91 111.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.555 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.675 HD11 HG22 ' A' ' 64' ' ' VAL . 14.6 pt -104.9 163.35 17.35 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.567 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.6 Cg_exo -61.59 136.02 60.37 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 121.937 1.758 . . . . 0.0 112.019 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.6 -52.91 34.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.389 0.614 . . . . 0.0 111.075 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 6.1 p-10 -71.59 -18.32 62.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.482 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.667 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.8 t0 -75.2 -22.57 57.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.387 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' HG22 ' A' ' 45' ' ' VAL . 61.7 t -67.18 -43.79 88.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.547 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.97 -14.25 60.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.086 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 39.4 t30 -73.81 -40.62 63.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.043 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.5 pp -79.26 134.35 36.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.344 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.17 -1.02 27.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.305 -171.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.508 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 44.3 p -131.8 149.13 52.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.176 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -69.88 -21.27 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 109.745 177.355 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -75.53 -39.51 34.98 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.573 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.08 -35.44 79.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.492 0.663 . . . . 0.0 109.215 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -58.4 -46.42 86.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.326 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.774 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.12 -51.84 58.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.946 -174.604 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.662 ' HD3' HD12 ' A' ' 78' ' ' LEU . 34.1 mmtp -57.26 -37.81 72.91 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.532 0.52 . . . . 0.0 110.848 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.477 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 35.5 t80 -63.07 -43.57 98.19 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.269 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -65.31 -48.15 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.159 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 8' ' ' ILE . 96.8 mt -56.04 -46.17 78.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.587 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -71.7 -6.27 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -128.91 1.55 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 13.9 pt20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.885 -0.143 . . . . 0.0 111.082 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.543 ' H ' HG22 ' A' ' 4' ' ' THR . 49.0 tt0 -59.95 -55.67 31.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.35 -39.87 89.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.67 -53.57 49.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.409 0.623 . . . . 0.0 110.53 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.871 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.53 -30.23 46.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.086 -177.184 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -62.38 -39.48 84.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.766 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.45 97.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.59 -47.41 84.09 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.992 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.8 -39.07 90.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.041 0.448 . . . . 0.0 109.807 177.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.09 -55.73 31.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.218 177.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.46 -41.01 52.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.919 0.866 . . . . 0.0 109.832 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' A' ' 51' ' ' ALA . 9.4 mm -64.2 -57.84 9.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.56 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.846 HG11 HD12 ' A' ' 37' ' ' LEU . 4.2 t -72.05 -23.89 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.446 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -59.48 -30.33 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.612 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.77 -20.6 49.5 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.406 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.629 HD11 ' HB ' ' A' ' 47' ' ' VAL . 47.4 mt -90.47 -54.23 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.929 -175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.06 -93.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.29 0.07 OUTLIER Glycine 0 CA--C 1.522 0.504 0 C-N-CA 119.189 -1.482 . . . . 0.0 115.471 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.836 HG13 HD13 ' A' ' 37' ' ' LEU . 17.5 mm -86.68 124.14 69.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 118.124 0.962 . . . . 0.0 108.608 166.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.55 155.3 42.79 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.736 2.291 . . . . 0.0 112.034 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.787 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 90.9 t -57.54 -40.9 77.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.761 -173.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.28 -16.53 52.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.875 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' A' ' 22' ' ' ILE . 24.5 t70 -80.65 -15.51 56.38 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.739 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 13' ' ' ALA . 57.6 t -65.08 121.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.737 0.78 . . . . 0.0 110.555 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 16.9 mtpp -139.64 146.79 40.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.901 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.561 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 39.1 mt -70.95 -7.22 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 110.19 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 6.3 p-10 -107.99 8.97 28.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.955 -177.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HG2' ' CG1' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -105.85 145.91 30.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.868 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 14.8 m -95.45 138.04 33.68 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -170.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.5 m-85 -58.34 -46.24 86.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.388 0.614 . . . . 0.0 110.229 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.8 p -77.55 -30.76 52.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.717 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' CB ' ' HB2' ' A' ' 32' ' ' SER . 1.4 t70 -92.53 -50.25 5.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.857 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.83 -52.27 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.762 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.846 HD12 HG11 ' A' ' 16' ' ' VAL . 3.3 mm? -67.85 -11.5 58.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.723 -168.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.93 35.75 25.6 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.53 0.519 . . . . 0.0 110.536 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.405 -172.144 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.33 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.195 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 44' ' ' MET . 40.7 m -51.52 -59.48 4.21 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.622 0.576 . . . . 0.0 112.083 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.14 -40.89 77.99 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.961 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.498 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -50.42 -56.6 10.75 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.59 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 11.8 ptm -62.7 -47.0 85.53 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.908 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.0 t -68.18 -24.48 30.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.005 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.49 -66.13 0.81 Allowed 'General case' 0 C--O 1.242 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 111.493 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.662 HG12 HG23 ' A' ' 15' ' ' ILE . 7.8 t -84.28 -24.67 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.509 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.639 ' HA ' HG21 ' A' ' 15' ' ' ILE . 40.5 t -77.47 -20.24 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.419 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.706 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 2.9 t -74.78 -33.16 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -18.35 64.48 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.396 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.988 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -82.29 -38.31 24.55 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.845 176.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.706 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.7 -45.99 77.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.15 -176.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.09 -27.1 66.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.31 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.8 ptp180 -79.2 -7.14 58.0 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.393 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -116.12 15.62 16.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t70 54.71 70.74 0.59 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.732 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.1 p -139.13 165.89 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 57' ' ' VAL . 14.7 pttm -133.78 110.49 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.991 0.424 . . . . 0.0 110.179 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 ' OE1' ' A' ' 52' ' ' GLU . 29.1 pt -121.85 154.63 60.8 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.474 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 141.74 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 111.956 173.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.54 -51.4 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.437 0.637 . . . . 0.0 109.509 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.162 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -34.85 79.15 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.229 0.331 . . . . 0.0 110.963 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.629 ' HB ' HG22 ' A' ' 45' ' ' VAL . 43.0 t -61.5 -39.16 81.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.077 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -18.22 51.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 110.608 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -74.37 -24.15 59.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.152 0.501 . . . . 0.0 109.904 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.734 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -97.57 130.21 44.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.43 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -96.08 -1.56 48.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.543 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.868 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 59.2 p -122.41 146.5 47.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.704 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 2.1 p -65.92 -34.91 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.852 177.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.55 -30.28 76.08 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.89 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 2.3 t70 -68.1 -49.1 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -58.48 -45.73 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.586 0.707 . . . . 0.0 110.099 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.725 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 17.0 m -59.62 -51.7 68.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.628 -177.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -66.09 -30.46 70.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.197 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.62 -46.58 85.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.918 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.542 HG23 HG11 ' A' ' 57' ' ' VAL . 87.4 mt -63.62 -40.98 91.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.219 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 8' ' ' ILE . 92.2 mt -66.64 -26.68 67.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.847 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.03 -34.03 20.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.423 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -119.77 20.73 12.21 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.429 ' HA ' HG23 ' A' ' 57' ' ' VAL . 14.2 pt20 . . . . . 0 C--N 1.325 -0.497 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.734 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 5' ' ' GLN . 1.2 m . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.633 ' H ' HG22 ' A' ' 4' ' ' THR . 38.0 tt0 -58.66 -55.62 32.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -54.0 -44.83 71.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -67.72 -56.29 9.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.399 0.618 . . . . 0.0 111.027 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.681 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -67.44 -30.65 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.139 -174.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.66 -43.53 97.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.446 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.34 92.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.685 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.556 ' HA3' ' CZ ' ' A' ' 55' ' ' PHE . . . -68.5 -44.15 74.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.427 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.37 -46.31 89.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.75 -52.51 63.69 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.766 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.79 -36.48 58.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.646 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.07 -31.89 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.672 -173.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG11 HD12 ' A' ' 37' ' ' LEU . 19.9 t -74.2 -28.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.246 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -59.25 -29.76 67.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.949 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.73 -22.12 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.718 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.1 mt -92.89 -54.02 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.296 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.47 -93.12 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.27 50.99 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.696 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.772 HG13 HD13 ' A' ' 37' ' ' LEU . 22.7 mm -94.08 120.21 65.87 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 162.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.31 153.79 72.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 111.722 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.644 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.4 m -60.66 -17.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.43 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.57 -20.98 53.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.763 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 22' ' ' ILE . 17.7 t0 -106.07 -11.84 15.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.871 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 13' ' ' ALA . 97.3 t -71.85 123.24 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.273 0.558 . . . . 0.0 110.954 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 70' ' ' VAL . 75.8 mttt -148.09 166.36 28.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 24.2 mt -78.35 -3.34 42.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.036 0.446 . . . . 0.0 110.64 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.69 -30.06 15.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.527 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -84.88 139.67 31.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.396 0.617 . . . . 0.0 110.504 -168.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.792 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 16.2 m -85.26 138.61 32.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.834 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.584 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -58.46 -51.24 70.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.303 0.573 . . . . 0.0 110.55 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.6 p -69.8 -33.84 72.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.291 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.76 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 36.2 t70 -92.42 -69.25 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.774 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -69.46 -55.55 9.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.063 -177.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.815 HD12 HG11 ' A' ' 16' ' ' VAL . 3.6 mm? -63.64 -16.64 61.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 63.3 24.5 14.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.774 0.797 . . . . 0.0 109.712 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -92.72 150.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.613 -172.473 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.4 161.63 14.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.652 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 17.8 m -48.3 -50.9 28.3 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.447 0.467 . . . . 0.0 111.544 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -42.6 69.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.722 ' HB2' HG22 ' A' ' 39' ' ' VAL . 15.2 m -50.95 -52.06 46.21 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.466 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.715 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 13.1 ptt? -63.67 -47.84 79.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.797 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 64' ' ' VAL . 80.1 t -57.38 -26.64 26.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.051 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.37 -65.73 0.82 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.958 -0.464 . . . . 0.0 111.185 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 15' ' ' ILE . 21.0 t -87.05 -21.3 7.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.36 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.6 t -79.51 -20.48 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.634 -0.666 . . . . 0.0 110.219 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.639 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.6 t -75.87 -34.64 28.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -59.36 -24.08 63.08 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.99 168.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.12 -33.85 24.23 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.117 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.685 ' O ' HG12 ' A' ' 57' ' ' VAL . 2.5 pt-20 -64.19 -48.12 77.15 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.559 0.695 . . . . 0.0 109.561 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.65 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 32.2 mt-10 -72.73 -22.38 60.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.254 -172.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 7.4 ptp180 -80.79 -10.64 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.215 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' CZ ' ' HA3' ' A' ' 11' ' ' GLY . 58.1 m-85 -105.7 4.08 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 57.04 70.93 0.61 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.0 p -132.39 166.67 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 57' ' ' VAL . 4.4 mptt -123.79 110.56 15.06 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.622 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.497 HG13 ' HD2' ' A' ' 60' ' ' PRO . 5.9 tt -134.86 135.46 23.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 0.0 110.588 172.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD2' HG13 ' A' ' 59' ' ' ILE . 18.6 Cg_endo -66.88 150.79 83.08 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.572 2.182 . . . . 0.0 112.849 175.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.7 -48.06 50.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.948 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 1.039 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -53.74 -44.37 69.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.588 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -62.94 -33.89 76.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -171.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.93 ' HB ' HG22 ' A' ' 45' ' ' VAL . 12.0 t -68.37 -41.33 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.841 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 1.039 ' HE3' ' HA ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.29 -0.76 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 122.105 -0.372 . . . . 0.0 111.766 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -91.19 -31.24 16.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.834 0.35 . . . . 0.0 110.302 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 73' ' ' ALA . 2.9 pp -81.63 145.23 30.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.431 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -110.51 -5.19 15.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.897 -172.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.792 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 43.8 p -127.25 153.72 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 31' ' ' LYS . 2.1 p -74.12 -22.4 18.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.47 0.652 . . . . 0.0 110.025 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -73.43 -31.47 60.99 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.182 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.05 -46.2 85.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HA ' HD22 ' A' ' 67' ' ' LEU . . . -57.09 -45.15 83.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.815 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -67.13 -45.52 76.88 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.633 -175.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 1.012 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 5.8 mmpt? -62.53 -31.02 71.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.58 -49.34 48.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 109.918 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.6 mt -58.29 -49.35 82.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 8' ' ' ILE . 73.5 mt -69.45 -20.97 63.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.235 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.4 -21.88 32.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.205 0.526 . . . . 0.0 110.692 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -125.19 22.7 7.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.524 ' HA ' HG23 ' A' ' 57' ' ' VAL . 28.3 pt20 . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.016 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.594 ' H ' HG22 ' A' ' 4' ' ' THR . 13.6 tt0 -53.2 -56.43 16.47 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -171.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.87 -38.39 90.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -67.67 -54.18 21.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.143 0.497 . . . . 0.0 111.124 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.755 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -67.14 -32.74 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.33 -39.37 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.569 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.95 94.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.61 59.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.054 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -61.37 -53.83 51.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.04 -50.6 72.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.934 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -55.29 -35.83 65.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.347 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -81.15 -31.71 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.807 -177.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.811 HG11 HD12 ' A' ' 37' ' ' LEU . 22.4 t -74.61 -26.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 O-C-N 121.915 -0.491 . . . . 0.0 109.69 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.4 -28.62 70.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -66.58 -36.31 82.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.149 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 47' ' ' VAL . 27.3 mt -80.27 -52.61 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.421 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.87 -84.7 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.82 53.63 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.933 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.811 HG13 HD13 ' A' ' 37' ' ' LEU . 22.8 mm -89.43 125.05 62.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 165.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.3 146.57 60.58 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.452 2.101 . . . . 0.0 111.395 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.708 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 31.4 m -54.51 -35.06 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -81.31 -17.79 48.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.836 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HB3' HG23 ' A' ' 22' ' ' ILE . 12.6 t70 -83.35 -22.51 32.82 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.999 0.428 . . . . 0.0 110.603 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 13' ' ' ALA . 72.4 t -62.78 129.18 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.908 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -145.64 159.37 43.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.398 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.512 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.2 mp -77.37 -3.83 42.1 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.981 0.419 . . . . 0.0 110.547 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.12 1.58 24.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.17 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.72 140.44 37.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.683 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.905 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.7 m -87.41 136.83 32.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.463 -170.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.638 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.17 -49.79 76.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 110.196 177.184 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.5 p -69.54 -34.32 74.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 9.5 t70 -91.59 -68.68 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.307 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.8 m-20 -72.92 -52.38 14.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.895 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.811 HD12 HG11 ' A' ' 16' ' ' VAL . 3.7 mm? -66.35 -10.45 43.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.127 -172.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 61.38 31.44 19.2 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.803 0.69 . . . . 0.0 109.944 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.5 OUTLIER -102.66 153.13 5.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.418 -171.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.7 170.89 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.605 170.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 44' ' ' MET . 24.8 t -57.33 -59.77 4.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.421 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.0 tm? -68.53 -39.15 81.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.372 -176.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.504 ' HB2' HG22 ' A' ' 39' ' ' VAL . 13.3 m -48.87 -53.53 19.1 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.008 0.432 . . . . 0.0 111.637 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.617 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 20.3 ptt? -65.27 -42.83 92.81 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.574 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 98.7 t -60.18 -26.19 35.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.07 0.462 . . . . 0.0 110.389 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.12 -65.39 0.85 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.856 -0.528 . . . . 0.0 111.413 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' HB ' HD11 ' A' ' 19' ' ' ILE . 15.8 t -85.72 -23.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.137 -173.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.2 t -79.32 -23.21 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.481 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.737 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.3 t -76.63 -31.8 20.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 109.329 169.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.64 -25.85 67.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.379 0.609 . . . . 0.0 109.789 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.07 -37.7 26.0 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.972 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.9 pt-20 -61.83 -51.63 67.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.484 0.659 . . . . 0.0 109.643 -175.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.636 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.7 mt-10 -71.35 -22.85 61.85 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.649 -171.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.2 ptm180 -75.01 -19.37 60.11 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -97.91 6.92 47.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t0 60.54 57.94 2.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.656 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.766 HG11 HG23 ' A' ' 77' ' ' ILE . 13.3 p -134.3 161.65 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.201 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 13.4 tptp -127.82 112.93 15.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.111 175.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 tt -118.12 117.32 35.23 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.819 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.58 138.88 39.47 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.448 2.099 . . . . 0.0 111.726 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 5.2 p-10 -58.33 -29.55 66.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.529 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.632 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 32.7 t70 -67.53 -25.31 65.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.023 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.81 -37.94 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.642 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 46.7 t -63.54 -53.86 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.045 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.632 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -63.36 -9.95 14.42 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 176.315 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.5 -41.36 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.773 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 1.2 pp -67.6 137.1 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.453 0.644 . . . . 0.0 110.988 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -96.21 -20.68 18.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.195 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.905 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 14.8 p -119.95 154.55 34.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.543 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.4 p -63.53 -31.15 51.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 109.999 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -63.72 -33.79 88.2 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.523 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 51.1 m-20 -57.92 -52.73 64.29 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -57.49 -52.21 66.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.743 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.769 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.0 m -56.94 -52.92 63.27 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.019 -173.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HA ' HD12 ' A' ' 78' ' ' LEU . 4.2 tppp? -65.98 -31.34 72.19 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.592 0.234 . . . . 0.0 110.452 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.94 -43.07 84.16 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.257 0.551 . . . . 0.0 109.619 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.766 HG23 HG11 ' A' ' 57' ' ' VAL . 46.5 mt -59.99 -46.57 93.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.239 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 74' ' ' THR . 95.0 mt -62.35 -28.03 69.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.109 -175.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.69 -39.62 44.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.093 0.473 . . . . 0.0 111.084 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.471 ' O ' HG23 ' A' ' 57' ' ' VAL . 69.0 m-70 -105.62 21.69 16.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.272 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.915 -172.116 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 8' ' ' ILE . 12.7 tt0 -50.49 -56.3 12.16 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.26 -41.24 88.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.69 -45.92 41.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.879 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.92 -33.97 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.36 -39.75 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.983 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.37 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.14 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.5 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.48 -45.4 78.49 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.992 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.34 -40.01 96.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.634 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -54.89 41.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 41.9 tt0 -52.9 -42.44 65.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.432 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.934 HG13 ' HB2' ' A' ' 51' ' ' ALA . 8.0 mm -62.61 -53.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.292 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 37' ' ' LEU . 13.2 t -71.2 -23.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.461 . . . . 0.0 110.303 -177.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -65.85 -19.68 65.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.009 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 5.1 mm-40 -83.16 -29.66 28.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.145 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 47' ' ' VAL . 32.3 mt -84.86 -53.02 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.631 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.34 -86.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.05 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.35 56.84 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.573 -1.299 . . . . 0.0 114.492 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.842 HG13 HD13 ' A' ' 37' ' ' LEU . 12.8 mm -87.88 124.81 66.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 164.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 147.95 49.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 111.757 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.634 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 79.2 t -54.61 -40.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.645 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -75.41 -17.02 60.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.298 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 22' ' ' ILE . 1.6 t70 -90.09 -5.71 56.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.142 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 13' ' ' ALA . 46.0 t -68.83 116.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.549 0.69 . . . . 0.0 109.696 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 13.6 mtpp -132.78 144.89 50.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.454 -171.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.2 mp -74.08 -3.43 29.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.873 0.368 . . . . 0.0 110.997 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 5.8 p-10 -108.03 -7.91 16.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.762 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.93 140.0 30.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.442 -177.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.821 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.2 m -87.98 135.77 33.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.448 -170.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -56.67 -48.16 78.22 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.277 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.5 p -71.8 -33.65 68.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.201 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 5.0 t70 -92.13 -65.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.199 0.523 . . . . 0.0 111.651 -173.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.1 m-20 -75.82 -52.76 9.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.673 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.004 HD12 HG11 ' A' ' 16' ' ' VAL . 2.9 mm? -66.19 -14.54 62.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.791 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 61.76 32.91 18.13 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.856 0.836 . . . . 0.0 109.38 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.4 OUTLIER -98.81 146.96 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.809 -171.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.498 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 8.2 m-20 -95.92 173.84 7.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.674 ' HB3' ' HD3' ' A' ' 65' ' ' LYS . 13.6 m -57.25 -56.32 23.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.565 . . . . 0.0 110.471 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -65.59 -40.49 92.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.583 ' HB2' HG22 ' A' ' 39' ' ' VAL . 14.7 m -50.59 -54.72 20.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 15.3 ptt? -66.36 -40.96 90.11 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.646 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.64 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 82.5 t -63.09 -24.95 37.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.704 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -74.32 -66.41 0.73 Allowed 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.74 -0.6 . . . . 0.0 111.659 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG12 HG23 ' A' ' 15' ' ' ILE . 11.8 t -91.12 -22.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.578 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 44' ' ' MET . 21.5 t -80.46 -21.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.619 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.1 t -73.95 -33.57 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.609 0.718 . . . . 0.0 109.302 167.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.36 66.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.339 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.934 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -81.14 -45.75 15.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.671 ' O ' HG12 ' A' ' 57' ' ' VAL . 8.1 pt-20 -59.31 -49.11 79.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.034 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.8 pt-20 -62.68 -30.67 71.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.724 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -78.7 -5.0 51.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.275 0.56 . . . . 0.0 110.343 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 68.7 m-85 -114.2 22.38 13.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.345 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 71.75 17.47 5.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.507 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.678 HG11 HG23 ' A' ' 77' ' ' ILE . 9.6 p -114.49 158.29 14.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.075 -0.391 . . . . 0.0 110.435 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 50.1 mtpt -134.06 111.3 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' HB ' ' HE2' ' A' ' 76' ' ' TYR . 21.4 pt -108.53 163.36 17.14 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.825 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.0 Cg_exo -65.3 129.61 23.21 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.942 1.761 . . . . 0.0 111.623 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.79 -49.2 63.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 110.06 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.41 -19.52 64.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.275 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.825 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 2.7 t0 -74.0 -38.08 64.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.652 ' HA ' HD21 ' A' ' 67' ' ' LEU . 22.2 t -60.12 -42.75 91.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HD3' ' HB3' ' A' ' 41' ' ' SER . 17.6 tptp -59.91 -31.08 69.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.795 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.63 -26.99 40.98 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.154 -0.341 . . . . 0.0 111.255 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.717 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -83.7 136.58 34.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.292 -178.518 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.36 -22.77 22.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.131 -173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.821 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 32.8 p -120.2 156.98 30.05 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.887 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -67.72 -36.96 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.1 -41.51 96.59 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.025 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.96 -50.73 72.19 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -54.79 -50.28 68.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.58 0.705 . . . . 0.0 110.936 176.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.795 HG23 HD12 ' A' ' 8' ' ' ILE . 12.4 m -58.98 -49.49 77.69 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.686 -174.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HD2' HD12 ' A' ' 78' ' ' LEU . 7.6 tptm -65.95 -38.65 89.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.449 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 59.3 t80 -56.91 -43.34 81.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.678 HG23 HG11 ' A' ' 57' ' ' VAL . 82.0 mt -65.18 -49.9 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.536 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 8' ' ' ILE . 91.5 mt -54.15 -44.99 71.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.21 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -86.68 -3.63 59.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.475 ' O ' HG23 ' A' ' 57' ' ' VAL . 29.9 m-70 -124.69 15.22 8.73 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.244 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.546 0.213 . . . . 0.0 111.498 -173.155 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.565 ' H ' HG22 ' A' ' 4' ' ' THR . 24.8 tt0 -58.99 -55.71 31.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -167.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -32.22 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.868 0.366 . . . . 0.0 111.144 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.05 -47.65 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.848 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.35 -33.11 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.11 -43.02 95.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.1 95.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.937 0.398 . . . . 0.0 110.875 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.806 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.51 -33.03 75.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.341 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -68.62 -48.64 63.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.13 -46.77 85.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.58 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -52.39 -36.74 54.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.496 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.59 -35.6 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.81 -174.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.724 HG11 HD12 ' A' ' 37' ' ' LEU . 36.2 t -71.17 -23.97 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 109.776 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -62.6 -24.57 67.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.28 -38.48 63.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 109.958 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.717 HD11 ' HB ' ' A' ' 47' ' ' VAL . 24.9 mt -71.04 -53.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.694 -174.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.24 -86.14 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.452 -175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 64.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.685 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 37' ' ' LEU . 23.2 mm -99.61 131.35 24.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 164.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.99 148.34 48.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.465 2.11 . . . . 0.0 111.633 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.694 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 93.9 t -59.88 -38.57 76.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.15 0.5 . . . . 0.0 111.304 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -76.71 -18.31 58.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' A' ' 22' ' ' ILE . 11.2 t70 -83.23 -22.74 33.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.68 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 13' ' ' ALA . 75.2 t -66.4 122.28 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.572 0.701 . . . . 0.0 110.729 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 82.1 mttt -144.04 169.76 17.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.207 -176.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.751 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.6 mp -81.57 -2.5 50.25 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.494 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -110.38 2.01 18.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.83 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.05 141.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.725 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 24.9 m -88.4 136.46 32.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.881 0.372 . . . . 0.0 111.658 -170.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.58 -47.83 84.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.535 0.684 . . . . 0.0 110.426 178.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 38.9 p -72.95 -33.66 66.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.354 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.725 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.5 t70 -91.67 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 111.539 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -49.11 18.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.287 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.798 HD13 HG13 ' A' ' 22' ' ' ILE . 3.5 mm? -70.23 -14.73 62.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.659 -176.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.49 31.88 20.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.847 0.832 . . . . 0.0 110.129 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -97.66 151.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.881 -169.087 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.4 m-20 -104.0 166.25 10.53 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 p -51.23 -55.65 16.98 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.709 0.631 . . . . 0.0 111.32 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -62.96 -48.97 76.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.598 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.606 ' HB2' ' H ' ' A' ' 40' ' ' ASP . 13.0 m -50.94 -54.29 25.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.646 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.671 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 4.8 ptm -59.74 -49.43 77.78 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.698 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.5 t -68.81 -22.31 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.16 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.82 -66.2 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.661 -0.649 . . . . 0.0 111.743 -174.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 19' ' ' ILE . 16.6 t -87.88 -21.74 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.052 -173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.9 t -78.82 -26.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.286 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.69 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -72.72 -35.04 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.01 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.23 0.538 . . . . 0.0 109.918 171.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -83.49 -39.6 20.3 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.131 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 4.5 pt-20 -59.81 -48.31 82.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.494 0.664 . . . . 0.0 109.559 -175.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.62 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.2 mt-10 -64.56 -33.64 76.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.169 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -81.31 -6.03 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.374 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.806 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 62.1 m-85 -105.25 6.71 33.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 170.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.38 68.36 0.77 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.553 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -140.59 161.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.353 174.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 57' ' ' VAL . 25.3 tptp -122.88 110.56 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 169.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.5 pt -119.08 151.35 50.49 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.76 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.1 Cg_exo -61.79 121.21 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.991 1.794 . . . . 0.0 110.847 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.06 -39.29 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 0.0 110.215 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.33 -36.36 81.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.76 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -66.91 -34.79 78.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.315 -174.736 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.698 ' HB ' HG22 ' A' ' 45' ' ' VAL . 21.3 t -58.42 -36.45 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.165 0.507 . . . . 0.0 110.657 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -75.19 -28.46 60.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.895 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.49 -21.87 44.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.691 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -84.71 123.48 30.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 0.0 110.585 177.793 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -82.3 -14.68 54.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.009 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 73.4 p -119.71 148.74 43.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.33 -36.16 76.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.041 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -66.97 -30.21 75.7 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.953 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.531 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 4.0 t70 -61.6 -40.68 95.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -67.97 -39.46 83.33 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.114 176.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -65.15 -51.81 58.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.007 -172.198 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.42 -37.03 79.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.246 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 14.6 t80 -63.34 -38.61 91.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.396 0.617 . . . . 0.0 110.706 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.501 HG23 HG11 ' A' ' 57' ' ' VAL . 52.5 mt -68.99 -33.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.533 0.682 . . . . 0.0 110.261 175.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.848 HD21 HG21 ' A' ' 8' ' ' ILE . 96.8 mt -77.97 -35.51 50.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.416 -172.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.9 -4.88 58.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.6 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -123.44 15.01 9.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.581 ' HA ' HG23 ' A' ' 57' ' ' VAL . 14.0 pt20 . . . . . 0 C--O 1.234 0.27 0 CA-C-O 120.698 0.285 . . . . 0.0 111.557 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.714 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.3 tt0 -55.61 -55.59 30.31 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 9' ' ' VAL . 9.2 pt-20 -64.5 -39.17 93.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.899 0.381 . . . . 0.0 111.566 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.34 -54.35 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.0 110.885 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.768 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.67 -31.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.689 -177.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -69.71 -31.73 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.253 -177.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.82 74.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.63 78.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.774 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -72.32 -49.39 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' CB ' HG21 ' A' ' 27' ' ' VAL . . . -52.52 -53.63 43.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -50.23 -42.45 51.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.117 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.953 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.38 -27.94 6.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.536 -169.485 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.85 HG11 HD12 ' A' ' 37' ' ' LEU . 45.8 t -76.05 -24.76 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -68.05 -21.49 65.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.043 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 5.2 mm-40 -70.54 -29.07 65.45 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.349 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 47' ' ' VAL . 39.3 mt -92.88 -55.29 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.553 -171.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.13 -89.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.205 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.52 44.11 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.206 -1.473 . . . . 0.0 115.117 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.803 HG13 HD13 ' A' ' 37' ' ' LEU . 14.2 mm -78.24 124.82 85.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.8 142.72 83.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.274 1.982 . . . . 0.0 111.152 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.449 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 34.6 m -59.2 -20.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.976 0.417 . . . . 0.0 111.657 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.82 -18.67 46.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.249 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 22' ' ' ILE . 1.5 t70 -100.77 -7.91 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.647 0.26 . . . . 0.0 111.329 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 13' ' ' ALA . 84.6 t -68.21 118.2 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.325 0.583 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 70' ' ' VAL . 49.6 mtpt -143.17 160.33 40.63 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.207 -170.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.616 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.0 mp -74.14 -3.75 31.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.091 0.472 . . . . 0.0 110.864 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.61 -15.58 18.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.904 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.83 142.94 28.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.427 -173.389 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 16.0 t -84.4 134.24 34.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.889 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.542 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.03 -49.8 76.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.529 0.68 . . . . 0.0 109.843 177.146 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.1 p -71.95 -31.82 66.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.179 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.9 t70 -92.68 -68.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.896 -175.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -77.08 -45.24 27.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.976 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.85 HD12 HG11 ' A' ' 16' ' ' VAL . 4.0 mm? -66.73 -16.26 64.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.616 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 57.29 42.52 25.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.872 0.844 . . . . 0.0 108.83 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -110.64 144.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.638 -173.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 166.61 15.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 8.2 m -54.77 -52.29 63.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.586 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -72.62 -42.02 64.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.216 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -48.11 -55.23 10.77 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 123.29 0.369 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.588 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 19.9 ptt? -64.35 -48.6 74.91 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.569 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.774 HG22 ' HB ' ' A' ' 64' ' ' VAL . 55.7 t -54.78 -28.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.854 0.359 . . . . 0.0 111.209 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.6 -65.52 0.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.85 -0.531 . . . . 0.0 111.565 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.765 ' HB ' HD11 ' A' ' 19' ' ' ILE . 15.2 t -85.36 -22.61 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.645 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 44' ' ' MET . 55.6 t -78.83 -25.51 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.521 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.677 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.92 -36.25 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.18 -23.47 66.63 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.232 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.953 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -83.34 -35.94 24.79 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.911 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -69.94 -48.62 57.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.42 -23.57 66.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.848 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 4.4 ptm180 -71.96 -10.71 60.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.478 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -111.09 18.42 19.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.913 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 68.89 25.63 6.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.93 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.717 HG11 HG23 ' A' ' 77' ' ' ILE . 11.5 p -115.16 151.25 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -135.08 124.41 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.196 0.522 . . . . 0.0 110.905 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 64' ' ' VAL . 7.0 pt -116.02 166.23 12.87 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.93 125.67 17.08 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 121.401 1.401 . . . . 0.0 110.446 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.57 -42.93 24.76 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.479 0.657 . . . . 0.0 110.861 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.1 t70 -63.08 -19.71 64.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.656 -176.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.92 -25.4 40.53 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.377 -0.202 . . . . 0.0 111.517 -173.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.774 ' HB ' HG22 ' A' ' 45' ' ' VAL . 43.8 t -64.77 -33.38 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.588 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 3.5 tmmm? -66.1 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.403 171.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -71.1 -26.82 63.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.954 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 73' ' ' ALA . 1.1 pp -94.63 134.65 36.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.388 0.613 . . . . 0.0 110.751 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -97.36 -6.58 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.795 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 69.6 p -129.69 152.24 49.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.482 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -70.55 -22.27 23.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 109.831 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.79 -36.79 41.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.586 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 6.0 t0 -58.62 -42.55 88.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.622 0.725 . . . . 0.0 109.082 176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HA ' HD22 ' A' ' 67' ' ' LEU . . . -60.19 -48.26 82.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.921 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.742 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -63.08 -50.65 69.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.547 -172.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.545 ' HD3' HD12 ' A' ' 78' ' ' LEU . 23.7 mmtp -58.96 -39.67 82.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.124 0.265 . . . . 0.0 111.251 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 42.2 t80 -62.93 -44.59 95.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.026 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.717 HG23 HG11 ' A' ' 57' ' ' VAL . 61.2 mt -61.76 -44.56 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.734 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.768 HD21 HG21 ' A' ' 8' ' ' ILE . 92.3 mt -65.55 -40.95 93.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.322 -174.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -75.07 -32.51 61.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.927 0.394 . . . . 0.0 111.669 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.52 22.54 15.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--N 1.325 -0.462 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.762 -177.716 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' H ' HG22 ' A' ' 4' ' ' THR . 19.2 tt0 -55.73 -55.97 25.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.4 pm0 -67.64 -36.37 80.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.682 0.277 . . . . 0.0 111.546 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.47 -52.71 56.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.326 0.584 . . . . 0.0 110.613 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.869 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -69.91 -33.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.012 -178.457 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -59.99 -41.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.78 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.15 94.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.507 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.93 96.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.129 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -47.56 82.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.02 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.42 -50.13 70.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.543 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.64 -36.42 62.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.828 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.802 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.52 -32.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.807 -174.077 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.754 HG11 HD12 ' A' ' 37' ' ' LEU . 21.2 t -72.31 -24.27 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 121.63 -0.669 . . . . 0.0 109.981 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -62.56 -28.69 70.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.703 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.68 -23.65 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.356 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 47' ' ' VAL . 44.5 mt -86.78 -52.98 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.995 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.46 -75.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.71 53.73 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.874 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.807 HG13 HD13 ' A' ' 37' ' ' LEU . 11.1 mm -80.94 129.94 65.56 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 165.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.672 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 7.3 Cg_endo -52.04 140.34 49.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.322 2.014 . . . . 0.0 111.187 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 23.3 m -57.34 -26.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 mm-40 -80.47 -18.74 47.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.672 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 1.8 t70 -95.23 -8.48 35.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.587 -172.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 13' ' ' ALA . 53.1 t -68.5 111.22 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.611 0.72 . . . . 0.0 110.052 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -132.06 162.13 31.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.631 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 23.8 mt -74.64 -5.61 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.136 0.493 . . . . 0.0 110.378 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.88 -19.2 19.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.022 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -93.53 143.92 25.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.935 -175.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.922 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.0 m -90.39 135.04 33.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.294 -173.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.7 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.6 m-85 -54.73 -52.52 62.21 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 110.206 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -60.54 -43.95 96.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.757 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.14 -68.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.142 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.97 -45.91 83.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.833 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.807 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -72.98 -11.57 60.62 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t0 56.55 43.58 25.49 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.968 0.792 . . . . 0.0 108.896 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.492 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -105.61 146.33 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.417 -172.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 44' ' ' MET . 3.7 m-20 -91.79 153.44 19.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.457 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 50.6 m -55.87 -41.6 74.61 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.601 0.563 . . . . 0.0 111.677 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -72.48 -43.4 63.74 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.568 ' OG ' HG23 ' A' ' 19' ' ' ILE . 1.9 t -58.99 -49.48 77.73 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.974 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.541 ' HE2' HG12 ' A' ' 64' ' ' VAL . 13.6 ptm -57.1 -49.04 77.11 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.883 HG22 ' HB ' ' A' ' 64' ' ' VAL . 79.1 t -60.14 -25.92 34.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.295 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.87 -64.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.911 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' A' ' 19' ' ' ILE . 11.6 t -85.0 -22.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.349 -173.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 44' ' ' MET . 49.4 t -78.38 -28.15 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.134 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.687 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 12.7 t -71.36 -33.1 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.561 0.696 . . . . 0.0 109.3 169.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -60.82 -26.7 67.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.095 0.474 . . . . 0.0 110.05 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.802 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.3 -38.1 24.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.892 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 9.2 pt-20 -63.86 -46.49 84.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.8 mt-10 -70.19 -26.4 63.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.252 -173.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -77.8 -6.15 53.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 67.1 m-85 -111.47 19.19 18.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 174.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.59 40.21 6.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.632 174.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.9 p -127.86 159.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 173.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.36 112.85 10.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.01 0.433 . . . . 0.0 110.095 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.542 HD11 HG22 ' A' ' 64' ' ' VAL . 14.2 pt -107.83 163.97 15.8 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.49 133.62 40.81 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.574 1.516 . . . . 0.0 109.771 170.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.63 -34.59 67.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 8.4 t70 -69.43 -18.24 63.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.818 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 66' ' ' ASN . 4.6 t70 -70.15 -31.01 68.31 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.231 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.883 ' HB ' HG22 ' A' ' 45' ' ' VAL . 41.1 t -62.42 -51.51 71.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.448 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -4.98 52.07 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.163 0.506 . . . . 0.0 111.142 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 2.5 t-20 -73.13 -39.08 66.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -89.69 147.04 24.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.216 175.471 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -108.27 -13.43 14.9 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.536 -174.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.922 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 61.4 p -108.2 151.66 25.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.7 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -70.03 -29.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.589 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -66.75 -30.75 76.73 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.744 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 4.8 t70 -65.59 -53.52 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.817 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -53.64 -50.52 65.54 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.425 0.631 . . . . 0.0 110.717 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 21.7 m -55.07 -52.82 62.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.98 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.482 ' HD2' HD12 ' A' ' 78' ' ' LEU . 13.3 tptp -64.68 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.15 -46.26 90.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.136 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.609 HG23 HG11 ' A' ' 57' ' ' VAL . 90.8 mt -60.68 -46.43 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.322 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 8' ' ' ILE . 83.6 mt -55.14 -42.75 73.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.683 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.1 -4.97 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -128.47 7.52 5.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.86 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.433 0.159 . . . . 0.0 110.728 -176.243 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.494 ' H ' HG22 ' A' ' 4' ' ' THR . 16.0 tt0 -61.29 -55.67 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -63.28 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.541 -173.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.16 -51.43 46.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.76 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -66.35 -32.53 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.902 -178.022 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.96 -42.69 95.74 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.35 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.523 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.9 -49.05 61.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.7 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -42.32 88.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.67 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.64 -56.71 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.248 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -49.93 -44.52 50.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.836 0.826 . . . . 0.0 110.051 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.824 HG13 ' HB2' ' A' ' 51' ' ' ALA . 15.3 mm -60.88 -54.49 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.231 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.734 HG11 HD12 ' A' ' 37' ' ' LEU . 16.1 t -69.23 -24.2 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.583 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -63.33 -27.04 69.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.7 -30.66 62.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.888 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 47' ' ' VAL . 42.6 mt -84.51 -54.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.323 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -122.78 -84.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.682 -171.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.74 43.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.44 -1.362 . . . . 0.0 114.54 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.802 HG13 HD13 ' A' ' 37' ' ' LEU . 18.3 mm -82.76 126.69 72.52 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 118.158 0.979 . . . . 0.0 108.655 167.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.747 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.7 Cg_endo -56.43 145.55 78.71 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.244 1.963 . . . . 0.0 111.48 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.67 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 27.0 m -56.61 -32.97 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.07 -17.12 51.19 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.558 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.747 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 16.1 t70 -87.28 -14.03 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.635 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' A' ' 13' ' ' ALA . 91.3 t -69.73 122.81 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.321 0.581 . . . . 0.0 110.443 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.511 ' O ' HG13 ' A' ' 70' ' ' VAL . 58.7 mtpt -145.78 164.16 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -171.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.3 mp -78.28 -2.72 39.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.69 -25.62 16.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.983 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -91.14 142.53 27.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.327 0.584 . . . . 0.0 110.842 -169.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.641 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 3.6 m -82.82 136.45 34.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.03 -172.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.52 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.67 -43.29 94.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.328 0.585 . . . . 0.0 110.117 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.9 p -72.69 -38.96 67.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.636 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.1 t70 -92.01 -60.65 1.8 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.896 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.05 -50.05 10.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.251 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.802 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -66.25 -28.12 68.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 t0 60.12 67.92 0.82 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.739 0.78 . . . . 0.0 109.873 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.6 OUTLIER -128.04 155.46 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.682 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 42.2 m-20 -103.95 168.15 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.455 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 34.0 t -49.4 -57.58 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.721 0.638 . . . . 0.0 111.38 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.81 -40.39 83.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.017 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.726 ' HB2' HG22 ' A' ' 39' ' ' VAL . 4.6 m -51.68 -53.81 34.95 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.855 0.36 . . . . 0.0 111.149 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.564 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 14.4 ptt? -65.7 -49.89 66.87 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.759 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.894 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.31 -23.3 29.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.088 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.92 -65.41 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.934 -0.479 . . . . 0.0 111.208 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.772 HG12 HG23 ' A' ' 15' ' ' ILE . 11.6 t -86.12 -25.17 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.893 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HA ' HG21 ' A' ' 15' ' ' ILE . 21.6 t -80.27 -20.17 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.659 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.7 t -77.71 -33.36 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.552 0.691 . . . . 0.0 109.233 166.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.32 -19.9 62.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.399 0.618 . . . . 0.0 109.65 168.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.824 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -85.93 -33.39 21.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.966 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.754 ' O ' HG12 ' A' ' 57' ' ' VAL . 3.6 pt-20 -65.68 -50.85 63.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.585 -175.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.671 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 39.5 mt-10 -56.67 -37.53 70.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.44 -175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.3 ptp180 -72.2 -7.79 51.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.295 -174.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.56 10.47 21.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.589 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 63.22 39.28 9.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.643 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -114.84 165.49 9.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 57' ' ' VAL . 61.2 tttp -126.97 111.27 13.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.309 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 tt -131.71 120.32 17.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.136 0.493 . . . . 0.0 110.539 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 51.4 Cg_exo -56.8 148.78 64.25 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.038 2.492 . . . . 0.0 113.299 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.21 -47.24 65.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.05 -33.76 73.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.919 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -31.11 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.772 -174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.894 ' HB ' HG22 ' A' ' 45' ' ' VAL . 11.1 t -73.34 -42.26 57.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.564 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 12.6 tmtt? -55.95 -40.62 73.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.921 171.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -76.5 -2.79 33.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -172.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 4.6 pp -107.03 139.47 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.093 0.473 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -114.24 1.06 14.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.668 -172.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 28.5 p -128.52 153.42 47.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 172.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 28' ' ' LYS . 1.1 p -68.88 -21.79 25.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -70.9 -32.24 66.55 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.95 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 67' ' ' LEU . 13.1 m-20 -57.15 -51.21 70.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.796 0.332 . . . . 0.0 110.19 174.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.47 72.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.193 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.733 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -61.63 -53.1 60.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.686 -174.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.488 ' HD2' HD12 ' A' ' 78' ' ' LEU . 3.7 tptp -62.98 -31.77 72.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.616 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.56 -45.96 77.63 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.479 ' HA ' HG21 ' A' ' 57' ' ' VAL . 52.4 mt -63.66 -46.25 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.224 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.76 HD21 HG21 ' A' ' 8' ' ' ILE . 97.6 mt -61.07 -25.36 66.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.78 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.75 -40.3 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' C ' HG23 ' A' ' 57' ' ' VAL . 95.0 m-70 -101.49 21.31 14.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -171.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.049 -179.105 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.563 ' H ' HG22 ' A' ' 4' ' ' THR . 12.3 tt0 -47.24 -55.32 8.85 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -169.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 1.1 pm0 -71.52 -36.4 71.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.741 0.305 . . . . 0.0 111.524 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -70.73 -47.53 59.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 110.145 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.868 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.76 -31.13 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.47 -39.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.01 97.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 110.402 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.41 -43.12 79.74 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.705 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.74 -48.56 80.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.675 ' HA ' HG21 ' A' ' 27' ' ' VAL . . . -51.92 -50.09 61.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.366 0.603 . . . . 0.0 111.359 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.88 -30.64 71.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.784 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -86.58 -34.73 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.026 -177.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.812 HG11 HD12 ' A' ' 37' ' ' LEU . 15.7 t -69.62 -24.86 27.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.479 0.657 . . . . 0.0 109.449 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.07 -24.06 66.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB2' HG11 ' A' ' 47' ' ' VAL . 3.8 mm-40 -72.94 -21.38 60.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 47' ' ' VAL . 46.0 mt -93.56 -52.84 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.589 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.34 -88.58 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.1 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.363 -1.399 . . . . 0.0 114.907 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.788 HG13 HD13 ' A' ' 37' ' ' LEU . 14.6 mm -79.68 125.97 81.42 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.5 Cg_endo -56.02 148.32 58.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.3 2.0 . . . . 0.0 111.307 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 32.7 m -62.67 -19.25 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 -175.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.83 -19.75 47.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 22' ' ' ILE . 40.8 t0 -98.88 -21.25 16.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.576 -171.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 13' ' ' ALA . 83.5 t -64.52 118.72 7.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.298 0.57 . . . . 0.0 110.826 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' O ' HG13 ' A' ' 70' ' ' VAL . 58.5 mtpt -147.55 172.65 13.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.985 -172.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.484 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.3 mp -80.81 -3.86 52.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.311 0.576 . . . . 0.0 110.044 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.432 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.5 m-20 -92.79 -23.01 19.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.501 -173.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.07 141.58 30.04 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.521 -169.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.763 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 27.4 m -82.37 136.28 35.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.618 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.54 -50.62 72.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.598 . . . . 0.0 110.104 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.4 p -65.43 -39.63 92.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.67 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 6.7 m-20 -91.99 -69.51 0.74 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.798 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 22' ' ' ILE . 4.0 m-20 -63.41 -49.71 72.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.682 -175.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.812 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -71.39 -9.85 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.28 -174.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.16 38.54 29.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.112 0.482 . . . . 0.0 110.238 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.18 147.47 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.148 0.499 . . . . 0.0 111.319 -171.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.2 169.34 9.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.101 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.401 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 44.0 m -59.93 -45.73 91.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.559 0.537 . . . . 0.0 111.806 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -46.99 64.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.524 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 5.3 m -49.16 -57.11 7.24 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.733 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.414 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 7.9 ptm -57.38 -51.81 67.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.747 HG22 ' HB ' ' A' ' 64' ' ' VAL . 77.2 t -63.57 -24.46 35.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -176.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -75.28 -64.24 1.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.606 -0.684 . . . . 0.0 111.665 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.7 HG12 HG23 ' A' ' 15' ' ' ILE . 16.7 t -85.08 -23.67 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.166 -174.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 44' ' ' MET . 39.4 t -79.28 -27.09 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.433 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.71 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.2 t -70.83 -35.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.764 0.792 . . . . 0.0 109.025 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -22.45 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.14 -39.36 17.97 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.945 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.71 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 7.1 pt-20 -60.67 -48.23 82.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.405 0.621 . . . . 0.0 109.588 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 36.2 mt-10 -62.48 -36.81 83.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.789 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 12.9 ptp180 -76.71 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 111.179 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 63.2 m-85 -103.66 15.05 29.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 109.781 172.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 58.79 59.08 2.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.489 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 52' ' ' GLU . 10.4 p -143.96 160.62 15.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -134.15 112.36 11.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.195 0.522 . . . . 0.0 110.041 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 64' ' ' VAL . 18.2 pt -118.35 159.39 43.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 137.57 47.97 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.355 2.036 . . . . 0.0 111.838 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.53 -47.3 66.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.5 -32.25 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.277 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.29 -44.59 87.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.747 ' HB ' HG22 ' A' ' 45' ' ' VAL . 39.5 t -54.65 -42.17 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 110.453 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 2.1 tmtm? -77.3 -22.75 51.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.31 -37.9 51.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.422 -175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -72.58 137.76 46.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.825 0.821 . . . . 0.0 111.471 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -86.88 -28.78 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.671 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 p -117.63 154.23 31.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -63.75 -28.66 45.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -32.96 85.95 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.591 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 59.0 m-20 -60.8 -55.97 26.79 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.426 0.155 . . . . 0.0 110.586 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -53.81 -52.65 59.64 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.318 0.58 . . . . 0.0 110.374 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.79 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.6 m -53.14 -51.3 62.4 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.769 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HD2' HD12 ' A' ' 78' ' ' LEU . 8.8 tptm -65.43 -36.23 83.31 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.728 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -66.61 -39.93 88.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.183 0.516 . . . . 0.0 109.755 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.58 HG23 HG11 ' A' ' 57' ' ' VAL . 71.3 mt -61.51 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 172.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.868 HD21 HG21 ' A' ' 8' ' ' ILE . 91.5 mt -65.21 -24.76 67.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.689 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -82.0 -51.06 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -92.29 11.52 25.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.155 -172.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 0.0 110.881 -178.194 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.61 113.92 13.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.172 0.51 . . . . 0.0 112.098 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.07 146.49 41.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.32 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -88.86 -170.08 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.304 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.584 ' H ' HG22 ' A' ' 4' ' ' THR . 17.9 tt0 -57.62 -56.02 27.27 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -168.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.21 -34.46 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.541 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.91 -53.28 49.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.324 0.583 . . . . 0.0 110.297 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.761 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.4 -34.98 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.953 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG23 HG21 ' A' ' 74' ' ' THR . 2.1 t -59.85 -41.77 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.863 -0.153 . . . . 0.0 110.932 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.14 86.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.66 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.73 -31.44 73.19 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.882 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -72.09 -50.63 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.632 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.24 -49.66 68.97 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.487 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -53.07 -36.27 60.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.861 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -34.31 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.785 -174.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 37' ' ' LEU . 44.6 t -69.24 -25.13 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.56 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -62.98 -21.43 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.147 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.54 -27.64 51.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.713 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.75 HD11 ' HB ' ' A' ' 47' ' ' VAL . 49.8 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.381 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.22 -87.17 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.6 53.38 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.529 -1.32 . . . . 0.0 114.128 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.825 HG13 HD13 ' A' ' 37' ' ' LEU . 19.3 mm -88.63 125.86 61.74 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.13 144.57 46.58 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.406 2.071 . . . . 0.0 111.434 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.632 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 19.4 m -54.58 -32.94 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.47 -18.08 49.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.518 ' HB3' HG23 ' A' ' 22' ' ' ILE . 25.9 t0 -86.75 -18.31 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.461 HG21 ' CB ' ' A' ' 13' ' ' ALA . 93.0 t -63.8 112.71 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.666 0.746 . . . . 0.0 110.325 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.0 mttp -135.51 162.81 31.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.758 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.901 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.7 mp -76.97 -3.09 37.14 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.87 0.366 . . . . 0.0 110.499 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -8.06 22.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.593 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -101.53 140.06 36.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.873 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.6 m -85.31 133.56 34.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.072 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.581 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -59.98 -46.9 87.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.428 0.633 . . . . 0.0 110.321 178.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.9 p -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.392 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.66 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 26.4 t70 -93.88 -68.85 0.78 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.095 0.474 . . . . 0.0 112.091 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.51 -49.06 58.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.644 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.825 HD13 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -67.47 -21.01 65.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.072 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 59.0 38.24 24.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.829 0.823 . . . . 0.0 109.621 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -101.13 156.08 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.595 -174.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-20 -99.84 155.08 17.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.12 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.9 m -51.41 -45.02 62.41 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.068 0.855 . . . . 0.0 111.426 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -48.17 59.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.2 m -54.31 -51.06 65.85 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.615 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.684 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.5 ptm -60.4 -47.5 85.81 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.677 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.828 HG22 ' HB ' ' A' ' 64' ' ' VAL . 54.6 t -61.61 -27.88 42.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.288 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.96 -65.37 0.85 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.834 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HB ' HD11 ' A' ' 19' ' ' ILE . 13.3 t -86.09 -20.82 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.865 -173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.8 t -79.92 -26.45 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.309 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.699 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -70.62 -35.73 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.384 0.611 . . . . 0.0 109.524 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.5 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 110.054 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.861 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.09 -33.53 24.35 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.765 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.2 pt-20 -67.97 -49.72 60.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.196 0.522 . . . . 0.0 109.815 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 21.3 mt-10 -67.38 -21.89 65.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.1 ptm180 -72.32 -19.62 61.63 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.04 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.541 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 93.2 m-85 -99.89 -4.49 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 109.874 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t0 65.23 67.92 0.51 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.5 p -117.45 164.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.706 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 57' ' ' VAL . 33.1 mmtm -122.59 109.73 14.67 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 111.049 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -140.61 143.15 31.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.962 173.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -60.92 138.37 78.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.249 1.966 . . . . 0.0 111.575 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -47.52 -57.19 5.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.844 0.83 . . . . 0.0 111.162 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.597 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 12.0 t70 -64.7 -20.72 66.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.5 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.82 -22.02 66.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.24 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 45' ' ' VAL . 58.6 t -64.25 -29.35 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.688 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.597 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -74.66 -14.45 60.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 110.809 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 9.7 t30 -79.63 -32.6 41.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.534 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.979 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -82.78 122.85 28.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -88.86 -11.37 44.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 31.6 p -125.55 155.99 39.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -67.08 -32.58 58.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.901 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -70.76 -35.08 66.36 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.909 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.64 -37.75 82.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -63.31 -46.56 86.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.809 175.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.816 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -62.78 -49.52 74.65 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.64 -170.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HD2' HD12 ' A' ' 78' ' ' LEU . 30.8 mmmt -62.47 -37.03 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.457 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 27.9 t80 -67.43 -40.82 85.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.02 0.438 . . . . 0.0 110.015 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.76 -36.84 77.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.236 0.541 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.816 ' HG ' ' O ' ' A' ' 74' ' ' THR . 90.0 mt -71.83 -26.73 62.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.24 -35.72 27.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.741 0.305 . . . . 0.0 111.044 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 20.63 18.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.883 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HA ' HG23 ' A' ' 57' ' ' VAL . 13.3 pt20 -76.16 152.5 36.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.209 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.264 177.788 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB1' ' OE1' ' A' ' 81' ' ' GLN . . . -81.74 131.68 35.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.689 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.96 140.66 47.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.446 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.635 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -84.71 -169.98 2.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.593 0.235 . . . . 0.0 110.77 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -68.06 -47.53 68.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.635 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.4 pm0 -61.89 -42.03 98.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.177 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.24 -51.72 34.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.628 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.962 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.4 -36.26 77.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.027 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.1 -41.85 90.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.18 97.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.438 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 15' ' ' ILE . . . -64.63 -45.52 92.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.177 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.7 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.48 -50.97 70.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -53.13 -57.59 9.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.52 -33.34 74.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.191 0.52 . . . . 0.0 110.504 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.713 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.0 -34.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.961 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.704 HG11 HD12 ' A' ' 37' ' ' LEU . 22.0 t -74.16 -24.98 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.822 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.2 -28.72 69.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.844 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.78 -38.42 90.92 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.477 0.656 . . . . 0.0 109.726 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.2 mt -75.53 -53.28 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.172 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.86 -86.18 0.53 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.796 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.26 61.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.06 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.779 HG13 HD13 ' A' ' 37' ' ' LEU . 16.7 mm -88.37 134.2 35.0 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.26 142.16 57.37 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.263 1.975 . . . . 0.0 111.197 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.671 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 28.8 m -62.4 -30.67 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 111.505 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 2.0 pm0 -80.56 -17.04 52.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.211 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.85 -14.34 42.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 110.256 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' A' ' 13' ' ' ALA . 89.0 t -71.87 115.24 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.708 0.766 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 70' ' ' VAL . 26.0 mtpp -136.17 169.42 17.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.914 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.73 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.4 mp -78.37 -2.7 39.51 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.11 0.481 . . . . 0.0 110.701 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.96 -21.82 17.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.681 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.88 144.02 25.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.389 -170.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.879 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 15.7 m -83.98 135.13 34.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.479 -172.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -62.05 -46.9 87.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.293 0.568 . . . . 0.0 110.438 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.8 p -77.64 -29.5 51.72 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.879 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 25.9 t70 -92.22 -66.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.72 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.96 -56.37 5.8 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.084 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.779 HD13 HG13 ' A' ' 22' ' ' ILE . 2.8 mm? -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.749 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.87 65.9 1.38 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.981 0.8 . . . . 0.0 110.044 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.522 HG11 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -123.22 143.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.082 -172.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.677 ' O ' ' HG2' ' A' ' 44' ' ' MET . 5.3 m-20 -88.71 162.6 16.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -53.76 -49.57 67.93 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.957 0.785 . . . . 0.0 110.594 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -49.77 72.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 109.676 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.564 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -55.32 -50.28 70.01 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.046 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.677 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.0 ptm -62.43 -43.5 98.66 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.977 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 94.7 t -69.02 -25.63 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.848 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -72.8 -65.79 0.75 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.618 -0.676 . . . . 0.0 111.349 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.686 HG12 HG23 ' A' ' 15' ' ' ILE . 7.4 t -87.71 -22.48 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.263 -173.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 44' ' ' MET . 36.1 t -78.98 -26.43 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.798 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -69.64 -38.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.06 -25.1 63.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 110.675 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.713 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.71 -37.24 21.18 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.798 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 8.1 pt-20 -68.15 -48.9 64.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.576 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.9 mt-10 -64.18 -27.98 69.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.081 -174.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 54' ' ' ARG . 6.2 ptp180 -76.12 -9.43 58.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 111.096 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 80.5 m-85 -105.93 17.96 22.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 66.62 24.16 10.17 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.595 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 77' ' ' ILE . 11.3 p -113.86 151.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 58' ' ' LYS . 2.1 tmtt? -135.78 113.77 11.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.222 170.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.734 HD11 HG22 ' A' ' 64' ' ' VAL . 13.0 pt -102.98 165.61 13.33 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.697 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 50.1 Cg_exo -54.94 119.4 6.44 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.527 1.485 . . . . 0.0 111.01 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.57 -40.55 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 110.553 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.47 -23.39 67.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.408 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 20.5 t70 -78.04 -25.63 47.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.782 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.734 HG22 HD11 ' A' ' 59' ' ' ILE . 44.7 t -62.32 -32.06 53.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.97 -31.86 66.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.974 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -72.04 -39.7 68.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.743 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.087 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.24 131.69 39.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.385 0.612 . . . . 0.0 110.872 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -104.94 -1.29 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.517 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.71 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 66.0 p -126.85 147.87 50.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -66.22 -32.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 109.798 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -67.71 -43.38 84.86 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.87 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.26 -41.69 84.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.087 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -59.5 -59.76 4.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.153 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 12.7 m -58.27 -47.11 84.64 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.02 -173.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD3' HD21 ' A' ' 29' ' ' LEU . 35.3 tptt -66.04 -33.33 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.44 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 54.1 t80 -66.92 -42.19 85.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.692 HG23 HG11 ' A' ' 57' ' ' VAL . 66.3 mt -58.12 -46.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.286 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.962 HD21 HG21 ' A' ' 8' ' ' ILE . 81.7 mt -66.66 -38.17 86.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.311 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -74.27 -21.04 59.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -128.48 29.11 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' OE1' ' HB1' ' A' ' 2' ' ' ALA . 3.6 pt20 -79.38 -179.53 6.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.783 0.325 . . . . 0.0 111.444 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.987 -178.306 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.773 0.32 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.32 44.01 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.409 ' O ' HD22 ' A' ' 78' ' ' LEU . . . -114.19 131.02 56.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.23 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -87.88 -166.25 1.53 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.602 ' H ' HG22 ' A' ' 4' ' ' THR . 5.9 tt0 -63.04 -56.01 20.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.968 0.168 . . . . 0.0 111.178 -171.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.515 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.1 pm0 -60.67 -36.04 77.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.69 0.281 . . . . 0.0 111.279 -173.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -69.34 -56.27 7.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.445 0.64 . . . . 0.0 110.397 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.799 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.25 -34.62 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.946 -177.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -61.43 -39.12 81.75 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.794 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.9 88.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.637 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.4 -39.08 91.54 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.703 HD22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -66.72 -51.63 53.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.35 -48.69 76.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.734 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -51.83 -36.44 48.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.819 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.849 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.19 -40.27 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.142 -174.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 37' ' ' LEU . 13.2 t -68.34 -24.63 29.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.347 0.594 . . . . 0.0 109.592 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.95 -27.19 65.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.57 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.89 -47.88 42.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.205 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 47' ' ' VAL . 20.1 mt -59.02 -52.79 56.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.057 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.99 -84.48 0.61 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.835 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.38 59.48 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.985 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.83 HG13 HD13 ' A' ' 37' ' ' LEU . 29.0 mm -94.91 128.54 38.88 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 148.48 42.67 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.567 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.656 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.6 m -64.65 -17.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.66 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.15 -21.31 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.196 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' HB3' HG23 ' A' ' 22' ' ' ILE . 22.2 t0 -99.17 -13.51 19.73 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 111.457 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.96 121.95 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.328 0.585 . . . . 0.0 110.3 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.4 mtpt -145.23 165.61 27.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.683 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.592 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 8.4 mp -75.64 -0.97 22.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.464 0.65 . . . . 0.0 109.863 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -97.17 -22.39 16.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.007 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.04 141.57 29.28 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.608 -172.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.822 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 13.7 t -81.21 132.97 35.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.245 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.55 -47.76 84.31 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.552 0.692 . . . . 0.0 110.074 176.213 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.6 p -74.58 -37.46 62.91 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.549 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 33.5 t70 -92.35 -59.7 2.02 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.16 -49.43 23.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD13 HG13 ' A' ' 22' ' ' ILE . 3.2 mm? -72.58 -16.55 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.621 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 57.07 34.59 25.13 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.064 0.935 . . . . 0.0 109.455 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -87.79 160.47 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 -171.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.758 ' O ' ' HG2' ' A' ' 44' ' ' MET . 1.2 t70 -112.93 155.46 24.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.976 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 34.9 t -41.74 -59.47 1.65 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.362 1.039 . . . . 0.0 112.17 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.77 62.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.531 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 24.5 m -53.46 -51.2 63.47 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.802 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.758 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.1 ptm -62.98 -47.49 82.95 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' A' ' 64' ' ' VAL . 97.1 t -66.2 -22.6 30.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.881 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -75.39 -66.94 0.71 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.609 -0.682 . . . . 0.0 111.752 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG12 HG23 ' A' ' 15' ' ' ILE . 4.9 t -84.17 -22.85 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.799 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.0 t -79.9 -22.6 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.214 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.706 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.1 t -68.44 -37.32 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 166.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.33 -25.01 68.1 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.378 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.849 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.54 -37.4 25.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.351 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.706 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 3.5 pt-20 -67.17 -48.66 67.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.473 0.654 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.63 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 85.1 mt-10 -70.44 -23.61 62.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.949 -172.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.3 ptm180 -73.36 -10.81 60.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.891 0.377 . . . . 0.0 110.367 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 55.1 m-85 -109.41 19.49 19.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.426 175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 66.95 26.8 9.05 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.476 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.767 HG11 HG23 ' A' ' 77' ' ' ILE . 10.2 p -118.02 155.63 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 35.7 tptt -134.83 114.71 12.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.179 0.514 . . . . 0.0 110.585 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.674 HD11 HG22 ' A' ' 64' ' ' VAL . 20.5 pt -104.11 163.33 17.54 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.439 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 27.8 Cg_exo -61.16 132.36 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.963 1.775 . . . . 0.0 111.165 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.76 -51.48 49.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.0 111.002 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.24 -20.57 64.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.92 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 9.0 t70 -71.67 -34.44 69.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.816 -0.174 . . . . 0.0 110.968 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.674 ' HB ' HG22 ' A' ' 45' ' ' VAL . 41.9 t -59.91 -39.48 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 15.7 tptp -72.03 -20.17 61.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.92 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -75.13 -35.16 61.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -81.04 153.78 27.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.0 mptp? -104.99 -29.05 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.086 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.822 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.1 p -111.11 156.64 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.26 -31.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.592 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.4 -35.72 92.1 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.196 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 63.3 m-20 -56.26 -57.35 12.62 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.662 0.268 . . . . 0.0 110.431 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.617 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.99 -44.7 78.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.372 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.757 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 19.7 m -56.51 -53.74 53.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.752 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -66.23 -37.19 84.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 40.5 t80 -59.68 -41.71 91.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.698 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.767 HG23 HG11 ' A' ' 57' ' ' VAL . 58.6 mt -64.94 -48.44 84.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.803 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.799 HD21 HG21 ' A' ' 8' ' ' ILE . 85.8 mt -64.63 -44.26 91.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.444 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -5.26 59.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 76' ' ' TYR . 26.3 m-70 -126.43 15.43 7.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 81' ' ' GLN . 3.2 pt20 -76.56 153.21 35.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.502 -174.241 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.785 0.326 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.0 31.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.59 117.03 17.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 -175.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -81.1 177.86 8.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.535 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -49.81 -53.12 27.28 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 7' ' ' GLU . 8.3 pt-20 -55.22 -49.09 72.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 111.54 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 6' ' ' GLU . 36.5 mt-10 -66.55 -50.7 62.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.214 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.874 HG21 HD21 ' A' ' 78' ' ' LEU . 3.0 tt -67.13 -35.33 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.862 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.96 -35.9 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.379 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.22 -43.42 78.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.924 0.392 . . . . 0.0 110.665 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.3 85.51 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.801 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -43.86 97.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.12 -54.89 37.49 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.149 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -52.8 -43.39 65.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.56 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 47' ' ' VAL . 7.3 mm -62.27 -53.8 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.247 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.735 HG11 HD12 ' A' ' 37' ' ' LEU . 12.1 t -70.48 -23.34 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 0.0 110.635 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -60.79 -29.23 69.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.41 -43.23 67.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 110.274 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.543 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.4 mt -65.53 -52.56 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.185 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -76.4 0.57 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.1 51.31 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.379 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 37' ' ' LEU . 10.6 mm -80.55 124.86 81.82 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.749 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 8.1 Cg_endo -53.38 147.27 37.73 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.698 2.266 . . . . 0.0 111.525 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.1 m -61.39 -30.82 48.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -172.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.21 -17.29 52.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.856 0.36 . . . . 0.0 111.401 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.749 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 2.7 t70 -86.03 -18.97 31.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.941 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 13' ' ' ALA . 84.5 t -67.41 120.39 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.658 0.742 . . . . 0.0 110.525 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HE3' ' OD1' ' A' ' 30' ' ' ASP . 26.2 mtpp -142.36 165.23 27.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.441 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.565 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 7.6 mp -77.95 -3.27 41.05 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.421 ' OD1' ' HE3' ' A' ' 28' ' ' LYS . 12.8 p-10 -107.29 -8.31 16.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -90.71 139.81 30.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.7 m -89.1 135.59 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.376 -171.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -58.04 -47.56 82.72 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 110.193 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 p -72.12 -32.13 66.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.481 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.76 -69.84 0.73 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.272 0.558 . . . . 0.0 111.602 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.67 -48.4 26.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.941 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.813 HD13 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -66.68 -17.91 65.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.441 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.04 36.06 18.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.935 0.874 . . . . 0.0 109.679 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -98.47 150.13 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.746 -171.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.762 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.6 t70 -97.53 154.62 17.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.996 173.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 45' ' ' VAL . 30.4 m -51.99 -44.85 64.25 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.699 0.624 . . . . 0.0 111.632 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 tp -77.58 -39.34 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.954 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 51.6 m -55.34 -48.67 73.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.762 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 6.4 ptm -62.47 -45.84 91.22 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.749 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.2 t -64.36 -23.04 32.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.713 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.21 -65.73 0.81 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.936 -0.478 . . . . 0.0 111.696 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 15' ' ' ILE . 18.9 t -89.67 -20.53 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.272 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 44' ' ' MET . 19.8 t -80.08 -17.0 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.665 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.0 t -78.57 -34.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 121.536 0.684 . . . . 0.0 109.209 165.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -59.5 -24.18 63.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.567 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.7 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -81.76 -38.76 25.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.677 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.727 ' O ' HG12 ' A' ' 57' ' ' VAL . 5.9 pt-20 -60.4 -47.4 86.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.692 0.758 . . . . 0.0 109.46 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 22.6 mt-10 -74.75 -21.74 59.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.809 -171.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 3.7 ptp180 -74.21 -12.15 60.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.019 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.0 10.13 39.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.72 30.42 16.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.001 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -115.17 162.74 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.575 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 24.3 mmmt -128.7 116.02 18.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.252 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 64' ' ' VAL . 44.2 pt -117.61 158.7 44.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.666 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 18.7 Cg_exo -69.43 135.44 31.25 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.548 2.165 . . . . 0.0 112.302 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.8 -58.15 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.592 0.711 . . . . 0.0 110.79 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -17.75 64.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.349 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.666 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.3 t0 -76.07 -19.56 58.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.105 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.834 ' HB ' HG22 ' A' ' 45' ' ' VAL . 24.6 t -72.73 -52.61 22.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.514 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -68.82 -7.25 32.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -76.43 -36.21 58.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.087 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.741 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.1 pp -89.24 128.17 35.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.47 0.652 . . . . 0.0 111.016 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.92 1.0 55.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.89 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 74.7 p -130.15 147.91 51.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.553 0.216 . . . . 0.0 110.543 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 31' ' ' LYS . 1.6 p -69.43 -34.42 62.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.943 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.6 -41.37 97.28 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.91 -49.75 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -52.45 -54.27 34.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.627 0.727 . . . . 0.0 111.164 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.773 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.1 m -58.08 -48.55 79.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.636 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.622 ' HD2' HD12 ' A' ' 78' ' ' LEU . 12.2 tptp -69.2 -29.09 66.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.216 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.24 -46.35 80.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.802 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.51 -36.78 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.307 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 8' ' ' ILE . 92.3 mt -70.6 -31.86 69.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.768 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.26 -42.2 17.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.064 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -96.08 13.24 27.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -64.91 135.3 55.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.496 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.075 -175.438 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.805 0.336 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.48 147.22 23.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.038 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.47 136.67 32.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.817 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -99.62 -170.96 1.97 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.582 ' H ' HG22 ' A' ' 4' ' ' THR . 15.2 tp60 -48.7 -53.36 19.15 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -62.23 -46.85 87.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.16 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.32 -43.41 50.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.845 0.355 . . . . 0.0 111.284 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.691 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.48 -34.1 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.59 -42.41 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.129 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.92 92.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.607 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.571 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -66.8 -39.18 93.48 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.92 -49.45 70.37 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.02 -50.45 70.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.68 -36.51 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -39.36 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.254 -175.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 37' ' ' LEU . 41.7 t -70.11 -24.99 26.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.097 0.475 . . . . 0.0 110.079 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -62.29 -24.53 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -72.33 -39.46 68.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 109.795 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.724 HD11 ' HB ' ' A' ' 47' ' ' VAL . 26.9 mt -72.63 -50.64 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.226 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.83 -77.75 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.259 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.62 44.19 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.788 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.824 HG13 HD13 ' A' ' 37' ' ' LEU . 9.1 mm -75.04 134.97 74.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 26' ' ' ASP . 51.3 Cg_exo -53.61 144.14 53.9 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.469 2.113 . . . . 0.0 111.449 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 82.3 t -59.69 -38.13 74.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.364 . . . . 0.0 111.021 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -74.29 -17.95 60.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.68 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' HB3' HG23 ' A' ' 22' ' ' ILE . 14.0 t0 -87.51 -16.84 33.55 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.214 -0.304 . . . . 0.0 111.594 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 13' ' ' ALA . 89.8 t -64.97 116.96 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.566 0.698 . . . . 0.0 110.445 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -141.02 162.02 36.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.194 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' CA ' ' A' ' 71' ' ' GLY . 9.7 mp -79.25 -4.19 49.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.35 -8.38 21.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -97.56 134.57 40.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 18.1 m -89.39 140.91 29.04 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 111.46 -170.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.637 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 1.1 m-85 -58.81 -50.92 72.15 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 110.152 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.3 p -69.53 -33.06 72.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.406 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.18 -68.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 10.3 t0 -78.42 -51.52 9.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.4 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.824 HD13 HG13 ' A' ' 22' ' ' ILE . 3.8 mm? -64.8 -13.31 55.09 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 58.13 38.83 26.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 109.539 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.41 149.79 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.913 -172.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.76 166.29 11.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 p -54.83 -56.72 16.36 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.099 0.249 . . . . 0.0 111.634 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.34 -38.87 92.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.533 0.206 . . . . 0.0 111.263 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 25.1 m -52.66 -54.37 34.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.031 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.671 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 15.2 ptt? -64.26 -48.02 77.34 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.646 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.1 t -55.28 -28.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.994 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.22 -66.13 0.87 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.761 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.724 ' HB ' HD11 ' A' ' 19' ' ' ILE . 14.4 t -83.33 -22.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.134 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 44' ' ' MET . 44.9 t -79.9 -19.92 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.917 -0.489 . . . . 0.0 110.295 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -75.22 -32.88 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.249 167.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -62.0 -24.32 66.97 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.605 169.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.53 -32.48 28.62 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.888 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.8 pt-20 -66.11 -54.08 29.99 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.643 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 16.5 mt-10 -71.61 -20.36 61.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.227 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 13.3 ptm180 -69.68 -15.24 63.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.101 0.477 . . . . 0.0 110.048 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.571 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 65.3 m-85 -107.3 15.03 25.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.014 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.33 27.37 8.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.72 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.1 p -113.67 165.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.535 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 17.1 pttm -132.26 119.1 20.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 110.427 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.04 154.65 53.36 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -63.73 128.96 23.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.899 1.732 . . . . 0.0 111.524 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.49 -40.07 58.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.479 0.657 . . . . 0.0 109.709 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.78 -35.5 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.104 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -74.42 -29.64 61.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.898 ' HB ' HG22 ' A' ' 45' ' ' VAL . 21.7 t -61.58 -40.59 87.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.376 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.17 -5.65 59.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 177.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -80.82 -23.64 39.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.067 0.46 . . . . 0.0 110.282 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -95.28 143.72 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.412 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 11.9 mptt -101.54 -17.66 16.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.806 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 19.1 p -118.77 156.06 30.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.599 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -65.38 -33.99 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.035 0.445 . . . . 0.0 109.944 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' CA ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.8 -35.58 86.99 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 69.5 m-20 -58.8 -58.54 8.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.516 0.186 . . . . 0.0 110.638 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -55.26 -47.65 75.15 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.0 m -57.02 -54.08 50.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.088 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 1.6 tppp? -69.78 -31.43 69.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.211 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -61.08 -45.28 95.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.933 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.572 HG23 HG11 ' A' ' 57' ' ' VAL . 61.2 mt -59.49 -44.5 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 74' ' ' THR . 81.2 mt -71.96 -29.11 63.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.964 -174.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.76 -24.89 61.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.651 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -124.1 28.92 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -68.37 170.74 8.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.148 0.499 . . . . 0.0 112.089 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.755 179.322 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.848 0.356 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.12 166.64 10.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.472 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' A' ' 7' ' ' GLU . . . -105.96 140.08 39.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.291 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -86.66 -168.98 2.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.95 178.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.484 ' H ' HG22 ' A' ' 4' ' ' THR . 12.2 tt0 -55.35 -56.61 18.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.19 -34.41 78.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 0.0 111.491 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.56 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 39.5 mt-10 -70.7 -51.21 29.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.778 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.46 -32.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.77 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.2 -44.02 90.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.89 87.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 110.69 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -70.86 -42.86 59.92 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.983 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.56 -40.95 98.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.744 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.85 -51.67 68.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.103 177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -54.21 -39.59 66.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.197 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 51' ' ' ALA . 6.4 mm -67.93 -52.77 35.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.218 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.831 HG11 HD12 ' A' ' 37' ' ' LEU . 5.8 t -68.03 -22.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.148 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.51 -31.61 69.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -76.66 -24.82 53.27 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 110.411 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.51 HG21 HG23 ' A' ' 39' ' ' VAL . 22.2 mt -81.92 -54.36 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.671 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.41 -78.05 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.938 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.74 57.49 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.557 -1.306 . . . . 0.0 114.696 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.792 HG13 HD13 ' A' ' 37' ' ' LEU . 20.9 mm -90.72 129.81 43.24 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 164.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.54 147.16 39.73 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.349 2.033 . . . . 0.0 111.981 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.744 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 25.3 m -61.09 -26.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.441 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.34 -17.52 48.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.64 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 22' ' ' ILE . 2.3 t70 -96.23 -15.55 21.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.742 HG21 ' HA ' ' A' ' 13' ' ' ALA . 76.9 t -68.66 126.74 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.592 0.711 . . . . 0.0 110.571 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HE2' ' HB3' ' A' ' 30' ' ' ASP . 42.5 mtpt -140.2 173.45 11.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.692 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 30.2 mt -82.07 -3.29 54.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.895 0.855 . . . . 0.0 108.695 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.555 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 6.2 t70 -95.62 -27.1 15.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.592 -170.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.86 144.15 25.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.991 -174.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.793 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 22.3 m -84.54 135.35 34.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.653 ' CD2' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -60.82 -48.13 83.2 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.242 0.544 . . . . 0.0 110.135 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 p -66.59 -38.07 86.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.503 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -92.75 -65.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.989 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.3 m-20 -69.42 -48.53 60.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.848 -174.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.831 HD12 HG11 ' A' ' 16' ' ' VAL . 3.6 mm? -74.87 -4.59 38.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.131 -171.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.36 58.8 5.1 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.934 0.772 . . . . 0.0 109.34 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -122.44 152.21 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.689 -170.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.611 ' H ' ' HB3' ' A' ' 43' ' ' SER . 12.4 t70 -119.46 162.31 19.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.621 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.6 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 p -39.25 -58.09 1.25 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -74.35 -44.52 51.99 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.375 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 40' ' ' ASP . 30.6 t -45.27 -58.98 2.9 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.643 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.482 ' HE2' HG12 ' A' ' 64' ' ' VAL . 10.4 ptm -60.78 -50.15 74.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.754 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' A' ' 64' ' ' VAL . 70.0 t -63.76 -21.64 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.103 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.944 -0.472 . . . . 0.0 111.372 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.746 HG12 HG23 ' A' ' 15' ' ' ILE . 6.6 t -89.92 -21.67 6.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.858 -173.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 44' ' ' MET . 38.6 t -79.78 -24.01 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.172 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.693 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.4 t -70.27 -39.06 76.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 167.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.0 -21.56 61.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.579 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.59 -46.57 11.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.842 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 10.6 pt-20 -63.25 -46.53 86.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 110.159 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.78 -24.98 64.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.485 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 14.7 ptm180 -75.19 -18.65 60.12 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.215 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.404 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 88.0 m-85 -97.27 9.89 41.0 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.39 0.614 . . . . 0.0 109.361 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 66.36 52.6 1.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.198 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.3 p -137.52 152.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -134.32 112.12 10.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.679 0.276 . . . . 0.0 110.54 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.714 HD11 HG22 ' A' ' 64' ' ' VAL . 8.1 pt -110.01 165.23 13.06 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.37 134.74 43.15 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.699 1.599 . . . . 0.0 111.393 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB3' HG11 ' A' ' 45' ' ' VAL . 1.6 m-20 -51.38 -43.8 61.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.742 0.782 . . . . 0.0 110.068 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.13 -31.33 65.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.861 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.47 -35.23 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.166 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.714 HG22 HD11 ' A' ' 59' ' ' ILE . 55.5 t -58.45 -42.63 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.6 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 16.6 tptp -74.66 -20.63 59.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.838 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -73.63 -28.24 61.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.054 0.454 . . . . 0.0 110.011 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -88.22 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 111.004 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -99.72 -14.8 18.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.354 -171.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.793 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 26.2 p -115.45 157.68 23.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.653 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.2 p -70.19 -24.27 25.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.448 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -37.14 94.02 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.815 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.711 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.2 m-20 -56.92 -58.07 9.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.41 0.148 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.638 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.65 -50.17 70.94 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.27 0.557 . . . . 0.0 110.747 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.746 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 37.0 m -55.25 -50.68 68.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.926 -176.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -67.74 -31.27 71.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.357 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.45 -42.96 86.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.756 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.475 HG23 HG11 ' A' ' 57' ' ' VAL . 91.0 mt -59.81 -40.31 82.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.262 174.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 8' ' ' ILE . 87.8 mt -73.07 -38.86 66.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.002 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.84 -27.44 55.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.283 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -116.55 26.57 9.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 111.419 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -71.01 134.05 46.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.407 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.819 176.196 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.75 158.47 28.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.27 120.22 22.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.249 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -85.07 -171.47 3.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 4' ' ' THR . 12.6 tt0 -51.58 -56.11 15.39 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -169.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -64.83 -35.37 80.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.73 -48.46 31.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.851 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.895 HG21 HD21 ' A' ' 78' ' ' LEU . 1.8 tt -68.57 -33.34 59.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.06 -35.96 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.301 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.25 85.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.755 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -71.02 -38.23 63.98 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.32 -44.44 96.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.846 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.78 -48.75 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.16 -32.88 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.139 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.966 HG21 ' HB2' ' A' ' 51' ' ' ALA . 4.1 mm -78.08 -50.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.561 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.794 HG11 HD12 ' A' ' 37' ' ' LEU . 9.3 t -67.11 -23.53 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.23 0.538 . . . . 0.0 109.982 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.44 -25.11 65.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.33 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HB3' HG11 ' A' ' 47' ' ' VAL . 7.6 tp10 -73.65 -30.13 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.091 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.598 HD11 ' HB ' ' A' ' 47' ' ' VAL . 36.2 mt -84.53 -52.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.679 -172.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 -88.26 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.752 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.38 56.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.512 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.793 HG13 HD13 ' A' ' 37' ' ' LEU . 26.9 mm -98.27 122.27 54.48 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 163.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.51 145.99 44.55 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.444 2.096 . . . . 0.0 111.5 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.846 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 35.3 m -58.7 -22.02 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.176 0.512 . . . . 0.0 111.887 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.81 -17.66 46.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.797 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 22' ' ' ILE . 3.4 t70 -102.24 -9.42 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -172.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 13' ' ' ALA . 36.1 t -68.13 123.14 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.396 0.617 . . . . 0.0 110.404 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' O ' HG13 ' A' ' 70' ' ' VAL . 57.0 mttt -141.21 166.16 25.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.575 -171.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 10.2 mp -78.59 -2.98 41.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.296 0.57 . . . . 0.0 109.485 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.09 -20.2 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.648 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -99.79 144.74 28.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.948 -172.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.77 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 18.5 t -87.39 134.0 33.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.086 -172.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.632 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -58.57 -42.66 88.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.0 110.253 176.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.0 p -79.02 -32.55 45.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.636 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.8 t70 -92.95 -56.59 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.052 0.453 . . . . 0.0 111.824 -175.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -88.93 -40.35 13.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.119 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.794 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -78.32 -3.85 45.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.526 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 52.7 38.84 27.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.082 0.467 . . . . 0.0 110.865 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.611 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.4 OUTLIER -108.41 141.03 24.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.46 . . . . 0.0 111.874 -170.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.749 ' O ' ' HG2' ' A' ' 44' ' ' MET . 13.8 m-20 -95.23 162.39 13.71 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.931 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -50.37 -41.7 52.18 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.942 0.776 . . . . 0.0 111.137 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.55 -53.36 16.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.564 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.533 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 18.7 m -51.41 -48.81 62.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.526 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.749 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.4 ptm -60.56 -56.76 17.51 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.768 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.791 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.37 -24.47 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.468 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.08 -65.44 0.8 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.596 -0.69 . . . . 0.0 111.287 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.793 HG12 HG23 ' A' ' 15' ' ' ILE . 11.1 t -88.01 -20.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.698 -173.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.4 t -79.83 -19.75 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.976 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -73.83 -34.56 40.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 165.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -63.02 -21.78 66.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.843 169.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.966 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.47 -34.39 23.41 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.727 ' O ' HG12 ' A' ' 57' ' ' VAL . 9.6 pt-20 -68.57 -49.9 55.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.564 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 37.9 mt-10 -67.56 -25.1 65.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.469 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -72.11 -16.61 62.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.054 0.454 . . . . 0.0 110.63 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.755 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 82.0 m-85 -106.53 15.77 25.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.66 33.16 18.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.861 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.2 p -111.64 161.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' N ' HG22 ' A' ' 57' ' ' VAL . 18.0 mttp -134.88 110.8 9.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 pt -121.27 160.81 44.07 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.1 Cg_exo -66.28 137.91 49.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.645 2.23 . . . . 0.0 111.683 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.78 -44.53 96.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.118 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.38 -18.35 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.985 0.421 . . . . 0.0 110.661 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 7.3 t70 -67.14 -41.93 85.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.791 ' HB ' HG22 ' A' ' 45' ' ' VAL . 37.7 t -59.77 -47.66 90.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.129 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.512 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.38 -1.5 30.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.396 . . . . 0.0 111.683 -176.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -92.05 -36.6 13.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.33 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -74.58 138.35 42.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.777 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -94.98 -20.63 19.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.155 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.769 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.8 p -116.48 156.39 26.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.632 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -66.53 -29.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -63.71 -36.23 93.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.589 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.4 m-20 -55.03 -59.27 4.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.595 0.235 . . . . 0.0 111.041 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.27 -47.9 74.8 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.773 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 11.5 m -57.54 -51.64 68.65 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.83 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD2' HD12 ' A' ' 78' ' ' LEU . 10.8 tptp -65.84 -34.92 79.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.136 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.81 -45.8 90.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.241 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.723 HG23 HG11 ' A' ' 57' ' ' VAL . 81.2 mt -57.18 -45.53 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.893 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 8' ' ' ILE . 94.6 mt -65.05 -21.85 66.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.554 -171.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.71 -22.7 27.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.175 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.02 27.8 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.538 ' HA ' HG23 ' A' ' 57' ' ' VAL . 29.6 pt20 -74.74 148.09 40.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.773 179.068 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.05 156.19 19.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.984 0.421 . . . . 0.0 110.866 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.57 118.94 37.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -78.15 -176.82 4.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.836 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' H ' HG22 ' A' ' 4' ' ' THR . 0.4 OUTLIER -58.58 -52.95 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -176.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 3.0 pm0 -59.5 -35.15 73.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.042 0.448 . . . . 0.0 111.264 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.53 -58.4 4.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.623 0.725 . . . . 0.0 110.599 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.805 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.67 -33.51 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.326 -175.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.92 -42.14 91.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.93 -0.123 . . . . 0.0 110.78 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.92 91.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.367 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA3' ' CE2' ' A' ' 55' ' ' PHE . . . -69.75 -41.49 73.89 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.526 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.14 -47.49 84.3 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -50.4 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.71 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.67 -37.0 58.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.898 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.27 -34.23 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.599 -174.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.801 HG11 HD12 ' A' ' 37' ' ' LEU . 47.0 t -70.7 -24.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 O-C-N 121.645 -0.659 . . . . 0.0 109.482 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.21 -20.73 66.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.943 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -75.49 -29.47 59.55 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.207 0.527 . . . . 0.0 110.209 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 47' ' ' VAL . 28.1 mt -83.74 -52.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.13 -91.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.264 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.44 54.36 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.036 -1.554 . . . . 0.0 114.789 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.759 HG13 HD13 ' A' ' 37' ' ' LEU . 22.2 mm -87.92 125.11 65.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 164.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 146.14 51.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.6 2.2 . . . . 0.0 111.169 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.2 m -60.68 -26.75 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.865 0.364 . . . . 0.0 111.773 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.26 -18.88 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.088 0.471 . . . . 0.0 111.355 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 22' ' ' ILE . 25.2 t0 -90.28 -18.9 24.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.971 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 13' ' ' ALA . 87.7 t -66.52 117.02 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.651 0.739 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HE2' ' OD1' ' A' ' 30' ' ' ASP . 31.1 mtpt -141.82 170.76 15.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.688 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.669 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 23.4 mt -81.57 -4.18 55.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.007 0.432 . . . . 0.0 110.221 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 3.7 p-10 -111.36 13.5 21.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -173.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -114.18 143.21 45.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.539 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.643 ' HB2' ' HB2' ' A' ' 35' ' ' ASP . 13.4 m -82.11 136.16 35.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.754 0.311 . . . . 0.0 110.637 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -65.15 -47.63 76.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.258 0.551 . . . . 0.0 109.931 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.3 p -67.2 -38.23 84.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.327 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.5 m-20 -91.73 -68.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.706 -173.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.86 -48.4 54.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.244 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.801 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -68.86 -10.94 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 55.73 51.7 12.02 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.81 0.814 . . . . 0.0 109.551 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -122.18 146.35 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.539 -169.509 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' A' ' 44' ' ' MET . 20.2 m-20 -102.71 162.68 12.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.978 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 t -49.16 -51.07 34.72 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.258 0.974 . . . . 0.0 111.195 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.01 -43.4 68.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.586 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB2' ' H ' ' A' ' 40' ' ' ASP . 12.0 m -55.21 -55.8 27.16 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.743 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.6 ptm -55.43 -58.4 7.9 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.474 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' A' ' 64' ' ' VAL . 63.7 t -58.09 -26.46 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.695 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.1 -65.65 0.78 Allowed 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.601 -0.687 . . . . 0.0 111.415 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' HB ' HD11 ' A' ' 19' ' ' ILE . 11.0 t -84.88 -23.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.808 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 44' ' ' MET . 65.6 t -74.1 -31.11 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.998 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.8 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 6.2 t -69.36 -34.72 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.376 0.608 . . . . 0.0 109.678 171.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.87 67.49 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.95 -0.469 . . . . 0.0 110.616 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.01 -41.12 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.875 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.8 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -61.62 -44.29 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.181 0.515 . . . . 0.0 110.315 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.83 -31.62 71.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.347 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.2 ptm180 -74.76 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.053 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.679 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 57.3 m-85 -104.51 13.21 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.606 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 57.45 70.54 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.083 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 52' ' ' GLU . 10.0 p -129.43 165.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 171.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' N ' HG22 ' A' ' 57' ' ' VAL . 64.3 mttm -128.08 111.55 13.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 0.0 110.232 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -149.12 132.84 8.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.429 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 20.5 Cg_exo -64.96 140.96 68.57 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.134 1.89 . . . . 0.0 111.299 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.604 ' HB2' ' CG1' ' A' ' 45' ' ' VAL . 7.8 p-10 -56.51 -32.01 64.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.74 0.781 . . . . 0.0 110.083 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 28.7 t70 -60.11 -27.03 66.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.429 -1.259 . . . . 0.0 111.53 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.04 -36.12 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.817 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.655 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 21.4 t -60.69 -44.35 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.613 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -79.8 -2.41 43.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 0.0 111.36 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -92.78 -19.49 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.163 0.506 . . . . 0.0 109.78 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 1.5 pp -93.97 128.3 40.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -97.14 3.55 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.545 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.585 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 81.5 p -129.03 143.99 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -64.71 -37.24 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.991 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -63.45 -32.6 84.7 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.818 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 11.7 t70 -59.96 -51.22 70.58 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.632 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -55.51 -49.58 72.21 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.693 175.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.774 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 1.8 m -58.91 -52.53 65.35 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.642 -173.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HD2' HD12 ' A' ' 78' ' ' LEU . 14.5 tptp -65.97 -34.79 78.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.071 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CD2' HD12 ' A' ' 59' ' ' ILE . 53.0 t80 -62.33 -47.28 84.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.766 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.467 ' HA ' HG21 ' A' ' 57' ' ' VAL . 54.0 mt -58.81 -46.7 90.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.594 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 8' ' ' ILE . 86.7 mt -61.44 -26.4 67.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.946 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.57 -29.74 21.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 111.598 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -115.73 30.45 7.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 29.9 pt20 -89.04 154.86 19.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.496 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.204 178.329 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.58 106.85 18.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.57 142.6 46.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -75.53 -179.64 4.75 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.957 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.595 ' H ' HG22 ' A' ' 4' ' ' THR . 47.2 tt0 -54.39 -56.38 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -66.89 -32.78 74.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 111.452 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.05 -47.94 19.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.95 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.23 -34.72 67.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.97 -38.41 79.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.635 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.58 80.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.757 0.313 . . . . 0.0 110.476 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.591 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.11 -36.93 91.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.851 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -68.58 -49.34 60.13 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.74 -46.23 84.75 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -51.27 -36.37 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.567 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.879 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.1 -37.6 11.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.556 -175.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 37' ' ' LEU . 21.3 t -68.82 -25.32 30.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.85 -0.532 . . . . 0.0 110.16 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.61 -24.2 67.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.924 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.09 -41.74 63.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.945 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 47' ' ' VAL . 25.3 mt -68.08 -53.26 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.152 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.89 -84.93 0.61 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.763 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.78 54.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.389 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.802 HG13 HD13 ' A' ' 37' ' ' LEU . 23.7 mm -82.27 130.45 59.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 166.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.33 137.52 38.89 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.195 1.93 . . . . 0.0 111.07 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 29.0 m -56.8 -27.73 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.46 -18.29 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.518 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -90.71 -16.59 28.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.104 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.37 116.9 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.671 0.748 . . . . 0.0 110.19 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 70' ' ' VAL . 25.5 mtpp -134.65 167.22 21.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.93 -173.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.741 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.7 mp -79.45 -2.96 44.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.494 0.664 . . . . 0.0 109.754 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.16 -13.23 19.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.955 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -100.72 143.29 31.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.492 -174.076 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.854 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 75.4 m -84.22 134.89 34.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.373 -173.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -58.7 -42.15 87.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 110.169 176.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 p -77.67 -36.49 51.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.269 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 10.8 t70 -91.02 -57.28 2.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 1.8 m-20 -77.48 -56.8 4.23 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.802 HD13 HG13 ' A' ' 22' ' ' ILE . 2.7 mm? -68.67 -13.64 62.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.429 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 54.13 36.44 24.82 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.187 0.994 . . . . 0.0 110.292 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -97.59 148.71 5.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.223 -171.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.1 m-20 -94.83 163.43 13.35 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' MET . 66.9 m -56.25 -42.69 77.79 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.441 0.463 . . . . 0.0 111.534 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -72.37 -47.08 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.813 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.464 ' HB2' HG22 ' A' ' 39' ' ' VAL . 14.5 m -50.82 -51.93 46.16 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 3.5 ptp -59.18 -59.41 5.51 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.733 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 81.8 t -58.59 -21.68 18.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.025 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -70.04 -65.82 0.67 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.961 -0.462 . . . . 0.0 110.835 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG12 HG23 ' A' ' 15' ' ' ILE . 11.6 t -89.51 -22.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.274 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.29 -25.19 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 122.165 -0.335 . . . . 0.0 110.481 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.733 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.6 t -74.93 -36.4 38.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.44 64.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.12 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.879 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.67 -33.12 21.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.714 ' O ' HG12 ' A' ' 57' ' ' VAL . 6.8 pt-20 -68.61 -49.2 61.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 109.792 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 35.1 mt-10 -66.63 -27.44 67.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.303 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.3 ptm180 -73.63 -12.88 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.084 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.591 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 67.5 m-85 -104.22 3.69 33.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.326 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 57.43 58.79 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.245 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -120.59 162.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.991 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 57' ' ' VAL . 80.5 tttt -124.14 110.89 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.981 0.419 . . . . 0.0 110.587 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 ' HD2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -134.57 136.93 26.52 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.942 176.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 126.57 21.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.259 1.973 . . . . 0.0 111.47 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.62 -35.55 68.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.93 -19.52 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.96 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 23.6 t70 -82.53 -21.26 35.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.56 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 45' ' ' VAL . 45.6 t -66.58 -38.88 82.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.681 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -84.16 -3.51 58.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.105 0.479 . . . . 0.0 110.611 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 30.7 t30 -82.11 -36.19 27.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.221 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.4 pp -84.07 126.83 33.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.522 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -2.59 55.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.996 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.854 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 78.6 p -122.48 147.93 45.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -66.49 -33.28 62.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.896 178.148 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -64.08 -36.84 93.77 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.131 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 1.9 t0 -60.63 -47.07 87.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -56.14 -54.76 41.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.459 0.647 . . . . 0.0 110.412 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.825 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.8 m -53.69 -50.49 65.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.617 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.696 ' HD2' HD12 ' A' ' 78' ' ' LEU . 12.9 tptm -66.12 -35.78 81.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.755 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' HD2' HD12 ' A' ' 59' ' ' ILE . 72.2 t80 -64.71 -42.24 95.4 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.99 -42.37 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.116 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 8' ' ' ILE . 82.2 mt -63.85 -23.0 67.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.209 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.76 -40.71 13.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.984 0.421 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -104.38 20.3 18.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.816 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HA ' HG23 ' A' ' 57' ' ' VAL . 12.4 pt20 -86.33 139.93 30.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.622 0.248 . . . . 0.0 110.61 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.206 -178.031 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 121.236 0.541 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.69 166.5 22.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.328 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 7' ' ' GLU . . . -114.96 140.43 49.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.896 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -79.26 -174.85 4.35 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.292 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.597 ' H ' HG22 ' A' ' 4' ' ' THR . 20.8 tt0 -54.54 -55.35 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -169.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -67.33 -34.38 77.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.197 0.522 . . . . 0.0 110.977 -173.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB3' ' HB1' ' A' ' 3' ' ' ALA . 40.0 tp10 -75.09 -47.12 30.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.409 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.704 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -69.39 -31.45 49.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.09 -41.13 90.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 110.325 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.68 93.8 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.353 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.78 -51.16 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.94 -52.68 62.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.05 -40.88 46.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.718 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.807 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -85.01 -29.75 6.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.158 -172.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.801 HG11 HD12 ' A' ' 37' ' ' LEU . 42.2 t -76.43 -24.73 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 121.711 -0.618 . . . . 0.0 109.818 176.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.97 -30.96 71.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.505 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 15.4 tp10 -62.79 -41.47 99.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.178 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.534 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 28.9 mt -76.84 -54.45 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.001 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.51 -77.75 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.792 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.76 61.23 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.504 -1.332 . . . . 0.0 114.817 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.8 HG13 HD13 ' A' ' 37' ' ' LEU . 17.1 mm -87.98 129.22 51.02 Favored Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.7 141.28 35.27 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 111.548 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.66 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 91.1 t -56.32 -33.68 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.212 -174.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -76.65 -21.53 55.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.015 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.49 -15.54 37.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.552 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.454 HG21 ' CB ' ' A' ' 13' ' ' ALA . 72.6 t -69.17 121.0 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 70' ' ' VAL . 57.9 mtpt -144.39 177.16 8.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.256 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.617 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 19.8 mt -81.69 -7.32 59.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.048 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -92.83 -32.44 14.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.456 -171.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.651 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.71 139.23 32.88 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.702 -168.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.774 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.3 m -87.65 135.34 33.4 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.645 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.01 -45.6 82.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.407 0.622 . . . . 0.0 110.403 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.1 p -75.46 -33.41 60.84 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.214 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.774 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 15.2 t70 -91.64 -58.01 2.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.947 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.92 -47.15 8.06 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.633 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.801 HD12 HG11 ' A' ' 16' ' ' VAL . 3.9 mm? -67.38 -16.72 64.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.021 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.63 32.82 16.13 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.57 0.544 . . . . 0.0 110.535 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -99.25 147.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.592 -171.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.1 m-20 -96.67 164.53 12.55 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 p -55.65 -48.78 74.42 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.673 0.608 . . . . 0.0 111.522 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -50.95 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 19.1 m -47.6 -52.46 17.74 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.839 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 8.8 ptm -61.98 -50.67 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.262 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 64' ' ' VAL . 86.5 t -60.38 -25.23 33.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.944 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.51 -65.82 0.77 Allowed 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.879 -0.513 . . . . 0.0 111.226 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.591 HG12 HG12 ' A' ' 15' ' ' ILE . 6.7 t -88.36 -21.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.108 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -79.45 -27.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.102 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.653 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.44 -34.7 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.421 0.629 . . . . 0.0 109.389 169.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.39 68.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.355 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.807 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -80.36 -35.75 34.99 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.653 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 11.2 pt-20 -70.57 -52.72 19.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 29.8 mt-10 -66.08 -20.68 66.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.5 ptm180 -71.97 -5.31 33.93 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.803 -0.56 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.415 ' CB ' HE22 ' A' ' 81' ' ' GLN . 80.1 m-85 -119.76 13.02 12.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.738 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 59.77 41.92 17.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.727 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.701 HG11 HG23 ' A' ' 77' ' ' ILE . 9.5 p -115.17 137.56 48.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -134.28 117.89 16.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.252 0.548 . . . . 0.0 111.263 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.632 HD11 ' CG2' ' A' ' 64' ' ' VAL . 6.4 pt -116.38 164.94 16.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.591 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 63' ' ' ASP . 34.4 Cg_exo -61.76 134.48 50.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.586 1.524 . . . . 0.0 110.932 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.31 -41.14 62.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.632 . . . . 0.0 111.061 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.01 -20.49 66.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.229 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.19 -41.95 66.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.604 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 59' ' ' ILE . 48.2 t -59.22 -43.48 89.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -22.54 66.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.005 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.29 -17.71 23.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.442 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.3 pp -87.93 128.27 35.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.512 0.672 . . . . 0.0 110.688 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -90.83 -8.43 49.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.808 -170.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 13.2 p -128.73 157.16 42.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.36 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 28' ' ' LYS . 1.5 p -76.68 -18.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.88 -42.78 24.47 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.105 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.68 -39.29 84.02 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -57.44 -56.87 16.3 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.304 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.785 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -59.36 -50.6 73.33 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.52 -177.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HD2' HD12 ' A' ' 78' ' ' LEU . 1.5 tptm -62.4 -37.57 86.31 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.713 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.62 -41.06 98.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.701 HG23 HG11 ' A' ' 57' ' ' VAL . 27.7 mt -62.61 -52.36 60.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 74' ' ' THR . 84.2 mt -60.41 -35.0 74.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.36 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.34 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.533 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -98.95 7.85 45.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.435 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 77' ' ' ILE . 5.2 mm-40 -68.39 150.5 48.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.959 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.352 -177.232 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.682 0.277 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 126.95 32.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 110.96 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.408 ' HB1' ' CB ' ' A' ' 7' ' ' GLU . . . -102.24 125.68 49.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.515 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -165.29 0.55 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.535 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.78 -56.41 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.64 -30.54 65.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.747 0.308 . . . . 0.0 111.296 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' CB ' ' HB1' ' A' ' 3' ' ' ALA . 71.1 mm-40 -65.12 -53.53 43.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 110.24 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.8 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.82 -33.55 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.661 -178.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.91 -37.63 78.7 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.779 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.73 94.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.498 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.97 -39.87 89.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.937 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -63.05 -48.88 76.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.611 ' HA ' HG21 ' A' ' 27' ' ' VAL . . . -55.71 -50.0 71.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.032 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.93 -38.45 67.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.136 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.896 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.74 -33.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.752 HG11 HD12 ' A' ' 37' ' ' LEU . 43.8 t -74.34 -23.91 18.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -63.36 -24.43 67.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.741 174.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.02 -27.9 63.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.533 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.843 HD11 ' HB ' ' A' ' 47' ' ' VAL . 47.3 mt -91.26 -53.79 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.559 -173.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.81 -82.03 0.64 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.07 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.32 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.778 HG13 HD13 ' A' ' 37' ' ' LEU . 20.5 mm -88.33 130.73 44.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 166.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 9.8 Cg_endo -53.3 141.49 59.96 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.368 2.046 . . . . 0.0 111.017 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 34.9 m -62.88 -20.66 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.411 . . . . 0.0 111.717 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.44 -20.63 39.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -97.9 -8.75 27.55 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.161 -173.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 13' ' ' ALA . 68.9 t -67.23 110.21 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.688 0.756 . . . . 0.0 109.379 175.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' O ' HG13 ' A' ' 70' ' ' VAL . 55.5 mtpt -135.84 164.49 27.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.267 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.729 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.1 mp -74.68 -2.89 28.27 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.182 0.515 . . . . 0.0 110.238 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -104.26 -7.65 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.555 -171.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.612 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.78 141.58 35.85 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.29 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.796 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 16.2 m -83.64 132.3 34.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.089 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.63 -48.63 80.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.244 0.545 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -70.26 -35.55 73.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.491 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.796 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 14.4 t70 -91.5 -69.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.617 -173.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.15 -44.35 63.24 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.749 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.778 HD13 HG13 ' A' ' 22' ' ' ILE . 3.6 mm? -70.53 -15.87 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.51 29.99 19.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.569 0.7 . . . . 0.0 109.832 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.48 145.13 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.926 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.1 159.09 15.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 m -53.41 -42.64 67.22 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.335 0.397 . . . . 0.0 111.67 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -45.61 50.0 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.485 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 14.7 m -52.03 -53.04 46.61 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.527 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 9.6 ptm -59.09 -49.8 76.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.933 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.727 HG22 ' HB ' ' A' ' 64' ' ' VAL . 97.7 t -61.82 -26.22 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.2 -65.73 0.81 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.667 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 19' ' ' ILE . 20.3 t -89.27 -19.83 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.138 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 44' ' ' MET . 28.0 t -79.97 -22.0 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.661 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -76.39 -30.93 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 167.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.81 -25.34 67.44 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.552 168.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.28 -36.28 27.23 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.599 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.6 pt-20 -64.04 -45.76 87.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.634 0.73 . . . . 0.0 109.586 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.645 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 42.2 mt-10 -75.13 -21.47 58.83 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.246 -171.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -77.35 -4.84 47.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.214 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.07 16.66 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 59.13 51.54 6.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.601 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 52' ' ' GLU . 8.0 p -133.07 155.43 41.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -134.91 111.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.555 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.675 HD11 HG22 ' A' ' 64' ' ' VAL . 14.6 pt -104.9 163.35 17.35 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.567 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.6 Cg_exo -61.59 136.02 60.37 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 121.937 1.758 . . . . 0.0 112.019 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.6 -52.91 34.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.389 0.614 . . . . 0.0 111.075 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 6.1 p-10 -71.59 -18.32 62.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.482 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.667 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.8 t0 -75.2 -22.57 57.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.387 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' HG22 ' A' ' 45' ' ' VAL . 61.7 t -67.18 -43.79 88.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.547 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.97 -14.25 60.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.086 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 39.4 t30 -73.81 -40.62 63.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.043 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.5 pp -79.26 134.35 36.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.344 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.17 -1.02 27.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.305 -171.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.508 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 44.3 p -131.8 149.13 52.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.176 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -69.88 -21.27 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 109.745 177.355 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -75.53 -39.51 34.98 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.573 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.08 -35.44 79.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.492 0.663 . . . . 0.0 109.215 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -58.4 -46.42 86.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.326 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.774 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.12 -51.84 58.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.946 -174.604 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.662 ' HD3' HD12 ' A' ' 78' ' ' LEU . 34.1 mmtp -57.26 -37.81 72.91 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.532 0.52 . . . . 0.0 110.848 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.477 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 35.5 t80 -63.07 -43.57 98.19 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.269 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -65.31 -48.15 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.159 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 8' ' ' ILE . 96.8 mt -56.04 -46.17 78.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.587 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -71.7 -6.27 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -128.91 1.55 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 8.6 pt20 -68.65 155.87 39.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.885 -0.143 . . . . 0.0 111.082 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.988 177.163 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 mtm . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.09 43.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.42 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.47 122.74 43.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -85.15 -161.67 0.62 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.911 -178.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.543 ' H ' HG22 ' A' ' 4' ' ' THR . 49.0 tt0 -59.95 -55.67 31.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.35 -39.87 89.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.67 -53.57 49.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.409 0.623 . . . . 0.0 110.53 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.871 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.53 -30.23 46.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.086 -177.184 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -62.38 -39.48 84.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.766 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.45 97.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.59 -47.41 84.09 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.992 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.8 -39.07 90.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.041 0.448 . . . . 0.0 109.807 177.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.09 -55.73 31.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.218 177.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.46 -41.01 52.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.919 0.866 . . . . 0.0 109.832 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' A' ' 51' ' ' ALA . 9.4 mm -64.2 -57.84 9.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.56 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.846 HG11 HD12 ' A' ' 37' ' ' LEU . 4.2 t -72.05 -23.89 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.446 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -59.48 -30.33 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.612 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.77 -20.6 49.5 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.406 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.629 HD11 ' HB ' ' A' ' 47' ' ' VAL . 47.4 mt -90.47 -54.23 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.929 -175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.06 -93.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.29 0.07 OUTLIER Glycine 0 CA--C 1.522 0.504 0 C-N-CA 119.189 -1.482 . . . . 0.0 115.471 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.836 HG13 HD13 ' A' ' 37' ' ' LEU . 17.5 mm -86.68 124.14 69.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 118.124 0.962 . . . . 0.0 108.608 166.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.55 155.3 42.79 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.736 2.291 . . . . 0.0 112.034 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.787 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 90.9 t -57.54 -40.9 77.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.761 -173.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.28 -16.53 52.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.875 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' A' ' 22' ' ' ILE . 24.5 t70 -80.65 -15.51 56.38 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.739 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 13' ' ' ALA . 57.6 t -65.08 121.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.737 0.78 . . . . 0.0 110.555 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 16.9 mtpp -139.64 146.79 40.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.901 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.561 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 39.1 mt -70.95 -7.22 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 110.19 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 6.3 p-10 -107.99 8.97 28.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.955 -177.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HG2' ' CG1' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -105.85 145.91 30.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.868 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 14.8 m -95.45 138.04 33.68 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -170.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.5 m-85 -58.34 -46.24 86.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.388 0.614 . . . . 0.0 110.229 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.8 p -77.55 -30.76 52.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.717 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' CB ' ' HB2' ' A' ' 32' ' ' SER . 1.4 t70 -92.53 -50.25 5.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.857 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.83 -52.27 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.762 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.846 HD12 HG11 ' A' ' 16' ' ' VAL . 3.3 mm? -67.85 -11.5 58.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.723 -168.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.93 35.75 25.6 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.53 0.519 . . . . 0.0 110.536 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.405 -172.144 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.33 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.195 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 44' ' ' MET . 40.7 m -51.52 -59.48 4.21 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.622 0.576 . . . . 0.0 112.083 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.14 -40.89 77.99 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.961 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.498 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -50.42 -56.6 10.75 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.59 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 11.8 ptm -62.7 -47.0 85.53 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.908 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.0 t -68.18 -24.48 30.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.005 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.49 -66.13 0.81 Allowed 'General case' 0 C--O 1.242 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 111.493 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.662 HG12 HG23 ' A' ' 15' ' ' ILE . 7.8 t -84.28 -24.67 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.509 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.639 ' HA ' HG21 ' A' ' 15' ' ' ILE . 40.5 t -77.47 -20.24 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.419 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.706 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 2.9 t -74.78 -33.16 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -18.35 64.48 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.396 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.988 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -82.29 -38.31 24.55 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.845 176.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.706 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.7 -45.99 77.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.15 -176.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.09 -27.1 66.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.31 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.8 ptp180 -79.2 -7.14 58.0 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.393 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -116.12 15.62 16.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t70 54.71 70.74 0.59 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.732 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.1 p -139.13 165.89 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 57' ' ' VAL . 14.7 pttm -133.78 110.49 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.991 0.424 . . . . 0.0 110.179 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 ' OE1' ' A' ' 52' ' ' GLU . 29.1 pt -121.85 154.63 60.8 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.474 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 141.74 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 111.956 173.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.54 -51.4 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.437 0.637 . . . . 0.0 109.509 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.162 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -34.85 79.15 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.229 0.331 . . . . 0.0 110.963 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.629 ' HB ' HG22 ' A' ' 45' ' ' VAL . 43.0 t -61.5 -39.16 81.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.077 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -18.22 51.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 110.608 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -74.37 -24.15 59.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.152 0.501 . . . . 0.0 109.904 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.734 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -97.57 130.21 44.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.43 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -96.08 -1.56 48.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.543 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.868 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 59.2 p -122.41 146.5 47.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.704 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 2.1 p -65.92 -34.91 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.852 177.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.55 -30.28 76.08 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.89 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 2.3 t70 -68.1 -49.1 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -58.48 -45.73 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.586 0.707 . . . . 0.0 110.099 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.725 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 17.0 m -59.62 -51.7 68.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.628 -177.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -66.09 -30.46 70.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.197 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.62 -46.58 85.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.918 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.542 HG23 HG11 ' A' ' 57' ' ' VAL . 87.4 mt -63.62 -40.98 91.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.219 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 8' ' ' ILE . 92.2 mt -66.64 -26.68 67.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.847 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.03 -34.03 20.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.423 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -119.77 20.73 12.21 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.429 ' HA ' HG23 ' A' ' 57' ' ' VAL . 3.3 pt20 -68.17 148.13 51.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.734 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.044 -177.007 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.45 156.02 16.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 7' ' ' GLU . . . -110.91 122.35 47.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 5' ' ' GLN . 1.2 m -89.33 -158.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.633 ' H ' HG22 ' A' ' 4' ' ' THR . 38.0 tt0 -58.66 -55.62 32.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -54.0 -44.83 71.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 49.7 mm-40 -67.72 -56.29 9.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.399 0.618 . . . . 0.0 111.027 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.681 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -67.44 -30.65 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.139 -174.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.66 -43.53 97.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.446 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.34 92.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.685 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.556 ' HA3' ' CZ ' ' A' ' 55' ' ' PHE . . . -68.5 -44.15 74.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.427 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.37 -46.31 89.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.75 -52.51 63.69 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.766 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.79 -36.48 58.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.646 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.07 -31.89 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.672 -173.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG11 HD12 ' A' ' 37' ' ' LEU . 19.9 t -74.2 -28.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.246 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -59.25 -29.76 67.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.949 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.73 -22.12 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.718 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.1 mt -92.89 -54.02 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.296 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.47 -93.12 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.27 50.99 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.696 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.772 HG13 HD13 ' A' ' 37' ' ' LEU . 22.7 mm -94.08 120.21 65.87 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 162.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.31 153.79 72.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 111.722 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.644 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.4 m -60.66 -17.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.43 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.57 -20.98 53.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.763 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 22' ' ' ILE . 17.7 t0 -106.07 -11.84 15.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.871 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 13' ' ' ALA . 97.3 t -71.85 123.24 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.273 0.558 . . . . 0.0 110.954 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 70' ' ' VAL . 75.8 mttt -148.09 166.36 28.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 24.2 mt -78.35 -3.34 42.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.036 0.446 . . . . 0.0 110.64 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.69 -30.06 15.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.527 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -84.88 139.67 31.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.396 0.617 . . . . 0.0 110.504 -168.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.792 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 16.2 m -85.26 138.61 32.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.834 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.584 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -58.46 -51.24 70.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.303 0.573 . . . . 0.0 110.55 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.6 p -69.8 -33.84 72.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.291 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.76 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 36.2 t70 -92.42 -69.25 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.774 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -69.46 -55.55 9.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.063 -177.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.815 HD12 HG11 ' A' ' 16' ' ' VAL . 3.6 mm? -63.64 -16.64 61.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 63.3 24.5 14.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.774 0.797 . . . . 0.0 109.712 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -92.72 150.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.613 -172.473 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.4 161.63 14.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.652 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 17.8 m -48.3 -50.9 28.3 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.447 0.467 . . . . 0.0 111.544 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -42.6 69.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.722 ' HB2' HG22 ' A' ' 39' ' ' VAL . 15.2 m -50.95 -52.06 46.21 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.466 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.715 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 13.1 ptt? -63.67 -47.84 79.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.797 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 64' ' ' VAL . 80.1 t -57.38 -26.64 26.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.051 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.37 -65.73 0.82 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.958 -0.464 . . . . 0.0 111.185 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 15' ' ' ILE . 21.0 t -87.05 -21.3 7.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.36 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.6 t -79.51 -20.48 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.634 -0.666 . . . . 0.0 110.219 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.639 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.6 t -75.87 -34.64 28.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -59.36 -24.08 63.08 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.99 168.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.12 -33.85 24.23 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.117 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.685 ' O ' HG12 ' A' ' 57' ' ' VAL . 2.5 pt-20 -64.19 -48.12 77.15 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.559 0.695 . . . . 0.0 109.561 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 32.2 mt-10 -72.73 -22.38 60.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.254 -172.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 7.4 ptp180 -80.79 -10.64 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.215 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' CZ ' ' HA3' ' A' ' 11' ' ' GLY . 58.1 m-85 -105.7 4.08 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 57.04 70.93 0.61 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.0 p -132.39 166.67 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 57' ' ' VAL . 4.4 mptt -123.79 110.56 15.06 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.622 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.497 HG13 ' HD2' ' A' ' 60' ' ' PRO . 5.9 tt -134.86 135.46 23.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 0.0 110.588 172.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD2' HG13 ' A' ' 59' ' ' ILE . 18.6 Cg_endo -66.88 150.79 83.08 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.572 2.182 . . . . 0.0 112.849 175.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.7 -48.06 50.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.948 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 1.039 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -53.74 -44.37 69.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.588 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -62.94 -33.89 76.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -171.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.93 ' HB ' HG22 ' A' ' 45' ' ' VAL . 12.0 t -68.37 -41.33 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.841 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 1.039 ' HE3' ' HA ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.29 -0.76 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 122.105 -0.372 . . . . 0.0 111.766 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -91.19 -31.24 16.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.834 0.35 . . . . 0.0 110.302 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 73' ' ' ALA . 2.9 pp -81.63 145.23 30.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.431 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -110.51 -5.19 15.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.897 -172.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.792 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 43.8 p -127.25 153.72 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 31' ' ' LYS . 2.1 p -74.12 -22.4 18.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.47 0.652 . . . . 0.0 110.025 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -73.43 -31.47 60.99 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.182 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.05 -46.2 85.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HA ' HD22 ' A' ' 67' ' ' LEU . . . -57.09 -45.15 83.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.815 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -67.13 -45.52 76.88 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.633 -175.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 1.012 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 5.8 mmpt? -62.53 -31.02 71.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.58 -49.34 48.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 109.918 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.6 mt -58.29 -49.35 82.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 8' ' ' ILE . 73.5 mt -69.45 -20.97 63.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.235 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.4 -21.88 32.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.205 0.526 . . . . 0.0 110.692 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -125.19 22.7 7.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.524 ' HA ' HG23 ' A' ' 57' ' ' VAL . 3.6 pt20 -75.84 140.33 42.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.016 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 O-C-N 123.852 0.72 . . . . 0.0 111.665 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.73 138.38 44.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 111.15 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.21 106.12 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -73.05 -168.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.594 ' H ' HG22 ' A' ' 4' ' ' THR . 13.6 tt0 -53.2 -56.43 16.47 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -171.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.87 -38.39 90.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -67.67 -54.18 21.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.143 0.497 . . . . 0.0 111.124 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.755 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -67.14 -32.74 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.33 -39.37 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.569 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.95 94.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.61 59.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.054 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -61.37 -53.83 51.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.04 -50.6 72.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.934 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -55.29 -35.83 65.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.347 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -81.15 -31.71 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.807 -177.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.811 HG11 HD12 ' A' ' 37' ' ' LEU . 22.4 t -74.61 -26.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 O-C-N 121.915 -0.491 . . . . 0.0 109.69 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.4 -28.62 70.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -66.58 -36.31 82.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.149 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 47' ' ' VAL . 27.3 mt -80.27 -52.61 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.421 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.87 -84.7 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.82 53.63 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.933 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.811 HG13 HD13 ' A' ' 37' ' ' LEU . 22.8 mm -89.43 125.05 62.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 165.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.3 146.57 60.58 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.452 2.101 . . . . 0.0 111.395 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.708 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 31.4 m -54.51 -35.06 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -81.31 -17.79 48.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.836 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HB3' HG23 ' A' ' 22' ' ' ILE . 12.6 t70 -83.35 -22.51 32.82 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.999 0.428 . . . . 0.0 110.603 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 13' ' ' ALA . 72.4 t -62.78 129.18 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.908 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -145.64 159.37 43.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.398 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.512 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.2 mp -77.37 -3.83 42.1 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.981 0.419 . . . . 0.0 110.547 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.12 1.58 24.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.17 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.72 140.44 37.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.683 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.905 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.7 m -87.41 136.83 32.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.463 -170.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.638 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.17 -49.79 76.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 110.196 177.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.5 p -69.54 -34.32 74.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 9.5 t70 -91.59 -68.68 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.307 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.8 m-20 -72.92 -52.38 14.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.895 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.811 HD12 HG11 ' A' ' 16' ' ' VAL . 3.7 mm? -66.35 -10.45 43.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.127 -172.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 61.38 31.44 19.2 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.803 0.69 . . . . 0.0 109.944 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.5 OUTLIER -102.66 153.13 5.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.418 -171.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.7 170.89 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.605 170.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 44' ' ' MET . 24.8 t -57.33 -59.77 4.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.421 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.0 tm? -68.53 -39.15 81.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.372 -176.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.504 ' HB2' HG22 ' A' ' 39' ' ' VAL . 13.3 m -48.87 -53.53 19.1 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.008 0.432 . . . . 0.0 111.637 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.617 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 20.3 ptt? -65.27 -42.83 92.81 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.574 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 98.7 t -60.18 -26.19 35.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.07 0.462 . . . . 0.0 110.389 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.12 -65.39 0.85 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.856 -0.528 . . . . 0.0 111.413 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' HB ' HD11 ' A' ' 19' ' ' ILE . 15.8 t -85.72 -23.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.137 -173.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.2 t -79.32 -23.21 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.481 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.737 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.3 t -76.63 -31.8 20.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 109.329 169.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.64 -25.85 67.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.379 0.609 . . . . 0.0 109.789 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.07 -37.7 26.0 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.972 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.9 pt-20 -61.83 -51.63 67.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.484 0.659 . . . . 0.0 109.643 -175.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.636 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.7 mt-10 -71.35 -22.85 61.85 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.649 -171.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.2 ptm180 -75.01 -19.37 60.11 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -97.91 6.92 47.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t0 60.54 57.94 2.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.656 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.766 HG11 HG23 ' A' ' 77' ' ' ILE . 13.3 p -134.3 161.65 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.201 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 58' ' ' LYS . 13.4 tptp -127.82 112.93 15.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.111 175.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 tt -118.12 117.32 35.23 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.819 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.58 138.88 39.47 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.448 2.099 . . . . 0.0 111.726 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 5.2 p-10 -58.33 -29.55 66.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.529 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.632 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 32.7 t70 -67.53 -25.31 65.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.023 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.81 -37.94 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.642 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 46.7 t -63.54 -53.86 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.045 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.632 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -63.36 -9.95 14.42 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 176.315 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.5 -41.36 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.773 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 1.2 pp -67.6 137.1 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.453 0.644 . . . . 0.0 110.988 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -96.21 -20.68 18.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.195 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.905 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 14.8 p -119.95 154.55 34.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.543 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.4 p -63.53 -31.15 51.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 109.999 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -63.72 -33.79 88.2 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.523 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 51.1 m-20 -57.92 -52.73 64.29 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -57.49 -52.21 66.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.743 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.769 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.0 m -56.94 -52.92 63.27 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.019 -173.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HA ' HD12 ' A' ' 78' ' ' LEU . 4.2 tppp? -65.98 -31.34 72.19 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.592 0.234 . . . . 0.0 110.452 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.94 -43.07 84.16 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.257 0.551 . . . . 0.0 109.619 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.766 HG23 HG11 ' A' ' 57' ' ' VAL . 46.5 mt -59.99 -46.57 93.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.239 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 74' ' ' THR . 95.0 mt -62.35 -28.03 69.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.109 -175.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.69 -39.62 44.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.093 0.473 . . . . 0.0 111.084 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.471 ' O ' HG23 ' A' ' 57' ' ' VAL . 69.0 m-70 -105.62 21.69 16.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.272 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -79.98 175.65 10.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.915 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.787 176.283 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' HA ' ' OE1' ' A' ' 81' ' ' GLN . . . -69.97 111.9 5.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.164 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 7' ' ' GLU . . . -116.41 147.16 41.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.297 -172.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -90.4 -175.34 4.45 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.116 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 8' ' ' ILE . 12.7 tt0 -50.49 -56.3 12.16 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.26 -41.24 88.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 3' ' ' ALA . 85.1 tt0 -74.69 -45.92 41.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.879 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.92 -33.97 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.36 -39.75 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.983 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.37 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.14 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.5 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.48 -45.4 78.49 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.992 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.34 -40.01 96.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.634 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -54.89 41.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 41.9 tt0 -52.9 -42.44 65.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.432 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.934 HG13 ' HB2' ' A' ' 51' ' ' ALA . 8.0 mm -62.61 -53.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.292 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 37' ' ' LEU . 13.2 t -71.2 -23.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.461 . . . . 0.0 110.303 -177.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -65.85 -19.68 65.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.009 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 5.1 mm-40 -83.16 -29.66 28.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.145 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 47' ' ' VAL . 32.3 mt -84.86 -53.02 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.631 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.34 -86.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.05 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.35 56.84 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.573 -1.299 . . . . 0.0 114.492 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.842 HG13 HD13 ' A' ' 37' ' ' LEU . 12.8 mm -87.88 124.81 66.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 164.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 147.95 49.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 111.757 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.634 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 79.2 t -54.61 -40.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.645 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -75.41 -17.02 60.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.298 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 22' ' ' ILE . 1.6 t70 -90.09 -5.71 56.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.142 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 13' ' ' ALA . 46.0 t -68.83 116.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.549 0.69 . . . . 0.0 109.696 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 13.6 mtpp -132.78 144.89 50.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.454 -171.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.2 mp -74.08 -3.43 29.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.873 0.368 . . . . 0.0 110.997 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 5.8 p-10 -108.03 -7.91 16.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.762 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.93 140.0 30.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.442 -177.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.821 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.2 m -87.98 135.77 33.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.448 -170.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -56.67 -48.16 78.22 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.277 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.5 p -71.8 -33.65 68.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.201 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 5.0 t70 -92.13 -65.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.199 0.523 . . . . 0.0 111.651 -173.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.1 m-20 -75.82 -52.76 9.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.673 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.004 HD12 HG11 ' A' ' 16' ' ' VAL . 2.9 mm? -66.19 -14.54 62.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.791 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 61.76 32.91 18.13 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.856 0.836 . . . . 0.0 109.38 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.4 OUTLIER -98.81 146.96 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.809 -171.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 8.2 m-20 -95.92 173.84 7.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.674 ' HB3' ' HD3' ' A' ' 65' ' ' LYS . 13.6 m -57.25 -56.32 23.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.565 . . . . 0.0 110.471 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -65.59 -40.49 92.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.583 ' HB2' HG22 ' A' ' 39' ' ' VAL . 14.7 m -50.59 -54.72 20.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 15.3 ptt? -66.36 -40.96 90.11 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.646 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.64 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 82.5 t -63.09 -24.95 37.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.704 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -74.32 -66.41 0.73 Allowed 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.74 -0.6 . . . . 0.0 111.659 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG12 HG23 ' A' ' 15' ' ' ILE . 11.8 t -91.12 -22.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.578 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 44' ' ' MET . 21.5 t -80.46 -21.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.619 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.1 t -73.95 -33.57 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.609 0.718 . . . . 0.0 109.302 167.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.36 66.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.339 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.934 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -81.14 -45.75 15.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.671 ' O ' HG12 ' A' ' 57' ' ' VAL . 8.1 pt-20 -59.31 -49.11 79.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.034 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.8 pt-20 -62.68 -30.67 71.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.724 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -78.7 -5.0 51.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.275 0.56 . . . . 0.0 110.343 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 68.7 m-85 -114.2 22.38 13.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.345 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 71.75 17.47 5.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.507 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.678 HG11 HG23 ' A' ' 77' ' ' ILE . 9.6 p -114.49 158.29 14.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.075 -0.391 . . . . 0.0 110.435 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 50.1 mtpt -134.06 111.3 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.449 ' HB ' ' HE2' ' A' ' 76' ' ' TYR . 21.4 pt -108.53 163.36 17.14 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.825 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.0 Cg_exo -65.3 129.61 23.21 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.942 1.761 . . . . 0.0 111.623 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.79 -49.2 63.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 110.06 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.41 -19.52 64.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.275 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.825 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 2.7 t0 -74.0 -38.08 64.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.652 ' HA ' HD21 ' A' ' 67' ' ' LEU . 22.2 t -60.12 -42.75 91.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HD3' ' HB3' ' A' ' 41' ' ' SER . 17.6 tptp -59.91 -31.08 69.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.795 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.63 -26.99 40.98 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.154 -0.341 . . . . 0.0 111.255 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.717 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -83.7 136.58 34.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.292 -178.518 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.36 -22.77 22.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.131 -173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.821 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 32.8 p -120.2 156.98 30.05 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.887 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -67.72 -36.96 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.1 -41.51 96.59 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.025 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.96 -50.73 72.19 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -54.79 -50.28 68.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.58 0.705 . . . . 0.0 110.936 176.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.795 HG23 HD12 ' A' ' 8' ' ' ILE . 12.4 m -58.98 -49.49 77.69 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.686 -174.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HD2' HD12 ' A' ' 78' ' ' LEU . 7.6 tptm -65.95 -38.65 89.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.449 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 59.3 t80 -56.91 -43.34 81.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.678 HG23 HG11 ' A' ' 57' ' ' VAL . 82.0 mt -65.18 -49.9 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.536 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 8' ' ' ILE . 91.5 mt -54.15 -44.99 71.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.21 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -86.68 -3.63 59.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.475 ' O ' HG23 ' A' ' 57' ' ' VAL . 29.9 m-70 -124.69 15.22 8.73 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.244 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 2' ' ' ALA . 10.5 pt20 -86.15 153.99 21.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.546 0.213 . . . . 0.0 111.498 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.077 176.293 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.0 167.17 10.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.98 135.46 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -86.83 -167.17 1.79 Allowed 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.565 ' H ' HG22 ' A' ' 4' ' ' THR . 24.8 tt0 -58.99 -55.71 31.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -167.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -32.22 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.868 0.366 . . . . 0.0 111.144 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.05 -47.65 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.848 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.35 -33.11 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.11 -43.02 95.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.1 95.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.937 0.398 . . . . 0.0 110.875 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.806 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.51 -33.03 75.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.341 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -68.62 -48.64 63.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.13 -46.77 85.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.58 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -52.39 -36.74 54.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.496 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.59 -35.6 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.81 -174.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.724 HG11 HD12 ' A' ' 37' ' ' LEU . 36.2 t -71.17 -23.97 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 109.776 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -62.6 -24.57 67.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.28 -38.48 63.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 109.958 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.717 HD11 ' HB ' ' A' ' 47' ' ' VAL . 24.9 mt -71.04 -53.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.694 -174.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.24 -86.14 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.452 -175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 64.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.685 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 37' ' ' LEU . 23.2 mm -99.61 131.35 24.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 164.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.99 148.34 48.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.465 2.11 . . . . 0.0 111.633 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.694 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 93.9 t -59.88 -38.57 76.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.15 0.5 . . . . 0.0 111.304 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -76.71 -18.31 58.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' A' ' 22' ' ' ILE . 11.2 t70 -83.23 -22.74 33.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.68 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 13' ' ' ALA . 75.2 t -66.4 122.28 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.572 0.701 . . . . 0.0 110.729 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 82.1 mttt -144.04 169.76 17.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.207 -176.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.751 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.6 mp -81.57 -2.5 50.25 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.494 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -110.38 2.01 18.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.83 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.05 141.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.725 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 24.9 m -88.4 136.46 32.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.881 0.372 . . . . 0.0 111.658 -170.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.58 -47.83 84.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.535 0.684 . . . . 0.0 110.426 178.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 38.9 p -72.95 -33.66 66.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.354 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.725 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.5 t70 -91.67 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 111.539 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -49.11 18.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.287 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.798 HD13 HG13 ' A' ' 22' ' ' ILE . 3.5 mm? -70.23 -14.73 62.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.659 -176.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.49 31.88 20.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.847 0.832 . . . . 0.0 110.129 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -97.66 151.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.881 -169.087 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.4 m-20 -104.0 166.25 10.53 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 p -51.23 -55.65 16.98 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.709 0.631 . . . . 0.0 111.32 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -62.96 -48.97 76.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.598 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.606 ' HB2' ' H ' ' A' ' 40' ' ' ASP . 13.0 m -50.94 -54.29 25.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.646 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.671 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 4.8 ptm -59.74 -49.43 77.78 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.698 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.5 t -68.81 -22.31 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.16 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.82 -66.2 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.661 -0.649 . . . . 0.0 111.743 -174.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 19' ' ' ILE . 16.6 t -87.88 -21.74 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.052 -173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.9 t -78.82 -26.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.286 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.69 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -72.72 -35.04 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.01 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.23 0.538 . . . . 0.0 109.918 171.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -83.49 -39.6 20.3 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.131 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 4.5 pt-20 -59.81 -48.31 82.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.494 0.664 . . . . 0.0 109.559 -175.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.62 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.2 mt-10 -64.56 -33.64 76.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.169 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -81.31 -6.03 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.374 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.806 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 62.1 m-85 -105.25 6.71 33.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 170.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.38 68.36 0.77 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.553 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -140.59 161.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.353 174.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 57' ' ' VAL . 25.3 tptp -122.88 110.56 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 169.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.5 pt -119.08 151.35 50.49 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.76 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.1 Cg_exo -61.79 121.21 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.991 1.794 . . . . 0.0 110.847 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.06 -39.29 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 0.0 110.215 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.33 -36.36 81.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.76 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -66.91 -34.79 78.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.315 -174.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.698 ' HB ' HG22 ' A' ' 45' ' ' VAL . 21.3 t -58.42 -36.45 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.165 0.507 . . . . 0.0 110.657 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -75.19 -28.46 60.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.895 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.49 -21.87 44.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.691 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -84.71 123.48 30.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 0.0 110.585 177.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -82.3 -14.68 54.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.009 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 73.4 p -119.71 148.74 43.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.33 -36.16 76.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.041 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -66.97 -30.21 75.7 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.953 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.531 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 4.0 t70 -61.6 -40.68 95.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -67.97 -39.46 83.33 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.114 176.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -65.15 -51.81 58.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.007 -172.198 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.42 -37.03 79.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.246 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 14.6 t80 -63.34 -38.61 91.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.396 0.617 . . . . 0.0 110.706 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.501 HG23 HG11 ' A' ' 57' ' ' VAL . 52.5 mt -68.99 -33.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.533 0.682 . . . . 0.0 110.261 175.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.848 HD21 HG21 ' A' ' 8' ' ' ILE . 96.8 mt -77.97 -35.51 50.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.416 -172.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.9 -4.88 58.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.6 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -123.44 15.01 9.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.581 ' HA ' HG23 ' A' ' 57' ' ' VAL . 14.0 pt20 -73.93 157.82 35.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.698 0.285 . . . . 0.0 111.557 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.554 177.654 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.3 108.38 13.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 7' ' ' GLU . . . -91.33 138.38 31.63 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.183 -165.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -88.42 -168.87 2.34 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 174.488 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.714 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.3 tt0 -55.61 -55.59 30.31 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 9' ' ' VAL . 9.2 pt-20 -64.5 -39.17 93.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.899 0.381 . . . . 0.0 111.566 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 42.3 mt-10 -64.34 -54.35 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.0 110.885 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.768 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.67 -31.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.689 -177.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -69.71 -31.73 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.253 -177.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.82 74.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.63 78.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.774 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -72.32 -49.39 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' CB ' HG21 ' A' ' 27' ' ' VAL . . . -52.52 -53.63 43.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -50.23 -42.45 51.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.117 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.953 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.38 -27.94 6.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.536 -169.485 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.85 HG11 HD12 ' A' ' 37' ' ' LEU . 45.8 t -76.05 -24.76 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -68.05 -21.49 65.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.043 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 5.2 mm-40 -70.54 -29.07 65.45 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.349 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 47' ' ' VAL . 39.3 mt -92.88 -55.29 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.553 -171.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.13 -89.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.205 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.52 44.11 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.206 -1.473 . . . . 0.0 115.117 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.803 HG13 HD13 ' A' ' 37' ' ' LEU . 14.2 mm -78.24 124.82 85.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.8 142.72 83.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.274 1.982 . . . . 0.0 111.152 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.449 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 34.6 m -59.2 -20.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.976 0.417 . . . . 0.0 111.657 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.82 -18.67 46.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.249 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 22' ' ' ILE . 1.5 t70 -100.77 -7.91 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.647 0.26 . . . . 0.0 111.329 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 13' ' ' ALA . 84.6 t -68.21 118.2 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.325 0.583 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 70' ' ' VAL . 49.6 mtpt -143.17 160.33 40.63 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.207 -170.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.616 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.0 mp -74.14 -3.75 31.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.091 0.472 . . . . 0.0 110.864 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.61 -15.58 18.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.904 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.83 142.94 28.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.427 -173.389 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 16.0 t -84.4 134.24 34.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.889 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.542 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.03 -49.8 76.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.529 0.68 . . . . 0.0 109.843 177.146 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.1 p -71.95 -31.82 66.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.179 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.9 t70 -92.68 -68.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.896 -175.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -77.08 -45.24 27.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.976 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.85 HD12 HG11 ' A' ' 16' ' ' VAL . 4.0 mm? -66.73 -16.26 64.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.616 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 57.29 42.52 25.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.872 0.844 . . . . 0.0 108.83 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -110.64 144.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.638 -173.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 166.61 15.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 8.2 m -54.77 -52.29 63.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.586 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -72.62 -42.02 64.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.216 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -48.11 -55.23 10.77 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 123.29 0.369 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.588 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 19.9 ptt? -64.35 -48.6 74.91 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.569 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.774 HG22 ' HB ' ' A' ' 64' ' ' VAL . 55.7 t -54.78 -28.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.854 0.359 . . . . 0.0 111.209 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.6 -65.52 0.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.85 -0.531 . . . . 0.0 111.565 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.765 ' HB ' HD11 ' A' ' 19' ' ' ILE . 15.2 t -85.36 -22.61 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.645 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 44' ' ' MET . 55.6 t -78.83 -25.51 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.521 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.677 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.92 -36.25 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.18 -23.47 66.63 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.232 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.953 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -83.34 -35.94 24.79 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.911 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -69.94 -48.62 57.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.42 -23.57 66.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.848 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 4.4 ptm180 -71.96 -10.71 60.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.478 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -111.09 18.42 19.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.913 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 68.89 25.63 6.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.93 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.717 HG11 HG23 ' A' ' 77' ' ' ILE . 11.5 p -115.16 151.25 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -135.08 124.41 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.196 0.522 . . . . 0.0 110.905 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 64' ' ' VAL . 7.0 pt -116.02 166.23 12.87 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.93 125.67 17.08 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 121.401 1.401 . . . . 0.0 110.446 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.57 -42.93 24.76 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.479 0.657 . . . . 0.0 110.861 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.1 t70 -63.08 -19.71 64.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.656 -176.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.92 -25.4 40.53 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.377 -0.202 . . . . 0.0 111.517 -173.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.774 ' HB ' HG22 ' A' ' 45' ' ' VAL . 43.8 t -64.77 -33.38 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.588 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 3.5 tmmm? -66.1 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.403 171.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -71.1 -26.82 63.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.954 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 73' ' ' ALA . 1.1 pp -94.63 134.65 36.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.388 0.613 . . . . 0.0 110.751 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -97.36 -6.58 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.795 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 69.6 p -129.69 152.24 49.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.482 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -70.55 -22.27 23.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 109.831 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.79 -36.79 41.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.586 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 6.0 t0 -58.62 -42.55 88.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.622 0.725 . . . . 0.0 109.082 176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HA ' HD22 ' A' ' 67' ' ' LEU . . . -60.19 -48.26 82.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.921 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.742 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -63.08 -50.65 69.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.547 -172.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.545 ' HD3' HD12 ' A' ' 78' ' ' LEU . 23.7 mmtp -58.96 -39.67 82.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.124 0.265 . . . . 0.0 111.251 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 42.2 t80 -62.93 -44.59 95.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.026 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.717 HG23 HG11 ' A' ' 57' ' ' VAL . 61.2 mt -61.76 -44.56 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.734 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.768 HD21 HG21 ' A' ' 8' ' ' ILE . 92.3 mt -65.55 -40.95 93.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.322 -174.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -75.07 -32.51 61.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.927 0.394 . . . . 0.0 111.669 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.52 22.54 15.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -77.02 -172.65 2.43 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.762 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.076 -179.085 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.8 128.56 42.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 173.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.84 138.66 48.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.237 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -84.78 -171.84 3.85 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.211 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' H ' HG22 ' A' ' 4' ' ' THR . 19.2 tt0 -55.73 -55.97 25.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.4 pm0 -67.64 -36.37 80.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.682 0.277 . . . . 0.0 111.546 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.47 -52.71 56.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.326 0.584 . . . . 0.0 110.613 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.869 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -69.91 -33.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.012 -178.457 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -59.99 -41.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.78 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.15 94.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.507 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.93 96.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.129 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -47.56 82.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.02 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.42 -50.13 70.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.543 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.64 -36.42 62.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.828 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.802 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.52 -32.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.807 -174.077 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.754 HG11 HD12 ' A' ' 37' ' ' LEU . 21.2 t -72.31 -24.27 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 121.63 -0.669 . . . . 0.0 109.981 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -62.56 -28.69 70.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.703 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.68 -23.65 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.356 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 47' ' ' VAL . 44.5 mt -86.78 -52.98 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.995 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.46 -75.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.71 53.73 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.874 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.807 HG13 HD13 ' A' ' 37' ' ' LEU . 11.1 mm -80.94 129.94 65.56 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 165.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.672 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 7.3 Cg_endo -52.04 140.34 49.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.322 2.014 . . . . 0.0 111.187 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 23.3 m -57.34 -26.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 mm-40 -80.47 -18.74 47.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.672 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 1.8 t70 -95.23 -8.48 35.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.587 -172.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 13' ' ' ALA . 53.1 t -68.5 111.22 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.611 0.72 . . . . 0.0 110.052 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -132.06 162.13 31.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.631 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 23.8 mt -74.64 -5.61 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.136 0.493 . . . . 0.0 110.378 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.88 -19.2 19.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.022 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -93.53 143.92 25.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.935 -175.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.922 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.0 m -90.39 135.04 33.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.294 -173.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.7 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.6 m-85 -54.73 -52.52 62.21 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 110.206 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -60.54 -43.95 96.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.757 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.14 -68.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.142 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.97 -45.91 83.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.833 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.807 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -72.98 -11.57 60.62 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t0 56.55 43.58 25.49 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.968 0.792 . . . . 0.0 108.896 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.492 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -105.61 146.33 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.417 -172.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 44' ' ' MET . 3.7 m-20 -91.79 153.44 19.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.457 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 50.6 m -55.87 -41.6 74.61 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.601 0.563 . . . . 0.0 111.677 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -72.48 -43.4 63.74 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.568 ' OG ' HG23 ' A' ' 19' ' ' ILE . 1.9 t -58.99 -49.48 77.73 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.974 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.541 ' HE2' HG12 ' A' ' 64' ' ' VAL . 13.6 ptm -57.1 -49.04 77.11 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.883 HG22 ' HB ' ' A' ' 64' ' ' VAL . 79.1 t -60.14 -25.92 34.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.295 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.87 -64.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.911 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' A' ' 19' ' ' ILE . 11.6 t -85.0 -22.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.349 -173.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 44' ' ' MET . 49.4 t -78.38 -28.15 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.134 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.687 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 12.7 t -71.36 -33.1 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.561 0.696 . . . . 0.0 109.3 169.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -60.82 -26.7 67.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.095 0.474 . . . . 0.0 110.05 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.802 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.3 -38.1 24.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.892 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 9.2 pt-20 -63.86 -46.49 84.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.8 mt-10 -70.19 -26.4 63.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.252 -173.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -77.8 -6.15 53.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 67.1 m-85 -111.47 19.19 18.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 174.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.59 40.21 6.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.632 174.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.9 p -127.86 159.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 173.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.36 112.85 10.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.01 0.433 . . . . 0.0 110.095 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.542 HD11 HG22 ' A' ' 64' ' ' VAL . 14.2 pt -107.83 163.97 15.8 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.49 133.62 40.81 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.574 1.516 . . . . 0.0 109.771 170.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.63 -34.59 67.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 8.4 t70 -69.43 -18.24 63.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.818 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 66' ' ' ASN . 4.6 t70 -70.15 -31.01 68.31 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.231 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.883 ' HB ' HG22 ' A' ' 45' ' ' VAL . 41.1 t -62.42 -51.51 71.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.448 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -4.98 52.07 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.163 0.506 . . . . 0.0 111.142 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 2.5 t-20 -73.13 -39.08 66.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -89.69 147.04 24.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.216 175.471 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -108.27 -13.43 14.9 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.536 -174.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.922 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 61.4 p -108.2 151.66 25.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.7 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -70.03 -29.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.589 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -66.75 -30.75 76.73 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.744 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 4.8 t70 -65.59 -53.52 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.817 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -53.64 -50.52 65.54 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.425 0.631 . . . . 0.0 110.717 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 21.7 m -55.07 -52.82 62.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.98 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.482 ' HD2' HD12 ' A' ' 78' ' ' LEU . 13.3 tptp -64.68 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.15 -46.26 90.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.136 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.609 HG23 HG11 ' A' ' 57' ' ' VAL . 90.8 mt -60.68 -46.43 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.322 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 8' ' ' ILE . 83.6 mt -55.14 -42.75 73.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.683 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.1 -4.97 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -128.47 7.52 5.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.86 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 78' ' ' LEU . 8.6 pt20 -77.47 157.46 30.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.433 0.159 . . . . 0.0 110.728 -176.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.492 176.81 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.9 mmm . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.48 111.77 8.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.585 ' HB1' ' HB2' ' A' ' 7' ' ' GLU . . . -115.65 145.53 42.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.612 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -87.7 -165.17 1.23 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 173.129 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.494 ' H ' HG22 ' A' ' 4' ' ' THR . 16.0 tt0 -61.29 -55.67 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -63.28 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.541 -173.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.585 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 3.4 mp0 -68.16 -51.43 46.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.76 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -66.35 -32.53 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.902 -178.022 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.96 -42.69 95.74 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.35 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.523 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.9 -49.05 61.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.7 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -42.32 88.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.67 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.64 -56.71 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.248 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -49.93 -44.52 50.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.836 0.826 . . . . 0.0 110.051 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.824 HG13 ' HB2' ' A' ' 51' ' ' ALA . 15.3 mm -60.88 -54.49 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.231 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.734 HG11 HD12 ' A' ' 37' ' ' LEU . 16.1 t -69.23 -24.2 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.583 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -63.33 -27.04 69.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.7 -30.66 62.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.888 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 47' ' ' VAL . 42.6 mt -84.51 -54.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.323 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -122.78 -84.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.682 -171.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.74 43.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.44 -1.362 . . . . 0.0 114.54 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.802 HG13 HD13 ' A' ' 37' ' ' LEU . 18.3 mm -82.76 126.69 72.52 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 118.158 0.979 . . . . 0.0 108.655 167.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.747 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.7 Cg_endo -56.43 145.55 78.71 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.244 1.963 . . . . 0.0 111.48 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.67 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 27.0 m -56.61 -32.97 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.07 -17.12 51.19 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.558 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.747 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 16.1 t70 -87.28 -14.03 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.635 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' A' ' 13' ' ' ALA . 91.3 t -69.73 122.81 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.321 0.581 . . . . 0.0 110.443 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.511 ' O ' HG13 ' A' ' 70' ' ' VAL . 58.7 mtpt -145.78 164.16 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -171.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.3 mp -78.28 -2.72 39.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.69 -25.62 16.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.983 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -91.14 142.53 27.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.327 0.584 . . . . 0.0 110.842 -169.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.641 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 3.6 m -82.82 136.45 34.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.03 -172.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.52 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.67 -43.29 94.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.328 0.585 . . . . 0.0 110.117 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.9 p -72.69 -38.96 67.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.636 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.1 t70 -92.01 -60.65 1.8 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.896 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.05 -50.05 10.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.251 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.802 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -66.25 -28.12 68.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 t0 60.12 67.92 0.82 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.739 0.78 . . . . 0.0 109.873 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.6 OUTLIER -128.04 155.46 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.682 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 42.2 m-20 -103.95 168.15 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.455 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 34.0 t -49.4 -57.58 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.721 0.638 . . . . 0.0 111.38 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.81 -40.39 83.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.017 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.726 ' HB2' HG22 ' A' ' 39' ' ' VAL . 4.6 m -51.68 -53.81 34.95 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.855 0.36 . . . . 0.0 111.149 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.564 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 14.4 ptt? -65.7 -49.89 66.87 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.759 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.894 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.31 -23.3 29.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.088 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.92 -65.41 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.934 -0.479 . . . . 0.0 111.208 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.772 HG12 HG23 ' A' ' 15' ' ' ILE . 11.6 t -86.12 -25.17 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.893 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HA ' HG21 ' A' ' 15' ' ' ILE . 21.6 t -80.27 -20.17 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.659 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.7 t -77.71 -33.36 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.552 0.691 . . . . 0.0 109.233 166.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.32 -19.9 62.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.399 0.618 . . . . 0.0 109.65 168.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.824 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -85.93 -33.39 21.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.966 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.754 ' O ' HG12 ' A' ' 57' ' ' VAL . 3.6 pt-20 -65.68 -50.85 63.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.585 -175.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.671 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 39.5 mt-10 -56.67 -37.53 70.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.44 -175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.3 ptp180 -72.2 -7.79 51.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.295 -174.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.56 10.47 21.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.589 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 63.22 39.28 9.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.643 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -114.84 165.49 9.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 57' ' ' VAL . 61.2 tttp -126.97 111.27 13.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.309 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 tt -131.71 120.32 17.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.136 0.493 . . . . 0.0 110.539 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 51.4 Cg_exo -56.8 148.78 64.25 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.038 2.492 . . . . 0.0 113.299 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.21 -47.24 65.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.05 -33.76 73.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.919 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -31.11 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.772 -174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.894 ' HB ' HG22 ' A' ' 45' ' ' VAL . 11.1 t -73.34 -42.26 57.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.564 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 12.6 tmtt? -55.95 -40.62 73.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.921 171.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -76.5 -2.79 33.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -172.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 4.6 pp -107.03 139.47 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.093 0.473 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -114.24 1.06 14.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.668 -172.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 28.5 p -128.52 153.42 47.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 172.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 28' ' ' LYS . 1.1 p -68.88 -21.79 25.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -70.9 -32.24 66.55 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.95 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 67' ' ' LEU . 13.1 m-20 -57.15 -51.21 70.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.796 0.332 . . . . 0.0 110.19 174.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.47 72.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.193 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.733 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -61.63 -53.1 60.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.686 -174.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.488 ' HD2' HD12 ' A' ' 78' ' ' LEU . 3.7 tptp -62.98 -31.77 72.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.616 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.56 -45.96 77.63 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.479 ' HA ' HG21 ' A' ' 57' ' ' VAL . 52.4 mt -63.66 -46.25 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.224 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.76 HD21 HG21 ' A' ' 8' ' ' ILE . 97.6 mt -61.07 -25.36 66.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.78 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.75 -40.3 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' C ' HG23 ' A' ' 57' ' ' VAL . 95.0 m-70 -101.49 21.31 14.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -171.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -89.75 161.25 16.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.049 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.185 171.754 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.757 0.313 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.8 128.05 48.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.131 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.94 117.89 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -81.31 -175.44 5.47 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -176.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.563 ' H ' HG22 ' A' ' 4' ' ' THR . 12.3 tt0 -47.24 -55.32 8.85 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -169.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 1.1 pm0 -71.52 -36.4 71.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.741 0.305 . . . . 0.0 111.524 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -70.73 -47.53 59.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 110.145 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.868 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.76 -31.13 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.47 -39.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.01 97.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 110.402 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.41 -43.12 79.74 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.705 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.74 -48.56 80.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.675 ' HA ' HG21 ' A' ' 27' ' ' VAL . . . -51.92 -50.09 61.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.366 0.603 . . . . 0.0 111.359 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.88 -30.64 71.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.784 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -86.58 -34.73 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.026 -177.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.812 HG11 HD12 ' A' ' 37' ' ' LEU . 15.7 t -69.62 -24.86 27.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.479 0.657 . . . . 0.0 109.449 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.07 -24.06 66.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB2' HG11 ' A' ' 47' ' ' VAL . 3.8 mm-40 -72.94 -21.38 60.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 47' ' ' VAL . 46.0 mt -93.56 -52.84 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.589 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.34 -88.58 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.1 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.363 -1.399 . . . . 0.0 114.907 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.788 HG13 HD13 ' A' ' 37' ' ' LEU . 14.6 mm -79.68 125.97 81.42 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.5 Cg_endo -56.02 148.32 58.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.3 2.0 . . . . 0.0 111.307 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 32.7 m -62.67 -19.25 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 -175.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.83 -19.75 47.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 22' ' ' ILE . 40.8 t0 -98.88 -21.25 16.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.576 -171.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 13' ' ' ALA . 83.5 t -64.52 118.72 7.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.298 0.57 . . . . 0.0 110.826 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' O ' HG13 ' A' ' 70' ' ' VAL . 58.5 mtpt -147.55 172.65 13.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.985 -172.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.484 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.3 mp -80.81 -3.86 52.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.311 0.576 . . . . 0.0 110.044 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.432 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.5 m-20 -92.79 -23.01 19.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.501 -173.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.07 141.58 30.04 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.521 -169.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.763 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 27.4 m -82.37 136.28 35.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.618 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.54 -50.62 72.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.598 . . . . 0.0 110.104 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.4 p -65.43 -39.63 92.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.67 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 6.7 m-20 -91.99 -69.51 0.74 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.798 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 22' ' ' ILE . 4.0 m-20 -63.41 -49.71 72.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.682 -175.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.812 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -71.39 -9.85 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.28 -174.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.16 38.54 29.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.112 0.482 . . . . 0.0 110.238 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.18 147.47 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.148 0.499 . . . . 0.0 111.319 -171.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.2 169.34 9.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.101 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.401 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 44.0 m -59.93 -45.73 91.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.559 0.537 . . . . 0.0 111.806 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -46.99 64.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.524 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 5.3 m -49.16 -57.11 7.24 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.733 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.414 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 7.9 ptm -57.38 -51.81 67.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.747 HG22 ' HB ' ' A' ' 64' ' ' VAL . 77.2 t -63.57 -24.46 35.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -176.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -75.28 -64.24 1.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.606 -0.684 . . . . 0.0 111.665 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.7 HG12 HG23 ' A' ' 15' ' ' ILE . 16.7 t -85.08 -23.67 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.166 -174.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 44' ' ' MET . 39.4 t -79.28 -27.09 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.433 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.71 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.2 t -70.83 -35.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.764 0.792 . . . . 0.0 109.025 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -22.45 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.14 -39.36 17.97 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.945 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.71 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 7.1 pt-20 -60.67 -48.23 82.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.405 0.621 . . . . 0.0 109.588 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 36.2 mt-10 -62.48 -36.81 83.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.789 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 12.9 ptp180 -76.71 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 111.179 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 63.2 m-85 -103.66 15.05 29.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 109.781 172.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 58.79 59.08 2.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.489 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 52' ' ' GLU . 10.4 p -143.96 160.62 15.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -134.15 112.36 11.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.195 0.522 . . . . 0.0 110.041 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 64' ' ' VAL . 18.2 pt -118.35 159.39 43.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 137.57 47.97 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.355 2.036 . . . . 0.0 111.838 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.53 -47.3 66.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.5 -32.25 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.277 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.29 -44.59 87.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.747 ' HB ' HG22 ' A' ' 45' ' ' VAL . 39.5 t -54.65 -42.17 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 110.453 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 2.1 tmtm? -77.3 -22.75 51.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.31 -37.9 51.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.422 -175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -72.58 137.76 46.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.825 0.821 . . . . 0.0 111.471 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -86.88 -28.78 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.671 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 p -117.63 154.23 31.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -63.75 -28.66 45.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -32.96 85.95 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.591 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 59.0 m-20 -60.8 -55.97 26.79 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.426 0.155 . . . . 0.0 110.586 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -53.81 -52.65 59.64 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.318 0.58 . . . . 0.0 110.374 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.79 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.6 m -53.14 -51.3 62.4 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.769 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HD2' HD12 ' A' ' 78' ' ' LEU . 8.8 tptm -65.43 -36.23 83.31 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.728 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -66.61 -39.93 88.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.183 0.516 . . . . 0.0 109.755 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.58 HG23 HG11 ' A' ' 57' ' ' VAL . 71.3 mt -61.51 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 172.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.868 HD21 HG21 ' A' ' 8' ' ' ILE . 91.5 mt -65.21 -24.76 67.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.689 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -82.0 -51.06 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -92.29 11.52 25.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.155 -172.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -67.03 149.67 50.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 0.0 110.881 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.194 179.198 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.584 ' H ' HG22 ' A' ' 4' ' ' THR . 17.9 tt0 -57.62 -56.02 27.27 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -168.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.21 -34.46 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.541 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.91 -53.28 49.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.324 0.583 . . . . 0.0 110.297 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.761 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.4 -34.98 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.953 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG23 HG21 ' A' ' 74' ' ' THR . 2.1 t -59.85 -41.77 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.863 -0.153 . . . . 0.0 110.932 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.14 86.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.66 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.73 -31.44 73.19 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.882 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -72.09 -50.63 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.632 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.24 -49.66 68.97 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.487 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -53.07 -36.27 60.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.861 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -34.31 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.785 -174.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 37' ' ' LEU . 44.6 t -69.24 -25.13 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.56 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -62.98 -21.43 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.147 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.54 -27.64 51.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.713 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.75 HD11 ' HB ' ' A' ' 47' ' ' VAL . 49.8 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.381 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.22 -87.17 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.6 53.38 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.529 -1.32 . . . . 0.0 114.128 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.825 HG13 HD13 ' A' ' 37' ' ' LEU . 19.3 mm -88.63 125.86 61.74 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.13 144.57 46.58 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.406 2.071 . . . . 0.0 111.434 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.632 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 19.4 m -54.58 -32.94 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.47 -18.08 49.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.518 ' HB3' HG23 ' A' ' 22' ' ' ILE . 25.9 t0 -86.75 -18.31 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.461 HG21 ' CB ' ' A' ' 13' ' ' ALA . 93.0 t -63.8 112.71 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.666 0.746 . . . . 0.0 110.325 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.0 mttp -135.51 162.81 31.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.758 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.901 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.7 mp -76.97 -3.09 37.14 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.87 0.366 . . . . 0.0 110.499 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -8.06 22.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.593 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -101.53 140.06 36.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.873 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.6 m -85.31 133.56 34.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.072 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.581 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -59.98 -46.9 87.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.428 0.633 . . . . 0.0 110.321 178.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.9 p -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.392 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.66 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 26.4 t70 -93.88 -68.85 0.78 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.095 0.474 . . . . 0.0 112.091 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.51 -49.06 58.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.644 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.825 HD13 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -67.47 -21.01 65.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.072 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 59.0 38.24 24.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.829 0.823 . . . . 0.0 109.621 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -101.13 156.08 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.595 -174.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-20 -99.84 155.08 17.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.12 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.9 m -51.41 -45.02 62.41 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.068 0.855 . . . . 0.0 111.426 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -48.17 59.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.2 m -54.31 -51.06 65.85 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.615 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.684 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.5 ptm -60.4 -47.5 85.81 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.677 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.828 HG22 ' HB ' ' A' ' 64' ' ' VAL . 54.6 t -61.61 -27.88 42.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.288 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.96 -65.37 0.85 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.834 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HB ' HD11 ' A' ' 19' ' ' ILE . 13.3 t -86.09 -20.82 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.865 -173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.8 t -79.92 -26.45 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.309 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.699 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -70.62 -35.73 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.384 0.611 . . . . 0.0 109.524 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.5 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 110.054 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.861 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.09 -33.53 24.35 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.765 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.2 pt-20 -67.97 -49.72 60.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.196 0.522 . . . . 0.0 109.815 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.603 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 21.3 mt-10 -67.38 -21.89 65.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.1 ptm180 -72.32 -19.62 61.63 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.04 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.541 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 93.2 m-85 -99.89 -4.49 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 109.874 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t0 65.23 67.92 0.51 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.5 p -117.45 164.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.706 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 57' ' ' VAL . 33.1 mmtm -122.59 109.73 14.67 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 111.049 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -140.61 143.15 31.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.962 173.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -60.92 138.37 78.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.249 1.966 . . . . 0.0 111.575 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -47.52 -57.19 5.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.844 0.83 . . . . 0.0 111.162 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.597 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 12.0 t70 -64.7 -20.72 66.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.5 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.82 -22.02 66.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.24 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 45' ' ' VAL . 58.6 t -64.25 -29.35 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.688 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.597 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -74.66 -14.45 60.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 110.809 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 9.7 t30 -79.63 -32.6 41.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.534 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.979 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -82.78 122.85 28.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -88.86 -11.37 44.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 31.6 p -125.55 155.99 39.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -67.08 -32.58 58.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.901 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -70.76 -35.08 66.36 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.909 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.64 -37.75 82.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -63.31 -46.56 86.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.809 175.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.816 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -62.78 -49.52 74.65 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.64 -170.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HD2' HD12 ' A' ' 78' ' ' LEU . 30.8 mmmt -62.47 -37.03 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.457 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 27.9 t80 -67.43 -40.82 85.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.02 0.438 . . . . 0.0 110.015 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.76 -36.84 77.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.236 0.541 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.816 ' HG ' ' O ' ' A' ' 74' ' ' THR . 90.0 mt -71.83 -26.73 62.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.24 -35.72 27.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.741 0.305 . . . . 0.0 111.044 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 20.63 18.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.883 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HA ' HG23 ' A' ' 57' ' ' VAL . 4.0 pt20 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.209 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.635 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 120.593 0.235 . . . . 0.0 110.77 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -68.06 -47.53 68.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.635 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.4 pm0 -61.89 -42.03 98.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.177 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.24 -51.72 34.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.628 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.962 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.4 -36.26 77.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.027 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.1 -41.85 90.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.18 97.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.438 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 15' ' ' ILE . . . -64.63 -45.52 92.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.177 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.7 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.48 -50.97 70.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -53.13 -57.59 9.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.52 -33.34 74.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.191 0.52 . . . . 0.0 110.504 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.713 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.0 -34.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.961 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.704 HG11 HD12 ' A' ' 37' ' ' LEU . 22.0 t -74.16 -24.98 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.822 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.2 -28.72 69.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.844 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.78 -38.42 90.92 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.477 0.656 . . . . 0.0 109.726 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.2 mt -75.53 -53.28 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.172 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.86 -86.18 0.53 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.796 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.26 61.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.06 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.779 HG13 HD13 ' A' ' 37' ' ' LEU . 16.7 mm -88.37 134.2 35.0 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.26 142.16 57.37 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.263 1.975 . . . . 0.0 111.197 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.671 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 28.8 m -62.4 -30.67 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 111.505 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 2.0 pm0 -80.56 -17.04 52.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.211 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.85 -14.34 42.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 110.256 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' A' ' 13' ' ' ALA . 89.0 t -71.87 115.24 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.708 0.766 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 70' ' ' VAL . 26.0 mtpp -136.17 169.42 17.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.914 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.73 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.4 mp -78.37 -2.7 39.51 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.11 0.481 . . . . 0.0 110.701 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.96 -21.82 17.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.681 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.88 144.02 25.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.389 -170.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.879 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 15.7 m -83.98 135.13 34.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.479 -172.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -62.05 -46.9 87.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.293 0.568 . . . . 0.0 110.438 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.8 p -77.64 -29.5 51.72 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.879 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 25.9 t70 -92.22 -66.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.72 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.96 -56.37 5.8 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.084 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.779 HD13 HG13 ' A' ' 22' ' ' ILE . 2.8 mm? -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.749 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.87 65.9 1.38 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.981 0.8 . . . . 0.0 110.044 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.522 HG11 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -123.22 143.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.082 -172.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.677 ' O ' ' HG2' ' A' ' 44' ' ' MET . 5.3 m-20 -88.71 162.6 16.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -53.76 -49.57 67.93 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.957 0.785 . . . . 0.0 110.594 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -49.77 72.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 109.676 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.564 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -55.32 -50.28 70.01 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.046 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.677 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.0 ptm -62.43 -43.5 98.66 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.977 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 94.7 t -69.02 -25.63 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.848 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -72.8 -65.79 0.75 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.618 -0.676 . . . . 0.0 111.349 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.686 HG12 HG23 ' A' ' 15' ' ' ILE . 7.4 t -87.71 -22.48 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.263 -173.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 44' ' ' MET . 36.1 t -78.98 -26.43 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.798 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -69.64 -38.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.06 -25.1 63.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 110.675 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.713 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.71 -37.24 21.18 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.798 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 8.1 pt-20 -68.15 -48.9 64.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.576 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.9 mt-10 -64.18 -27.98 69.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.081 -174.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 54' ' ' ARG . 6.2 ptp180 -76.12 -9.43 58.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 111.096 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 80.5 m-85 -105.93 17.96 22.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 66.62 24.16 10.17 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.595 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 77' ' ' ILE . 11.3 p -113.86 151.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 58' ' ' LYS . 2.1 tmtt? -135.78 113.77 11.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.222 170.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.734 HD11 HG22 ' A' ' 64' ' ' VAL . 13.0 pt -102.98 165.61 13.33 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.697 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 50.1 Cg_exo -54.94 119.4 6.44 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.527 1.485 . . . . 0.0 111.01 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.57 -40.55 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 110.553 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.47 -23.39 67.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.408 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 20.5 t70 -78.04 -25.63 47.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.782 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.734 HG22 HD11 ' A' ' 59' ' ' ILE . 44.7 t -62.32 -32.06 53.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.97 -31.86 66.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.974 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -72.04 -39.7 68.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.743 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.087 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.24 131.69 39.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.385 0.612 . . . . 0.0 110.872 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -104.94 -1.29 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.517 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.71 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 66.0 p -126.85 147.87 50.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -66.22 -32.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 109.798 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -67.71 -43.38 84.86 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.87 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.26 -41.69 84.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.087 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -59.5 -59.76 4.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.153 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 12.7 m -58.27 -47.11 84.64 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.02 -173.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD3' HD21 ' A' ' 29' ' ' LEU . 35.3 tptt -66.04 -33.33 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.44 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 54.1 t80 -66.92 -42.19 85.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.692 HG23 HG11 ' A' ' 57' ' ' VAL . 66.3 mt -58.12 -46.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.286 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.962 HD21 HG21 ' A' ' 8' ' ' ILE . 81.7 mt -66.66 -38.17 86.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.311 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -74.27 -21.04 59.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -128.48 29.11 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 3.6 pt20 . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 120.783 0.325 . . . . 0.0 111.444 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.602 ' H ' HG22 ' A' ' 4' ' ' THR . 5.9 tt0 -63.04 -56.01 20.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.968 0.168 . . . . 0.0 111.178 -171.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.515 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.1 pm0 -60.67 -36.04 77.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.69 0.281 . . . . 0.0 111.279 -173.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -69.34 -56.27 7.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.445 0.64 . . . . 0.0 110.397 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.799 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.25 -34.62 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.946 -177.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -61.43 -39.12 81.75 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.794 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.9 88.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.637 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.4 -39.08 91.54 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.703 HD22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -66.72 -51.63 53.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.35 -48.69 76.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.734 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -51.83 -36.44 48.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.819 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.849 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.19 -40.27 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.142 -174.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 37' ' ' LEU . 13.2 t -68.34 -24.63 29.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.347 0.594 . . . . 0.0 109.592 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.95 -27.19 65.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.57 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.89 -47.88 42.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.205 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 47' ' ' VAL . 20.1 mt -59.02 -52.79 56.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.057 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.99 -84.48 0.61 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.835 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.38 59.48 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.985 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.83 HG13 HD13 ' A' ' 37' ' ' LEU . 29.0 mm -94.91 128.54 38.88 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 148.48 42.67 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.567 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.656 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.6 m -64.65 -17.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.66 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.15 -21.31 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.196 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' HB3' HG23 ' A' ' 22' ' ' ILE . 22.2 t0 -99.17 -13.51 19.73 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 111.457 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.96 121.95 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.328 0.585 . . . . 0.0 110.3 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.4 mtpt -145.23 165.61 27.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.683 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.592 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 8.4 mp -75.64 -0.97 22.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.464 0.65 . . . . 0.0 109.863 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -97.17 -22.39 16.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.007 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.04 141.57 29.28 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.608 -172.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.822 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 13.7 t -81.21 132.97 35.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.245 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.55 -47.76 84.31 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.552 0.692 . . . . 0.0 110.074 176.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.6 p -74.58 -37.46 62.91 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.549 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 33.5 t70 -92.35 -59.7 2.02 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.16 -49.43 23.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD13 HG13 ' A' ' 22' ' ' ILE . 3.2 mm? -72.58 -16.55 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.621 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 57.07 34.59 25.13 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.064 0.935 . . . . 0.0 109.455 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -87.79 160.47 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 -171.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.758 ' O ' ' HG2' ' A' ' 44' ' ' MET . 1.2 t70 -112.93 155.46 24.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.976 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 34.9 t -41.74 -59.47 1.65 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.362 1.039 . . . . 0.0 112.17 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.77 62.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.531 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 24.5 m -53.46 -51.2 63.47 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.802 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.758 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.1 ptm -62.98 -47.49 82.95 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' A' ' 64' ' ' VAL . 97.1 t -66.2 -22.6 30.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.881 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -75.39 -66.94 0.71 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.609 -0.682 . . . . 0.0 111.752 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.707 HG12 HG23 ' A' ' 15' ' ' ILE . 4.9 t -84.17 -22.85 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.799 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.0 t -79.9 -22.6 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.214 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.706 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.1 t -68.44 -37.32 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 166.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.33 -25.01 68.1 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.378 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.849 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.54 -37.4 25.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.351 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.706 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 3.5 pt-20 -67.17 -48.66 67.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.473 0.654 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.63 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 85.1 mt-10 -70.44 -23.61 62.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.949 -172.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.3 ptm180 -73.36 -10.81 60.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.891 0.377 . . . . 0.0 110.367 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 55.1 m-85 -109.41 19.49 19.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.426 175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 66.95 26.8 9.05 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.476 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.767 HG11 HG23 ' A' ' 77' ' ' ILE . 10.2 p -118.02 155.63 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 58' ' ' LYS . 35.7 tptt -134.83 114.71 12.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.179 0.514 . . . . 0.0 110.585 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.674 HD11 HG22 ' A' ' 64' ' ' VAL . 20.5 pt -104.11 163.33 17.54 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.439 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 27.8 Cg_exo -61.16 132.36 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.963 1.775 . . . . 0.0 111.165 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.76 -51.48 49.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.0 111.002 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.24 -20.57 64.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.92 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 9.0 t70 -71.67 -34.44 69.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.816 -0.174 . . . . 0.0 110.968 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.674 ' HB ' HG22 ' A' ' 45' ' ' VAL . 41.9 t -59.91 -39.48 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 15.7 tptp -72.03 -20.17 61.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.92 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -75.13 -35.16 61.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -81.04 153.78 27.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.0 mptp? -104.99 -29.05 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.086 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.822 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.1 p -111.11 156.64 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.26 -31.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.592 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.4 -35.72 92.1 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.196 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 63.3 m-20 -56.26 -57.35 12.62 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.662 0.268 . . . . 0.0 110.431 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.617 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.99 -44.7 78.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.372 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.757 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 19.7 m -56.51 -53.74 53.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.752 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -66.23 -37.19 84.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 40.5 t80 -59.68 -41.71 91.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.698 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.767 HG23 HG11 ' A' ' 57' ' ' VAL . 58.6 mt -64.94 -48.44 84.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.803 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.799 HD21 HG21 ' A' ' 8' ' ' ILE . 85.8 mt -64.63 -44.26 91.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.444 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -5.26 59.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 76' ' ' TYR . 26.3 m-70 -126.43 15.43 7.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 81' ' ' GLN . 3.2 pt20 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -49.81 -53.12 27.28 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 7' ' ' GLU . 8.3 pt-20 -55.22 -49.09 72.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 111.54 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 6' ' ' GLU . 36.5 mt-10 -66.55 -50.7 62.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.214 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.874 HG21 HD21 ' A' ' 78' ' ' LEU . 3.0 tt -67.13 -35.33 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.862 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.96 -35.9 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.379 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.22 -43.42 78.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.924 0.392 . . . . 0.0 110.665 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.3 85.51 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.801 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -43.86 97.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.12 -54.89 37.49 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.149 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -52.8 -43.39 65.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.56 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 47' ' ' VAL . 7.3 mm -62.27 -53.8 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.247 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.735 HG11 HD12 ' A' ' 37' ' ' LEU . 12.1 t -70.48 -23.34 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 0.0 110.635 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -60.79 -29.23 69.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.41 -43.23 67.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 110.274 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.543 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.4 mt -65.53 -52.56 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.185 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -76.4 0.57 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.1 51.31 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.379 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 37' ' ' LEU . 10.6 mm -80.55 124.86 81.82 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.749 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 8.1 Cg_endo -53.38 147.27 37.73 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.698 2.266 . . . . 0.0 111.525 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.1 m -61.39 -30.82 48.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -172.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.21 -17.29 52.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.856 0.36 . . . . 0.0 111.401 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.749 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 2.7 t70 -86.03 -18.97 31.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.941 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 13' ' ' ALA . 84.5 t -67.41 120.39 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.658 0.742 . . . . 0.0 110.525 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HE3' ' OD1' ' A' ' 30' ' ' ASP . 26.2 mtpp -142.36 165.23 27.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.441 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.565 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 7.6 mp -77.95 -3.27 41.05 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.421 ' OD1' ' HE3' ' A' ' 28' ' ' LYS . 12.8 p-10 -107.29 -8.31 16.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -90.71 139.81 30.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.7 m -89.1 135.59 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.376 -171.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -58.04 -47.56 82.72 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 110.193 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 p -72.12 -32.13 66.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.481 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.76 -69.84 0.73 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.272 0.558 . . . . 0.0 111.602 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.67 -48.4 26.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.941 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.813 HD13 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -66.68 -17.91 65.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.441 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.04 36.06 18.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.935 0.874 . . . . 0.0 109.679 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -98.47 150.13 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.746 -171.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.762 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.6 t70 -97.53 154.62 17.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.996 173.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 45' ' ' VAL . 30.4 m -51.99 -44.85 64.25 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.699 0.624 . . . . 0.0 111.632 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 tp -77.58 -39.34 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.954 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 51.6 m -55.34 -48.67 73.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.762 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 6.4 ptm -62.47 -45.84 91.22 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.749 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.2 t -64.36 -23.04 32.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.713 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.21 -65.73 0.81 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.936 -0.478 . . . . 0.0 111.696 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 15' ' ' ILE . 18.9 t -89.67 -20.53 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.272 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 44' ' ' MET . 19.8 t -80.08 -17.0 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.665 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.0 t -78.57 -34.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 121.536 0.684 . . . . 0.0 109.209 165.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -59.5 -24.18 63.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.567 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.7 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -81.76 -38.76 25.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.677 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.727 ' O ' HG12 ' A' ' 57' ' ' VAL . 5.9 pt-20 -60.4 -47.4 86.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.692 0.758 . . . . 0.0 109.46 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 22.6 mt-10 -74.75 -21.74 59.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.809 -171.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 3.7 ptp180 -74.21 -12.15 60.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.019 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.0 10.13 39.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.72 30.42 16.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.001 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -115.17 162.74 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.575 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 24.3 mmmt -128.7 116.02 18.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.252 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 64' ' ' VAL . 44.2 pt -117.61 158.7 44.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.666 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 18.7 Cg_exo -69.43 135.44 31.25 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.548 2.165 . . . . 0.0 112.302 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.8 -58.15 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.592 0.711 . . . . 0.0 110.79 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -17.75 64.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.349 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.666 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.3 t0 -76.07 -19.56 58.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.105 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.834 ' HB ' HG22 ' A' ' 45' ' ' VAL . 24.6 t -72.73 -52.61 22.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.514 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -68.82 -7.25 32.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -76.43 -36.21 58.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.087 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.741 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.1 pp -89.24 128.17 35.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.47 0.652 . . . . 0.0 111.016 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.92 1.0 55.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.89 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 74.7 p -130.15 147.91 51.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.553 0.216 . . . . 0.0 110.543 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 31' ' ' LYS . 1.6 p -69.43 -34.42 62.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.943 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.6 -41.37 97.28 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.91 -49.75 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -52.45 -54.27 34.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.627 0.727 . . . . 0.0 111.164 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.773 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.1 m -58.08 -48.55 79.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.636 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.622 ' HD2' HD12 ' A' ' 78' ' ' LEU . 12.2 tptp -69.2 -29.09 66.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.216 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.24 -46.35 80.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.802 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.51 -36.78 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.307 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 8' ' ' ILE . 92.3 mt -70.6 -31.86 69.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.768 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.26 -42.2 17.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.064 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -96.08 13.24 27.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.496 179.277 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.582 ' H ' HG22 ' A' ' 4' ' ' THR . 15.2 tp60 -48.7 -53.36 19.15 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -62.23 -46.85 87.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.32 -43.41 50.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.845 0.355 . . . . 0.0 111.284 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.691 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.48 -34.1 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.59 -42.41 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.129 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.92 92.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.607 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.571 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -66.8 -39.18 93.48 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.92 -49.45 70.37 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.02 -50.45 70.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.68 -36.51 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -39.36 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.254 -175.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 37' ' ' LEU . 41.7 t -70.11 -24.99 26.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.097 0.475 . . . . 0.0 110.079 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -62.29 -24.53 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -72.33 -39.46 68.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 109.795 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.724 HD11 ' HB ' ' A' ' 47' ' ' VAL . 26.9 mt -72.63 -50.64 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.226 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.83 -77.75 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.259 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.62 44.19 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.788 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.824 HG13 HD13 ' A' ' 37' ' ' LEU . 9.1 mm -75.04 134.97 74.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 26' ' ' ASP . 51.3 Cg_exo -53.61 144.14 53.9 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.469 2.113 . . . . 0.0 111.449 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 82.3 t -59.69 -38.13 74.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.364 . . . . 0.0 111.021 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -74.29 -17.95 60.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.68 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' HB3' HG23 ' A' ' 22' ' ' ILE . 14.0 t0 -87.51 -16.84 33.55 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.214 -0.304 . . . . 0.0 111.594 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 13' ' ' ALA . 89.8 t -64.97 116.96 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.566 0.698 . . . . 0.0 110.445 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -141.02 162.02 36.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.194 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' CA ' ' A' ' 71' ' ' GLY . 9.7 mp -79.25 -4.19 49.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.35 -8.38 21.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -97.56 134.57 40.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 18.1 m -89.39 140.91 29.04 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 111.46 -170.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.637 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 1.1 m-85 -58.81 -50.92 72.15 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 110.152 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.3 p -69.53 -33.06 72.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.406 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.18 -68.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 10.3 t0 -78.42 -51.52 9.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.4 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.824 HD13 HG13 ' A' ' 22' ' ' ILE . 3.8 mm? -64.8 -13.31 55.09 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 58.13 38.83 26.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 109.539 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.41 149.79 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.913 -172.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.76 166.29 11.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 p -54.83 -56.72 16.36 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.099 0.249 . . . . 0.0 111.634 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.34 -38.87 92.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.533 0.206 . . . . 0.0 111.263 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 25.1 m -52.66 -54.37 34.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.031 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.671 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 15.2 ptt? -64.26 -48.02 77.34 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.646 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.1 t -55.28 -28.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.994 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.22 -66.13 0.87 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.761 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.724 ' HB ' HD11 ' A' ' 19' ' ' ILE . 14.4 t -83.33 -22.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.134 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 44' ' ' MET . 44.9 t -79.9 -19.92 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.917 -0.489 . . . . 0.0 110.295 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -75.22 -32.88 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.249 167.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -62.0 -24.32 66.97 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.605 169.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.53 -32.48 28.62 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.888 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.8 pt-20 -66.11 -54.08 29.99 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.643 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 16.5 mt-10 -71.61 -20.36 61.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.227 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 13.3 ptm180 -69.68 -15.24 63.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.101 0.477 . . . . 0.0 110.048 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.571 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 65.3 m-85 -107.3 15.03 25.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.014 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.33 27.37 8.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.72 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.1 p -113.67 165.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.535 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 17.1 pttm -132.26 119.1 20.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 110.427 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.04 154.65 53.36 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -63.73 128.96 23.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.899 1.732 . . . . 0.0 111.524 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.49 -40.07 58.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.479 0.657 . . . . 0.0 109.709 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.78 -35.5 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.104 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -74.42 -29.64 61.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.898 ' HB ' HG22 ' A' ' 45' ' ' VAL . 21.7 t -61.58 -40.59 87.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.376 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.17 -5.65 59.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 177.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -80.82 -23.64 39.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.067 0.46 . . . . 0.0 110.282 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -95.28 143.72 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.412 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 11.9 mptt -101.54 -17.66 16.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.806 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 19.1 p -118.77 156.06 30.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.599 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -65.38 -33.99 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.035 0.445 . . . . 0.0 109.944 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' CA ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.8 -35.58 86.99 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 69.5 m-20 -58.8 -58.54 8.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.516 0.186 . . . . 0.0 110.638 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -55.26 -47.65 75.15 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.0 m -57.02 -54.08 50.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.088 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 1.6 tppp? -69.78 -31.43 69.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.211 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -61.08 -45.28 95.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.933 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.572 HG23 HG11 ' A' ' 57' ' ' VAL . 61.2 mt -59.49 -44.5 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 74' ' ' THR . 81.2 mt -71.96 -29.11 63.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.964 -174.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.76 -24.89 61.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.651 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -124.1 28.92 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.148 0.499 . . . . 0.0 112.089 -173.719 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.484 ' H ' HG22 ' A' ' 4' ' ' THR . 12.2 tt0 -55.35 -56.61 18.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.19 -34.41 78.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 0.0 111.491 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -70.7 -51.21 29.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.778 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.46 -32.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.77 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.2 -44.02 90.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.89 87.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 110.69 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -70.86 -42.86 59.92 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.983 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.56 -40.95 98.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.744 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.85 -51.67 68.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.103 177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -54.21 -39.59 66.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.197 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 51' ' ' ALA . 6.4 mm -67.93 -52.77 35.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.218 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.831 HG11 HD12 ' A' ' 37' ' ' LEU . 5.8 t -68.03 -22.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.148 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.51 -31.61 69.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -76.66 -24.82 53.27 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 110.411 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.51 HG21 HG23 ' A' ' 39' ' ' VAL . 22.2 mt -81.92 -54.36 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.671 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.41 -78.05 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.938 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.74 57.49 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.557 -1.306 . . . . 0.0 114.696 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.792 HG13 HD13 ' A' ' 37' ' ' LEU . 20.9 mm -90.72 129.81 43.24 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 164.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.54 147.16 39.73 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.349 2.033 . . . . 0.0 111.981 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.744 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 25.3 m -61.09 -26.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.441 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.34 -17.52 48.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.64 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 22' ' ' ILE . 2.3 t70 -96.23 -15.55 21.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.742 HG21 ' HA ' ' A' ' 13' ' ' ALA . 76.9 t -68.66 126.74 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.592 0.711 . . . . 0.0 110.571 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HE2' ' HB3' ' A' ' 30' ' ' ASP . 42.5 mtpt -140.2 173.45 11.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.692 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 30.2 mt -82.07 -3.29 54.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.895 0.855 . . . . 0.0 108.695 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.555 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 6.2 t70 -95.62 -27.1 15.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.592 -170.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.86 144.15 25.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.991 -174.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.793 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 22.3 m -84.54 135.35 34.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.653 ' CD2' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -60.82 -48.13 83.2 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.242 0.544 . . . . 0.0 110.135 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 p -66.59 -38.07 86.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.503 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -92.75 -65.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.989 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.3 m-20 -69.42 -48.53 60.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.848 -174.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.831 HD12 HG11 ' A' ' 16' ' ' VAL . 3.6 mm? -74.87 -4.59 38.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.131 -171.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.36 58.8 5.1 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.934 0.772 . . . . 0.0 109.34 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -122.44 152.21 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.689 -170.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.611 ' H ' ' HB3' ' A' ' 43' ' ' SER . 12.4 t70 -119.46 162.31 19.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.621 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.6 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 p -39.25 -58.09 1.25 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -74.35 -44.52 51.99 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.375 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 40' ' ' ASP . 30.6 t -45.27 -58.98 2.9 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.643 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.482 ' HE2' HG12 ' A' ' 64' ' ' VAL . 10.4 ptm -60.78 -50.15 74.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.754 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' A' ' 64' ' ' VAL . 70.0 t -63.76 -21.64 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.103 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.944 -0.472 . . . . 0.0 111.372 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.746 HG12 HG23 ' A' ' 15' ' ' ILE . 6.6 t -89.92 -21.67 6.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.858 -173.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 44' ' ' MET . 38.6 t -79.78 -24.01 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.172 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.693 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.4 t -70.27 -39.06 76.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 167.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.0 -21.56 61.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.579 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.59 -46.57 11.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.842 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 10.6 pt-20 -63.25 -46.53 86.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 110.159 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.78 -24.98 64.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.485 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 14.7 ptm180 -75.19 -18.65 60.12 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.215 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 88.0 m-85 -97.27 9.89 41.0 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.39 0.614 . . . . 0.0 109.361 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 66.36 52.6 1.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.198 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.3 p -137.52 152.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -134.32 112.12 10.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.679 0.276 . . . . 0.0 110.54 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.714 HD11 HG22 ' A' ' 64' ' ' VAL . 8.1 pt -110.01 165.23 13.06 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.37 134.74 43.15 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.699 1.599 . . . . 0.0 111.393 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB3' HG11 ' A' ' 45' ' ' VAL . 1.6 m-20 -51.38 -43.8 61.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.742 0.782 . . . . 0.0 110.068 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.13 -31.33 65.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.861 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.47 -35.23 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.166 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.714 HG22 HD11 ' A' ' 59' ' ' ILE . 55.5 t -58.45 -42.63 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.6 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 16.6 tptp -74.66 -20.63 59.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.838 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -73.63 -28.24 61.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.054 0.454 . . . . 0.0 110.011 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -88.22 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 111.004 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -99.72 -14.8 18.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.354 -171.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.793 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 26.2 p -115.45 157.68 23.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.653 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.2 p -70.19 -24.27 25.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.448 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -37.14 94.02 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.815 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.711 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.2 m-20 -56.92 -58.07 9.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.41 0.148 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.638 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.65 -50.17 70.94 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.27 0.557 . . . . 0.0 110.747 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.746 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 37.0 m -55.25 -50.68 68.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.926 -176.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -67.74 -31.27 71.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.357 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.45 -42.96 86.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.756 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.475 HG23 HG11 ' A' ' 57' ' ' VAL . 91.0 mt -59.81 -40.31 82.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.262 174.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 8' ' ' ILE . 87.8 mt -73.07 -38.86 66.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.002 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.84 -27.44 55.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.283 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -116.55 26.57 9.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 111.419 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.407 -177.835 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 4' ' ' THR . 12.6 tt0 -51.58 -56.11 15.39 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -169.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -64.83 -35.37 80.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.73 -48.46 31.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.851 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.895 HG21 HD21 ' A' ' 78' ' ' LEU . 1.8 tt -68.57 -33.34 59.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.06 -35.96 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.301 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.25 85.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.755 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -71.02 -38.23 63.98 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.32 -44.44 96.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.846 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.78 -48.75 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.16 -32.88 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.139 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.966 HG21 ' HB2' ' A' ' 51' ' ' ALA . 4.1 mm -78.08 -50.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.561 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.794 HG11 HD12 ' A' ' 37' ' ' LEU . 9.3 t -67.11 -23.53 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.23 0.538 . . . . 0.0 109.982 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.44 -25.11 65.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.33 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HB3' HG11 ' A' ' 47' ' ' VAL . 7.6 tp10 -73.65 -30.13 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.091 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.598 HD11 ' HB ' ' A' ' 47' ' ' VAL . 36.2 mt -84.53 -52.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.679 -172.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 -88.26 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.752 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.38 56.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.512 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.793 HG13 HD13 ' A' ' 37' ' ' LEU . 26.9 mm -98.27 122.27 54.48 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 163.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.51 145.99 44.55 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.444 2.096 . . . . 0.0 111.5 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.846 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 35.3 m -58.7 -22.02 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.176 0.512 . . . . 0.0 111.887 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.81 -17.66 46.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.797 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 22' ' ' ILE . 3.4 t70 -102.24 -9.42 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -172.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 13' ' ' ALA . 36.1 t -68.13 123.14 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.396 0.617 . . . . 0.0 110.404 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' O ' HG13 ' A' ' 70' ' ' VAL . 57.0 mttt -141.21 166.16 25.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.575 -171.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 10.2 mp -78.59 -2.98 41.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.296 0.57 . . . . 0.0 109.485 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.09 -20.2 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.648 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -99.79 144.74 28.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.948 -172.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.77 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 18.5 t -87.39 134.0 33.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.086 -172.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.632 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -58.57 -42.66 88.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.0 110.253 176.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.0 p -79.02 -32.55 45.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.636 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.8 t70 -92.95 -56.59 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.052 0.453 . . . . 0.0 111.824 -175.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -88.93 -40.35 13.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.119 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.794 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -78.32 -3.85 45.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.526 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 52.7 38.84 27.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.082 0.467 . . . . 0.0 110.865 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.611 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.4 OUTLIER -108.41 141.03 24.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.46 . . . . 0.0 111.874 -170.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.749 ' O ' ' HG2' ' A' ' 44' ' ' MET . 13.8 m-20 -95.23 162.39 13.71 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.931 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -50.37 -41.7 52.18 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.942 0.776 . . . . 0.0 111.137 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.55 -53.36 16.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.564 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.533 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 18.7 m -51.41 -48.81 62.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.526 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.749 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.4 ptm -60.56 -56.76 17.51 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.768 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.791 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.37 -24.47 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.468 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.08 -65.44 0.8 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.596 -0.69 . . . . 0.0 111.287 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.793 HG12 HG23 ' A' ' 15' ' ' ILE . 11.1 t -88.01 -20.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.698 -173.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.4 t -79.83 -19.75 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.976 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -73.83 -34.56 40.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 165.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -63.02 -21.78 66.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.843 169.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.966 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.47 -34.39 23.41 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.727 ' O ' HG12 ' A' ' 57' ' ' VAL . 9.6 pt-20 -68.57 -49.9 55.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.564 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 37.9 mt-10 -67.56 -25.1 65.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.469 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -72.11 -16.61 62.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.054 0.454 . . . . 0.0 110.63 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.755 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 82.0 m-85 -106.53 15.77 25.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.66 33.16 18.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.861 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.2 p -111.64 161.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' N ' HG22 ' A' ' 57' ' ' VAL . 18.0 mttp -134.88 110.8 9.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 pt -121.27 160.81 44.07 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.1 Cg_exo -66.28 137.91 49.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.645 2.23 . . . . 0.0 111.683 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.78 -44.53 96.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.118 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.38 -18.35 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.985 0.421 . . . . 0.0 110.661 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 7.3 t70 -67.14 -41.93 85.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.791 ' HB ' HG22 ' A' ' 45' ' ' VAL . 37.7 t -59.77 -47.66 90.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.129 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.512 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.38 -1.5 30.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.396 . . . . 0.0 111.683 -176.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -92.05 -36.6 13.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.33 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -74.58 138.35 42.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.777 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -94.98 -20.63 19.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.155 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.769 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.8 p -116.48 156.39 26.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.632 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -66.53 -29.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -63.71 -36.23 93.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.589 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.4 m-20 -55.03 -59.27 4.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.595 0.235 . . . . 0.0 111.041 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.27 -47.9 74.8 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.773 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 11.5 m -57.54 -51.64 68.65 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.83 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD2' HD12 ' A' ' 78' ' ' LEU . 10.8 tptp -65.84 -34.92 79.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.136 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.81 -45.8 90.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.241 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.723 HG23 HG11 ' A' ' 57' ' ' VAL . 81.2 mt -57.18 -45.53 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.893 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 8' ' ' ILE . 94.6 mt -65.05 -21.85 66.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.554 -171.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.71 -22.7 27.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.175 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.02 27.8 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.538 ' HA ' HG23 ' A' ' 57' ' ' VAL . 4.4 pt20 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 120.659 0.266 . . . . 0.0 110.836 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' H ' HG22 ' A' ' 4' ' ' THR . 0.4 OUTLIER -58.58 -52.95 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -176.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 3.0 pm0 -59.5 -35.15 73.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.042 0.448 . . . . 0.0 111.264 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.53 -58.4 4.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.623 0.725 . . . . 0.0 110.599 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.805 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.67 -33.51 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.326 -175.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.92 -42.14 91.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.93 -0.123 . . . . 0.0 110.78 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.92 91.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.367 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA3' ' CE2' ' A' ' 55' ' ' PHE . . . -69.75 -41.49 73.89 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.526 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.14 -47.49 84.3 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -50.4 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.71 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.67 -37.0 58.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.898 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.27 -34.23 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.599 -174.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.801 HG11 HD12 ' A' ' 37' ' ' LEU . 47.0 t -70.7 -24.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 O-C-N 121.645 -0.659 . . . . 0.0 109.482 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.21 -20.73 66.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.943 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -75.49 -29.47 59.55 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.207 0.527 . . . . 0.0 110.209 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 47' ' ' VAL . 28.1 mt -83.74 -52.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.13 -91.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.264 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.44 54.36 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.036 -1.554 . . . . 0.0 114.789 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.759 HG13 HD13 ' A' ' 37' ' ' LEU . 22.2 mm -87.92 125.11 65.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 164.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 146.14 51.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.6 2.2 . . . . 0.0 111.169 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.2 m -60.68 -26.75 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.865 0.364 . . . . 0.0 111.773 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.26 -18.88 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.088 0.471 . . . . 0.0 111.355 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 22' ' ' ILE . 25.2 t0 -90.28 -18.9 24.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.971 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 13' ' ' ALA . 87.7 t -66.52 117.02 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.651 0.739 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HE2' ' OD1' ' A' ' 30' ' ' ASP . 31.1 mtpt -141.82 170.76 15.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.688 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.669 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 23.4 mt -81.57 -4.18 55.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.007 0.432 . . . . 0.0 110.221 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 3.7 p-10 -111.36 13.5 21.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -173.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -114.18 143.21 45.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.539 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.643 ' HB2' ' HB2' ' A' ' 35' ' ' ASP . 13.4 m -82.11 136.16 35.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.754 0.311 . . . . 0.0 110.637 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -65.15 -47.63 76.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.258 0.551 . . . . 0.0 109.931 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.3 p -67.2 -38.23 84.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.327 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.5 m-20 -91.73 -68.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.706 -173.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.86 -48.4 54.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.244 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.801 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -68.86 -10.94 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 55.73 51.7 12.02 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.81 0.814 . . . . 0.0 109.551 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -122.18 146.35 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.539 -169.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' A' ' 44' ' ' MET . 20.2 m-20 -102.71 162.68 12.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.978 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 t -49.16 -51.07 34.72 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.258 0.974 . . . . 0.0 111.195 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.01 -43.4 68.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.586 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB2' ' H ' ' A' ' 40' ' ' ASP . 12.0 m -55.21 -55.8 27.16 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.743 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.6 ptm -55.43 -58.4 7.9 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.474 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' A' ' 64' ' ' VAL . 63.7 t -58.09 -26.46 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.695 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.1 -65.65 0.78 Allowed 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.601 -0.687 . . . . 0.0 111.415 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' HB ' HD11 ' A' ' 19' ' ' ILE . 11.0 t -84.88 -23.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.808 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 44' ' ' MET . 65.6 t -74.1 -31.11 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.998 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.8 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 6.2 t -69.36 -34.72 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.376 0.608 . . . . 0.0 109.678 171.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.87 67.49 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.95 -0.469 . . . . 0.0 110.616 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.01 -41.12 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.875 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.8 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -61.62 -44.29 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.181 0.515 . . . . 0.0 110.315 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.83 -31.62 71.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.347 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.2 ptm180 -74.76 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.053 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.679 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 57.3 m-85 -104.51 13.21 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.606 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 57.45 70.54 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.083 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 52' ' ' GLU . 10.0 p -129.43 165.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 171.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' N ' HG22 ' A' ' 57' ' ' VAL . 64.3 mttm -128.08 111.55 13.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 0.0 110.232 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -149.12 132.84 8.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.429 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 20.5 Cg_exo -64.96 140.96 68.57 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.134 1.89 . . . . 0.0 111.299 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.604 ' HB2' ' CG1' ' A' ' 45' ' ' VAL . 7.8 p-10 -56.51 -32.01 64.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.74 0.781 . . . . 0.0 110.083 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 28.7 t70 -60.11 -27.03 66.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.429 -1.259 . . . . 0.0 111.53 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.04 -36.12 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.817 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.655 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 21.4 t -60.69 -44.35 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.613 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -79.8 -2.41 43.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 0.0 111.36 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -92.78 -19.49 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.163 0.506 . . . . 0.0 109.78 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 1.5 pp -93.97 128.3 40.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -97.14 3.55 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.545 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.585 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 81.5 p -129.03 143.99 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -64.71 -37.24 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.991 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -63.45 -32.6 84.7 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.818 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 11.7 t70 -59.96 -51.22 70.58 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.632 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -55.51 -49.58 72.21 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.693 175.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.774 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 1.8 m -58.91 -52.53 65.35 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.642 -173.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HD2' HD12 ' A' ' 78' ' ' LEU . 14.5 tptp -65.97 -34.79 78.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.071 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CD2' HD12 ' A' ' 59' ' ' ILE . 53.0 t80 -62.33 -47.28 84.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.766 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.467 ' HA ' HG21 ' A' ' 57' ' ' VAL . 54.0 mt -58.81 -46.7 90.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.594 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 8' ' ' ILE . 86.7 mt -61.44 -26.4 67.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.946 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.57 -29.74 21.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 111.598 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -115.73 30.45 7.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt20 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.496 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 120.464 0.173 . . . . 0.0 110.957 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.595 ' H ' HG22 ' A' ' 4' ' ' THR . 47.2 tt0 -54.39 -56.38 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -66.89 -32.78 74.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 111.452 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.05 -47.94 19.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.95 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.23 -34.72 67.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.97 -38.41 79.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.635 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.58 80.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.757 0.313 . . . . 0.0 110.476 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.591 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.11 -36.93 91.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.851 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -68.58 -49.34 60.13 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.74 -46.23 84.75 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -51.27 -36.37 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.567 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.879 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.1 -37.6 11.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.556 -175.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 37' ' ' LEU . 21.3 t -68.82 -25.32 30.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.85 -0.532 . . . . 0.0 110.16 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.61 -24.2 67.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.924 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.09 -41.74 63.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.945 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 47' ' ' VAL . 25.3 mt -68.08 -53.26 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.152 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.89 -84.93 0.61 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.763 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.78 54.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.389 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.802 HG13 HD13 ' A' ' 37' ' ' LEU . 23.7 mm -82.27 130.45 59.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 166.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.33 137.52 38.89 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.195 1.93 . . . . 0.0 111.07 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 29.0 m -56.8 -27.73 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.46 -18.29 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.518 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -90.71 -16.59 28.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.104 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.37 116.9 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.671 0.748 . . . . 0.0 110.19 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 70' ' ' VAL . 25.5 mtpp -134.65 167.22 21.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.93 -173.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.741 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.7 mp -79.45 -2.96 44.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.494 0.664 . . . . 0.0 109.754 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.16 -13.23 19.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.955 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -100.72 143.29 31.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.492 -174.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.854 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 75.4 m -84.22 134.89 34.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.373 -173.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -58.7 -42.15 87.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 110.169 176.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 p -77.67 -36.49 51.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.269 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 10.8 t70 -91.02 -57.28 2.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 1.8 m-20 -77.48 -56.8 4.23 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.802 HD13 HG13 ' A' ' 22' ' ' ILE . 2.7 mm? -68.67 -13.64 62.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.429 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 54.13 36.44 24.82 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.187 0.994 . . . . 0.0 110.292 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -97.59 148.71 5.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.223 -171.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.1 m-20 -94.83 163.43 13.35 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' MET . 66.9 m -56.25 -42.69 77.79 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.441 0.463 . . . . 0.0 111.534 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -72.37 -47.08 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.813 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.464 ' HB2' HG22 ' A' ' 39' ' ' VAL . 14.5 m -50.82 -51.93 46.16 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 3.5 ptp -59.18 -59.41 5.51 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.733 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 81.8 t -58.59 -21.68 18.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.025 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -70.04 -65.82 0.67 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.961 -0.462 . . . . 0.0 110.835 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG12 HG23 ' A' ' 15' ' ' ILE . 11.6 t -89.51 -22.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.274 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.29 -25.19 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 122.165 -0.335 . . . . 0.0 110.481 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.733 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.6 t -74.93 -36.4 38.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.44 64.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.12 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.879 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.67 -33.12 21.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.714 ' O ' HG12 ' A' ' 57' ' ' VAL . 6.8 pt-20 -68.61 -49.2 61.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 109.792 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 35.1 mt-10 -66.63 -27.44 67.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.303 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.3 ptm180 -73.63 -12.88 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.084 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.591 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 67.5 m-85 -104.22 3.69 33.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.326 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 57.43 58.79 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.245 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -120.59 162.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.991 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 57' ' ' VAL . 80.5 tttt -124.14 110.89 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.981 0.419 . . . . 0.0 110.587 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 ' HD2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -134.57 136.93 26.52 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.942 176.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 126.57 21.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.259 1.973 . . . . 0.0 111.47 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.62 -35.55 68.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.93 -19.52 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.96 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 23.6 t70 -82.53 -21.26 35.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.56 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 45' ' ' VAL . 45.6 t -66.58 -38.88 82.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.681 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -84.16 -3.51 58.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.105 0.479 . . . . 0.0 110.611 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 30.7 t30 -82.11 -36.19 27.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.221 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.4 pp -84.07 126.83 33.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.522 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -2.59 55.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.996 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.854 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 78.6 p -122.48 147.93 45.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -66.49 -33.28 62.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.896 178.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -64.08 -36.84 93.77 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.131 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 1.9 t0 -60.63 -47.07 87.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -56.14 -54.76 41.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.459 0.647 . . . . 0.0 110.412 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.825 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.8 m -53.69 -50.49 65.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.617 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.696 ' HD2' HD12 ' A' ' 78' ' ' LEU . 12.9 tptm -66.12 -35.78 81.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.755 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' HD2' HD12 ' A' ' 59' ' ' ILE . 72.2 t80 -64.71 -42.24 95.4 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.99 -42.37 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.116 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 8' ' ' ILE . 82.2 mt -63.85 -23.0 67.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.209 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.76 -40.71 13.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.984 0.421 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -104.38 20.3 18.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.816 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HA ' HG23 ' A' ' 57' ' ' VAL . 3.3 pt20 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.622 0.248 . . . . 0.0 110.61 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.597 ' H ' HG22 ' A' ' 4' ' ' THR . 20.8 tt0 -54.54 -55.35 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -169.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -67.33 -34.38 77.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.197 0.522 . . . . 0.0 110.977 -173.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -75.09 -47.12 30.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.409 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.704 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -69.39 -31.45 49.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.09 -41.13 90.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 110.325 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.68 93.8 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.353 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.78 -51.16 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.94 -52.68 62.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.05 -40.88 46.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.718 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.807 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -85.01 -29.75 6.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.158 -172.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.801 HG11 HD12 ' A' ' 37' ' ' LEU . 42.2 t -76.43 -24.73 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 121.711 -0.618 . . . . 0.0 109.818 176.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.97 -30.96 71.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.505 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 15.4 tp10 -62.79 -41.47 99.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.178 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.534 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 28.9 mt -76.84 -54.45 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.001 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.51 -77.75 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.792 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.76 61.23 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.504 -1.332 . . . . 0.0 114.817 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.8 HG13 HD13 ' A' ' 37' ' ' LEU . 17.1 mm -87.98 129.22 51.02 Favored Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.7 141.28 35.27 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 111.548 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.66 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 91.1 t -56.32 -33.68 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.212 -174.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -76.65 -21.53 55.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.015 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.49 -15.54 37.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.552 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.454 HG21 ' CB ' ' A' ' 13' ' ' ALA . 72.6 t -69.17 121.0 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 70' ' ' VAL . 57.9 mtpt -144.39 177.16 8.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.256 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.617 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 19.8 mt -81.69 -7.32 59.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.048 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -92.83 -32.44 14.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.456 -171.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.651 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.71 139.23 32.88 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.702 -168.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.774 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.3 m -87.65 135.34 33.4 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.645 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.01 -45.6 82.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.407 0.622 . . . . 0.0 110.403 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.1 p -75.46 -33.41 60.84 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.214 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.774 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 15.2 t70 -91.64 -58.01 2.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.947 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.92 -47.15 8.06 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.633 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.801 HD12 HG11 ' A' ' 16' ' ' VAL . 3.9 mm? -67.38 -16.72 64.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.021 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.63 32.82 16.13 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.57 0.544 . . . . 0.0 110.535 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -99.25 147.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.592 -171.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.1 m-20 -96.67 164.53 12.55 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 p -55.65 -48.78 74.42 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.673 0.608 . . . . 0.0 111.522 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -50.95 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 19.1 m -47.6 -52.46 17.74 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.839 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 8.8 ptm -61.98 -50.67 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.262 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 64' ' ' VAL . 86.5 t -60.38 -25.23 33.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.944 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.51 -65.82 0.77 Allowed 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.879 -0.513 . . . . 0.0 111.226 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.591 HG12 HG12 ' A' ' 15' ' ' ILE . 6.7 t -88.36 -21.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.108 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -79.45 -27.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.102 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.653 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.44 -34.7 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.421 0.629 . . . . 0.0 109.389 169.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.39 68.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.355 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.807 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -80.36 -35.75 34.99 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.653 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 11.2 pt-20 -70.57 -52.72 19.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 29.8 mt-10 -66.08 -20.68 66.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.5 ptm180 -71.97 -5.31 33.93 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.803 -0.56 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.415 ' CB ' HE22 ' A' ' 81' ' ' GLN . 80.1 m-85 -119.76 13.02 12.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.738 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 59.77 41.92 17.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.727 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.701 HG11 HG23 ' A' ' 77' ' ' ILE . 9.5 p -115.17 137.56 48.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -134.28 117.89 16.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.252 0.548 . . . . 0.0 111.263 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.632 HD11 ' CG2' ' A' ' 64' ' ' VAL . 6.4 pt -116.38 164.94 16.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.591 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 63' ' ' ASP . 34.4 Cg_exo -61.76 134.48 50.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.586 1.524 . . . . 0.0 110.932 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.31 -41.14 62.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.632 . . . . 0.0 111.061 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.01 -20.49 66.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.229 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.19 -41.95 66.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.604 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 59' ' ' ILE . 48.2 t -59.22 -43.48 89.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -22.54 66.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.005 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.29 -17.71 23.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.442 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.3 pp -87.93 128.27 35.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.512 0.672 . . . . 0.0 110.688 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -90.83 -8.43 49.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.808 -170.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 13.2 p -128.73 157.16 42.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.36 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 28' ' ' LYS . 1.5 p -76.68 -18.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.88 -42.78 24.47 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.105 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.68 -39.29 84.02 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -57.44 -56.87 16.3 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.304 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.785 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -59.36 -50.6 73.33 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.52 -177.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HD2' HD12 ' A' ' 78' ' ' LEU . 1.5 tptm -62.4 -37.57 86.31 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.713 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.62 -41.06 98.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.701 HG23 HG11 ' A' ' 57' ' ' VAL . 27.7 mt -62.61 -52.36 60.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 74' ' ' THR . 84.2 mt -60.41 -35.0 74.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.36 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.34 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.533 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -98.95 7.85 45.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.435 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 77' ' ' ILE . 5.2 mm-40 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.959 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.78 -56.41 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.64 -30.54 65.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.747 0.308 . . . . 0.0 111.296 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -65.12 -53.53 43.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 110.24 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.8 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.82 -33.55 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.661 -178.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.91 -37.63 78.7 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.779 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.73 94.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.498 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.97 -39.87 89.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.937 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -63.05 -48.88 76.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.611 ' HA ' HG21 ' A' ' 27' ' ' VAL . . . -55.71 -50.0 71.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.032 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.93 -38.45 67.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.136 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.896 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.74 -33.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.752 HG11 HD12 ' A' ' 37' ' ' LEU . 43.8 t -74.34 -23.91 18.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -63.36 -24.43 67.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.741 174.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.02 -27.9 63.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.533 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.843 HD11 ' HB ' ' A' ' 47' ' ' VAL . 47.3 mt -91.26 -53.79 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.559 -173.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.81 -82.03 0.64 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.07 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.32 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.778 HG13 HD13 ' A' ' 37' ' ' LEU . 20.5 mm -88.33 130.73 44.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 166.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 9.8 Cg_endo -53.3 141.49 59.96 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.368 2.046 . . . . 0.0 111.017 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 34.9 m -62.88 -20.66 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.411 . . . . 0.0 111.717 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.44 -20.63 39.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -97.9 -8.75 27.55 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.161 -173.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 13' ' ' ALA . 68.9 t -67.23 110.21 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.688 0.756 . . . . 0.0 109.379 175.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' O ' HG13 ' A' ' 70' ' ' VAL . 55.5 mtpt -135.84 164.49 27.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.267 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.729 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.1 mp -74.68 -2.89 28.27 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.182 0.515 . . . . 0.0 110.238 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -104.26 -7.65 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.555 -171.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.612 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.78 141.58 35.85 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.29 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.796 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 16.2 m -83.64 132.3 34.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.089 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.63 -48.63 80.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.244 0.545 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -70.26 -35.55 73.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.491 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.796 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 14.4 t70 -91.5 -69.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.617 -173.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.15 -44.35 63.24 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.749 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.778 HD13 HG13 ' A' ' 22' ' ' ILE . 3.6 mm? -70.53 -15.87 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.51 29.99 19.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.569 0.7 . . . . 0.0 109.832 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.48 145.13 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.926 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.1 159.09 15.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 m -53.41 -42.64 67.22 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.335 0.397 . . . . 0.0 111.67 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -45.61 50.0 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.485 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 14.7 m -52.03 -53.04 46.61 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.527 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 9.6 ptm -59.09 -49.8 76.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.933 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.727 HG22 ' HB ' ' A' ' 64' ' ' VAL . 97.7 t -61.82 -26.22 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.2 -65.73 0.81 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.667 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 19' ' ' ILE . 20.3 t -89.27 -19.83 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.138 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 44' ' ' MET . 28.0 t -79.97 -22.0 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.661 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -76.39 -30.93 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 167.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.81 -25.34 67.44 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.552 168.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.28 -36.28 27.23 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.599 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.6 pt-20 -64.04 -45.76 87.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.634 0.73 . . . . 0.0 109.586 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.645 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 42.2 mt-10 -75.13 -21.47 58.83 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.246 -171.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -77.35 -4.84 47.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.214 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.07 16.66 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 59.13 51.54 6.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.601 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 52' ' ' GLU . 8.0 p -133.07 155.43 41.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -134.91 111.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.555 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.675 HD11 HG22 ' A' ' 64' ' ' VAL . 14.6 pt -104.9 163.35 17.35 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.567 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.6 Cg_exo -61.59 136.02 60.37 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 121.937 1.758 . . . . 0.0 112.019 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.6 -52.91 34.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.389 0.614 . . . . 0.0 111.075 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 6.1 p-10 -71.59 -18.32 62.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.482 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.667 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.8 t0 -75.2 -22.57 57.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.387 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' HG22 ' A' ' 45' ' ' VAL . 61.7 t -67.18 -43.79 88.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.547 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.97 -14.25 60.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.086 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 39.4 t30 -73.81 -40.62 63.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.043 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.5 pp -79.26 134.35 36.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.344 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.17 -1.02 27.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.305 -171.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.508 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 44.3 p -131.8 149.13 52.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.176 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -69.88 -21.27 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 109.745 177.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -75.53 -39.51 34.98 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.573 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.08 -35.44 79.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.492 0.663 . . . . 0.0 109.215 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -58.4 -46.42 86.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.326 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.774 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.12 -51.84 58.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.946 -174.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.662 ' HD3' HD12 ' A' ' 78' ' ' LEU . 34.1 mmtp -57.26 -37.81 72.91 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.532 0.52 . . . . 0.0 110.848 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.477 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 35.5 t80 -63.07 -43.57 98.19 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.269 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -65.31 -48.15 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.159 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 8' ' ' ILE . 96.8 mt -56.04 -46.17 78.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.587 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -71.7 -6.27 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -128.91 1.55 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 8.6 pt20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.885 -0.143 . . . . 0.0 111.082 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.543 ' H ' HG22 ' A' ' 4' ' ' THR . 49.0 tt0 -59.95 -55.67 31.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.35 -39.87 89.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.67 -53.57 49.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.409 0.623 . . . . 0.0 110.53 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.871 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.53 -30.23 46.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.086 -177.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -62.38 -39.48 84.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.766 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.45 97.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.59 -47.41 84.09 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.992 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.8 -39.07 90.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.041 0.448 . . . . 0.0 109.807 177.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.09 -55.73 31.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.218 177.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.46 -41.01 52.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.919 0.866 . . . . 0.0 109.832 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' A' ' 51' ' ' ALA . 9.4 mm -64.2 -57.84 9.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.56 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.846 HG11 HD12 ' A' ' 37' ' ' LEU . 4.2 t -72.05 -23.89 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.446 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -59.48 -30.33 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.612 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.77 -20.6 49.5 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.406 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.629 HD11 ' HB ' ' A' ' 47' ' ' VAL . 47.4 mt -90.47 -54.23 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.929 -175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.06 -93.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.29 0.07 OUTLIER Glycine 0 CA--C 1.522 0.504 0 C-N-CA 119.189 -1.482 . . . . 0.0 115.471 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.836 HG13 HD13 ' A' ' 37' ' ' LEU . 17.5 mm -86.68 124.14 69.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 118.124 0.962 . . . . 0.0 108.608 166.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.55 155.3 42.79 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.736 2.291 . . . . 0.0 112.034 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.787 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 90.9 t -57.54 -40.9 77.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.761 -173.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.28 -16.53 52.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.875 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' A' ' 22' ' ' ILE . 24.5 t70 -80.65 -15.51 56.38 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.739 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 13' ' ' ALA . 57.6 t -65.08 121.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.737 0.78 . . . . 0.0 110.555 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 16.9 mtpp -139.64 146.79 40.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.901 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.561 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 39.1 mt -70.95 -7.22 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 110.19 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 6.3 p-10 -107.99 8.97 28.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.955 -177.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HG2' ' CG1' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -105.85 145.91 30.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.868 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 14.8 m -95.45 138.04 33.68 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -170.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.5 m-85 -58.34 -46.24 86.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.388 0.614 . . . . 0.0 110.229 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.8 p -77.55 -30.76 52.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.717 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' CB ' ' HB2' ' A' ' 32' ' ' SER . 1.4 t70 -92.53 -50.25 5.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.857 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.83 -52.27 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.762 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.846 HD12 HG11 ' A' ' 16' ' ' VAL . 3.3 mm? -67.85 -11.5 58.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.723 -168.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.93 35.75 25.6 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.53 0.519 . . . . 0.0 110.536 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.405 -172.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.33 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.195 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 44' ' ' MET . 40.7 m -51.52 -59.48 4.21 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.622 0.576 . . . . 0.0 112.083 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.14 -40.89 77.99 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.961 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.498 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -50.42 -56.6 10.75 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.59 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 11.8 ptm -62.7 -47.0 85.53 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.908 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.0 t -68.18 -24.48 30.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.005 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.49 -66.13 0.81 Allowed 'General case' 0 C--O 1.242 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 111.493 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.662 HG12 HG23 ' A' ' 15' ' ' ILE . 7.8 t -84.28 -24.67 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.509 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.639 ' HA ' HG21 ' A' ' 15' ' ' ILE . 40.5 t -77.47 -20.24 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.419 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.706 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 2.9 t -74.78 -33.16 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -18.35 64.48 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.396 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.988 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -82.29 -38.31 24.55 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.845 176.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.706 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.7 -45.99 77.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.15 -176.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.09 -27.1 66.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.31 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.8 ptp180 -79.2 -7.14 58.0 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.393 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -116.12 15.62 16.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t70 54.71 70.74 0.59 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.732 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.1 p -139.13 165.89 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 57' ' ' VAL . 14.7 pttm -133.78 110.49 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.991 0.424 . . . . 0.0 110.179 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 ' OE1' ' A' ' 52' ' ' GLU . 29.1 pt -121.85 154.63 60.8 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.474 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 141.74 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 111.956 173.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.54 -51.4 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.437 0.637 . . . . 0.0 109.509 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.162 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -34.85 79.15 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.229 0.331 . . . . 0.0 110.963 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.629 ' HB ' HG22 ' A' ' 45' ' ' VAL . 43.0 t -61.5 -39.16 81.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.077 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -18.22 51.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 110.608 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -74.37 -24.15 59.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.152 0.501 . . . . 0.0 109.904 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.734 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -97.57 130.21 44.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.43 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -96.08 -1.56 48.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.543 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.868 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 59.2 p -122.41 146.5 47.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.704 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 2.1 p -65.92 -34.91 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.852 177.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.55 -30.28 76.08 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.89 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 2.3 t70 -68.1 -49.1 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -58.48 -45.73 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.586 0.707 . . . . 0.0 110.099 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.725 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 17.0 m -59.62 -51.7 68.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.628 -177.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -66.09 -30.46 70.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.197 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.62 -46.58 85.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.918 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.542 HG23 HG11 ' A' ' 57' ' ' VAL . 87.4 mt -63.62 -40.98 91.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.219 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 8' ' ' ILE . 92.2 mt -66.64 -26.68 67.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.847 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.03 -34.03 20.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.423 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -119.77 20.73 12.21 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.429 ' HA ' HG23 ' A' ' 57' ' ' VAL . 3.3 pt20 . . . . . 0 C--N 1.325 -0.497 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.734 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 5' ' ' GLN . 1.2 m . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.633 ' H ' HG22 ' A' ' 4' ' ' THR . 38.0 tt0 -58.66 -55.62 32.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -54.0 -44.83 71.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -67.72 -56.29 9.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.399 0.618 . . . . 0.0 111.027 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.681 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -67.44 -30.65 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.139 -174.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.66 -43.53 97.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.446 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.34 92.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.685 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.556 ' HA3' ' CZ ' ' A' ' 55' ' ' PHE . . . -68.5 -44.15 74.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.427 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.37 -46.31 89.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.75 -52.51 63.69 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.766 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.79 -36.48 58.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.646 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.07 -31.89 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.672 -173.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG11 HD12 ' A' ' 37' ' ' LEU . 19.9 t -74.2 -28.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.246 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.25 -29.76 67.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.949 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.73 -22.12 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.718 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.1 mt -92.89 -54.02 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.296 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.47 -93.12 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.27 50.99 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.696 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.772 HG13 HD13 ' A' ' 37' ' ' LEU . 22.7 mm -94.08 120.21 65.87 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 162.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.31 153.79 72.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 111.722 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.644 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.4 m -60.66 -17.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.43 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.57 -20.98 53.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.763 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 22' ' ' ILE . 17.7 t0 -106.07 -11.84 15.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.871 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 13' ' ' ALA . 97.3 t -71.85 123.24 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.273 0.558 . . . . 0.0 110.954 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 70' ' ' VAL . 75.8 mttt -148.09 166.36 28.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 24.2 mt -78.35 -3.34 42.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.036 0.446 . . . . 0.0 110.64 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.69 -30.06 15.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.527 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -84.88 139.67 31.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.396 0.617 . . . . 0.0 110.504 -168.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.792 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 16.2 m -85.26 138.61 32.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.834 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.584 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -58.46 -51.24 70.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.303 0.573 . . . . 0.0 110.55 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.6 p -69.8 -33.84 72.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.291 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.76 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 36.2 t70 -92.42 -69.25 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.774 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -69.46 -55.55 9.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.063 -177.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.815 HD12 HG11 ' A' ' 16' ' ' VAL . 3.6 mm? -63.64 -16.64 61.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 63.3 24.5 14.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.774 0.797 . . . . 0.0 109.712 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -92.72 150.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.613 -172.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.4 161.63 14.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.652 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 17.8 m -48.3 -50.9 28.3 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.447 0.467 . . . . 0.0 111.544 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -42.6 69.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.722 ' HB2' HG22 ' A' ' 39' ' ' VAL . 15.2 m -50.95 -52.06 46.21 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.466 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.715 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 13.1 ptt? -63.67 -47.84 79.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.797 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 64' ' ' VAL . 80.1 t -57.38 -26.64 26.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.051 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.37 -65.73 0.82 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.958 -0.464 . . . . 0.0 111.185 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 15' ' ' ILE . 21.0 t -87.05 -21.3 7.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.36 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.6 t -79.51 -20.48 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.634 -0.666 . . . . 0.0 110.219 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.639 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.6 t -75.87 -34.64 28.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -59.36 -24.08 63.08 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.99 168.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.12 -33.85 24.23 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.117 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.685 ' O ' HG12 ' A' ' 57' ' ' VAL . 2.5 pt-20 -64.19 -48.12 77.15 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.559 0.695 . . . . 0.0 109.561 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.65 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 32.2 mt-10 -72.73 -22.38 60.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.254 -172.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 7.4 ptp180 -80.79 -10.64 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.215 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' CZ ' ' HA3' ' A' ' 11' ' ' GLY . 58.1 m-85 -105.7 4.08 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 57.04 70.93 0.61 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.0 p -132.39 166.67 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 57' ' ' VAL . 4.4 mptt -123.79 110.56 15.06 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.622 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.497 HG13 ' HD2' ' A' ' 60' ' ' PRO . 5.9 tt -134.86 135.46 23.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 0.0 110.588 172.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD2' HG13 ' A' ' 59' ' ' ILE . 18.6 Cg_endo -66.88 150.79 83.08 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.572 2.182 . . . . 0.0 112.849 175.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.7 -48.06 50.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.948 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 1.039 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -53.74 -44.37 69.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.588 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -62.94 -33.89 76.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -171.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.93 ' HB ' HG22 ' A' ' 45' ' ' VAL . 12.0 t -68.37 -41.33 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.841 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 1.039 ' HE3' ' HA ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.29 -0.76 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 122.105 -0.372 . . . . 0.0 111.766 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -91.19 -31.24 16.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.834 0.35 . . . . 0.0 110.302 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 73' ' ' ALA . 2.9 pp -81.63 145.23 30.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.431 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -110.51 -5.19 15.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.897 -172.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.792 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 43.8 p -127.25 153.72 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 31' ' ' LYS . 2.1 p -74.12 -22.4 18.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.47 0.652 . . . . 0.0 110.025 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -73.43 -31.47 60.99 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.182 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.05 -46.2 85.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HA ' HD22 ' A' ' 67' ' ' LEU . . . -57.09 -45.15 83.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.815 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -67.13 -45.52 76.88 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.633 -175.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 1.012 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 5.8 mmpt? -62.53 -31.02 71.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.58 -49.34 48.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 109.918 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.6 mt -58.29 -49.35 82.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 8' ' ' ILE . 73.5 mt -69.45 -20.97 63.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.235 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.4 -21.88 32.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.205 0.526 . . . . 0.0 110.692 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -125.19 22.7 7.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.524 ' HA ' HG23 ' A' ' 57' ' ' VAL . 3.6 pt20 . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.016 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.594 ' H ' HG22 ' A' ' 4' ' ' THR . 13.6 tt0 -53.2 -56.43 16.47 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -171.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.87 -38.39 90.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -67.67 -54.18 21.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.143 0.497 . . . . 0.0 111.124 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.755 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -67.14 -32.74 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.33 -39.37 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.569 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.95 94.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.61 59.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.054 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -61.37 -53.83 51.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.04 -50.6 72.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.934 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -55.29 -35.83 65.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.347 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -81.15 -31.71 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.807 -177.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.811 HG11 HD12 ' A' ' 37' ' ' LEU . 22.4 t -74.61 -26.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 O-C-N 121.915 -0.491 . . . . 0.0 109.69 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.4 -28.62 70.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -66.58 -36.31 82.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.149 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 47' ' ' VAL . 27.3 mt -80.27 -52.61 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.421 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.87 -84.7 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.82 53.63 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.933 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.811 HG13 HD13 ' A' ' 37' ' ' LEU . 22.8 mm -89.43 125.05 62.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 165.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.3 146.57 60.58 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.452 2.101 . . . . 0.0 111.395 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.708 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 31.4 m -54.51 -35.06 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -81.31 -17.79 48.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.836 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HB3' HG23 ' A' ' 22' ' ' ILE . 12.6 t70 -83.35 -22.51 32.82 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.999 0.428 . . . . 0.0 110.603 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 13' ' ' ALA . 72.4 t -62.78 129.18 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.908 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -145.64 159.37 43.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.398 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.512 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.2 mp -77.37 -3.83 42.1 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.981 0.419 . . . . 0.0 110.547 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.12 1.58 24.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.17 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.72 140.44 37.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.683 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.905 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.7 m -87.41 136.83 32.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.463 -170.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.638 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.17 -49.79 76.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 110.196 177.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.5 p -69.54 -34.32 74.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 9.5 t70 -91.59 -68.68 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.307 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.8 m-20 -72.92 -52.38 14.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.895 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.811 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -66.35 -10.45 43.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.127 -172.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 61.38 31.44 19.2 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.803 0.69 . . . . 0.0 109.944 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.5 OUTLIER -102.66 153.13 5.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.418 -171.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.7 170.89 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.605 170.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 44' ' ' MET . 24.8 t -57.33 -59.77 4.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.421 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.0 tm? -68.53 -39.15 81.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.372 -176.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.504 ' HB2' HG22 ' A' ' 39' ' ' VAL . 13.3 m -48.87 -53.53 19.1 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.008 0.432 . . . . 0.0 111.637 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.617 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 20.3 ptt? -65.27 -42.83 92.81 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.574 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 98.7 t -60.18 -26.19 35.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.07 0.462 . . . . 0.0 110.389 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.12 -65.39 0.85 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.856 -0.528 . . . . 0.0 111.413 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' HB ' HD11 ' A' ' 19' ' ' ILE . 15.8 t -85.72 -23.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.137 -173.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.2 t -79.32 -23.21 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.481 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.737 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.3 t -76.63 -31.8 20.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 109.329 169.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.64 -25.85 67.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.379 0.609 . . . . 0.0 109.789 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.07 -37.7 26.0 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.972 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.9 pt-20 -61.83 -51.63 67.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.484 0.659 . . . . 0.0 109.643 -175.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.636 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.7 mt-10 -71.35 -22.85 61.85 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.649 -171.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.2 ptm180 -75.01 -19.37 60.11 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -97.91 6.92 47.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t0 60.54 57.94 2.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.656 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.766 HG11 HG23 ' A' ' 77' ' ' ILE . 13.3 p -134.3 161.65 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.201 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 58' ' ' LYS . 13.4 tptp -127.82 112.93 15.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.111 175.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 tt -118.12 117.32 35.23 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.819 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.58 138.88 39.47 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.448 2.099 . . . . 0.0 111.726 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 5.2 p-10 -58.33 -29.55 66.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.529 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.632 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 32.7 t70 -67.53 -25.31 65.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.023 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.81 -37.94 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.642 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 46.7 t -63.54 -53.86 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.045 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.632 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -63.36 -9.95 14.42 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 176.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.5 -41.36 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.773 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 1.2 pp -67.6 137.1 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.453 0.644 . . . . 0.0 110.988 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -96.21 -20.68 18.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.195 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.905 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 14.8 p -119.95 154.55 34.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.543 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.4 p -63.53 -31.15 51.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 109.999 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -63.72 -33.79 88.2 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.523 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 51.1 m-20 -57.92 -52.73 64.29 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -57.49 -52.21 66.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.743 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.769 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.0 m -56.94 -52.92 63.27 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.019 -173.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HA ' HD12 ' A' ' 78' ' ' LEU . 4.2 tppp? -65.98 -31.34 72.19 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.592 0.234 . . . . 0.0 110.452 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.94 -43.07 84.16 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.257 0.551 . . . . 0.0 109.619 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.766 HG23 HG11 ' A' ' 57' ' ' VAL . 46.5 mt -59.99 -46.57 93.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.239 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 74' ' ' THR . 95.0 mt -62.35 -28.03 69.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.109 -175.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.69 -39.62 44.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.093 0.473 . . . . 0.0 111.084 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.471 ' O ' HG23 ' A' ' 57' ' ' VAL . 69.0 m-70 -105.62 21.69 16.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.272 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.915 -172.116 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 8' ' ' ILE . 12.7 tt0 -50.49 -56.3 12.16 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.26 -41.24 88.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.69 -45.92 41.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.879 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.92 -33.97 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.36 -39.75 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.983 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.37 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.14 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.5 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.48 -45.4 78.49 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.992 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.34 -40.01 96.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.634 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -54.89 41.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 41.9 tt0 -52.9 -42.44 65.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.432 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.934 HG13 ' HB2' ' A' ' 51' ' ' ALA . 8.0 mm -62.61 -53.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.292 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 37' ' ' LEU . 13.2 t -71.2 -23.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.461 . . . . 0.0 110.303 -177.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -65.85 -19.68 65.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.009 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 5.1 mm-40 -83.16 -29.66 28.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.145 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 47' ' ' VAL . 32.3 mt -84.86 -53.02 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.631 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.34 -86.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.05 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.35 56.84 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.573 -1.299 . . . . 0.0 114.492 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.842 HG13 HD13 ' A' ' 37' ' ' LEU . 12.8 mm -87.88 124.81 66.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 164.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 147.95 49.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 111.757 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.634 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 79.2 t -54.61 -40.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.645 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -75.41 -17.02 60.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.298 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 22' ' ' ILE . 1.6 t70 -90.09 -5.71 56.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.142 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 13' ' ' ALA . 46.0 t -68.83 116.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.549 0.69 . . . . 0.0 109.696 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 13.6 mtpp -132.78 144.89 50.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.454 -171.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.2 mp -74.08 -3.43 29.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.873 0.368 . . . . 0.0 110.997 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 5.8 p-10 -108.03 -7.91 16.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.762 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.93 140.0 30.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.442 -177.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.821 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.2 m -87.98 135.77 33.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.448 -170.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -56.67 -48.16 78.22 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.277 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.5 p -71.8 -33.65 68.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.201 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 5.0 t70 -92.13 -65.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.199 0.523 . . . . 0.0 111.651 -173.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.1 m-20 -75.82 -52.76 9.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.673 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.004 HD12 HG11 ' A' ' 16' ' ' VAL . 2.9 mm? -66.19 -14.54 62.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.791 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 61.76 32.91 18.13 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.856 0.836 . . . . 0.0 109.38 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.4 OUTLIER -98.81 146.96 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.809 -171.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.498 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 8.2 m-20 -95.92 173.84 7.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.674 ' HB3' ' HD3' ' A' ' 65' ' ' LYS . 13.6 m -57.25 -56.32 23.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.565 . . . . 0.0 110.471 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -65.59 -40.49 92.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.583 ' HB2' HG22 ' A' ' 39' ' ' VAL . 14.7 m -50.59 -54.72 20.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 15.3 ptt? -66.36 -40.96 90.11 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.646 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.64 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 82.5 t -63.09 -24.95 37.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.704 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -74.32 -66.41 0.73 Allowed 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.74 -0.6 . . . . 0.0 111.659 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG12 HG23 ' A' ' 15' ' ' ILE . 11.8 t -91.12 -22.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.578 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 44' ' ' MET . 21.5 t -80.46 -21.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.619 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.1 t -73.95 -33.57 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.609 0.718 . . . . 0.0 109.302 167.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.36 66.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.339 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.934 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -81.14 -45.75 15.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.671 ' O ' HG12 ' A' ' 57' ' ' VAL . 8.1 pt-20 -59.31 -49.11 79.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.034 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.8 pt-20 -62.68 -30.67 71.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.724 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -78.7 -5.0 51.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.275 0.56 . . . . 0.0 110.343 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 68.7 m-85 -114.2 22.38 13.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.345 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 71.75 17.47 5.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.507 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.678 HG11 HG23 ' A' ' 77' ' ' ILE . 9.6 p -114.49 158.29 14.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.075 -0.391 . . . . 0.0 110.435 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 50.1 mtpt -134.06 111.3 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' HB ' ' HE2' ' A' ' 76' ' ' TYR . 21.4 pt -108.53 163.36 17.14 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.825 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.0 Cg_exo -65.3 129.61 23.21 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.942 1.761 . . . . 0.0 111.623 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.79 -49.2 63.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 110.06 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.41 -19.52 64.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.275 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.825 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 2.7 t0 -74.0 -38.08 64.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.652 ' HA ' HD21 ' A' ' 67' ' ' LEU . 22.2 t -60.12 -42.75 91.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HD3' ' HB3' ' A' ' 41' ' ' SER . 17.6 tptp -59.91 -31.08 69.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.795 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.63 -26.99 40.98 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.154 -0.341 . . . . 0.0 111.255 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.717 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -83.7 136.58 34.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.292 -178.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.36 -22.77 22.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.131 -173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.821 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 32.8 p -120.2 156.98 30.05 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.887 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -67.72 -36.96 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.1 -41.51 96.59 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.025 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.96 -50.73 72.19 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -54.79 -50.28 68.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.58 0.705 . . . . 0.0 110.936 176.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.795 HG23 HD12 ' A' ' 8' ' ' ILE . 12.4 m -58.98 -49.49 77.69 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.686 -174.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HD2' HD12 ' A' ' 78' ' ' LEU . 7.6 tptm -65.95 -38.65 89.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.449 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 59.3 t80 -56.91 -43.34 81.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.678 HG23 HG11 ' A' ' 57' ' ' VAL . 82.0 mt -65.18 -49.9 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.536 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 8' ' ' ILE . 91.5 mt -54.15 -44.99 71.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.21 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -86.68 -3.63 59.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.475 ' O ' HG23 ' A' ' 57' ' ' VAL . 29.9 m-70 -124.69 15.22 8.73 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.244 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.546 0.213 . . . . 0.0 111.498 -173.155 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.565 ' H ' HG22 ' A' ' 4' ' ' THR . 24.8 tt0 -58.99 -55.71 31.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -167.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -32.22 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.868 0.366 . . . . 0.0 111.144 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.05 -47.65 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.848 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.35 -33.11 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.11 -43.02 95.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.1 95.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.937 0.398 . . . . 0.0 110.875 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.806 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.51 -33.03 75.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.341 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -68.62 -48.64 63.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.13 -46.77 85.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.58 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -52.39 -36.74 54.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.496 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.59 -35.6 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.81 -174.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.724 HG11 HD12 ' A' ' 37' ' ' LEU . 36.2 t -71.17 -23.97 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 109.776 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -62.6 -24.57 67.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.28 -38.48 63.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 109.958 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.717 HD11 ' HB ' ' A' ' 47' ' ' VAL . 24.9 mt -71.04 -53.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.694 -174.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.24 -86.14 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.452 -175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 64.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.685 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 37' ' ' LEU . 23.2 mm -99.61 131.35 24.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 164.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.99 148.34 48.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.465 2.11 . . . . 0.0 111.633 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.694 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 93.9 t -59.88 -38.57 76.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.15 0.5 . . . . 0.0 111.304 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -76.71 -18.31 58.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' A' ' 22' ' ' ILE . 11.2 t70 -83.23 -22.74 33.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.68 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 13' ' ' ALA . 75.2 t -66.4 122.28 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.572 0.701 . . . . 0.0 110.729 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 82.1 mttt -144.04 169.76 17.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.207 -176.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.751 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.6 mp -81.57 -2.5 50.25 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.494 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -110.38 2.01 18.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.83 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.05 141.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.725 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 24.9 m -88.4 136.46 32.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.881 0.372 . . . . 0.0 111.658 -170.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.58 -47.83 84.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.535 0.684 . . . . 0.0 110.426 178.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 38.9 p -72.95 -33.66 66.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.354 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.725 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.5 t70 -91.67 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 111.539 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -49.11 18.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.287 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.798 HD13 HG13 ' A' ' 22' ' ' ILE . 3.5 mm? -70.23 -14.73 62.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.659 -176.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.49 31.88 20.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.847 0.832 . . . . 0.0 110.129 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -97.66 151.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.881 -169.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.4 m-20 -104.0 166.25 10.53 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 p -51.23 -55.65 16.98 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.709 0.631 . . . . 0.0 111.32 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -62.96 -48.97 76.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.598 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.606 ' HB2' ' H ' ' A' ' 40' ' ' ASP . 13.0 m -50.94 -54.29 25.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.646 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.671 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 4.8 ptm -59.74 -49.43 77.78 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.698 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.5 t -68.81 -22.31 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.16 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.82 -66.2 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.661 -0.649 . . . . 0.0 111.743 -174.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 19' ' ' ILE . 16.6 t -87.88 -21.74 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.052 -173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.9 t -78.82 -26.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.286 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.69 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -72.72 -35.04 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.01 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.23 0.538 . . . . 0.0 109.918 171.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -83.49 -39.6 20.3 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.131 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 4.5 pt-20 -59.81 -48.31 82.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.494 0.664 . . . . 0.0 109.559 -175.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.62 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.2 mt-10 -64.56 -33.64 76.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.169 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -81.31 -6.03 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.374 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.806 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 62.1 m-85 -105.25 6.71 33.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 170.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.38 68.36 0.77 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.553 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -140.59 161.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.353 174.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 57' ' ' VAL . 25.3 tptp -122.88 110.56 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 169.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.5 pt -119.08 151.35 50.49 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.76 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.1 Cg_exo -61.79 121.21 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.991 1.794 . . . . 0.0 110.847 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.06 -39.29 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 0.0 110.215 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.33 -36.36 81.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.76 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -66.91 -34.79 78.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.315 -174.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.698 ' HB ' HG22 ' A' ' 45' ' ' VAL . 21.3 t -58.42 -36.45 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.165 0.507 . . . . 0.0 110.657 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -75.19 -28.46 60.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.895 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.49 -21.87 44.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.691 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -84.71 123.48 30.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 0.0 110.585 177.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -82.3 -14.68 54.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.009 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 73.4 p -119.71 148.74 43.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.33 -36.16 76.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.041 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -66.97 -30.21 75.7 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.953 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.531 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 4.0 t70 -61.6 -40.68 95.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -67.97 -39.46 83.33 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.114 176.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -65.15 -51.81 58.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.007 -172.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.42 -37.03 79.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.246 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 14.6 t80 -63.34 -38.61 91.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.396 0.617 . . . . 0.0 110.706 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.501 HG23 HG11 ' A' ' 57' ' ' VAL . 52.5 mt -68.99 -33.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.533 0.682 . . . . 0.0 110.261 175.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.848 HD21 HG21 ' A' ' 8' ' ' ILE . 96.8 mt -77.97 -35.51 50.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.416 -172.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.9 -4.88 58.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.6 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -123.44 15.01 9.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.581 ' HA ' HG23 ' A' ' 57' ' ' VAL . 4.0 pt20 . . . . . 0 C--O 1.234 0.27 0 CA-C-O 120.698 0.285 . . . . 0.0 111.557 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.714 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.3 tt0 -55.61 -55.59 30.31 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 9' ' ' VAL . 9.2 pt-20 -64.5 -39.17 93.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.899 0.381 . . . . 0.0 111.566 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.34 -54.35 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.0 110.885 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.768 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.67 -31.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.689 -177.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -69.71 -31.73 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.253 -177.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.82 74.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.63 78.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.774 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -72.32 -49.39 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' CB ' HG21 ' A' ' 27' ' ' VAL . . . -52.52 -53.63 43.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -50.23 -42.45 51.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.117 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.953 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.38 -27.94 6.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.536 -169.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.85 HG11 HD12 ' A' ' 37' ' ' LEU . 45.8 t -76.05 -24.76 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -68.05 -21.49 65.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.043 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 5.2 mm-40 -70.54 -29.07 65.45 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.349 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 47' ' ' VAL . 39.3 mt -92.88 -55.29 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.553 -171.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.13 -89.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.205 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.52 44.11 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.206 -1.473 . . . . 0.0 115.117 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.803 HG13 HD13 ' A' ' 37' ' ' LEU . 14.2 mm -78.24 124.82 85.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.8 142.72 83.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.274 1.982 . . . . 0.0 111.152 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.449 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 34.6 m -59.2 -20.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.976 0.417 . . . . 0.0 111.657 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.82 -18.67 46.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.249 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 22' ' ' ILE . 1.5 t70 -100.77 -7.91 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.647 0.26 . . . . 0.0 111.329 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 13' ' ' ALA . 84.6 t -68.21 118.2 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.325 0.583 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 70' ' ' VAL . 49.6 mtpt -143.17 160.33 40.63 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.207 -170.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.616 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.0 mp -74.14 -3.75 31.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.091 0.472 . . . . 0.0 110.864 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.61 -15.58 18.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.904 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.83 142.94 28.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.427 -173.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 16.0 t -84.4 134.24 34.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.889 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.542 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.03 -49.8 76.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.529 0.68 . . . . 0.0 109.843 177.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.1 p -71.95 -31.82 66.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.179 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.9 t70 -92.68 -68.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.896 -175.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -77.08 -45.24 27.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.976 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.85 HD12 HG11 ' A' ' 16' ' ' VAL . 4.0 mm? -66.73 -16.26 64.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.616 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 57.29 42.52 25.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.872 0.844 . . . . 0.0 108.83 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -110.64 144.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.638 -173.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 166.61 15.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 8.2 m -54.77 -52.29 63.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.586 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -72.62 -42.02 64.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.216 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -48.11 -55.23 10.77 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 123.29 0.369 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.588 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 19.9 ptt? -64.35 -48.6 74.91 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.569 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.774 HG22 ' HB ' ' A' ' 64' ' ' VAL . 55.7 t -54.78 -28.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.854 0.359 . . . . 0.0 111.209 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.6 -65.52 0.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.85 -0.531 . . . . 0.0 111.565 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.765 ' HB ' HD11 ' A' ' 19' ' ' ILE . 15.2 t -85.36 -22.61 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.645 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 44' ' ' MET . 55.6 t -78.83 -25.51 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.521 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.677 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.92 -36.25 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.18 -23.47 66.63 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.232 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.953 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -83.34 -35.94 24.79 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.911 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -69.94 -48.62 57.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.42 -23.57 66.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.848 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 4.4 ptm180 -71.96 -10.71 60.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.478 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -111.09 18.42 19.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.913 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 68.89 25.63 6.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.93 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.717 HG11 HG23 ' A' ' 77' ' ' ILE . 11.5 p -115.16 151.25 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -135.08 124.41 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.196 0.522 . . . . 0.0 110.905 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 64' ' ' VAL . 7.0 pt -116.02 166.23 12.87 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.93 125.67 17.08 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 121.401 1.401 . . . . 0.0 110.446 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.57 -42.93 24.76 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.479 0.657 . . . . 0.0 110.861 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.1 t70 -63.08 -19.71 64.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.656 -176.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.92 -25.4 40.53 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.377 -0.202 . . . . 0.0 111.517 -173.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.774 ' HB ' HG22 ' A' ' 45' ' ' VAL . 43.8 t -64.77 -33.38 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.588 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 3.5 tmmm? -66.1 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.403 171.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -71.1 -26.82 63.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.954 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 73' ' ' ALA . 1.1 pp -94.63 134.65 36.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.388 0.613 . . . . 0.0 110.751 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -97.36 -6.58 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.795 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 69.6 p -129.69 152.24 49.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.482 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -70.55 -22.27 23.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 109.831 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.79 -36.79 41.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.586 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 6.0 t0 -58.62 -42.55 88.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.622 0.725 . . . . 0.0 109.082 176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HA ' HD22 ' A' ' 67' ' ' LEU . . . -60.19 -48.26 82.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.921 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.742 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -63.08 -50.65 69.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.547 -172.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.545 ' HD3' HD12 ' A' ' 78' ' ' LEU . 23.7 mmtp -58.96 -39.67 82.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.124 0.265 . . . . 0.0 111.251 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 42.2 t80 -62.93 -44.59 95.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.026 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.717 HG23 HG11 ' A' ' 57' ' ' VAL . 61.2 mt -61.76 -44.56 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.734 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.768 HD21 HG21 ' A' ' 8' ' ' ILE . 92.3 mt -65.55 -40.95 93.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.322 -174.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -75.07 -32.51 61.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.927 0.394 . . . . 0.0 111.669 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.52 22.54 15.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--N 1.325 -0.462 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.762 -177.716 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' H ' HG22 ' A' ' 4' ' ' THR . 19.2 tt0 -55.73 -55.97 25.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.4 pm0 -67.64 -36.37 80.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.682 0.277 . . . . 0.0 111.546 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.47 -52.71 56.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.326 0.584 . . . . 0.0 110.613 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.869 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -69.91 -33.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.012 -178.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -59.99 -41.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.78 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.15 94.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.507 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.93 96.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.129 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -47.56 82.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.42 -50.13 70.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.543 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.64 -36.42 62.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.828 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.802 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.52 -32.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.807 -174.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.754 HG11 HD12 ' A' ' 37' ' ' LEU . 21.2 t -72.31 -24.27 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 121.63 -0.669 . . . . 0.0 109.981 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -62.56 -28.69 70.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.703 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.68 -23.65 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.356 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 47' ' ' VAL . 44.5 mt -86.78 -52.98 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.995 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.46 -75.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.71 53.73 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.874 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.807 HG13 HD13 ' A' ' 37' ' ' LEU . 11.1 mm -80.94 129.94 65.56 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 165.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.672 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 7.3 Cg_endo -52.04 140.34 49.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.322 2.014 . . . . 0.0 111.187 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 23.3 m -57.34 -26.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 mm-40 -80.47 -18.74 47.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.672 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 1.8 t70 -95.23 -8.48 35.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.587 -172.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 13' ' ' ALA . 53.1 t -68.5 111.22 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.611 0.72 . . . . 0.0 110.052 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -132.06 162.13 31.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.631 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 23.8 mt -74.64 -5.61 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.136 0.493 . . . . 0.0 110.378 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.88 -19.2 19.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.022 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -93.53 143.92 25.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.935 -175.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.922 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.0 m -90.39 135.04 33.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.294 -173.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.7 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.6 m-85 -54.73 -52.52 62.21 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 110.206 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -60.54 -43.95 96.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.757 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.14 -68.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.142 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.97 -45.91 83.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.833 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.807 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -72.98 -11.57 60.62 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t0 56.55 43.58 25.49 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.968 0.792 . . . . 0.0 108.896 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.492 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -105.61 146.33 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.417 -172.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 44' ' ' MET . 3.7 m-20 -91.79 153.44 19.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.457 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 50.6 m -55.87 -41.6 74.61 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.601 0.563 . . . . 0.0 111.677 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -72.48 -43.4 63.74 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.568 ' OG ' HG23 ' A' ' 19' ' ' ILE . 1.9 t -58.99 -49.48 77.73 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.974 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.541 ' HE2' HG12 ' A' ' 64' ' ' VAL . 13.6 ptm -57.1 -49.04 77.11 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.883 HG22 ' HB ' ' A' ' 64' ' ' VAL . 79.1 t -60.14 -25.92 34.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.295 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.87 -64.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.911 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' A' ' 19' ' ' ILE . 11.6 t -85.0 -22.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.349 -173.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 44' ' ' MET . 49.4 t -78.38 -28.15 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.134 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.687 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 12.7 t -71.36 -33.1 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.561 0.696 . . . . 0.0 109.3 169.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -60.82 -26.7 67.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.095 0.474 . . . . 0.0 110.05 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.802 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.3 -38.1 24.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.892 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 9.2 pt-20 -63.86 -46.49 84.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.8 mt-10 -70.19 -26.4 63.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.252 -173.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -77.8 -6.15 53.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 67.1 m-85 -111.47 19.19 18.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 174.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.59 40.21 6.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.632 174.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.9 p -127.86 159.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 173.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.36 112.85 10.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.01 0.433 . . . . 0.0 110.095 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.542 HD11 HG22 ' A' ' 64' ' ' VAL . 14.2 pt -107.83 163.97 15.8 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.49 133.62 40.81 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.574 1.516 . . . . 0.0 109.771 170.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.63 -34.59 67.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 8.4 t70 -69.43 -18.24 63.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.818 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 66' ' ' ASN . 4.6 t70 -70.15 -31.01 68.31 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.231 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.883 ' HB ' HG22 ' A' ' 45' ' ' VAL . 41.1 t -62.42 -51.51 71.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.448 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -4.98 52.07 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.163 0.506 . . . . 0.0 111.142 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 2.5 t-20 -73.13 -39.08 66.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -89.69 147.04 24.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.216 175.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -108.27 -13.43 14.9 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.536 -174.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.922 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 61.4 p -108.2 151.66 25.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.7 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -70.03 -29.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.589 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -66.75 -30.75 76.73 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.744 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 4.8 t70 -65.59 -53.52 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.817 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -53.64 -50.52 65.54 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.425 0.631 . . . . 0.0 110.717 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 21.7 m -55.07 -52.82 62.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.98 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.482 ' HD2' HD12 ' A' ' 78' ' ' LEU . 13.3 tptp -64.68 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.15 -46.26 90.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.136 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.609 HG23 HG11 ' A' ' 57' ' ' VAL . 90.8 mt -60.68 -46.43 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.322 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 8' ' ' ILE . 83.6 mt -55.14 -42.75 73.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.683 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.1 -4.97 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -128.47 7.52 5.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.86 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 78' ' ' LEU . 8.6 pt20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.433 0.159 . . . . 0.0 110.728 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.494 ' H ' HG22 ' A' ' 4' ' ' THR . 16.0 tt0 -61.29 -55.67 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -63.28 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.541 -173.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.16 -51.43 46.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.76 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -66.35 -32.53 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.902 -178.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.96 -42.69 95.74 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.35 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.523 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.9 -49.05 61.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.7 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -42.32 88.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.67 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.64 -56.71 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.248 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -49.93 -44.52 50.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.836 0.826 . . . . 0.0 110.051 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.824 HG13 ' HB2' ' A' ' 51' ' ' ALA . 15.3 mm -60.88 -54.49 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.231 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.734 HG11 HD12 ' A' ' 37' ' ' LEU . 16.1 t -69.23 -24.2 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.583 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -63.33 -27.04 69.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.7 -30.66 62.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.888 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 47' ' ' VAL . 42.6 mt -84.51 -54.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.323 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -122.78 -84.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.682 -171.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.74 43.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.44 -1.362 . . . . 0.0 114.54 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.802 HG13 HD13 ' A' ' 37' ' ' LEU . 18.3 mm -82.76 126.69 72.52 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 118.158 0.979 . . . . 0.0 108.655 167.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.747 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.7 Cg_endo -56.43 145.55 78.71 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.244 1.963 . . . . 0.0 111.48 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.67 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 27.0 m -56.61 -32.97 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.07 -17.12 51.19 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.558 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.747 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 16.1 t70 -87.28 -14.03 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.635 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' A' ' 13' ' ' ALA . 91.3 t -69.73 122.81 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.321 0.581 . . . . 0.0 110.443 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.511 ' O ' HG13 ' A' ' 70' ' ' VAL . 58.7 mtpt -145.78 164.16 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -171.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.3 mp -78.28 -2.72 39.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.69 -25.62 16.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.983 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -91.14 142.53 27.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.327 0.584 . . . . 0.0 110.842 -169.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.641 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 3.6 m -82.82 136.45 34.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.03 -172.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.52 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.67 -43.29 94.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.328 0.585 . . . . 0.0 110.117 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.9 p -72.69 -38.96 67.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.636 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.1 t70 -92.01 -60.65 1.8 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.896 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.05 -50.05 10.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.251 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.802 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -66.25 -28.12 68.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 t0 60.12 67.92 0.82 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.739 0.78 . . . . 0.0 109.873 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.6 OUTLIER -128.04 155.46 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.682 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 42.2 m-20 -103.95 168.15 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.455 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 34.0 t -49.4 -57.58 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.721 0.638 . . . . 0.0 111.38 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.81 -40.39 83.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.017 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.726 ' HB2' HG22 ' A' ' 39' ' ' VAL . 4.6 m -51.68 -53.81 34.95 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.855 0.36 . . . . 0.0 111.149 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.564 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 14.4 ptt? -65.7 -49.89 66.87 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.759 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.894 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.31 -23.3 29.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.088 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.92 -65.41 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.934 -0.479 . . . . 0.0 111.208 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.772 HG12 HG23 ' A' ' 15' ' ' ILE . 11.6 t -86.12 -25.17 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.893 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HA ' HG21 ' A' ' 15' ' ' ILE . 21.6 t -80.27 -20.17 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.659 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.7 t -77.71 -33.36 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.552 0.691 . . . . 0.0 109.233 166.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.32 -19.9 62.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.399 0.618 . . . . 0.0 109.65 168.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.824 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -85.93 -33.39 21.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.966 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.754 ' O ' HG12 ' A' ' 57' ' ' VAL . 3.6 pt-20 -65.68 -50.85 63.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.585 -175.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.671 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 39.5 mt-10 -56.67 -37.53 70.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.44 -175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.3 ptp180 -72.2 -7.79 51.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.295 -174.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.56 10.47 21.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.589 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 63.22 39.28 9.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.643 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -114.84 165.49 9.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 57' ' ' VAL . 61.2 tttp -126.97 111.27 13.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.309 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 tt -131.71 120.32 17.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.136 0.493 . . . . 0.0 110.539 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 51.4 Cg_exo -56.8 148.78 64.25 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.038 2.492 . . . . 0.0 113.299 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.21 -47.24 65.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.05 -33.76 73.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.919 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -31.11 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.772 -174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.894 ' HB ' HG22 ' A' ' 45' ' ' VAL . 11.1 t -73.34 -42.26 57.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.564 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 12.6 tmtt? -55.95 -40.62 73.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.921 171.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -76.5 -2.79 33.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -172.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 4.6 pp -107.03 139.47 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.093 0.473 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -114.24 1.06 14.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.668 -172.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 28.5 p -128.52 153.42 47.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 172.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 28' ' ' LYS . 1.1 p -68.88 -21.79 25.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -70.9 -32.24 66.55 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.95 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 67' ' ' LEU . 13.1 m-20 -57.15 -51.21 70.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.796 0.332 . . . . 0.0 110.19 174.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.47 72.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.193 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.733 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -61.63 -53.1 60.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.686 -174.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.488 ' HD2' HD12 ' A' ' 78' ' ' LEU . 3.7 tptp -62.98 -31.77 72.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.616 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.56 -45.96 77.63 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.479 ' HA ' HG21 ' A' ' 57' ' ' VAL . 52.4 mt -63.66 -46.25 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.224 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.76 HD21 HG21 ' A' ' 8' ' ' ILE . 97.6 mt -61.07 -25.36 66.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.78 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.75 -40.3 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' C ' HG23 ' A' ' 57' ' ' VAL . 95.0 m-70 -101.49 21.31 14.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -171.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.049 -179.105 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.563 ' H ' HG22 ' A' ' 4' ' ' THR . 12.3 tt0 -47.24 -55.32 8.85 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -169.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.544 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.1 pm0 -71.52 -36.4 71.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.741 0.305 . . . . 0.0 111.524 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -70.73 -47.53 59.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 110.145 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.868 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.76 -31.13 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.47 -39.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.01 97.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 110.402 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.41 -43.12 79.74 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.705 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.74 -48.56 80.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.675 ' HA ' HG21 ' A' ' 27' ' ' VAL . . . -51.92 -50.09 61.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.366 0.603 . . . . 0.0 111.359 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.88 -30.64 71.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.784 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -86.58 -34.73 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.026 -177.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.812 HG11 HD12 ' A' ' 37' ' ' LEU . 15.7 t -69.62 -24.86 27.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.479 0.657 . . . . 0.0 109.449 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.07 -24.06 66.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB2' HG11 ' A' ' 47' ' ' VAL . 3.8 mm-40 -72.94 -21.38 60.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 47' ' ' VAL . 46.0 mt -93.56 -52.84 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.589 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.34 -88.58 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.1 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.363 -1.399 . . . . 0.0 114.907 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.788 HG13 HD13 ' A' ' 37' ' ' LEU . 14.6 mm -79.68 125.97 81.42 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.5 Cg_endo -56.02 148.32 58.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.3 2.0 . . . . 0.0 111.307 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 32.7 m -62.67 -19.25 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 -175.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.83 -19.75 47.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 22' ' ' ILE . 40.8 t0 -98.88 -21.25 16.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.576 -171.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 13' ' ' ALA . 83.5 t -64.52 118.72 7.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.298 0.57 . . . . 0.0 110.826 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' O ' HG13 ' A' ' 70' ' ' VAL . 58.5 mtpt -147.55 172.65 13.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.985 -172.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.484 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.3 mp -80.81 -3.86 52.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.311 0.576 . . . . 0.0 110.044 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.432 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.5 m-20 -92.79 -23.01 19.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.501 -173.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.07 141.58 30.04 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.521 -169.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.763 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 27.4 m -82.37 136.28 35.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.618 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.54 -50.62 72.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.598 . . . . 0.0 110.104 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.4 p -65.43 -39.63 92.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.67 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 6.7 m-20 -91.99 -69.51 0.74 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.798 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 22' ' ' ILE . 4.0 m-20 -63.41 -49.71 72.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.682 -175.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.812 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -71.39 -9.85 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.28 -174.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.16 38.54 29.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.112 0.482 . . . . 0.0 110.238 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.18 147.47 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.148 0.499 . . . . 0.0 111.319 -171.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.2 169.34 9.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.101 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.401 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 44.0 m -59.93 -45.73 91.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.559 0.537 . . . . 0.0 111.806 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -46.99 64.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.524 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 5.3 m -49.16 -57.11 7.24 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.733 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.414 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 7.9 ptm -57.38 -51.81 67.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.747 HG22 ' HB ' ' A' ' 64' ' ' VAL . 77.2 t -63.57 -24.46 35.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -176.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -75.28 -64.24 1.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.606 -0.684 . . . . 0.0 111.665 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.7 HG12 HG23 ' A' ' 15' ' ' ILE . 16.7 t -85.08 -23.67 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.166 -174.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 44' ' ' MET . 39.4 t -79.28 -27.09 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.433 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.71 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.2 t -70.83 -35.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.764 0.792 . . . . 0.0 109.025 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -22.45 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.14 -39.36 17.97 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.945 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.71 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 7.1 pt-20 -60.67 -48.23 82.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.405 0.621 . . . . 0.0 109.588 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 36.2 mt-10 -62.48 -36.81 83.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.789 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 12.9 ptp180 -76.71 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 111.179 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 63.2 m-85 -103.66 15.05 29.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 109.781 172.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 58.79 59.08 2.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.489 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 52' ' ' GLU . 10.4 p -143.96 160.62 15.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -134.15 112.36 11.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.195 0.522 . . . . 0.0 110.041 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 64' ' ' VAL . 18.2 pt -118.35 159.39 43.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 137.57 47.97 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.355 2.036 . . . . 0.0 111.838 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.53 -47.3 66.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.5 -32.25 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.277 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.29 -44.59 87.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.747 ' HB ' HG22 ' A' ' 45' ' ' VAL . 39.5 t -54.65 -42.17 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 110.453 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 2.1 tmtm? -77.3 -22.75 51.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.31 -37.9 51.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.422 -175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -72.58 137.76 46.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.825 0.821 . . . . 0.0 111.471 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -86.88 -28.78 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.671 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 p -117.63 154.23 31.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -63.75 -28.66 45.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -32.96 85.95 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.591 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 59.0 m-20 -60.8 -55.97 26.79 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.426 0.155 . . . . 0.0 110.586 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -53.81 -52.65 59.64 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.318 0.58 . . . . 0.0 110.374 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.79 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.6 m -53.14 -51.3 62.4 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.769 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HD2' HD12 ' A' ' 78' ' ' LEU . 8.8 tptm -65.43 -36.23 83.31 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.728 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -66.61 -39.93 88.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.183 0.516 . . . . 0.0 109.755 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.58 HG23 HG11 ' A' ' 57' ' ' VAL . 71.3 mt -61.51 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 172.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.868 HD21 HG21 ' A' ' 8' ' ' ILE . 91.5 mt -65.21 -24.76 67.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.689 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -82.0 -51.06 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -92.29 11.52 25.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.155 -172.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 0.0 110.881 -178.194 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.61 113.92 13.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.172 0.51 . . . . 0.0 112.098 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.07 146.49 41.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.32 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -88.86 -170.08 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.304 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.584 ' H ' HG22 ' A' ' 4' ' ' THR . 17.9 tt0 -57.62 -56.02 27.27 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -168.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.21 -34.46 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.664 0.269 . . . . 0.0 111.541 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.91 -53.28 49.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.324 0.583 . . . . 0.0 110.297 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.761 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.4 -34.98 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.953 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG23 HG21 ' A' ' 74' ' ' THR . 2.1 t -59.85 -41.77 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.863 -0.153 . . . . 0.0 110.932 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.14 86.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.66 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.73 -31.44 73.19 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.882 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -72.09 -50.63 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.632 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.24 -49.66 68.97 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.487 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -53.07 -36.27 60.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.861 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -34.31 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.785 -174.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 37' ' ' LEU . 44.6 t -69.24 -25.13 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.56 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -62.98 -21.43 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.147 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.54 -27.64 51.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.713 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.75 HD11 ' HB ' ' A' ' 47' ' ' VAL . 49.8 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.381 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.22 -87.17 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.6 53.38 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.529 -1.32 . . . . 0.0 114.128 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.825 HG13 HD13 ' A' ' 37' ' ' LEU . 19.3 mm -88.63 125.86 61.74 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.13 144.57 46.58 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.406 2.071 . . . . 0.0 111.434 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.632 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 19.4 m -54.58 -32.94 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.47 -18.08 49.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.518 ' HB3' HG23 ' A' ' 22' ' ' ILE . 25.9 t0 -86.75 -18.31 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.461 HG21 ' CB ' ' A' ' 13' ' ' ALA . 93.0 t -63.8 112.71 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.666 0.746 . . . . 0.0 110.325 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.0 mttp -135.51 162.81 31.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.758 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.901 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.7 mp -76.97 -3.09 37.14 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.87 0.366 . . . . 0.0 110.499 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -8.06 22.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.593 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -101.53 140.06 36.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.873 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.6 m -85.31 133.56 34.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.072 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.581 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -59.98 -46.9 87.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.428 0.633 . . . . 0.0 110.321 178.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.9 p -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.392 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.66 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 26.4 t70 -93.88 -68.85 0.78 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.095 0.474 . . . . 0.0 112.091 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.51 -49.06 58.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.644 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.825 HD13 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -67.47 -21.01 65.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.072 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 59.0 38.24 24.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.829 0.823 . . . . 0.0 109.621 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -101.13 156.08 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.595 -174.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-20 -99.84 155.08 17.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.12 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.9 m -51.41 -45.02 62.41 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.068 0.855 . . . . 0.0 111.426 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -48.17 59.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.2 m -54.31 -51.06 65.85 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.615 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.684 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.5 ptm -60.4 -47.5 85.81 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.677 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.828 HG22 ' HB ' ' A' ' 64' ' ' VAL . 54.6 t -61.61 -27.88 42.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.288 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.96 -65.37 0.85 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.834 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HB ' HD11 ' A' ' 19' ' ' ILE . 13.3 t -86.09 -20.82 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.865 -173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.8 t -79.92 -26.45 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.309 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.699 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -70.62 -35.73 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.384 0.611 . . . . 0.0 109.524 168.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.5 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 110.054 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.861 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.09 -33.53 24.35 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.765 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.2 pt-20 -67.97 -49.72 60.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.196 0.522 . . . . 0.0 109.815 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 21.3 mt-10 -67.38 -21.89 65.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.1 ptm180 -72.32 -19.62 61.63 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.04 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.541 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 93.2 m-85 -99.89 -4.49 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 109.874 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t0 65.23 67.92 0.51 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.5 p -117.45 164.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.706 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 57' ' ' VAL . 33.1 mmtm -122.59 109.73 14.67 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 111.049 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -140.61 143.15 31.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.962 173.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -60.92 138.37 78.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.249 1.966 . . . . 0.0 111.575 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -47.52 -57.19 5.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.844 0.83 . . . . 0.0 111.162 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.597 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 12.0 t70 -64.7 -20.72 66.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.5 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.82 -22.02 66.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.24 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 45' ' ' VAL . 58.6 t -64.25 -29.35 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.688 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.597 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -74.66 -14.45 60.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 110.809 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 9.7 t30 -79.63 -32.6 41.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.534 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.979 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -82.78 122.85 28.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -88.86 -11.37 44.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 31.6 p -125.55 155.99 39.78 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -67.08 -32.58 58.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.901 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -70.76 -35.08 66.36 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.909 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.64 -37.75 82.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -63.31 -46.56 86.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.809 175.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.816 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -62.78 -49.52 74.65 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.64 -170.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HD2' HD12 ' A' ' 78' ' ' LEU . 30.8 mmmt -62.47 -37.03 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.434 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.457 ' CE2' ' HB ' ' A' ' 59' ' ' ILE . 27.9 t80 -67.43 -40.82 85.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.02 0.438 . . . . 0.0 110.015 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.76 -36.84 77.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.236 0.541 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.816 ' HG ' ' O ' ' A' ' 74' ' ' THR . 90.0 mt -71.83 -26.73 62.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.24 -35.72 27.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.741 0.305 . . . . 0.0 111.044 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 20.63 18.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.883 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HA ' HG23 ' A' ' 57' ' ' VAL . 4.0 pt20 -76.16 152.5 36.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.209 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.264 177.788 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB1' ' OE1' ' A' ' 81' ' ' GLN . . . -81.74 131.68 35.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.689 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.96 140.66 47.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.446 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.635 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -84.71 -169.98 2.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.593 0.235 . . . . 0.0 110.77 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -68.06 -47.53 68.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.635 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.4 pm0 -61.89 -42.03 98.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.177 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.24 -51.72 34.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.628 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.962 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.4 -36.26 77.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.027 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.1 -41.85 90.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.18 97.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.438 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 15' ' ' ILE . . . -64.63 -45.52 92.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.177 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.7 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.48 -50.97 70.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -53.13 -57.59 9.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.563 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.52 -33.34 74.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.191 0.52 . . . . 0.0 110.504 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.713 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.0 -34.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.961 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.704 HG11 HD12 ' A' ' 37' ' ' LEU . 22.0 t -74.16 -24.98 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.822 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.2 -28.72 69.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.844 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.78 -38.42 90.92 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.477 0.656 . . . . 0.0 109.726 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.2 mt -75.53 -53.28 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.172 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.86 -86.18 0.53 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.796 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.26 61.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.06 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.779 HG13 HD13 ' A' ' 37' ' ' LEU . 16.7 mm -88.37 134.2 35.0 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.26 142.16 57.37 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.263 1.975 . . . . 0.0 111.197 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.671 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 28.8 m -62.4 -30.67 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.993 0.425 . . . . 0.0 111.505 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 2.0 pm0 -80.56 -17.04 52.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.211 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.85 -14.34 42.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.001 0.429 . . . . 0.0 110.256 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' A' ' 13' ' ' ALA . 89.0 t -71.87 115.24 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.708 0.766 . . . . 0.0 110.552 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 70' ' ' VAL . 26.0 mtpp -136.17 169.42 17.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.914 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.73 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.4 mp -78.37 -2.7 39.51 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.11 0.481 . . . . 0.0 110.701 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.96 -21.82 17.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.681 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.88 144.02 25.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.389 -170.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.879 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 15.7 m -83.98 135.13 34.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.479 -172.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -62.05 -46.9 87.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.293 0.568 . . . . 0.0 110.438 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.8 p -77.64 -29.5 51.72 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.879 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 25.9 t70 -92.22 -66.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.72 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.96 -56.37 5.8 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.084 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.779 HD13 HG13 ' A' ' 22' ' ' ILE . 2.8 mm? -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.749 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.87 65.9 1.38 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.981 0.8 . . . . 0.0 110.044 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.522 HG11 ' HB3' ' A' ' 44' ' ' MET . 1.0 OUTLIER -123.22 143.6 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.082 -172.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.677 ' O ' ' HG2' ' A' ' 44' ' ' MET . 5.3 m-20 -88.71 162.6 16.18 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -53.76 -49.57 67.93 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.957 0.785 . . . . 0.0 110.594 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -49.77 72.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 109.676 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.564 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -55.32 -50.28 70.01 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.046 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.677 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.0 ptm -62.43 -43.5 98.66 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.977 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 94.7 t -69.02 -25.63 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.848 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -72.8 -65.79 0.75 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.618 -0.676 . . . . 0.0 111.349 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.686 HG12 HG23 ' A' ' 15' ' ' ILE . 7.4 t -87.71 -22.48 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.263 -173.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 44' ' ' MET . 36.1 t -78.98 -26.43 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.798 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -69.64 -38.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.06 -25.1 63.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 110.675 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.713 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.71 -37.24 21.18 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.798 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 8.1 pt-20 -68.15 -48.9 64.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.184 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.576 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.9 mt-10 -64.18 -27.98 69.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.081 -174.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 54' ' ' ARG . 6.2 ptp180 -76.12 -9.43 58.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 111.096 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 80.5 m-85 -105.93 17.96 22.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 66.62 24.16 10.17 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.595 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 77' ' ' ILE . 11.3 p -113.86 151.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 58' ' ' LYS . 2.1 tmtt? -135.78 113.77 11.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.222 170.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.734 HD11 HG22 ' A' ' 64' ' ' VAL . 13.0 pt -102.98 165.61 13.33 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.697 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 50.1 Cg_exo -54.94 119.4 6.44 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.527 1.485 . . . . 0.0 111.01 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.57 -40.55 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 110.553 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.47 -23.39 67.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.408 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 20.5 t70 -78.04 -25.63 47.94 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.782 -175.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.734 HG22 HD11 ' A' ' 59' ' ' ILE . 44.7 t -62.32 -32.06 53.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -71.97 -31.86 66.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.974 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -72.04 -39.7 68.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.743 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.087 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.24 131.69 39.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.385 0.612 . . . . 0.0 110.872 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -104.94 -1.29 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.517 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.71 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 66.0 p -126.85 147.87 50.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -66.22 -32.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.136 0.493 . . . . 0.0 109.798 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -67.71 -43.38 84.86 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.87 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.26 -41.69 84.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.087 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -59.5 -59.76 4.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.153 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 12.7 m -58.27 -47.11 84.64 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.02 -173.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD3' HD21 ' A' ' 29' ' ' LEU . 35.3 tptt -66.04 -33.33 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.44 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 54.1 t80 -66.92 -42.19 85.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.028 0.442 . . . . 0.0 110.066 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.692 HG23 HG11 ' A' ' 57' ' ' VAL . 66.3 mt -58.12 -46.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.286 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.962 HD21 HG21 ' A' ' 8' ' ' ILE . 81.7 mt -66.66 -38.17 86.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.311 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -74.27 -21.04 59.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -128.48 29.11 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' OE1' ' HB1' ' A' ' 2' ' ' ALA . 3.6 pt20 -79.38 -179.53 6.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.783 0.325 . . . . 0.0 111.444 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.987 -178.306 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.773 0.32 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.32 44.01 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.409 ' O ' HD22 ' A' ' 78' ' ' LEU . . . -114.19 131.02 56.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.23 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -87.88 -166.25 1.53 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.602 ' H ' HG22 ' A' ' 4' ' ' THR . 5.9 tt0 -63.04 -56.01 20.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.968 0.168 . . . . 0.0 111.178 -171.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.515 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 1.1 pm0 -60.67 -36.04 77.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.69 0.281 . . . . 0.0 111.279 -173.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -69.34 -56.27 7.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.445 0.64 . . . . 0.0 110.397 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.799 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.25 -34.62 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.946 -177.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -61.43 -39.12 81.75 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.794 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.9 88.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.637 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.4 -39.08 91.54 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.703 HD22 ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -66.72 -51.63 53.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.35 -48.69 76.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.734 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -51.83 -36.44 48.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.819 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.849 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.19 -40.27 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.142 -174.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 37' ' ' LEU . 13.2 t -68.34 -24.63 29.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.347 0.594 . . . . 0.0 109.592 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.95 -27.19 65.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.57 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.89 -47.88 42.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.205 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 47' ' ' VAL . 20.1 mt -59.02 -52.79 56.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.057 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.99 -84.48 0.61 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.835 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.38 59.48 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.985 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.83 HG13 HD13 ' A' ' 37' ' ' LEU . 29.0 mm -94.91 128.54 38.88 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 166.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.45 148.48 42.67 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.567 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.656 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.6 m -64.65 -17.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.66 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.15 -21.31 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.196 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' HB3' HG23 ' A' ' 22' ' ' ILE . 22.2 t0 -99.17 -13.51 19.73 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 111.457 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.96 121.95 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.328 0.585 . . . . 0.0 110.3 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.4 mtpt -145.23 165.61 27.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.683 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.592 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 8.4 mp -75.64 -0.97 22.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.464 0.65 . . . . 0.0 109.863 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -97.17 -22.39 16.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.007 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.04 141.57 29.28 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.608 -172.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.822 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 13.7 t -81.21 132.97 35.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.245 -173.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.55 -47.76 84.31 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.552 0.692 . . . . 0.0 110.074 176.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.6 p -74.58 -37.46 62.91 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.549 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 33.5 t70 -92.35 -59.7 2.02 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.16 -49.43 23.68 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD13 HG13 ' A' ' 22' ' ' ILE . 3.2 mm? -72.58 -16.55 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.621 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 57.07 34.59 25.13 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.064 0.935 . . . . 0.0 109.455 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -87.79 160.47 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.713 -171.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.758 ' O ' ' HG2' ' A' ' 44' ' ' MET . 1.2 t70 -112.93 155.46 24.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.976 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 34.9 t -41.74 -59.47 1.65 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.362 1.039 . . . . 0.0 112.17 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.17 -42.77 62.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.531 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 24.5 m -53.46 -51.2 63.47 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.802 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.758 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 9.1 ptm -62.98 -47.49 82.95 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' A' ' 64' ' ' VAL . 97.1 t -66.2 -22.6 30.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.881 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -75.39 -66.94 0.71 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.609 -0.682 . . . . 0.0 111.752 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG12 HG23 ' A' ' 15' ' ' ILE . 4.9 t -84.17 -22.85 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.799 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.0 t -79.9 -22.6 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.214 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.706 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.1 t -68.44 -37.32 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 166.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.33 -25.01 68.1 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.378 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.849 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.54 -37.4 25.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.351 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.706 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 3.5 pt-20 -67.17 -48.66 67.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.473 0.654 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.63 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 85.1 mt-10 -70.44 -23.61 62.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.949 -172.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.3 ptm180 -73.36 -10.81 60.14 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.891 0.377 . . . . 0.0 110.367 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 8' ' ' ILE . 55.1 m-85 -109.41 19.49 19.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.426 175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 66.95 26.8 9.05 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.476 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.767 HG11 HG23 ' A' ' 77' ' ' ILE . 10.2 p -118.02 155.63 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 58' ' ' LYS . 35.7 tptt -134.83 114.71 12.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.179 0.514 . . . . 0.0 110.585 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.674 HD11 HG22 ' A' ' 64' ' ' VAL . 20.5 pt -104.11 163.33 17.54 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.439 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 27.8 Cg_exo -61.16 132.36 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.963 1.775 . . . . 0.0 111.165 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -50.76 -51.48 49.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.0 111.002 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.24 -20.57 64.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.92 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 9.0 t70 -71.67 -34.44 69.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.816 -0.174 . . . . 0.0 110.968 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.674 ' HB ' HG22 ' A' ' 45' ' ' VAL . 41.9 t -59.91 -39.48 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 15.7 tptp -72.03 -20.17 61.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.92 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -75.13 -35.16 61.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -81.04 153.78 27.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.336 0.588 . . . . 0.0 111.849 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.0 mptp? -104.99 -29.05 10.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.086 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.822 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.1 p -111.11 156.64 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.26 -31.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.592 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.4 -35.72 92.1 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.196 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 63.3 m-20 -56.26 -57.35 12.62 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.662 0.268 . . . . 0.0 110.431 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.617 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.99 -44.7 78.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.372 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.757 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 19.7 m -56.51 -53.74 53.98 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.752 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -66.23 -37.19 84.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.223 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 40.5 t80 -59.68 -41.71 91.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.698 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.767 HG23 HG11 ' A' ' 57' ' ' VAL . 58.6 mt -64.94 -48.44 84.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.803 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.799 HD21 HG21 ' A' ' 8' ' ' ILE . 85.8 mt -64.63 -44.26 91.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.444 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -5.26 59.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 76' ' ' TYR . 26.3 m-70 -126.43 15.43 7.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 81' ' ' GLN . 3.2 pt20 -76.56 153.21 35.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.502 -174.241 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.785 0.326 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.0 31.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.59 117.03 17.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 -175.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -81.1 177.86 8.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.535 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -49.81 -53.12 27.28 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 7' ' ' GLU . 8.3 pt-20 -55.22 -49.09 72.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 111.54 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 6' ' ' GLU . 36.5 mt-10 -66.55 -50.7 62.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.214 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.874 HG21 HD21 ' A' ' 78' ' ' LEU . 3.0 tt -67.13 -35.33 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.862 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.96 -35.9 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.379 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.22 -43.42 78.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.924 0.392 . . . . 0.0 110.665 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.99 -42.3 85.51 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.801 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -43.86 97.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.12 -54.89 37.49 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.149 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -52.8 -43.39 65.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.56 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 47' ' ' VAL . 7.3 mm -62.27 -53.8 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.247 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.735 HG11 HD12 ' A' ' 37' ' ' LEU . 12.1 t -70.48 -23.34 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 0.0 110.635 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -60.79 -29.23 69.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.183 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.41 -43.23 67.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 110.274 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.543 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.4 mt -65.53 -52.56 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.185 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -76.4 0.57 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.1 51.31 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.379 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 37' ' ' LEU . 10.6 mm -80.55 124.86 81.82 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.749 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 8.1 Cg_endo -53.38 147.27 37.73 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.698 2.266 . . . . 0.0 111.525 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.1 m -61.39 -30.82 48.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -172.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.21 -17.29 52.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.856 0.36 . . . . 0.0 111.401 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.749 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 2.7 t70 -86.03 -18.97 31.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.941 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 13' ' ' ALA . 84.5 t -67.41 120.39 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.658 0.742 . . . . 0.0 110.525 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HE3' ' OD1' ' A' ' 30' ' ' ASP . 26.2 mtpp -142.36 165.23 27.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.441 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.565 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 7.6 mp -77.95 -3.27 41.05 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.421 ' OD1' ' HE3' ' A' ' 28' ' ' LYS . 12.8 p-10 -107.29 -8.31 16.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -90.71 139.81 30.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.7 m -89.1 135.59 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.376 -171.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -58.04 -47.56 82.72 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 110.193 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 p -72.12 -32.13 66.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.481 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.76 -69.84 0.73 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.272 0.558 . . . . 0.0 111.602 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.67 -48.4 26.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.941 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.813 HD13 HG13 ' A' ' 22' ' ' ILE . 3.4 mm? -66.68 -17.91 65.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.441 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.1 t70 61.04 36.06 18.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.935 0.874 . . . . 0.0 109.679 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -98.47 150.13 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.746 -171.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.762 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.6 t70 -97.53 154.62 17.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.996 173.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 45' ' ' VAL . 30.4 m -51.99 -44.85 64.25 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.699 0.624 . . . . 0.0 111.632 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 tp -77.58 -39.34 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.954 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 51.6 m -55.34 -48.67 73.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.762 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 6.4 ptm -62.47 -45.84 91.22 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.749 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.2 t -64.36 -23.04 32.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.713 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.21 -65.73 0.81 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.936 -0.478 . . . . 0.0 111.696 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 15' ' ' ILE . 18.9 t -89.67 -20.53 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.272 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 44' ' ' MET . 19.8 t -80.08 -17.0 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.665 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.0 t -78.57 -34.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 121.536 0.684 . . . . 0.0 109.209 165.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -59.5 -24.18 63.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.567 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.7 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -81.76 -38.76 25.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.677 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.727 ' O ' HG12 ' A' ' 57' ' ' VAL . 5.9 pt-20 -60.4 -47.4 86.24 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.692 0.758 . . . . 0.0 109.46 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 22.6 mt-10 -74.75 -21.74 59.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.809 -171.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 3.7 ptp180 -74.21 -12.15 60.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.019 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.0 10.13 39.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.72 30.42 16.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.001 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -115.17 162.74 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.575 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 24.3 mmmt -128.7 116.02 18.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.252 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 64' ' ' VAL . 44.2 pt -117.61 158.7 44.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.666 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 18.7 Cg_exo -69.43 135.44 31.25 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.548 2.165 . . . . 0.0 112.302 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -49.8 -58.15 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.592 0.711 . . . . 0.0 110.79 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -17.75 64.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.349 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.666 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.3 t0 -76.07 -19.56 58.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.105 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.834 ' HB ' HG22 ' A' ' 45' ' ' VAL . 24.6 t -72.73 -52.61 22.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.514 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -68.82 -7.25 32.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -76.43 -36.21 58.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.087 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.741 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.1 pp -89.24 128.17 35.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.47 0.652 . . . . 0.0 111.016 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.92 1.0 55.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.89 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 74.7 p -130.15 147.91 51.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.553 0.216 . . . . 0.0 110.543 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 31' ' ' LYS . 1.6 p -69.43 -34.42 62.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.943 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.6 -41.37 97.28 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.91 -49.75 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -52.45 -54.27 34.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.627 0.727 . . . . 0.0 111.164 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.773 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.1 m -58.08 -48.55 79.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.636 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.622 ' HD2' HD12 ' A' ' 78' ' ' LEU . 12.2 tptp -69.2 -29.09 66.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.216 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -65.24 -46.35 80.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.802 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.51 -36.78 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.307 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 8' ' ' ILE . 92.3 mt -70.6 -31.86 69.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.768 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.26 -42.2 17.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.064 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -96.08 13.24 27.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.91 135.3 55.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.843 0.354 . . . . 0.0 110.496 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.075 -175.438 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.805 0.336 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.48 147.22 23.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.038 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.47 136.67 32.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.817 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -99.62 -170.96 1.97 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.582 ' H ' HG22 ' A' ' 4' ' ' THR . 15.2 tp60 -48.7 -53.36 19.15 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -62.23 -46.85 87.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.32 -43.41 50.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.845 0.355 . . . . 0.0 111.284 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.691 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.48 -34.1 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.59 -42.41 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.129 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.92 92.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.607 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.571 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -66.8 -39.18 93.48 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -64.92 -49.45 70.37 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -56.02 -50.45 70.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.237 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.68 -36.51 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.59 -39.36 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.254 -175.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 37' ' ' LEU . 41.7 t -70.11 -24.99 26.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.097 0.475 . . . . 0.0 110.079 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -62.29 -24.53 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -72.33 -39.46 68.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 109.795 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.724 HD11 ' HB ' ' A' ' 47' ' ' VAL . 26.9 mt -72.63 -50.64 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.226 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.83 -77.75 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.259 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.62 44.19 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.788 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.824 HG13 HD13 ' A' ' 37' ' ' LEU . 9.1 mm -75.04 134.97 74.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 26' ' ' ASP . 51.3 Cg_exo -53.61 144.14 53.9 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.469 2.113 . . . . 0.0 111.449 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 82.3 t -59.69 -38.13 74.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.364 . . . . 0.0 111.021 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -74.29 -17.95 60.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.68 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' HB3' HG23 ' A' ' 22' ' ' ILE . 14.0 t0 -87.51 -16.84 33.55 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.214 -0.304 . . . . 0.0 111.594 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 13' ' ' ALA . 89.8 t -64.97 116.96 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.566 0.698 . . . . 0.0 110.445 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -141.02 162.02 36.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.194 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' CA ' ' A' ' 71' ' ' GLY . 9.7 mp -79.25 -4.19 49.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.35 -8.38 21.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -97.56 134.57 40.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 18.1 m -89.39 140.91 29.04 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 111.46 -170.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.637 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 1.1 m-85 -58.81 -50.92 72.15 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 110.152 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.3 p -69.53 -33.06 72.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.406 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 12.4 t70 -92.18 -68.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 10.3 t0 -78.42 -51.52 9.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.4 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.824 HD13 HG13 ' A' ' 22' ' ' ILE . 3.8 mm? -64.8 -13.31 55.09 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 58.13 38.83 26.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 109.539 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.41 149.79 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.913 -172.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.76 166.29 11.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 p -54.83 -56.72 16.36 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.099 0.249 . . . . 0.0 111.634 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.34 -38.87 92.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.533 0.206 . . . . 0.0 111.263 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 25.1 m -52.66 -54.37 34.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.031 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.671 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 15.2 ptt? -64.26 -48.02 77.34 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.646 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.1 t -55.28 -28.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.994 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.22 -66.13 0.87 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.761 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.724 ' HB ' HD11 ' A' ' 19' ' ' ILE . 14.4 t -83.33 -22.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.134 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 44' ' ' MET . 44.9 t -79.9 -19.92 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.917 -0.489 . . . . 0.0 110.295 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.7 t -75.22 -32.88 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.249 167.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -62.0 -24.32 66.97 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.605 169.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.53 -32.48 28.62 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.888 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 5.8 pt-20 -66.11 -54.08 29.99 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.643 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 16.5 mt-10 -71.61 -20.36 61.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.227 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 13.3 ptm180 -69.68 -15.24 63.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.101 0.477 . . . . 0.0 110.048 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.571 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 65.3 m-85 -107.3 15.03 25.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.014 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.33 27.37 8.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.72 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.1 p -113.67 165.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.535 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 17.1 pttm -132.26 119.1 20.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 110.427 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 pt -119.04 154.65 53.36 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -63.73 128.96 23.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.899 1.732 . . . . 0.0 111.524 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.49 -40.07 58.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.479 0.657 . . . . 0.0 109.709 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.78 -35.5 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.104 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -74.42 -29.64 61.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.898 ' HB ' HG22 ' A' ' 45' ' ' VAL . 21.7 t -61.58 -40.59 87.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.376 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.17 -5.65 59.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 177.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -80.82 -23.64 39.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.067 0.46 . . . . 0.0 110.282 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -95.28 143.72 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.412 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 11.9 mptt -101.54 -17.66 16.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.806 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 19.1 p -118.77 156.06 30.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.599 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -65.38 -33.99 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.035 0.445 . . . . 0.0 109.944 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' CA ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.8 -35.58 86.99 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 69.5 m-20 -58.8 -58.54 8.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.516 0.186 . . . . 0.0 110.638 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -55.26 -47.65 75.15 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.85 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.729 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.0 m -57.02 -54.08 50.84 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.088 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 1.6 tppp? -69.78 -31.43 69.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.211 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -61.08 -45.28 95.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.933 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.572 HG23 HG11 ' A' ' 57' ' ' VAL . 61.2 mt -59.49 -44.5 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 74' ' ' THR . 81.2 mt -71.96 -29.11 63.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.964 -174.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.76 -24.89 61.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.651 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -124.1 28.92 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -68.37 170.74 8.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.148 0.499 . . . . 0.0 112.089 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.755 179.322 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.848 0.356 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.12 166.64 10.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.472 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' A' ' 7' ' ' GLU . . . -105.96 140.08 39.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.291 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -86.66 -168.98 2.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.95 178.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.484 ' H ' HG22 ' A' ' 4' ' ' THR . 12.2 tt0 -55.35 -56.61 18.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -171.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.19 -34.41 78.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 0.0 111.491 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.56 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 39.5 mt-10 -70.7 -51.21 29.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.778 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.46 -32.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.77 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.2 -44.02 90.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.89 87.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 110.69 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -70.86 -42.86 59.92 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.983 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.56 -40.95 98.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.744 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.85 -51.67 68.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.103 177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -54.21 -39.59 66.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.197 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 51' ' ' ALA . 6.4 mm -67.93 -52.77 35.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.218 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.831 HG11 HD12 ' A' ' 37' ' ' LEU . 5.8 t -68.03 -22.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.148 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.51 -31.61 69.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.518 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -76.66 -24.82 53.27 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 110.411 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.51 HG21 HG23 ' A' ' 39' ' ' VAL . 22.2 mt -81.92 -54.36 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.671 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.41 -78.05 0.48 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.938 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.74 57.49 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.557 -1.306 . . . . 0.0 114.696 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.792 HG13 HD13 ' A' ' 37' ' ' LEU . 20.9 mm -90.72 129.81 43.24 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 164.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.54 147.16 39.73 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.349 2.033 . . . . 0.0 111.981 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.744 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 25.3 m -61.09 -26.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.441 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.34 -17.52 48.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.64 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 22' ' ' ILE . 2.3 t70 -96.23 -15.55 21.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.742 HG21 ' HA ' ' A' ' 13' ' ' ALA . 76.9 t -68.66 126.74 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.592 0.711 . . . . 0.0 110.571 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HE2' ' HB3' ' A' ' 30' ' ' ASP . 42.5 mtpt -140.2 173.45 11.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.692 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 30.2 mt -82.07 -3.29 54.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.895 0.855 . . . . 0.0 108.695 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.555 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 6.2 t70 -95.62 -27.1 15.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.592 -170.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.86 144.15 25.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.991 -174.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.793 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 22.3 m -84.54 135.35 34.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.653 ' CD2' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -60.82 -48.13 83.2 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.242 0.544 . . . . 0.0 110.135 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 p -66.59 -38.07 86.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.503 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -92.75 -65.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.989 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.3 m-20 -69.42 -48.53 60.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.848 -174.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.831 HD12 HG11 ' A' ' 16' ' ' VAL . 3.6 mm? -74.87 -4.59 38.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.131 -171.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.36 58.8 5.1 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.934 0.772 . . . . 0.0 109.34 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -122.44 152.21 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.689 -170.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.611 ' H ' ' HB3' ' A' ' 43' ' ' SER . 12.4 t70 -119.46 162.31 19.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.621 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.6 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 p -39.25 -58.09 1.25 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -74.35 -44.52 51.99 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.375 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 40' ' ' ASP . 30.6 t -45.27 -58.98 2.9 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.643 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.482 ' HE2' HG12 ' A' ' 64' ' ' VAL . 10.4 ptm -60.78 -50.15 74.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.754 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' A' ' 64' ' ' VAL . 70.0 t -63.76 -21.64 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.103 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.944 -0.472 . . . . 0.0 111.372 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.746 HG12 HG23 ' A' ' 15' ' ' ILE . 6.6 t -89.92 -21.67 6.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.858 -173.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 44' ' ' MET . 38.6 t -79.78 -24.01 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.172 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.693 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.4 t -70.27 -39.06 76.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 167.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.0 -21.56 61.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.579 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.59 -46.57 11.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.842 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 10.6 pt-20 -63.25 -46.53 86.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 110.159 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.78 -24.98 64.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.485 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 14.7 ptm180 -75.19 -18.65 60.12 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.215 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.404 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 88.0 m-85 -97.27 9.89 41.0 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.39 0.614 . . . . 0.0 109.361 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 66.36 52.6 1.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.198 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.3 p -137.52 152.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -134.32 112.12 10.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.679 0.276 . . . . 0.0 110.54 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.714 HD11 HG22 ' A' ' 64' ' ' VAL . 8.1 pt -110.01 165.23 13.06 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.37 134.74 43.15 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.699 1.599 . . . . 0.0 111.393 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB3' HG11 ' A' ' 45' ' ' VAL . 1.6 m-20 -51.38 -43.8 61.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.742 0.782 . . . . 0.0 110.068 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.13 -31.33 65.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.861 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.47 -35.23 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.166 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.714 HG22 HD11 ' A' ' 59' ' ' ILE . 55.5 t -58.45 -42.63 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.6 ' HD3' ' HA ' ' A' ' 41' ' ' SER . 16.6 tptp -74.66 -20.63 59.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.838 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -73.63 -28.24 61.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.054 0.454 . . . . 0.0 110.011 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -88.22 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.119 0.485 . . . . 0.0 111.004 178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -99.72 -14.8 18.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.354 -171.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.793 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 26.2 p -115.45 157.68 23.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.653 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.2 p -70.19 -24.27 25.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.448 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -37.14 94.02 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.815 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.711 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.2 m-20 -56.92 -58.07 9.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.41 0.148 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.638 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.65 -50.17 70.94 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.27 0.557 . . . . 0.0 110.747 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.746 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 37.0 m -55.25 -50.68 68.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.926 -176.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -67.74 -31.27 71.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.357 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.45 -42.96 86.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.756 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.475 HG23 HG11 ' A' ' 57' ' ' VAL . 91.0 mt -59.81 -40.31 82.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.262 174.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 8' ' ' ILE . 87.8 mt -73.07 -38.86 66.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.002 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.84 -27.44 55.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.283 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -116.55 26.57 9.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 111.419 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.01 134.05 46.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.407 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.819 176.196 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.703 0.287 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.75 158.47 28.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.27 120.22 22.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.249 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -85.07 -171.47 3.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 4' ' ' THR . 12.6 tt0 -51.58 -56.11 15.39 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -169.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -64.83 -35.37 80.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.73 -48.46 31.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.851 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.895 HG21 HD21 ' A' ' 78' ' ' LEU . 1.8 tt -68.57 -33.34 59.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.06 -35.96 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.301 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.25 85.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.755 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -71.02 -38.23 63.98 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.32 -44.44 96.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.846 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.78 -48.75 80.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.16 -32.88 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.139 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.966 HG21 ' HB2' ' A' ' 51' ' ' ALA . 4.1 mm -78.08 -50.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.561 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.794 HG11 HD12 ' A' ' 37' ' ' LEU . 9.3 t -67.11 -23.53 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.23 0.538 . . . . 0.0 109.982 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.44 -25.11 65.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.33 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HB3' HG11 ' A' ' 47' ' ' VAL . 7.6 tp10 -73.65 -30.13 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.091 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.598 HD11 ' HB ' ' A' ' 47' ' ' VAL . 36.2 mt -84.53 -52.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.679 -172.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.74 -88.26 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.752 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.38 56.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.383 -1.389 . . . . 0.0 114.512 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.793 HG13 HD13 ' A' ' 37' ' ' LEU . 26.9 mm -98.27 122.27 54.48 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 163.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.51 145.99 44.55 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.444 2.096 . . . . 0.0 111.5 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.846 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 35.3 m -58.7 -22.02 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.176 0.512 . . . . 0.0 111.887 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.81 -17.66 46.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.797 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 22' ' ' ILE . 3.4 t70 -102.24 -9.42 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -172.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 13' ' ' ALA . 36.1 t -68.13 123.14 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.396 0.617 . . . . 0.0 110.404 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' O ' HG13 ' A' ' 70' ' ' VAL . 57.0 mttt -141.21 166.16 25.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.575 -171.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 10.2 mp -78.59 -2.98 41.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.296 0.57 . . . . 0.0 109.485 174.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.09 -20.2 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.648 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -99.79 144.74 28.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.948 -172.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.77 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 18.5 t -87.39 134.0 33.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.086 -172.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.632 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -58.57 -42.66 88.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.0 110.253 176.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.0 p -79.02 -32.55 45.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.636 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.8 t70 -92.95 -56.59 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.052 0.453 . . . . 0.0 111.824 -175.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -88.93 -40.35 13.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.119 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.794 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -78.32 -3.85 45.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.526 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 52.7 38.84 27.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.082 0.467 . . . . 0.0 110.865 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.611 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.4 OUTLIER -108.41 141.03 24.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.46 . . . . 0.0 111.874 -170.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.749 ' O ' ' HG2' ' A' ' 44' ' ' MET . 13.8 m-20 -95.23 162.39 13.71 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.931 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -50.37 -41.7 52.18 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.942 0.776 . . . . 0.0 111.137 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.7 tp -70.55 -53.36 16.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.564 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.533 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 18.7 m -51.41 -48.81 62.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.526 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.749 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.4 ptm -60.56 -56.76 17.51 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.768 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.791 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.37 -24.47 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.468 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.08 -65.44 0.8 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.596 -0.69 . . . . 0.0 111.287 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.793 HG12 HG23 ' A' ' 15' ' ' ILE . 11.1 t -88.01 -20.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.698 -173.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.4 t -79.83 -19.75 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.976 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -73.83 -34.56 40.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 165.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -63.02 -21.78 66.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.843 169.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.966 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.47 -34.39 23.41 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.594 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.727 ' O ' HG12 ' A' ' 57' ' ' VAL . 9.6 pt-20 -68.57 -49.9 55.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.564 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 37.9 mt-10 -67.56 -25.1 65.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.469 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -72.11 -16.61 62.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.054 0.454 . . . . 0.0 110.63 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.755 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 82.0 m-85 -106.53 15.77 25.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.66 33.16 18.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.861 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.2 p -111.64 161.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' N ' HG22 ' A' ' 57' ' ' VAL . 18.0 mttp -134.88 110.8 9.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.3 pt -121.27 160.81 44.07 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.1 Cg_exo -66.28 137.91 49.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.645 2.23 . . . . 0.0 111.683 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.78 -44.53 96.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.118 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.38 -18.35 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.985 0.421 . . . . 0.0 110.661 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 7.3 t70 -67.14 -41.93 85.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.791 ' HB ' HG22 ' A' ' 45' ' ' VAL . 37.7 t -59.77 -47.66 90.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.129 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.512 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.38 -1.5 30.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.396 . . . . 0.0 111.683 -176.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -92.05 -36.6 13.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.33 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -74.58 138.35 42.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.777 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -94.98 -20.63 19.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.155 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.769 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.8 p -116.48 156.39 26.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.632 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -66.53 -29.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -63.71 -36.23 93.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.589 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 56.4 m-20 -55.03 -59.27 4.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.595 0.235 . . . . 0.0 111.041 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -55.27 -47.9 74.8 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.773 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 11.5 m -57.54 -51.64 68.65 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.83 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD2' HD12 ' A' ' 78' ' ' LEU . 10.8 tptp -65.84 -34.92 79.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.136 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.81 -45.8 90.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.241 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.723 HG23 HG11 ' A' ' 57' ' ' VAL . 81.2 mt -57.18 -45.53 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.893 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 8' ' ' ILE . 94.6 mt -65.05 -21.85 66.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.554 -171.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.71 -22.7 27.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.175 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.02 27.8 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.538 ' HA ' HG23 ' A' ' 57' ' ' VAL . 4.4 pt20 -74.74 148.09 40.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.773 179.068 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.05 156.19 19.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.984 0.421 . . . . 0.0 110.866 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.57 118.94 37.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -78.15 -176.82 4.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.836 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' H ' HG22 ' A' ' 4' ' ' THR . 0.4 OUTLIER -58.58 -52.95 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -176.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 3.0 pm0 -59.5 -35.15 73.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.042 0.448 . . . . 0.0 111.264 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.53 -58.4 4.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.623 0.725 . . . . 0.0 110.599 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.805 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.67 -33.51 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.326 -175.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.92 -42.14 91.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.93 -0.123 . . . . 0.0 110.78 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.92 91.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.367 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA3' ' CE2' ' A' ' 55' ' ' PHE . . . -69.75 -41.49 73.89 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.526 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.14 -47.49 84.3 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -50.4 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.71 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.67 -37.0 58.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.898 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.27 -34.23 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.599 -174.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.801 HG11 HD12 ' A' ' 37' ' ' LEU . 47.0 t -70.7 -24.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 O-C-N 121.645 -0.659 . . . . 0.0 109.482 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.21 -20.73 66.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.943 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -75.49 -29.47 59.55 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.207 0.527 . . . . 0.0 110.209 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 47' ' ' VAL . 28.1 mt -83.74 -52.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.13 -91.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.264 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.44 54.36 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.036 -1.554 . . . . 0.0 114.789 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.759 HG13 HD13 ' A' ' 37' ' ' LEU . 22.2 mm -87.92 125.11 65.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 164.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 146.14 51.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.6 2.2 . . . . 0.0 111.169 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 33.2 m -60.68 -26.75 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.865 0.364 . . . . 0.0 111.773 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.26 -18.88 48.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.088 0.471 . . . . 0.0 111.355 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 22' ' ' ILE . 25.2 t0 -90.28 -18.9 24.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.971 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 13' ' ' ALA . 87.7 t -66.52 117.02 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.651 0.739 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HE2' ' OD1' ' A' ' 30' ' ' ASP . 31.1 mtpt -141.82 170.76 15.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.688 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.669 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 23.4 mt -81.57 -4.18 55.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.007 0.432 . . . . 0.0 110.221 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 3.7 p-10 -111.36 13.5 21.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -173.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -114.18 143.21 45.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.539 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.643 ' HB2' ' HB2' ' A' ' 35' ' ' ASP . 13.4 m -82.11 136.16 35.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.754 0.311 . . . . 0.0 110.637 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' H ' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -65.15 -47.63 76.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.258 0.551 . . . . 0.0 109.931 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.3 p -67.2 -38.23 84.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.327 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 1.5 m-20 -91.73 -68.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.706 -173.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.86 -48.4 54.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.244 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.801 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -68.86 -10.94 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 t70 55.73 51.7 12.02 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.81 0.814 . . . . 0.0 109.551 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -122.18 146.35 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.539 -169.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' A' ' 44' ' ' MET . 20.2 m-20 -102.71 162.68 12.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.978 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 t -49.16 -51.07 34.72 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.258 0.974 . . . . 0.0 111.195 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.01 -43.4 68.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.586 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB2' ' H ' ' A' ' 40' ' ' ASP . 12.0 m -55.21 -55.8 27.16 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.743 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 5.6 ptm -55.43 -58.4 7.9 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.474 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' A' ' 64' ' ' VAL . 63.7 t -58.09 -26.46 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.695 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.1 -65.65 0.78 Allowed 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.601 -0.687 . . . . 0.0 111.415 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' HB ' HD11 ' A' ' 19' ' ' ILE . 11.0 t -84.88 -23.33 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.808 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 44' ' ' MET . 65.6 t -74.1 -31.11 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.998 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.8 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 6.2 t -69.36 -34.72 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 121.376 0.608 . . . . 0.0 109.678 171.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.87 67.49 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.95 -0.469 . . . . 0.0 110.616 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.01 -41.12 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.875 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.8 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -61.62 -44.29 97.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.181 0.515 . . . . 0.0 110.315 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -67.83 -31.62 71.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.347 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.2 ptm180 -74.76 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.053 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.679 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 57.3 m-85 -104.51 13.21 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.606 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 57.45 70.54 0.64 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.083 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 52' ' ' GLU . 10.0 p -129.43 165.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 171.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' N ' HG22 ' A' ' 57' ' ' VAL . 64.3 mttm -128.08 111.55 13.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 0.0 110.232 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -149.12 132.84 8.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.429 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 20.5 Cg_exo -64.96 140.96 68.57 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.134 1.89 . . . . 0.0 111.299 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.604 ' HB2' ' CG1' ' A' ' 45' ' ' VAL . 7.8 p-10 -56.51 -32.01 64.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.74 0.781 . . . . 0.0 110.083 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 28.7 t70 -60.11 -27.03 66.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.429 -1.259 . . . . 0.0 111.53 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.04 -36.12 23.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.185 -0.206 . . . . 0.0 110.817 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.655 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 21.4 t -60.69 -44.35 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.613 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -79.8 -2.41 43.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 0.0 111.36 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -92.78 -19.49 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.163 0.506 . . . . 0.0 109.78 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 1.5 pp -93.97 128.3 40.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -97.14 3.55 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.545 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.585 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 81.5 p -129.03 143.99 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 1.4 p -64.71 -37.24 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.991 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -63.45 -32.6 84.7 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.818 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 11.7 t70 -59.96 -51.22 70.58 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.632 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -55.51 -49.58 72.21 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.693 175.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.774 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 1.8 m -58.91 -52.53 65.35 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.642 -173.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HD2' HD12 ' A' ' 78' ' ' LEU . 14.5 tptp -65.97 -34.79 78.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.071 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CD2' HD12 ' A' ' 59' ' ' ILE . 53.0 t80 -62.33 -47.28 84.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.766 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.467 ' HA ' HG21 ' A' ' 57' ' ' VAL . 54.0 mt -58.81 -46.7 90.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.594 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 8' ' ' ILE . 86.7 mt -61.44 -26.4 67.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.946 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.57 -29.74 21.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.781 0.324 . . . . 0.0 111.598 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -115.73 30.45 7.34 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt20 -89.04 154.86 19.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.496 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.204 178.329 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.58 106.85 18.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.41 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.57 142.6 46.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -75.53 -179.64 4.75 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.957 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.595 ' H ' HG22 ' A' ' 4' ' ' THR . 47.2 tt0 -54.39 -56.38 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -66.89 -32.78 74.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 111.452 -173.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.05 -47.94 19.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.95 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.23 -34.72 67.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.97 -38.41 79.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.635 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.58 80.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.757 0.313 . . . . 0.0 110.476 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.591 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.11 -36.93 91.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.851 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -68.58 -49.34 60.13 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.74 -46.23 84.75 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -51.27 -36.37 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.567 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.879 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.1 -37.6 11.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.556 -175.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 37' ' ' LEU . 21.3 t -68.82 -25.32 30.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.85 -0.532 . . . . 0.0 110.16 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.61 -24.2 67.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.924 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.09 -41.74 63.73 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.945 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 47' ' ' VAL . 25.3 mt -68.08 -53.26 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.152 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.89 -84.93 0.61 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.763 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.78 54.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.389 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.802 HG13 HD13 ' A' ' 37' ' ' LEU . 23.7 mm -82.27 130.45 59.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 166.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.33 137.52 38.89 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.195 1.93 . . . . 0.0 111.07 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 29.0 m -56.8 -27.73 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.46 -18.29 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.518 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -90.71 -16.59 28.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.104 -174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.37 116.9 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.671 0.748 . . . . 0.0 110.19 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 70' ' ' VAL . 25.5 mtpp -134.65 167.22 21.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.93 -173.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.741 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.7 mp -79.45 -2.96 44.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.494 0.664 . . . . 0.0 109.754 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.16 -13.23 19.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.955 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -100.72 143.29 31.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.492 -174.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.854 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 75.4 m -84.22 134.89 34.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.373 -173.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -58.7 -42.15 87.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 110.169 176.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 p -77.67 -36.49 51.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.269 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 10.8 t70 -91.02 -57.28 2.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 1.8 m-20 -77.48 -56.8 4.23 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.802 HD13 HG13 ' A' ' 22' ' ' ILE . 2.7 mm? -68.67 -13.64 62.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.429 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 54.13 36.44 24.82 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.187 0.994 . . . . 0.0 110.292 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -97.59 148.71 5.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.223 -171.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 44' ' ' MET . 7.1 m-20 -94.83 163.43 13.35 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' MET . 66.9 m -56.25 -42.69 77.79 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.441 0.463 . . . . 0.0 111.534 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.4 tp -72.37 -47.08 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.813 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.464 ' HB2' HG22 ' A' ' 39' ' ' VAL . 14.5 m -50.82 -51.93 46.16 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 3.5 ptp -59.18 -59.41 5.51 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.733 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 81.8 t -58.59 -21.68 18.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.025 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -70.04 -65.82 0.67 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.961 -0.462 . . . . 0.0 110.835 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG12 HG23 ' A' ' 15' ' ' ILE . 11.6 t -89.51 -22.56 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.274 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.29 -25.19 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 122.165 -0.335 . . . . 0.0 110.481 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.733 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.6 t -74.93 -36.4 38.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.44 64.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.12 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.879 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.67 -33.12 21.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.714 ' O ' HG12 ' A' ' 57' ' ' VAL . 6.8 pt-20 -68.61 -49.2 61.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.384 0.612 . . . . 0.0 109.792 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 35.1 mt-10 -66.63 -27.44 67.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.303 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 11.3 ptm180 -73.63 -12.88 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.084 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.591 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 67.5 m-85 -104.22 3.69 33.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.326 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 57.43 58.79 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.245 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.6 p -120.59 162.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.991 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 57' ' ' VAL . 80.5 tttt -124.14 110.89 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.981 0.419 . . . . 0.0 110.587 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 ' HD2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -134.57 136.93 26.52 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.942 176.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 126.57 21.05 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.259 1.973 . . . . 0.0 111.47 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.62 -35.55 68.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.93 -19.52 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.96 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 23.6 t70 -82.53 -21.26 35.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.56 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 45' ' ' VAL . 45.6 t -66.58 -38.88 82.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.681 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -84.16 -3.51 58.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.105 0.479 . . . . 0.0 110.611 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 30.7 t30 -82.11 -36.19 27.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.221 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.4 pp -84.07 126.83 33.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.522 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.78 -2.59 55.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.996 -175.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.854 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 78.6 p -122.48 147.93 45.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -66.49 -33.28 62.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.896 178.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -64.08 -36.84 93.77 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.131 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 1.9 t0 -60.63 -47.07 87.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -56.14 -54.76 41.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.459 0.647 . . . . 0.0 110.412 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.825 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.8 m -53.69 -50.49 65.75 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.617 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.696 ' HD2' HD12 ' A' ' 78' ' ' LEU . 12.9 tptm -66.12 -35.78 81.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.755 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' HD2' HD12 ' A' ' 59' ' ' ILE . 72.2 t80 -64.71 -42.24 95.4 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.99 -42.37 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.116 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 8' ' ' ILE . 82.2 mt -63.85 -23.0 67.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.209 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.76 -40.71 13.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.984 0.421 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -104.38 20.3 18.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.816 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HA ' HG23 ' A' ' 57' ' ' VAL . 3.3 pt20 -86.33 139.93 30.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.622 0.248 . . . . 0.0 110.61 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.206 -178.031 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 121.236 0.541 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.69 166.5 22.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.328 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 7' ' ' GLU . . . -114.96 140.43 49.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.896 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -79.26 -174.85 4.35 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.292 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.597 ' H ' HG22 ' A' ' 4' ' ' THR . 20.8 tt0 -54.54 -55.35 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -169.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' OE1' ' HB ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -67.33 -34.38 77.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.197 0.522 . . . . 0.0 110.977 -173.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB3' ' HB1' ' A' ' 3' ' ' ALA . 40.0 tp10 -75.09 -47.12 30.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.409 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.704 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -69.39 -31.45 49.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.09 -41.13 90.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.541 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 110.325 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.68 93.8 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.353 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.78 -51.16 66.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -54.94 -52.68 62.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.457 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.05 -40.88 46.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.718 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.807 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -85.01 -29.75 6.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.158 -172.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.801 HG11 HD12 ' A' ' 37' ' ' LEU . 42.2 t -76.43 -24.73 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 121.711 -0.618 . . . . 0.0 109.818 176.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.97 -30.96 71.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.505 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 15.4 tp10 -62.79 -41.47 99.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.178 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.534 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 28.9 mt -76.84 -54.45 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.001 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.51 -77.75 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.792 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.76 61.23 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.504 -1.332 . . . . 0.0 114.817 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.8 HG13 HD13 ' A' ' 37' ' ' LEU . 17.1 mm -87.98 129.22 51.02 Favored Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 164.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.7 141.28 35.27 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 111.548 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.66 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 91.1 t -56.32 -33.68 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.212 -174.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -76.65 -21.53 55.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.015 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.49 -15.54 37.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.552 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.454 HG21 ' CB ' ' A' ' 13' ' ' ALA . 72.6 t -69.17 121.0 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.548 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 70' ' ' VAL . 57.9 mtpt -144.39 177.16 8.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.256 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.617 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 19.8 mt -81.69 -7.32 59.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.048 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -92.83 -32.44 14.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.456 -171.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.651 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.71 139.23 32.88 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.702 -168.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.774 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 9.3 m -87.65 135.34 33.4 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.645 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.01 -45.6 82.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.407 0.622 . . . . 0.0 110.403 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.1 p -75.46 -33.41 60.84 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.214 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.774 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 15.2 t70 -91.64 -58.01 2.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.947 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.92 -47.15 8.06 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.633 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.801 HD12 HG11 ' A' ' 16' ' ' VAL . 3.9 mm? -67.38 -16.72 64.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.021 -175.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.63 32.82 16.13 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.57 0.544 . . . . 0.0 110.535 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -99.25 147.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.592 -171.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.1 m-20 -96.67 164.53 12.55 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 p -55.65 -48.78 74.42 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.673 0.608 . . . . 0.0 111.522 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -50.95 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 19.1 m -47.6 -52.46 17.74 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.839 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 8.8 ptm -61.98 -50.67 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.262 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 64' ' ' VAL . 86.5 t -60.38 -25.23 33.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.944 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.51 -65.82 0.77 Allowed 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.879 -0.513 . . . . 0.0 111.226 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.591 HG12 HG12 ' A' ' 15' ' ' ILE . 6.7 t -88.36 -21.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.108 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -79.45 -27.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.102 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.653 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.44 -34.7 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.421 0.629 . . . . 0.0 109.389 169.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.39 68.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.355 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.807 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -80.36 -35.75 34.99 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.653 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 11.2 pt-20 -70.57 -52.72 19.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 29.8 mt-10 -66.08 -20.68 66.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 7.5 ptm180 -71.97 -5.31 33.93 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.803 -0.56 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.415 ' CB ' HE22 ' A' ' 81' ' ' GLN . 80.1 m-85 -119.76 13.02 12.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.738 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 59.77 41.92 17.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.727 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.701 HG11 HG23 ' A' ' 77' ' ' ILE . 9.5 p -115.17 137.56 48.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -134.28 117.89 16.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.252 0.548 . . . . 0.0 111.263 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.632 HD11 ' CG2' ' A' ' 64' ' ' VAL . 6.4 pt -116.38 164.94 16.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.591 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 63' ' ' ASP . 34.4 Cg_exo -61.76 134.48 50.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.586 1.524 . . . . 0.0 110.932 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.31 -41.14 62.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.632 . . . . 0.0 111.061 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.01 -20.49 66.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.229 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.19 -41.95 66.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.604 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 59' ' ' ILE . 48.2 t -59.22 -43.48 89.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -22.54 66.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.005 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.29 -17.71 23.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.442 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.3 pp -87.93 128.27 35.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.512 0.672 . . . . 0.0 110.688 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -90.83 -8.43 49.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.808 -170.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 13.2 p -128.73 157.16 42.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.36 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 28' ' ' LYS . 1.5 p -76.68 -18.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.88 -42.78 24.47 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.105 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.68 -39.29 84.02 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -57.44 -56.87 16.3 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.304 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.785 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -59.36 -50.6 73.33 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.52 -177.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HD2' HD12 ' A' ' 78' ' ' LEU . 1.5 tptm -62.4 -37.57 86.31 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.713 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.62 -41.06 98.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.701 HG23 HG11 ' A' ' 57' ' ' VAL . 27.7 mt -62.61 -52.36 60.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 74' ' ' THR . 84.2 mt -60.41 -35.0 74.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.36 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.54 -36.34 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.533 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -98.95 7.85 45.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.435 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 77' ' ' ILE . 5.2 mm-40 -68.39 150.5 48.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.959 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.352 -177.232 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.682 0.277 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 126.95 32.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 110.96 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.408 ' HB1' ' CB ' ' A' ' 7' ' ' GLU . . . -102.24 125.68 49.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.515 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -165.29 0.55 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.535 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -56.78 -56.41 21.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.64 -30.54 65.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.747 0.308 . . . . 0.0 111.296 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' CB ' ' HB1' ' A' ' 3' ' ' ALA . 71.1 mm-40 -65.12 -53.53 43.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 110.24 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.8 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.82 -33.55 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.661 -178.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.91 -37.63 78.7 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.779 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.73 94.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.498 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.97 -39.87 89.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.937 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -63.05 -48.88 76.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.611 ' HA ' HG21 ' A' ' 27' ' ' VAL . . . -55.71 -50.0 71.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.032 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.93 -38.45 67.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.136 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.896 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.74 -33.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.752 HG11 HD12 ' A' ' 37' ' ' LEU . 43.8 t -74.34 -23.91 18.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -63.36 -24.43 67.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.741 174.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.02 -27.9 63.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.533 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.843 HD11 ' HB ' ' A' ' 47' ' ' VAL . 47.3 mt -91.26 -53.79 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.559 -173.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.81 -82.03 0.64 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.07 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.32 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.778 HG13 HD13 ' A' ' 37' ' ' LEU . 20.5 mm -88.33 130.73 44.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 166.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 9.8 Cg_endo -53.3 141.49 59.96 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.368 2.046 . . . . 0.0 111.017 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 34.9 m -62.88 -20.66 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.962 0.411 . . . . 0.0 111.717 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.44 -20.63 39.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -97.9 -8.75 27.55 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.161 -173.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 13' ' ' ALA . 68.9 t -67.23 110.21 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.688 0.756 . . . . 0.0 109.379 175.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' O ' HG13 ' A' ' 70' ' ' VAL . 55.5 mtpt -135.84 164.49 27.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.267 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.729 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.1 mp -74.68 -2.89 28.27 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.182 0.515 . . . . 0.0 110.238 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -104.26 -7.65 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.555 -171.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.612 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.78 141.58 35.85 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.29 -178.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.796 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 16.2 m -83.64 132.3 34.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.089 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.63 -48.63 80.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.244 0.545 . . . . 0.0 110.28 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -70.26 -35.55 73.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.491 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.796 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 14.4 t70 -91.5 -69.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.617 -173.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.15 -44.35 63.24 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.749 -173.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.778 HD13 HG13 ' A' ' 22' ' ' ILE . 3.6 mm? -70.53 -15.87 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 60.51 29.99 19.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.569 0.7 . . . . 0.0 109.832 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.48 145.13 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.926 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.1 159.09 15.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 m -53.41 -42.64 67.22 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.335 0.397 . . . . 0.0 111.67 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -45.61 50.0 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.485 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 14.7 m -52.03 -53.04 46.61 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.527 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 9.6 ptm -59.09 -49.8 76.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.933 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.727 HG22 ' HB ' ' A' ' 64' ' ' VAL . 97.7 t -61.82 -26.22 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.2 -65.73 0.81 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.667 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 19' ' ' ILE . 20.3 t -89.27 -19.83 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.138 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 44' ' ' MET . 28.0 t -79.97 -22.0 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.661 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.4 t -76.39 -30.93 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 167.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.81 -25.34 67.44 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.552 168.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.28 -36.28 27.23 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.599 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.6 pt-20 -64.04 -45.76 87.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.634 0.73 . . . . 0.0 109.586 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.645 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 42.2 mt-10 -75.13 -21.47 58.83 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.246 -171.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 17.5 ptm180 -77.35 -4.84 47.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.214 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.07 16.66 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 59.13 51.54 6.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.601 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 52' ' ' GLU . 8.0 p -133.07 155.43 41.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -134.91 111.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.555 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.675 HD11 HG22 ' A' ' 64' ' ' VAL . 14.6 pt -104.9 163.35 17.35 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.567 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.6 Cg_exo -61.59 136.02 60.37 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 121.937 1.758 . . . . 0.0 112.019 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.6 -52.91 34.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.389 0.614 . . . . 0.0 111.075 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 6.1 p-10 -71.59 -18.32 62.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.482 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.667 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 4.8 t0 -75.2 -22.57 57.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.387 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' HG22 ' A' ' 45' ' ' VAL . 61.7 t -67.18 -43.79 88.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.547 ' HD2' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.97 -14.25 60.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.086 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 39.4 t30 -73.81 -40.62 63.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.043 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.5 pp -79.26 134.35 36.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.344 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.17 -1.02 27.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.305 -171.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.508 ' HA ' ' H ' ' A' ' 33' ' ' PHE . 44.3 p -131.8 149.13 52.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.176 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -69.88 -21.27 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 109.745 177.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -75.53 -39.51 34.98 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.573 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.08 -35.44 79.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.492 0.663 . . . . 0.0 109.215 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -58.4 -46.42 86.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.326 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.774 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.12 -51.84 58.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.946 -174.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.662 ' HD3' HD12 ' A' ' 78' ' ' LEU . 34.1 mmtp -57.26 -37.81 72.91 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.532 0.52 . . . . 0.0 110.848 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.477 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 35.5 t80 -63.07 -43.57 98.19 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.269 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -65.31 -48.15 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.159 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 8' ' ' ILE . 96.8 mt -56.04 -46.17 78.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.587 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -71.7 -6.27 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -128.91 1.55 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 8.6 pt20 -68.65 155.87 39.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.885 -0.143 . . . . 0.0 111.082 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.988 177.163 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 mtm . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.09 43.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.42 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.47 122.74 43.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -85.15 -161.67 0.62 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.911 -178.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.543 ' H ' HG22 ' A' ' 4' ' ' THR . 49.0 tt0 -59.95 -55.67 31.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.35 -39.87 89.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.67 -53.57 49.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.409 0.623 . . . . 0.0 110.53 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.871 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.53 -30.23 46.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.086 -177.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -62.38 -39.48 84.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.766 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.45 97.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.59 -47.41 84.09 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.992 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.8 -39.07 90.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.041 0.448 . . . . 0.0 109.807 177.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.09 -55.73 31.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.218 177.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.46 -41.01 52.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.919 0.866 . . . . 0.0 109.832 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' A' ' 51' ' ' ALA . 9.4 mm -64.2 -57.84 9.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.56 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.846 HG11 HD12 ' A' ' 37' ' ' LEU . 4.2 t -72.05 -23.89 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.446 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -59.48 -30.33 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.612 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.77 -20.6 49.5 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.406 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.629 HD11 ' HB ' ' A' ' 47' ' ' VAL . 47.4 mt -90.47 -54.23 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.929 -175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.06 -93.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.75 39.29 0.07 OUTLIER Glycine 0 CA--C 1.522 0.504 0 C-N-CA 119.189 -1.482 . . . . 0.0 115.471 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.836 HG13 HD13 ' A' ' 37' ' ' LEU . 17.5 mm -86.68 124.14 69.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 118.124 0.962 . . . . 0.0 108.608 166.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.55 155.3 42.79 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.736 2.291 . . . . 0.0 112.034 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.787 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 90.9 t -57.54 -40.9 77.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.984 0.421 . . . . 0.0 111.761 -173.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -81.28 -16.53 52.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.875 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' A' ' 22' ' ' ILE . 24.5 t70 -80.65 -15.51 56.38 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.739 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 13' ' ' ALA . 57.6 t -65.08 121.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.737 0.78 . . . . 0.0 110.555 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 16.9 mtpp -139.64 146.79 40.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.901 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.561 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 39.1 mt -70.95 -7.22 44.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 110.19 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 6.3 p-10 -107.99 8.97 28.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.955 -177.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HG2' ' CG1' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -105.85 145.91 30.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.868 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 14.8 m -95.45 138.04 33.68 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -170.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.5 m-85 -58.34 -46.24 86.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.388 0.614 . . . . 0.0 110.229 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.8 p -77.55 -30.76 52.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.717 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' CB ' ' HB2' ' A' ' 32' ' ' SER . 1.4 t70 -92.53 -50.25 5.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.857 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.83 -52.27 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.762 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.846 HD12 HG11 ' A' ' 16' ' ' VAL . 3.3 mm? -67.85 -11.5 58.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.723 -168.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.93 35.75 25.6 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.53 0.519 . . . . 0.0 110.536 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.405 -172.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.33 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.195 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 44' ' ' MET . 40.7 m -51.52 -59.48 4.21 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.622 0.576 . . . . 0.0 112.083 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.14 -40.89 77.99 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.961 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.498 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 6.5 m -50.42 -56.6 10.75 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.59 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 11.8 ptm -62.7 -47.0 85.53 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.908 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.0 t -68.18 -24.48 30.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.005 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.49 -66.13 0.81 Allowed 'General case' 0 C--O 1.242 0.703 0 O-C-N 121.791 -0.568 . . . . 0.0 111.493 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.662 HG12 HG23 ' A' ' 15' ' ' ILE . 7.8 t -84.28 -24.67 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.509 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.639 ' HA ' HG21 ' A' ' 15' ' ' ILE . 40.5 t -77.47 -20.24 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.419 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.706 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 2.9 t -74.78 -33.16 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -18.35 64.48 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.396 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.988 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -82.29 -38.31 24.55 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.845 176.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.706 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -66.7 -45.99 77.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.15 -176.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.09 -27.1 66.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.31 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 16.8 ptp180 -79.2 -7.14 58.0 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.393 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -116.12 15.62 16.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t70 54.71 70.74 0.59 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.732 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 52' ' ' GLU . 7.1 p -139.13 165.89 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 57' ' ' VAL . 14.7 pttm -133.78 110.49 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.991 0.424 . . . . 0.0 110.179 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 ' OE1' ' A' ' 52' ' ' GLU . 29.1 pt -121.85 154.63 60.8 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.474 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 141.74 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 111.956 173.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.54 -51.4 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.437 0.637 . . . . 0.0 109.509 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.162 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -34.85 79.15 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.229 0.331 . . . . 0.0 110.963 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.629 ' HB ' HG22 ' A' ' 45' ' ' VAL . 43.0 t -61.5 -39.16 81.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.077 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -18.22 51.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 110.608 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -74.37 -24.15 59.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.152 0.501 . . . . 0.0 109.904 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.734 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -97.57 130.21 44.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.43 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -96.08 -1.56 48.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.543 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.868 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 59.2 p -122.41 146.5 47.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.704 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 2.1 p -65.92 -34.91 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.852 177.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -62.55 -30.28 76.08 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.89 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 2.3 t70 -68.1 -49.1 63.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -58.48 -45.73 88.09 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.586 0.707 . . . . 0.0 110.099 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.725 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 17.0 m -59.62 -51.7 68.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.628 -177.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -66.09 -30.46 70.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.197 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.62 -46.58 85.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.918 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.542 HG23 HG11 ' A' ' 57' ' ' VAL . 87.4 mt -63.62 -40.98 91.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.219 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 8' ' ' ILE . 92.2 mt -66.64 -26.68 67.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.847 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.03 -34.03 20.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.423 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -119.77 20.73 12.21 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.429 ' HA ' HG23 ' A' ' 57' ' ' VAL . 3.3 pt20 -68.17 148.13 51.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.734 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.044 -177.007 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.45 156.02 16.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 7' ' ' GLU . . . -110.91 122.35 47.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 5' ' ' GLN . 1.2 m -89.33 -158.89 0.53 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.633 ' H ' HG22 ' A' ' 4' ' ' THR . 38.0 tt0 -58.66 -55.62 32.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -54.0 -44.83 71.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 49.7 mm-40 -67.72 -56.29 9.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.399 0.618 . . . . 0.0 111.027 -177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.681 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -67.44 -30.65 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.139 -174.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.66 -43.53 97.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.446 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.34 92.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.685 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.556 ' HA3' ' CZ ' ' A' ' 55' ' ' PHE . . . -68.5 -44.15 74.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.427 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -62.37 -46.31 89.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.75 -52.51 63.69 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.766 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.79 -36.48 58.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.646 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.07 -31.89 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.672 -173.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG11 HD12 ' A' ' 37' ' ' LEU . 19.9 t -74.2 -28.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.246 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.25 -29.76 67.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.949 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.73 -22.12 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.718 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 47' ' ' VAL . 17.1 mt -92.89 -54.02 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.296 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.47 -93.12 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.27 50.99 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.696 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.772 HG13 HD13 ' A' ' 37' ' ' LEU . 22.7 mm -94.08 120.21 65.87 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 162.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.31 153.79 72.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 111.722 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.644 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 22.4 m -60.66 -17.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.43 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.57 -20.98 53.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.763 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 22' ' ' ILE . 17.7 t0 -106.07 -11.84 15.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.871 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 13' ' ' ALA . 97.3 t -71.85 123.24 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.273 0.558 . . . . 0.0 110.954 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 70' ' ' VAL . 75.8 mttt -148.09 166.36 28.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -171.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 24.2 mt -78.35 -3.34 42.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.036 0.446 . . . . 0.0 110.64 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.69 -30.06 15.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.527 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -84.88 139.67 31.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.396 0.617 . . . . 0.0 110.504 -168.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.792 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 16.2 m -85.26 138.61 32.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.834 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.584 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -58.46 -51.24 70.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.303 0.573 . . . . 0.0 110.55 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.6 p -69.8 -33.84 72.9 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.291 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.76 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 36.2 t70 -92.42 -69.25 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.774 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -69.46 -55.55 9.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.063 -177.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.815 HD12 HG11 ' A' ' 16' ' ' VAL . 3.6 mm? -63.64 -16.64 61.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 63.3 24.5 14.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.774 0.797 . . . . 0.0 109.712 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -92.72 150.12 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.613 -172.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.4 161.63 14.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.652 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 17.8 m -48.3 -50.9 28.3 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.447 0.467 . . . . 0.0 111.544 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -42.6 69.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.722 ' HB2' HG22 ' A' ' 39' ' ' VAL . 15.2 m -50.95 -52.06 46.21 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.466 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.715 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 13.1 ptt? -63.67 -47.84 79.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.797 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 64' ' ' VAL . 80.1 t -57.38 -26.64 26.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.051 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.37 -65.73 0.82 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.958 -0.464 . . . . 0.0 111.185 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 15' ' ' ILE . 21.0 t -87.05 -21.3 7.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.36 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 44' ' ' MET . 40.6 t -79.51 -20.48 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.634 -0.666 . . . . 0.0 110.219 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.639 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.6 t -75.87 -34.64 28.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -59.36 -24.08 63.08 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.99 168.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -84.12 -33.85 24.23 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.117 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.685 ' O ' HG12 ' A' ' 57' ' ' VAL . 2.5 pt-20 -64.19 -48.12 77.15 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.559 0.695 . . . . 0.0 109.561 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 32.2 mt-10 -72.73 -22.38 60.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.254 -172.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 7.4 ptp180 -80.79 -10.64 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.215 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' CZ ' ' HA3' ' A' ' 11' ' ' GLY . 58.1 m-85 -105.7 4.08 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 57.04 70.93 0.61 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.0 p -132.39 166.67 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 57' ' ' VAL . 4.4 mptt -123.79 110.56 15.06 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.622 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.497 HG13 ' HD2' ' A' ' 60' ' ' PRO . 5.9 tt -134.86 135.46 23.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 0.0 110.588 172.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD2' HG13 ' A' ' 59' ' ' ILE . 18.6 Cg_endo -66.88 150.79 83.08 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.572 2.182 . . . . 0.0 112.849 175.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.7 -48.06 50.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.948 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 1.039 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -53.74 -44.37 69.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.588 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -62.94 -33.89 76.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -171.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.93 ' HB ' HG22 ' A' ' 45' ' ' VAL . 12.0 t -68.37 -41.33 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.841 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 1.039 ' HE3' ' HA ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.29 -0.76 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 122.105 -0.372 . . . . 0.0 111.766 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -91.19 -31.24 16.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.834 0.35 . . . . 0.0 110.302 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 73' ' ' ALA . 2.9 pp -81.63 145.23 30.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.431 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -110.51 -5.19 15.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.897 -172.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.792 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 43.8 p -127.25 153.72 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 31' ' ' LYS . 2.1 p -74.12 -22.4 18.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.47 0.652 . . . . 0.0 110.025 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -73.43 -31.47 60.99 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.182 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.05 -46.2 85.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HA ' HD22 ' A' ' 67' ' ' LEU . . . -57.09 -45.15 83.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.815 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -67.13 -45.52 76.88 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.633 -175.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 1.012 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 5.8 mmpt? -62.53 -31.02 71.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -70.58 -49.34 48.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 109.918 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.6 mt -58.29 -49.35 82.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 8' ' ' ILE . 73.5 mt -69.45 -20.97 63.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.235 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.4 -21.88 32.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.205 0.526 . . . . 0.0 110.692 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -125.19 22.7 7.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.524 ' HA ' HG23 ' A' ' 57' ' ' VAL . 3.6 pt20 -75.84 140.33 42.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.016 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 O-C-N 123.852 0.72 . . . . 0.0 111.665 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.73 138.38 44.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 111.15 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.21 106.12 18.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -73.05 -168.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.594 ' H ' HG22 ' A' ' 4' ' ' THR . 13.6 tt0 -53.2 -56.43 16.47 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -171.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.87 -38.39 90.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -67.67 -54.18 21.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.143 0.497 . . . . 0.0 111.124 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.755 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -67.14 -32.74 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.33 -39.37 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.569 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.95 94.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.61 59.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.054 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -61.37 -53.83 51.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.04 -50.6 72.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.934 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -55.29 -35.83 65.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.347 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -81.15 -31.71 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.807 -177.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.811 HG11 HD12 ' A' ' 37' ' ' LEU . 22.4 t -74.61 -26.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 O-C-N 121.915 -0.491 . . . . 0.0 109.69 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.4 -28.62 70.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -66.58 -36.31 82.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.149 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 47' ' ' VAL . 27.3 mt -80.27 -52.61 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.421 -174.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.87 -84.7 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.82 53.63 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.933 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.811 HG13 HD13 ' A' ' 37' ' ' LEU . 22.8 mm -89.43 125.05 62.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 165.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.3 146.57 60.58 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.452 2.101 . . . . 0.0 111.395 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.708 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 31.4 m -54.51 -35.06 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -81.31 -17.79 48.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.836 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HB3' HG23 ' A' ' 22' ' ' ILE . 12.6 t70 -83.35 -22.51 32.82 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.999 0.428 . . . . 0.0 110.603 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 13' ' ' ALA . 72.4 t -62.78 129.18 25.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.908 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -145.64 159.37 43.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.398 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.512 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.2 mp -77.37 -3.83 42.1 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.981 0.419 . . . . 0.0 110.547 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.12 1.58 24.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.17 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -103.72 140.44 37.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.683 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.905 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 24.7 m -87.41 136.83 32.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.463 -170.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.638 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.17 -49.79 76.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 110.196 177.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.5 p -69.54 -34.32 74.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.363 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 9.5 t70 -91.59 -68.68 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.307 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.8 m-20 -72.92 -52.38 14.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.895 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.811 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -66.35 -10.45 43.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.127 -172.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 61.38 31.44 19.2 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.803 0.69 . . . . 0.0 109.944 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.5 OUTLIER -102.66 153.13 5.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.418 -171.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.7 170.89 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.605 170.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 44' ' ' MET . 24.8 t -57.33 -59.77 4.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.421 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.0 tm? -68.53 -39.15 81.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.372 -176.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.504 ' HB2' HG22 ' A' ' 39' ' ' VAL . 13.3 m -48.87 -53.53 19.1 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.008 0.432 . . . . 0.0 111.637 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.617 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 20.3 ptt? -65.27 -42.83 92.81 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.574 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 98.7 t -60.18 -26.19 35.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.07 0.462 . . . . 0.0 110.389 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.12 -65.39 0.85 Allowed 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.856 -0.528 . . . . 0.0 111.413 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' HB ' HD11 ' A' ' 19' ' ' ILE . 15.8 t -85.72 -23.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.137 -173.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 44' ' ' MET . 41.2 t -79.32 -23.21 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.481 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.737 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.3 t -76.63 -31.8 20.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 109.329 169.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.64 -25.85 67.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.379 0.609 . . . . 0.0 109.789 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.07 -37.7 26.0 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.972 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.737 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 6.9 pt-20 -61.83 -51.63 67.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.484 0.659 . . . . 0.0 109.643 -175.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.636 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.7 mt-10 -71.35 -22.85 61.85 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.649 -171.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.2 ptm180 -75.01 -19.37 60.11 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -97.91 6.92 47.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t0 60.54 57.94 2.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.656 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.766 HG11 HG23 ' A' ' 77' ' ' ILE . 13.3 p -134.3 161.65 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.201 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 58' ' ' LYS . 13.4 tptp -127.82 112.93 15.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.111 175.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 tt -118.12 117.32 35.23 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.819 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.58 138.88 39.47 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.448 2.099 . . . . 0.0 111.726 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 5.2 p-10 -58.33 -29.55 66.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.529 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.632 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 32.7 t70 -67.53 -25.31 65.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.023 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.81 -37.94 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.642 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 46.7 t -63.54 -53.86 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.045 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.632 ' HD2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -63.36 -9.95 14.42 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 176.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.5 -41.36 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.773 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 1.2 pp -67.6 137.1 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.453 0.644 . . . . 0.0 110.988 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -96.21 -20.68 18.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.195 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.905 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 14.8 p -119.95 154.55 34.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.543 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.4 p -63.53 -31.15 51.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 109.999 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -63.72 -33.79 88.2 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.523 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 51.1 m-20 -57.92 -52.73 64.29 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -57.49 -52.21 66.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.743 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.769 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 7.0 m -56.94 -52.92 63.27 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.019 -173.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HA ' HD12 ' A' ' 78' ' ' LEU . 4.2 tppp? -65.98 -31.34 72.19 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.592 0.234 . . . . 0.0 110.452 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.94 -43.07 84.16 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.257 0.551 . . . . 0.0 109.619 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.766 HG23 HG11 ' A' ' 57' ' ' VAL . 46.5 mt -59.99 -46.57 93.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.239 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 74' ' ' THR . 95.0 mt -62.35 -28.03 69.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.109 -175.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.69 -39.62 44.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.093 0.473 . . . . 0.0 111.084 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.471 ' O ' HG23 ' A' ' 57' ' ' VAL . 69.0 m-70 -105.62 21.69 16.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.272 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -79.98 175.65 10.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.915 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.787 176.283 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' HA ' ' OE1' ' A' ' 81' ' ' GLN . . . -69.97 111.9 5.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.164 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 7' ' ' GLU . . . -116.41 147.16 41.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.297 -172.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -90.4 -175.34 4.45 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.116 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 8' ' ' ILE . 12.7 tt0 -50.49 -56.3 12.16 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.26 -41.24 88.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 3' ' ' ALA . 85.1 tt0 -74.69 -45.92 41.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.879 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.92 -33.97 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.36 -39.75 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.983 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.37 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.14 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.5 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -67.48 -45.4 78.49 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.992 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -63.34 -40.01 96.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.634 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -57.82 -54.89 41.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 41.9 tt0 -52.9 -42.44 65.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.432 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.934 HG13 ' HB2' ' A' ' 51' ' ' ALA . 8.0 mm -62.61 -53.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.292 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 37' ' ' LEU . 13.2 t -71.2 -23.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.461 . . . . 0.0 110.303 -177.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -65.85 -19.68 65.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.009 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 5.1 mm-40 -83.16 -29.66 28.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.145 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 47' ' ' VAL . 32.3 mt -84.86 -53.02 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.631 -174.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.34 -86.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.05 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.35 56.84 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.573 -1.299 . . . . 0.0 114.492 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.842 HG13 HD13 ' A' ' 37' ' ' LEU . 12.8 mm -87.88 124.81 66.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 164.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 147.95 49.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 111.757 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.634 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 79.2 t -54.61 -40.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.645 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -75.41 -17.02 60.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.298 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 22' ' ' ILE . 1.6 t70 -90.09 -5.71 56.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.142 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 13' ' ' ALA . 46.0 t -68.83 116.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.549 0.69 . . . . 0.0 109.696 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 13.6 mtpp -132.78 144.89 50.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.454 -171.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.2 mp -74.08 -3.43 29.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.873 0.368 . . . . 0.0 110.997 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 5.8 p-10 -108.03 -7.91 16.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.762 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -91.93 140.0 30.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.442 -177.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.821 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 19.2 m -87.98 135.77 33.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.448 -170.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -56.67 -48.16 78.22 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.277 177.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.5 p -71.8 -33.65 68.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.201 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 5.0 t70 -92.13 -65.53 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.199 0.523 . . . . 0.0 111.651 -173.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 31' ' ' LYS . 3.1 m-20 -75.82 -52.76 9.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.673 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.004 HD12 HG11 ' A' ' 16' ' ' VAL . 2.9 mm? -66.19 -14.54 62.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.791 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 61.76 32.91 18.13 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.856 0.836 . . . . 0.0 109.38 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.4 OUTLIER -98.81 146.96 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.809 -171.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 8.2 m-20 -95.92 173.84 7.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.674 ' HB3' ' HD3' ' A' ' 65' ' ' LYS . 13.6 m -57.25 -56.32 23.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.565 . . . . 0.0 110.471 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -65.59 -40.49 92.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.583 ' HB2' HG22 ' A' ' 39' ' ' VAL . 14.7 m -50.59 -54.72 20.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 15.3 ptt? -66.36 -40.96 90.11 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.646 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.64 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 82.5 t -63.09 -24.95 37.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.704 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -74.32 -66.41 0.73 Allowed 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.74 -0.6 . . . . 0.0 111.659 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG12 HG23 ' A' ' 15' ' ' ILE . 11.8 t -91.12 -22.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.578 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 44' ' ' MET . 21.5 t -80.46 -21.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.619 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.1 t -73.95 -33.57 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.609 0.718 . . . . 0.0 109.302 167.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.36 66.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.339 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.934 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -81.14 -45.75 15.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.671 ' O ' HG12 ' A' ' 57' ' ' VAL . 8.1 pt-20 -59.31 -49.11 79.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.414 0.626 . . . . 0.0 110.034 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.8 pt-20 -62.68 -30.67 71.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.724 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -78.7 -5.0 51.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.275 0.56 . . . . 0.0 110.343 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 68.7 m-85 -114.2 22.38 13.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.345 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 71.75 17.47 5.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.507 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.678 HG11 HG23 ' A' ' 77' ' ' ILE . 9.6 p -114.49 158.29 14.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.075 -0.391 . . . . 0.0 110.435 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 50.1 mtpt -134.06 111.3 10.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.449 ' HB ' ' HE2' ' A' ' 76' ' ' TYR . 21.4 pt -108.53 163.36 17.14 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.825 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 24.0 Cg_exo -65.3 129.61 23.21 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.942 1.761 . . . . 0.0 111.623 176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.79 -49.2 63.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 110.06 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.41 -19.52 64.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.275 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.825 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 2.7 t0 -74.0 -38.08 64.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.652 ' HA ' HD21 ' A' ' 67' ' ' LEU . 22.2 t -60.12 -42.75 91.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.674 ' HD3' ' HB3' ' A' ' 41' ' ' SER . 17.6 tptp -59.91 -31.08 69.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.795 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.63 -26.99 40.98 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.154 -0.341 . . . . 0.0 111.255 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.717 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -83.7 136.58 34.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.292 -178.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -89.36 -22.77 22.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.131 -173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.821 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 32.8 p -120.2 156.98 30.05 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.887 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -67.72 -36.96 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -59.1 -41.51 96.59 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.025 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.96 -50.73 72.19 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -54.79 -50.28 68.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.58 0.705 . . . . 0.0 110.936 176.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.795 HG23 HD12 ' A' ' 8' ' ' ILE . 12.4 m -58.98 -49.49 77.69 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.686 -174.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HD2' HD12 ' A' ' 78' ' ' LEU . 7.6 tptm -65.95 -38.65 89.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.449 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 59.3 t80 -56.91 -43.34 81.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.678 HG23 HG11 ' A' ' 57' ' ' VAL . 82.0 mt -65.18 -49.9 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.536 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 8' ' ' ILE . 91.5 mt -54.15 -44.99 71.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.21 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -86.68 -3.63 59.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.475 ' O ' HG23 ' A' ' 57' ' ' VAL . 29.9 m-70 -124.69 15.22 8.73 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.244 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 2' ' ' ALA . 10.5 pt20 -86.15 153.99 21.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.546 0.213 . . . . 0.0 111.498 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.077 176.293 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.0 167.17 10.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.98 135.46 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -86.83 -167.17 1.79 Allowed 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.565 ' H ' HG22 ' A' ' 4' ' ' THR . 24.8 tt0 -58.99 -55.71 31.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -167.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -32.22 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.868 0.366 . . . . 0.0 111.144 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.05 -47.65 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.848 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.35 -33.11 52.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.11 -43.02 95.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.1 95.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.937 0.398 . . . . 0.0 110.875 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.806 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.51 -33.03 75.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.341 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -68.62 -48.64 63.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.13 -46.77 85.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.58 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -52.39 -36.74 54.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.496 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.59 -35.6 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.81 -174.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.724 HG11 HD12 ' A' ' 37' ' ' LEU . 36.2 t -71.17 -23.97 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 109.776 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -62.6 -24.57 67.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.28 -38.48 63.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.205 0.526 . . . . 0.0 109.958 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.717 HD11 ' HB ' ' A' ' 47' ' ' VAL . 24.9 mt -71.04 -53.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.694 -174.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.24 -86.14 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.452 -175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 64.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.685 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 37' ' ' LEU . 23.2 mm -99.61 131.35 24.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 164.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.99 148.34 48.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.465 2.11 . . . . 0.0 111.633 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.694 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 93.9 t -59.88 -38.57 76.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.15 0.5 . . . . 0.0 111.304 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -76.71 -18.31 58.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' A' ' 22' ' ' ILE . 11.2 t70 -83.23 -22.74 33.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.68 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 13' ' ' ALA . 75.2 t -66.4 122.28 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.572 0.701 . . . . 0.0 110.729 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 82.1 mttt -144.04 169.76 17.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.207 -176.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.751 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.6 mp -81.57 -2.5 50.25 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.494 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -110.38 2.01 18.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.83 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.05 141.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.725 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 24.9 m -88.4 136.46 32.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.881 0.372 . . . . 0.0 111.658 -170.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -59.58 -47.83 84.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.535 0.684 . . . . 0.0 110.426 178.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 38.9 p -72.95 -33.66 66.03 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.354 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.725 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.5 t70 -91.67 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 111.539 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -49.11 18.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.287 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.798 HD13 HG13 ' A' ' 22' ' ' ILE . 3.5 mm? -70.23 -14.73 62.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.659 -176.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.49 31.88 20.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.847 0.832 . . . . 0.0 110.129 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -97.66 151.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.881 -169.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 44' ' ' MET . 4.4 m-20 -104.0 166.25 10.53 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.2 p -51.23 -55.65 16.98 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.709 0.631 . . . . 0.0 111.32 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -62.96 -48.97 76.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.598 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.606 ' HB2' ' H ' ' A' ' 40' ' ' ASP . 13.0 m -50.94 -54.29 25.46 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.646 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.671 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 4.8 ptm -59.74 -49.43 77.78 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.698 HG22 ' HB ' ' A' ' 64' ' ' VAL . 85.5 t -68.81 -22.31 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.16 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.82 -66.2 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.661 -0.649 . . . . 0.0 111.743 -174.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 19' ' ' ILE . 16.6 t -87.88 -21.74 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.052 -173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 44' ' ' MET . 45.9 t -78.82 -26.59 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.286 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.69 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 2.9 t -72.72 -35.04 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.01 64.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.23 0.538 . . . . 0.0 109.918 171.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -83.49 -39.6 20.3 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.131 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 4.5 pt-20 -59.81 -48.31 82.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.494 0.664 . . . . 0.0 109.559 -175.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.62 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 33.2 mt-10 -64.56 -33.64 76.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.169 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -81.31 -6.03 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.374 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.806 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 62.1 m-85 -105.25 6.71 33.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 170.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.38 68.36 0.77 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.553 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -140.59 161.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.353 174.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 57' ' ' VAL . 25.3 tptp -122.88 110.56 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 169.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.5 pt -119.08 151.35 50.49 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.76 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 37.1 Cg_exo -61.79 121.21 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.991 1.794 . . . . 0.0 110.847 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.06 -39.29 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 0.0 110.215 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.33 -36.36 81.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.76 ' HB2' ' HB2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -66.91 -34.79 78.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.315 -174.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.698 ' HB ' HG22 ' A' ' 45' ' ' VAL . 21.3 t -58.42 -36.45 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.165 0.507 . . . . 0.0 110.657 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -75.19 -28.46 60.03 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.895 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.49 -21.87 44.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.691 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -84.71 123.48 30.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 0.0 110.585 177.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -82.3 -14.68 54.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.009 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 73.4 p -119.71 148.74 43.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -64.33 -36.16 76.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.041 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -66.97 -30.21 75.7 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.953 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.531 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 4.0 t70 -61.6 -40.68 95.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . . . -67.97 -39.46 83.33 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.114 176.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -65.15 -51.81 58.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.007 -172.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.42 -37.03 79.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.246 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 14.6 t80 -63.34 -38.61 91.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.396 0.617 . . . . 0.0 110.706 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.501 HG23 HG11 ' A' ' 57' ' ' VAL . 52.5 mt -68.99 -33.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.533 0.682 . . . . 0.0 110.261 175.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.848 HD21 HG21 ' A' ' 8' ' ' ILE . 96.8 mt -77.97 -35.51 50.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.416 -172.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.9 -4.88 58.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.6 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -123.44 15.01 9.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.581 ' HA ' HG23 ' A' ' 57' ' ' VAL . 4.0 pt20 -73.93 157.82 35.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.698 0.285 . . . . 0.0 111.557 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.554 177.654 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.3 108.38 13.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 7' ' ' GLU . . . -91.33 138.38 31.63 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.183 -165.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -88.42 -168.87 2.34 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.249 174.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.714 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.3 tt0 -55.61 -55.59 30.31 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 9' ' ' VAL . 9.2 pt-20 -64.5 -39.17 93.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.899 0.381 . . . . 0.0 111.566 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 42.3 mt-10 -64.34 -54.35 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.0 110.885 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.768 HG21 HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.67 -31.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.689 -177.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -69.71 -31.73 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.253 -177.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.82 74.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.79 -32.63 78.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.774 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -72.32 -49.39 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' CB ' HG21 ' A' ' 27' ' ' VAL . . . -52.52 -53.63 43.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -50.23 -42.45 51.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.117 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.953 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -86.38 -27.94 6.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.536 -169.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.85 HG11 HD12 ' A' ' 37' ' ' LEU . 45.8 t -76.05 -24.76 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -68.05 -21.49 65.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.043 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 5.2 mm-40 -70.54 -29.07 65.45 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.349 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 47' ' ' VAL . 39.3 mt -92.88 -55.29 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.553 -171.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.13 -89.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.205 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.52 44.11 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.206 -1.473 . . . . 0.0 115.117 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.803 HG13 HD13 ' A' ' 37' ' ' LEU . 14.2 mm -78.24 124.82 85.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.8 142.72 83.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.274 1.982 . . . . 0.0 111.152 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.449 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 34.6 m -59.2 -20.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.976 0.417 . . . . 0.0 111.657 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.82 -18.67 46.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.249 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 22' ' ' ILE . 1.5 t70 -100.77 -7.91 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.647 0.26 . . . . 0.0 111.329 -173.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 13' ' ' ALA . 84.6 t -68.21 118.2 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.325 0.583 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 70' ' ' VAL . 49.6 mtpt -143.17 160.33 40.63 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.207 -170.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.616 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.0 mp -74.14 -3.75 31.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.091 0.472 . . . . 0.0 110.864 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.61 -15.58 18.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.904 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.83 142.94 28.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.427 -173.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 16.0 t -84.4 134.24 34.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.889 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.542 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.03 -49.8 76.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.529 0.68 . . . . 0.0 109.843 177.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.1 p -71.95 -31.82 66.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.179 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 32' ' ' SER . 16.9 t70 -92.68 -68.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.896 -175.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -77.08 -45.24 27.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.976 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.85 HD12 HG11 ' A' ' 16' ' ' VAL . 4.0 mm? -66.73 -16.26 64.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.616 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 57.29 42.52 25.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.872 0.844 . . . . 0.0 108.83 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 44' ' ' MET . 0.3 OUTLIER -110.64 144.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.638 -173.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 166.61 15.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 8.2 m -54.77 -52.29 63.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.586 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -72.62 -42.02 64.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.216 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -48.11 -55.23 10.77 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 123.29 0.369 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.588 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 19.9 ptt? -64.35 -48.6 74.91 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.569 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.774 HG22 ' HB ' ' A' ' 64' ' ' VAL . 55.7 t -54.78 -28.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.854 0.359 . . . . 0.0 111.209 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.6 -65.52 0.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.85 -0.531 . . . . 0.0 111.565 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.765 ' HB ' HD11 ' A' ' 19' ' ' ILE . 15.2 t -85.36 -22.61 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.645 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 44' ' ' MET . 55.6 t -78.83 -25.51 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.521 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.677 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 3.2 t -69.92 -36.25 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.18 -23.47 66.63 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.232 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.953 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -83.34 -35.94 24.79 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.911 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 12.0 pt-20 -69.94 -48.62 57.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -66.42 -23.57 66.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.848 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 4.4 ptm180 -71.96 -10.71 60.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.478 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -111.09 18.42 19.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.913 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 68.89 25.63 6.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.93 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.717 HG11 HG23 ' A' ' 77' ' ' ILE . 11.5 p -115.16 151.25 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -135.08 124.41 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.196 0.522 . . . . 0.0 110.905 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 64' ' ' VAL . 7.0 pt -116.02 166.23 12.87 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.93 125.67 17.08 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 121.401 1.401 . . . . 0.0 110.446 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.57 -42.93 24.76 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.479 0.657 . . . . 0.0 110.861 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 24.1 t70 -63.08 -19.71 64.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.656 -176.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.92 -25.4 40.53 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.377 -0.202 . . . . 0.0 111.517 -173.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.774 ' HB ' HG22 ' A' ' 45' ' ' VAL . 43.8 t -64.77 -33.38 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.588 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 3.5 tmmm? -66.1 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.403 171.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -71.1 -26.82 63.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.954 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 73' ' ' ALA . 1.1 pp -94.63 134.65 36.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.388 0.613 . . . . 0.0 110.751 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -97.36 -6.58 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.795 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 69.6 p -129.69 152.24 49.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.482 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.2 p -70.55 -22.27 23.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 109.831 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.79 -36.79 41.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.586 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 6.0 t0 -58.62 -42.55 88.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.622 0.725 . . . . 0.0 109.082 176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HA ' HD22 ' A' ' 67' ' ' LEU . . . -60.19 -48.26 82.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.921 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.742 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -63.08 -50.65 69.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.547 -172.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.545 ' HD3' HD12 ' A' ' 78' ' ' LEU . 23.7 mmtp -58.96 -39.67 82.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.124 0.265 . . . . 0.0 111.251 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 42.2 t80 -62.93 -44.59 95.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.026 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.717 HG23 HG11 ' A' ' 57' ' ' VAL . 61.2 mt -61.76 -44.56 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.734 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.768 HD21 HG21 ' A' ' 8' ' ' ILE . 92.3 mt -65.55 -40.95 93.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.322 -174.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -75.07 -32.51 61.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.927 0.394 . . . . 0.0 111.669 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.52 22.54 15.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -77.02 -172.65 2.43 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.762 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.076 -179.085 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.8 128.56 42.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 173.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.84 138.66 48.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.237 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -84.78 -171.84 3.85 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.211 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' H ' HG22 ' A' ' 4' ' ' THR . 19.2 tt0 -55.73 -55.97 25.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.4 pm0 -67.64 -36.37 80.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.682 0.277 . . . . 0.0 111.546 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.47 -52.71 56.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.326 0.584 . . . . 0.0 110.613 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.869 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -69.91 -33.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.012 -178.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -59.99 -41.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.78 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.15 94.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.507 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.93 96.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.129 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -62.8 -47.56 82.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -55.42 -50.13 70.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.543 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.64 -36.42 62.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.828 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.802 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -87.52 -32.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.807 -174.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.754 HG11 HD12 ' A' ' 37' ' ' LEU . 21.2 t -72.31 -24.27 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 121.63 -0.669 . . . . 0.0 109.981 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -62.56 -28.69 70.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.703 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.68 -23.65 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.356 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 47' ' ' VAL . 44.5 mt -86.78 -52.98 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.995 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.46 -75.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.71 53.73 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.874 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.807 HG13 HD13 ' A' ' 37' ' ' LEU . 11.1 mm -80.94 129.94 65.56 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 165.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.672 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 7.3 Cg_endo -52.04 140.34 49.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.322 2.014 . . . . 0.0 111.187 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.679 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 23.3 m -57.34 -26.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.7 mm-40 -80.47 -18.74 47.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.672 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 1.8 t70 -95.23 -8.48 35.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.587 -172.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 13' ' ' ALA . 53.1 t -68.5 111.22 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.611 0.72 . . . . 0.0 110.052 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -132.06 162.13 31.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -174.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.631 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 23.8 mt -74.64 -5.61 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.136 0.493 . . . . 0.0 110.378 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.88 -19.2 19.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.022 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -93.53 143.92 25.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.935 -175.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.922 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 23.0 m -90.39 135.04 33.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.294 -173.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.7 ' CE2' ' HA ' ' A' ' 70' ' ' VAL . 1.6 m-85 -54.73 -52.52 62.21 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 110.206 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -60.54 -43.95 96.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.757 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.14 -68.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.142 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.97 -45.91 83.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.833 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.807 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -72.98 -11.57 60.62 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t0 56.55 43.58 25.49 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.968 0.792 . . . . 0.0 108.896 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.492 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -105.61 146.33 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.417 -172.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 44' ' ' MET . 3.7 m-20 -91.79 153.44 19.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.457 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 50.6 m -55.87 -41.6 74.61 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.601 0.563 . . . . 0.0 111.677 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -72.48 -43.4 63.74 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.568 ' OG ' HG23 ' A' ' 19' ' ' ILE . 1.9 t -58.99 -49.48 77.73 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.974 -176.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.541 ' HE2' HG12 ' A' ' 64' ' ' VAL . 13.6 ptm -57.1 -49.04 77.11 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.883 HG22 ' HB ' ' A' ' 64' ' ' VAL . 79.1 t -60.14 -25.92 34.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.295 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.87 -64.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.911 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' A' ' 19' ' ' ILE . 11.6 t -85.0 -22.82 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.349 -173.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 44' ' ' MET . 49.4 t -78.38 -28.15 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.134 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.687 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 12.7 t -71.36 -33.1 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.561 0.696 . . . . 0.0 109.3 169.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -60.82 -26.7 67.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.095 0.474 . . . . 0.0 110.05 171.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.802 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -82.3 -38.1 24.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.892 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 9.2 pt-20 -63.86 -46.49 84.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 25.8 mt-10 -70.19 -26.4 63.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.252 -173.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -77.8 -6.15 53.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 67.1 m-85 -111.47 19.19 18.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 174.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.59 40.21 6.15 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.632 174.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 52' ' ' GLU . 9.9 p -127.86 159.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 173.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -135.36 112.85 10.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.01 0.433 . . . . 0.0 110.095 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.542 HD11 HG22 ' A' ' 64' ' ' VAL . 14.2 pt -107.83 163.97 15.8 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.49 133.62 40.81 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.574 1.516 . . . . 0.0 109.771 170.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.63 -34.59 67.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.903 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 8.4 t70 -69.43 -18.24 63.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.818 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 66' ' ' ASN . 4.6 t70 -70.15 -31.01 68.31 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.231 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.883 ' HB ' HG22 ' A' ' 45' ' ' VAL . 41.1 t -62.42 -51.51 71.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.448 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -4.98 52.07 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.163 0.506 . . . . 0.0 111.142 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 2.5 t-20 -73.13 -39.08 66.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -89.69 147.04 24.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.216 175.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 68' ' ' LYS . 3.1 mptp? -108.27 -13.43 14.9 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.536 -174.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.922 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 61.4 p -108.2 151.66 25.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.7 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 1.1 p -70.03 -29.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.589 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 29' ' ' LEU . . . -66.75 -30.75 76.73 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.744 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 67' ' ' LEU . 4.8 t70 -65.59 -53.52 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.817 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -53.64 -50.52 65.54 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.425 0.631 . . . . 0.0 110.717 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.77 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 21.7 m -55.07 -52.82 62.0 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.98 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.482 ' HD2' HD12 ' A' ' 78' ' ' LEU . 13.3 tptp -64.68 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.15 -46.26 90.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.136 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.609 HG23 HG11 ' A' ' 57' ' ' VAL . 90.8 mt -60.68 -46.43 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.322 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 8' ' ' ILE . 83.6 mt -55.14 -42.75 73.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.683 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.1 -4.97 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -128.47 7.52 5.83 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.86 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 78' ' ' LEU . 8.6 pt20 -77.47 157.46 30.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.433 0.159 . . . . 0.0 110.728 -176.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.492 176.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.9 mmm . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.48 111.77 8.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.585 ' HB1' ' HB2' ' A' ' 7' ' ' GLU . . . -115.65 145.53 42.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.612 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -87.7 -165.17 1.23 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 173.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.494 ' H ' HG22 ' A' ' 4' ' ' THR . 16.0 tt0 -61.29 -55.67 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -63.28 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.541 -173.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.585 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 3.4 mp0 -68.16 -51.43 46.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.76 HG21 HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -66.35 -32.53 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.902 -178.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.96 -42.69 95.74 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.35 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.523 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.9 -49.05 61.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.7 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -42.32 88.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.67 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -58.64 -56.71 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.248 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -49.93 -44.52 50.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.836 0.826 . . . . 0.0 110.051 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.824 HG13 ' HB2' ' A' ' 51' ' ' ALA . 15.3 mm -60.88 -54.49 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.231 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.734 HG11 HD12 ' A' ' 37' ' ' LEU . 16.1 t -69.23 -24.2 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 0.0 110.583 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -63.33 -27.04 69.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.7 -30.66 62.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.888 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 47' ' ' VAL . 42.6 mt -84.51 -54.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.323 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -122.78 -84.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.682 -171.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.74 43.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.44 -1.362 . . . . 0.0 114.54 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.802 HG13 HD13 ' A' ' 37' ' ' LEU . 18.3 mm -82.76 126.69 72.52 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 118.158 0.979 . . . . 0.0 108.655 167.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.747 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.7 Cg_endo -56.43 145.55 78.71 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.244 1.963 . . . . 0.0 111.48 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.67 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 27.0 m -56.61 -32.97 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.07 -17.12 51.19 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.558 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.747 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 16.1 t70 -87.28 -14.03 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.635 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' A' ' 13' ' ' ALA . 91.3 t -69.73 122.81 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.321 0.581 . . . . 0.0 110.443 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.511 ' O ' HG13 ' A' ' 70' ' ' VAL . 58.7 mtpt -145.78 164.16 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -171.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 9.3 mp -78.28 -2.72 39.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.69 -25.62 16.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.983 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -91.14 142.53 27.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.327 0.584 . . . . 0.0 110.842 -169.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.641 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 3.6 m -82.82 136.45 34.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.03 -172.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.52 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.67 -43.29 94.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.328 0.585 . . . . 0.0 110.117 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.9 p -72.69 -38.96 67.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.636 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 32' ' ' SER . 19.1 t70 -92.01 -60.65 1.8 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.896 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.05 -50.05 10.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.251 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.802 HD13 HG13 ' A' ' 22' ' ' ILE . 3.7 mm? -66.25 -28.12 68.48 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 t0 60.12 67.92 0.82 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.739 0.78 . . . . 0.0 109.873 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.6 OUTLIER -128.04 155.46 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.682 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 42.2 m-20 -103.95 168.15 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.455 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 34.0 t -49.4 -57.58 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.721 0.638 . . . . 0.0 111.38 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.81 -40.39 83.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.017 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.726 ' HB2' HG22 ' A' ' 39' ' ' VAL . 4.6 m -51.68 -53.81 34.95 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.855 0.36 . . . . 0.0 111.149 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.564 ' CE ' ' HA ' ' A' ' 65' ' ' LYS . 14.4 ptt? -65.7 -49.89 66.87 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.759 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.894 HG22 ' HB ' ' A' ' 64' ' ' VAL . 99.0 t -61.31 -23.3 29.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.088 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.92 -65.41 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.934 -0.479 . . . . 0.0 111.208 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.772 HG12 HG23 ' A' ' 15' ' ' ILE . 11.6 t -86.12 -25.17 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.893 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HA ' HG21 ' A' ' 15' ' ' ILE . 21.6 t -80.27 -20.17 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.659 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 2.7 t -77.71 -33.36 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.552 0.691 . . . . 0.0 109.233 166.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 47' ' ' VAL . . . -61.32 -19.9 62.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.399 0.618 . . . . 0.0 109.65 168.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.824 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -85.93 -33.39 21.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.966 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.754 ' O ' HG12 ' A' ' 57' ' ' VAL . 3.6 pt-20 -65.68 -50.85 63.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.585 -175.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.671 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 39.5 mt-10 -56.67 -37.53 70.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.44 -175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 15.3 ptp180 -72.2 -7.79 51.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.295 -174.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.56 10.47 21.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.589 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 63.22 39.28 9.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.643 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 52' ' ' GLU . 11.3 p -114.84 165.49 9.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.381 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 57' ' ' VAL . 61.2 tttp -126.97 111.27 13.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.309 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 tt -131.71 120.32 17.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.136 0.493 . . . . 0.0 110.539 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 59' ' ' ILE . 51.4 Cg_exo -56.8 148.78 64.25 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.038 2.492 . . . . 0.0 113.299 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.21 -47.24 65.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.05 -33.76 73.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.919 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -31.11 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.772 -174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.894 ' HB ' HG22 ' A' ' 45' ' ' VAL . 11.1 t -73.34 -42.26 57.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.564 ' HA ' ' CE ' ' A' ' 44' ' ' MET . 12.6 tmtt? -55.95 -40.62 73.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.921 171.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -76.5 -2.79 33.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -172.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 64' ' ' VAL . 4.6 pp -107.03 139.47 41.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.093 0.473 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -114.24 1.06 14.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.668 -172.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 28.5 p -128.52 153.42 47.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 172.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 28' ' ' LYS . 1.1 p -68.88 -21.79 25.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -70.9 -32.24 66.55 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.95 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 67' ' ' LEU . 13.1 m-20 -57.15 -51.21 70.22 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.796 0.332 . . . . 0.0 110.19 174.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.47 72.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.193 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.733 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -61.63 -53.1 60.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.686 -174.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.488 ' HD2' HD12 ' A' ' 78' ' ' LEU . 3.7 tptp -62.98 -31.77 72.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.616 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.56 -45.96 77.63 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.479 ' HA ' HG21 ' A' ' 57' ' ' VAL . 52.4 mt -63.66 -46.25 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.224 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.76 HD21 HG21 ' A' ' 8' ' ' ILE . 97.6 mt -61.07 -25.36 66.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.78 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.75 -40.3 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' C ' HG23 ' A' ' 57' ' ' VAL . 95.0 m-70 -101.49 21.31 14.47 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -171.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -89.75 161.25 16.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.049 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.185 171.754 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.757 0.313 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.8 128.05 48.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.131 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.94 117.89 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -81.31 -175.44 5.47 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -176.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.563 ' H ' HG22 ' A' ' 4' ' ' THR . 12.3 tt0 -47.24 -55.32 8.85 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -169.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.544 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.1 pm0 -71.52 -36.4 71.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.741 0.305 . . . . 0.0 111.524 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -70.73 -47.53 59.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 110.145 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.868 HG21 HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.76 -31.13 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.47 -39.71 85.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.01 97.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 110.402 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA3' ' HZ ' ' A' ' 55' ' ' PHE . . . -68.41 -43.12 79.74 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.705 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -61.74 -48.56 80.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.675 ' HA ' HG21 ' A' ' 27' ' ' VAL . . . -51.92 -50.09 61.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.366 0.603 . . . . 0.0 111.359 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.88 -30.64 71.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.784 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -86.58 -34.73 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.026 -177.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.812 HG11 HD12 ' A' ' 37' ' ' LEU . 15.7 t -69.62 -24.86 27.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.479 0.657 . . . . 0.0 109.449 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.07 -24.06 66.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB2' HG11 ' A' ' 47' ' ' VAL . 3.8 mm-40 -72.94 -21.38 60.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 47' ' ' VAL . 46.0 mt -93.56 -52.84 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.589 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.34 -88.58 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.1 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.363 -1.399 . . . . 0.0 114.907 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.788 HG13 HD13 ' A' ' 37' ' ' LEU . 14.6 mm -79.68 125.97 81.42 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 26' ' ' ASP . 10.5 Cg_endo -56.02 148.32 58.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.3 2.0 . . . . 0.0 111.307 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 32.7 m -62.67 -19.25 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 -175.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.83 -19.75 47.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 22' ' ' ILE . 40.8 t0 -98.88 -21.25 16.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.576 -171.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 13' ' ' ALA . 83.5 t -64.52 118.72 7.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.298 0.57 . . . . 0.0 110.826 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' O ' HG13 ' A' ' 70' ' ' VAL . 58.5 mtpt -147.55 172.65 13.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.985 -172.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.484 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 10.3 mp -80.81 -3.86 52.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.311 0.576 . . . . 0.0 110.044 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.432 ' OD1' ' HE2' ' A' ' 28' ' ' LYS . 1.5 m-20 -92.79 -23.01 19.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.501 -173.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -97.07 141.58 30.04 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.521 -169.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.763 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 27.4 m -82.37 136.28 35.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.618 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -60.54 -50.62 72.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.598 . . . . 0.0 110.104 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.4 p -65.43 -39.63 92.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.67 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 6.7 m-20 -91.99 -69.51 0.74 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.798 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 22' ' ' ILE . 4.0 m-20 -63.41 -49.71 72.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.682 -175.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.812 HD12 HG11 ' A' ' 16' ' ' VAL . 3.8 mm? -71.39 -9.85 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.28 -174.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.16 38.54 29.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.112 0.482 . . . . 0.0 110.238 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 43' ' ' SER . 0.3 OUTLIER -104.18 147.47 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.148 0.499 . . . . 0.0 111.319 -171.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.2 169.34 9.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.101 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.401 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 44.0 m -59.93 -45.73 91.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.559 0.537 . . . . 0.0 111.806 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.85 -46.99 64.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.524 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . 5.3 m -49.16 -57.11 7.24 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.733 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.414 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 7.9 ptm -57.38 -51.81 67.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.747 HG22 ' HB ' ' A' ' 64' ' ' VAL . 77.2 t -63.57 -24.46 35.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -176.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -75.28 -64.24 1.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.606 -0.684 . . . . 0.0 111.665 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.7 HG12 HG23 ' A' ' 15' ' ' ILE . 16.7 t -85.08 -23.67 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.166 -174.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 44' ' ' MET . 39.4 t -79.28 -27.09 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.433 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.71 ' HA ' ' HG2' ' A' ' 52' ' ' GLU . 5.2 t -70.83 -35.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.764 0.792 . . . . 0.0 109.025 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.33 -22.45 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 15' ' ' ILE . . . -85.14 -39.36 17.97 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.945 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.71 ' HG2' ' HA ' ' A' ' 49' ' ' VAL . 7.1 pt-20 -60.67 -48.23 82.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.405 0.621 . . . . 0.0 109.588 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 36.2 mt-10 -62.48 -36.81 83.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.789 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 12.9 ptp180 -76.71 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 111.179 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HZ ' ' HA3' ' A' ' 11' ' ' GLY . 63.2 m-85 -103.66 15.05 29.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 109.781 172.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 58.79 59.08 2.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.489 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 52' ' ' GLU . 10.4 p -143.96 160.62 15.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -134.15 112.36 11.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.195 0.522 . . . . 0.0 110.041 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 64' ' ' VAL . 18.2 pt -118.35 159.39 43.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 137.57 47.97 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.355 2.036 . . . . 0.0 111.838 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.53 -47.3 66.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -59.5 -32.25 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.277 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.29 -44.59 87.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.747 ' HB ' HG22 ' A' ' 45' ' ' VAL . 39.5 t -54.65 -42.17 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 110.453 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 2.1 tmtm? -77.3 -22.75 51.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.31 -37.9 51.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.422 -175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -72.58 137.76 46.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.825 0.821 . . . . 0.0 111.471 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -86.88 -28.78 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.671 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 18.7 p -117.63 154.23 31.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -63.75 -28.66 45.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 29' ' ' LEU . . . -64.58 -32.96 85.95 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.591 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 59.0 m-20 -60.8 -55.97 26.79 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.426 0.155 . . . . 0.0 110.586 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' H ' HD13 ' A' ' 67' ' ' LEU . . . -53.81 -52.65 59.64 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.318 0.58 . . . . 0.0 110.374 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.79 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 20.6 m -53.14 -51.3 62.4 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.769 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HD2' HD12 ' A' ' 78' ' ' LEU . 8.8 tptm -65.43 -36.23 83.31 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.728 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -66.61 -39.93 88.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.183 0.516 . . . . 0.0 109.755 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.58 HG23 HG11 ' A' ' 57' ' ' VAL . 71.3 mt -61.51 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 172.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.868 HD21 HG21 ' A' ' 8' ' ' ILE . 91.5 mt -65.21 -24.76 67.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.689 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -82.0 -51.06 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -92.29 11.52 25.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.155 -172.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.03 149.67 50.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 0.0 110.881 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.194 179.198 . . . . . . . . 0 0 . 1 stop_ save_